#MIM_Number	Location	Phenotype	Phenotype_MIM_number	Inheritance	Phenotype_mapping_key
100650	12q24.12	Alcohol sensitivity, acute	610251	AD	3
100650	12q24.12	{Esophageal cancer, alcohol-related, susceptibility to}	_	_	3
100650	12q24.12	{Hangover, susceptibility to}	610251	AD	3
100650	12q24.12	{Sublingual nitroglycerin, susceptibility to poor response to}	_	_	3
100050	_	_	_	_	_
100070	19q13	Aortic aneurysm, familial abdominal 1	100070	AD	2
100100	1q43	?Prune belly syndrome	100100	AR	3
100200	_	_	_	_	_
100300	3q13.32-q13.33	Adams-Oliver syndrome 1	100300	AD	3
100500	_	_	_	_	_
100600	_	_	_	_	_
100640	_	_	_	_	_
100660	_	_	_	_	_
100670	_	_	_	_	_
100675	_	_	_	_	_
100678	6q25.3	?ACAT2 deficiency	614055	IC	1
100680	_	_	_	_	_
100690	2q31.1	Multiple pterygium syndrome, lethal type	253290	AR	3
100690	2q31.1	Myasthenic syndrome, congenital, 1A, slow-channel	601462	AD	3
100690	2q31.1	Myasthenic syndrome, congenital, 1B, fast-channel	608930	AD,AR	3
100700	_	_	_	_	_
100710	17p13.1	?Myasthenic syndrome, congenital, 2C, associated with acetylcholine receptor deficiency	616314	AR	3
100710	17p13.1	Myasthenic syndrome, congenital, 2A, slow-channel	616313	AD	3
100720	2q37.1	?Myasthenic syndrome, congenital, 3A, slow-channel	616321	AD	3
100720	2q37.1	?Myasthenic syndrome, congenital, 3C, associated with acetylcholine receptor deficiency	616323	AR	3
100720	2q37.1	Multiple pterygium syndrome, lethal type	253290	AR	3
100720	2q37.1	Myasthenic syndrome, congenital, 3B, fast-channel	616322	AR	3
100725	17p13.2	Myasthenic syndrome, congenital, 4A, slow-channel	605809	AD,AR	3
100725	17p13.2	Myasthenic syndrome, congenital, 4B, fast-channel	616324	AR	3
100725	17p13.2	Myasthenic syndrome, congenital, 4C, associated with acetylcholine receptor deficiency	608931	AR	3
100730	2q37.1	Escobar syndrome	265000	AR	3
100730	2q37.1	Multiple pterygium syndrome, lethal type	253290	AR	3
100735	_	_	_	_	_
100740	7q22.1	[Blood group, Yt system]	112100	_	3
100790	12q23.2	Central hypoventilation syndrome, congenital	209880	AD	3
100790	12q23.2	Haddad syndrome	209880	AD	3
100800	4p16.3	Achondroplasia	100800	AD	3
100820	_	_	_	_	_
100850	22q13.2	?Optic atrophy 9	616289	AR	3
100850	22q13.2	Infantile cerebellar-retinal degeneration	614559	AR	3
100880	_	_	_	_	_
100900	_	_	_	_	_
101000	22q12.2	Neurofibromatosis, type 2	101000	AD	3
101120	_	_	_	_	_
101200	10q26.13	Apert syndrome	101200	AD	3
101400	_	_	_	_	_
101600	_	_	_	_	_
101800	17q24.2	Acrodysostosis 1, with or without hormone resistance	101800	AD	3
101805	_	_	_	_	_
101840	_	_	_	_	_
101850	2p25-p12	?Keratoderma, palmoplantar, punctate type 3	101850	AD	2
101900	12q24.11	Acrokeratosis verruciformis	101900	AD	3
102000	_	_	_	_	_
102100	_	_	_	_	_
102150	_	_	_	_	_
102200	_	_	_	_	_
102300	12q12-q21	{Restless legs syndrome 1}	102300	AD	2
102350	_	_	_	_	_
102370	15q21.1	Acromicric dysplasia	102370	AD	3
102400	_	_	_	_	_
102480	22q13.33	?Male infertility due to acrosin deficiency	102480	_	2
102490	_	_	_	_	_
102500	1p12	Hajdu-Cheney syndrome	102500	AD	3
102510	2q36	Acropectorovertebral dysplasia	102510	AD	2
102520	_	_	_	_	_
102525	_	_	_	_	_
102530	3q26.31	?Spermatogenic failure 6	102530	AR	3
102540	15q14	Atrial septal defect 5	612794	AD	3
102540	15q14	Cardiomyopathy, dilated, 1R	613424	AD	3
102540	15q14	Cardiomyopathy, hypertrophic, 11	612098	AD	3
102540	15q14	Left ventricular noncompaction 4	613424	AD	3
102545	2p13.1	Visceral myopathy	155310	AD	3
102550	_	_	_	_	_
102560	17q25.3	Baraitser-Winter syndrome 2	614583	AD	3
102560	17q25.3	Deafness, autosomal dominant 20/26	604717	AD	3
102565	7q32.1	Cardiomyopathy, familial hypertrophic, 26	_	_	3
102565	7q32.1	Cardiomyopathy, familial restrictive 5	617047	AD	3
102565	7q32.1	Myopathy, distal, 4	614065	AD	3
102565	7q32.1	Myopathy, myofibrillar, 5	609524	AD	3
102570	_	_	_	_	_
102573	1q43	Cardiomyopathy, dilated, 1AA, with or without LVNC	612158	AD	3
102573	1q43	Cardiomyopathy, hypertrophic, 23, with or without LVNC	612158	AD	3
102574	11q13.2	[Alpha-actinin-3 deficiency]	617749	_	3
102574	11q13.2	[Sprinting performance]	617749	_	3
102575	14q24.1	Bleeding disorder, platelet-type, 15	615193	AD	3
102576	2q24.1	Fibrodysplasia ossificans progressiva	135100	AD	3
102577	_	_	_	_	_
102578	15q24.1	Leukemia, acute promyelocytic, PML/RARA type	_	_	3
102579	4p14	Cerebellar ataxia, neuropathy, and vestibular areflexia syndrome	614575	AR	3
102581	_	_	_	_	_
102582	17q21.2	Autoimmune disease, multisystem, infantile-onset, 1	615952	AD	3
102582	17q21.2	Hyper-IgE recurrent infection syndrome	147060	AD	3
102590	_	_	_	_	_
102593	_	_	_	_	_
102595	_	_	_	_	_
102600	16q24.3	Adenine phosphoribosyltransferase deficiency	614723	AR	3
102610	1q42.13	?Myopathy, scapulohumeroperoneal	616852	AD	3
102610	1q42.13	Myopathy, actin, congenital, with cores	161800	AD,AR	3
102610	1q42.13	Myopathy, actin, congenital, with excess of thin myofilaments	161800	AD,AR	3
102610	1q42.13	Myopathy, congenital, with fiber-type disproportion 1	255310	AD,AR	3
102610	1q42.13	Nemaline myopathy 3, autosomal dominant or recessive	161800	AD,AR	3
102620	10q23.31	Aortic aneurysm, familial thoracic 6	611788	AD	3
102620	10q23.31	Moyamoya disease 5	614042	_	3
102620	10q23.31	Multisystemic smooth muscle dysfunction syndrome	613834	AD	3
102630	7p22.1	?Dystonia, juvenile-onset	607371	AD	3
102630	7p22.1	Baraitser-Winter syndrome 1	243310	AD	3
102640	_	_	_	_	_
102642	_	_	_	_	_
102645	_	_	_	_	_
102650	_	_	_	_	_
102660	_	_	_	_	_
102670	_	_	_	_	_
102680	4p16.3	{Hypertension, essential, salt-sensitive}	145500	Mu	3
102681	_	_	_	_	_
102699	_	_	_	_	_
102700	_	_	_	_	_
102710	_	_	_	_	_
102720	_	_	_	_	_
102730	_	_	_	_	_
102750	10q22.2	Hypermethioninemia due to adenosine kinase deficiency	614300	AR	3
102770	1p13.2	Myopathy due to myoadenylate deaminase deficiency	615511	AR	3
102771	1p13.3	?Spastic paraplegia 63	615686	AR	3
102771	1p13.3	Pontocerebellar hypoplasia, type 9	615809	AR	3
102772	11p15.4	[AMP deaminase deficiency, erythrocytic]	612874	AR	3
102775	_	_	_	_	_
102776	_	_	_	_	_
102777	_	_	_	_	_
102800	_	_	_	_	_
102900	1q22	Adenosine triphosphate, elevated, of erythrocytes	102900	AD	3
102910	_	_	_	_	_
102920	_	_	_	_	_
102930	_	_	_	_	_
102940	_	_	_	_	_
102970	_	_	_	_	_
102980	_	_	_	_	_
102981	_	_	_	_	_
102990	_	_	_	_	_
103000	9q34.11	Hemolytic anemia due to adenylate kinase deficiency	612631	AR	3
103020	1p35.1	Reticular dysgenesis	267500	AR	3
103030	_	_	_	_	_
103050	22q13.1	Adenylosuccinase deficiency	103050	AR	3
103060	_	_	_	_	_
103070	_	_	_	_	_
103071	_	_	_	_	_
103072	7p12.3	?Deafness, autosomal recessive 44	610154	AR	3
103100	_	_	_	_	_
103180	1q42.13	Periventricular nodular heterotopia 8	618185	AD	3
103188	_	_	_	_	_
103190	_	_	_	_	_
103195	_	_	_	_	_
103200	_	_	_	_	_
103220	4q35.1	Mitochondrial DNA depletion syndrome 12A (cardiomyopathic type) AD	617184	AD	3
103220	4q35.1	Mitochondrial DNA depletion syndrome 12B (cardiomyopathic type) AR	615418	AR	3
103220	4q35.1	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 2	609283	AD	3
103230	_	_	_	_	_
103260	_	_	_	_	_
103270	17q25.1	Auditory neuropathy and optic atrophy	617717	AR	3
103275	_	_	_	_	_
103280	11p15.5	Beckwith-Wiedemann syndrome	130650	AD	3
103280	11p15.5	Silver-Russell syndrome	180860	AD	3
103280	11p15.5	Wilms tumor 2	194071	AD,SMu	3
103285	3q28	ADULT syndrome	103285	AD	3
103300	_	_	_	_	_
103320	1p36.33	Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects	615120	AR	3
103321	_	_	_	_	_
103390	_	_	_	_	_
103400	_	_	_	_	_
103420	_	_	_	_	_
103470	_	_	_	_	_
103500	3p13	Tietz albinism-deafness syndrome	103500	AD	3
103580	20q13.32	Pseudohypoparathyroidism Ia	103580	AD	3
103581	_	_	_	_	_
103600	4q13.3	Analbuminemia	616000	_	3
103600	4q13.3	[Dysalbuminemic hyperthyroxinemia]	615999	_	3
103700	_	_	_	_	_
103710	_	_	_	_	_
103720	4q23	{Aerodigestive tract cancer, squamous cell, alcohol-related, protection against}	103780	Mu	3
103720	4q23	{Alcohol dependence, protection against}	103780	Mu	3
103730	4q23	{Alcohol dependence, protection against}	103780	Mu	3
103730	4q23	{Parkinson disease, susceptibility to}	168600	AD,Mu	3
103735	_	_	_	_	_
103740	_	_	_	_	_
103780	_	_	_	_	_
103800	_	_	_	_	_
103830	_	_	_	_	_
103850	16p11.2	Glycogen storage disease XII	611881	AR	3
103870	_	_	_	_	_
103880	_	_	_	_	_
103890	_	_	_	_	_
103900	8q24.3	Aldosteronism, glucocorticoid-remediable	103900	AD	3
103920	_	_	_	_	_
103950	12p13.31	Alpha-2-macroglobulin deficiency	614036	AD	1
103950	12p13.31	{Alzheimer disease, susceptibility to}	104300	AD	3
104000	18p11.3-p11.2	Alopecia areata 1	104000	Mu	2
104100	6q22.31	Palmoplantar keratoderma with congenital alopecia	104100	AD	3
104110	_	_	_	_	_
104130	_	_	_	_	_
104145	_	_	_	_	_
104150	4q13.3	Alpha-fetoprotein deficiency	615969	AR	3
104150	4q13.3	[Hereditary persistence of alpha-fetoprotein]	615970	AD	3
104155	16q22.2-q22.3	Prostate cancer, somatic	176807	_	3
104160	11q12.3	Polycystic kidney disease 3	600666	AD	3
104170	22q13.2	Kanzaki disease	609242	AR	3
104170	22q13.2	Schindler disease, type I	609241	AR	3
104170	22q13.2	Schindler disease, type III	609241	AR	3
104175	_	_	_	_	_
104180	_	_	_	_	_
104200	2q36.3	Alport syndrome 3, autosomal dominant	104200	AD	3
104210	_	_	_	_	_
104219	_	_	_	_	_
104220	_	_	_	_	_
104221	_	_	_	_	_
104222	_	_	_	_	_
104225	4p16.3	Myopia 23, autosomal recessive	615431	AR	3
104230	_	_	_	_	_
104240	_	_	_	_	_
104250	4p16.3	{Congestive heart failure and beta-blocker response, modifier of}	_	_	3
104260	2q11.2	Epilepsy, myoclonic, familial adult, 2	607876	AD	3
104290	1q23.2	Alternating hemiplegia of childhood 1	104290	AD	3
104300	_	_	_	_	_
104310	19q13.32	Alzheimer disease-2	104310	AD	3
104311	14q24.2	?Acne inversa, familial, 3	613737	AD	3
104311	14q24.2	Alzheimer disease, type 3	607822	AD	3
104311	14q24.2	Alzheimer disease, type 3, with spastic paraparesis and apraxia	607822	AD	3
104311	14q24.2	Alzheimer disease, type 3, with spastic paraparesis and unusual plaques	607822	AD	3
104311	14q24.2	Cardiomyopathy, dilated, 1U	613694	AD	3
104311	14q24.2	Dementia, frontotemporal	600274	AD	3
104311	14q24.2	Pick disease	172700	AD	3
104350	_	_	_	_	_
104400	_	_	_	_	_
104500	4q13.3	Amelogenesis imperfecta, type IB	104500	AD	3
104510	17q21.33	Amelogenesis imperfecta, type IV	104510	AD	3
104530	1q32.2	Amelogenesis imperfecta, type IA	104530	AD	3
104570	_	_	_	_	_
104600	_	_	_	_	_
104610	_	_	_	_	_
104613	_	_	_	_	_
104614	2p21	Cystinuria	220100	AD,AR	3
104615	_	_	_	_	_
104620	3p21.2	Aminoacylase 1 deficiency	609924	AR	3
104640	_	_	_	_	_
104650	_	_	_	_	_
104660	_	_	_	_	_
104700	_	_	_	_	_
104701	_	_	_	_	_
104702	_	_	_	_	_
104740	_	_	_	_	_
104750	_	_	_	_	_
104751	_	_	_	_	_
104752	_	_	_	_	_
104760	21q21.3	Alzheimer disease 1, familial	104300	AD	3
104760	21q21.3	Cerebral amyloid angiopathy, Dutch, Italian, Iowa, Flemish, Arctic variants	605714	AD	3
104770	1q23.2	{?Amyloidosis, secondary, susceptibility to}	_	_	1
104775	_	_	_	_	_
104776	_	_	_	_	_
105120	9q33.2	Amyloidosis, Finnish type	105120	AD	3
105150	20p11.21	Cerebral amyloid angiopathy	105150	AD	3
105200	_	_	_	_	_
105210	18q12.1	Amyloidosis, hereditary, transthyretin-related	105210	AD	3
105250	5p13.1	Amyloidosis, primary localized cutaneous, 1	105250	AD	3
105300	_	_	_	_	_
105400	_	_	_	_	_
105500	15q21.2	{Amyotrophic lateral sclerosis-parkinsonism/dementia complex, susceptibility to}	105500	AD	3
105550	9p21.2	Frontotemporal dementia and/or amyotrophic lateral sclerosis 1	105550	AD	3
105563	_	_	_	_	_
105565	_	_	_	_	_
105570	_	_	_	_	_
105580	11q22-qter	?Anal canal carcinoma	105580	AD	2
105590	2p23.2-p23.1	{Neuroblastoma, susceptibility to, 3}	613014	_	3
105600	15q21	Dyserythropoietic anemia, congenital, type III	105600	AD	2
105650	19q13.2	Diamond-Blackfan anemia 1	105650	AD	3
105800	7q11.2	Aneurysm, intracranial berry, 1	105800	AD	2
105805	_	_	_	_	_
105830	15q11.2	Angelman syndrome	105830	AD	3
105835	_	_	_	_	_
105850	14q11.2	Amyotrophic lateral sclerosis 9	611895	_	3
106050	_	_	_	_	_
106070	_	_	_	_	_
106100	11q12.1	Angioedema, hereditary, types I and II	106100	AD,AR	3
106150	1q42.2	Renal tubular dysgenesis	267430	AR	3
106150	1q42.2	{Hypertension, essential, susceptibility to}	145500	Mu	3
106150	1q42.2	{Preeclampsia, susceptibility to}	_	_	3
106160	_	_	_	_	_
106165	3q24	Renal tubular dysgenesis	267430	AR	3
106165	3q24	{Hypertension, essential}	145500	Mu	3
106180	17q23.3	Renal tubular dysgenesis	267430	AR	3
106180	17q23.3	[Angiotensin I-converting enzyme, benign serum increase]	_	_	3
106180	17q23.3	{Microvascular complications of diabetes 3}	612624	_	3
106180	17q23.3	{Myocardial infarction, susceptibility to}	_	_	3
106180	17q23.3	{SARS, progression of}	_	_	3
106180	17q23.3	{Stroke, hemorrhagic}	614519	_	3
106190	12p11.23	?Anhidrosis, isolated, with normal sweat glands	106190	AR	3
106195	_	_	_	_	_
106200	_	_	_	_	_
106210	_	_	_	_	_
106220	_	_	_	_	_
106230	_	_	_	_	_
106240	_	_	_	_	_
106250	_	_	_	_	_
106260	3q28	Hay-Wells syndrome	106260	AD	3
106280	_	_	_	_	_
106300	6p21.33	{Spondyloarthropathy, susceptibility to, 1}	106300	Mu	3
106400	_	_	_	_	_
106410	4q25-q26	Cardiac arrhythmia, ankyrin-B-related	600919	AD	3
106410	4q25-q26	Long QT syndrome 4	600919	AD	3
106490	_	_	_	_	_
106491	_	_	_	_	_
106500	_	_	_	_	_
106600	4p16.2	Tooth agenesis, selective, 1, with or without orofacial cleft	106600	AD	3
106700	4q12	Total anomalous pulmonary venous return	106700	AD	2
106750	_	_	_	_	_
106900	_	_	_	_	_
106990	_	_	_	_	_
106995	_	_	_	_	_
107000	_	_	_	_	_
107100	_	_	_	_	_
107200	18p11.23-q12.2	Anosmia, isolated congenital	107200	AD	2
107240	_	_	_	_	_
107250	10q24.32	Anterior segment dysgenesis 1, multiple subtypes	107250	AD	3
107253	_	_	_	_	_
107254	_	_	_	_	_
107257	_	_	_	_	_
107260	_	_	_	_	_
107265	16p11.2	Immunodeficiency, common variable, 3	613493	AR	3
107266	_	_	_	_	_
107269	11p13	[Blood group, Indian system]	609027	_	3
107270	_	_	_	_	_
107271	11p13	Hemolytic anemia, CD59-mediated, with or without immune-mediated polyneuropathy	612300	AR	3
107272	_	_	_	_	_
107273	_	_	_	_	_
107280	14q32.13	Alpha-1-antichymotrypsin deficiency	_	_	3
107280	14q32.13	Cerebrovascular disease, occlusive	_	_	3
107285	_	_	_	_	_
107290	_	_	_	_	_
107300	1q25.1	Thrombophilia due to antithrombin III deficiency	613118	AD,AR	3
107310	1p36.11	?Lichtenstein-Knorr syndrome	616291	AR	3
107320	6p21.3	?Antiphospholipid syndrome, familial	107320	AD	2
107323	5q23.2	Epilepsy, pyridoxine-dependent	266100	AR	3
107325	_	_	_	_	_
107400	14q32.13	Emphysema due to AAT deficiency	613490	AR	3
107400	14q32.13	Emphysema-cirrhosis, due to AAT deficiency	613490	AR	3
107400	14q32.13	Hemorrhagic diathesis due to antithrombin Pittsburgh	613490	AR	3
107400	14q32.13	{Pulmonary disease, chronic obstructive, susceptibility to}	606963	_	1
107410	_	_	_	_	_
107440	_	_	_	_	_
107450	_	_	_	_	_
107460	_	_	_	_	_
107470	6q23.3	Immunodeficiency 27A, mycobacteriosis, AR	209950	AR	3
107470	6q23.3	Immunodeficiency 27B, mycobacteriosis, AD	615978	AD	3
107470	6q23.3	{H. pylori infection, susceptibility to}	600263	_	3
107470	6q23.3	{Hepatitis B virus infection, susceptibility to}	610424	_	3
107470	6q23.3	{Tuberculosis infection, protection against}	607948	_	3
107470	6q23.3	{Tuberculosis, susceptibility to}	607948	_	3
107480	_	_	_	_	_
107500	_	_	_	_	_
107550	_	_	_	_	_
107580	6p24.3	Branchiooculofacial syndrome	113620	AD	3
107600	10q11.21	?Aplasia cutis congenita, nonsyndromic	107600	AD	3
107601	_	_	_	_	_
107640	_	_	_	_	_
107650	_	_	_	_	_
107670	1q23.3	Apolipoprotein A-II deficiency	_	_	3
107670	1q23.3	{Hypercholesterolemia, familial, modifier of}	143890	AD	3
107680	11q23.3	Amyloidosis, 3 or more types	105200	AD	3
107680	11q23.3	ApoA-I and apoC-III deficiency, combined	_	_	3
107680	11q23.3	Corneal clouding, autosomal recessive	_	_	3
107680	11q23.3	Hypoalphalipoproteinemia	604091	_	3
107690	_	_	_	_	_
107700	_	_	_	_	_
107710	_	_	_	_	_
107720	11q23.3	Apolipoprotein C-III deficiency	614028	_	3
107730	2p24.1	Hypercholesterolemia, familial, 2	144010	AD	3
107730	2p24.1	Hypobetalipoproteinemia	615558	AR	3
107740	_	_	_	_	_
107741	19q13.32	Alzheimer disease-2	104310	AD	3
107741	19q13.32	Hyperlipoproteinemia, type III	617347	_	3
107741	19q13.32	Lipoprotein glomerulopathy	611771	_	3
107741	19q13.32	Sea-blue histiocyte disease	269600	AR	3
107741	19q13.32	{?Macular degeneration, age-related}	603075	AD	3
107741	19q13.32	{Coronary artery disease, severe, susceptibility to}	617347	_	3
107748	_	_	_	_	_
107750	_	_	_	_	_
107760	_	_	_	_	_
107770	12q13.3	?Keratosis pilaris atrophicans	604093	AR	3
107773	15q26.2	Congenital heart defects, multiple types, 4	615779	AD	3
107776	7p14.3	[Aquaporin-1 deficiency]	110450	_	3
107776	7p14.3	[Blood group, Colton]	110450	_	3
107777	12q13.12	Diabetes insipidus, nephrogenic	125800	AD,AR	3
107800	_	_	_	_	_
107820	5q34	Leukodystrophy, hypomyelinating, 9	616140	AR	3
107830	_	_	_	_	_
107840	_	_	_	_	_
107850	_	_	_	_	_
107900	_	_	_	_	_
107910	15q21.2	Aromatase deficiency	613546	_	3
107910	15q21.2	Aromatase excess syndrome	139300	AD	3
107920	_	_	_	_	_
107930	7p12.2-p12.1	Aromatic L-amino acid decarboxylase deficiency	608643	AR	3
107940	_	_	_	_	_
107941	_	_	_	_	_
107950	_	_	_	_	_
107970	14q24.3	Arrhythmogenic right ventricular dysplasia 1	107970	AD	3
108000	_	_	_	_	_
108010	_	_	_	_	_
108050	_	_	_	_	_
108100	_	_	_	_	_
108110	_	_	_	_	_
108120	_	_	_	_	_
108130	_	_	_	_	_
108140	_	_	_	_	_
108145	18p11.22-p11.21	Arthrogryposis, distal, type 5	108145	AD	3
108200	_	_	_	_	_
108300	12q13.11	Stickler syndrome, type I	108300	AD	3
108320	_	_	_	_	_
108330	_	_	_	_	_
108340	_	_	_	_	_
108345	_	_	_	_	_
108355	_	_	_	_	_
108360	_	_	_	_	_
108361	_	_	_	_	_
108370	7q21.3	Asparagine synthetase deficiency	615574	AR	3
108390	_	_	_	_	_
108400	_	_	_	_	_
108410	_	_	_	_	_
108420	Chr.1	Spermatogenic failure 2	108420	AD	2
108450	_	_	_	_	_
108500	19p13.13	Episodic ataxia, type 2	108500	AD	3
108600	12p13.31	Spastic ataxia 1, autosomal dominant	108600	AD	3
108650	_	_	_	_	_
108700	_	_	_	_	_
108720	3p14.3	Atelosteogenesis, type I	108720	AD	3
108721	3p14.3	Atelosteogenesis, type III	108721	AD	3
108725	19p13.3-p13.2	{Atherosclerosis, susceptibility to}	108725	AD	2
108728	_	_	_	_	_
108729	_	_	_	_	_
108730	16p11.2	Brody myopathy	601003	AR	3
108731	_	_	_	_	_
108732	_	_	_	_	_
108733	3p25.3	{Deafness, autosomal recessive 12, modifier of}	601386	AR	3
108740	12q24.11	Acrokeratosis verruciformis	101900	AD	3
108740	12q24.11	Darier disease	124200	AD	3
108745	_	_	_	_	_
108746	22q11.21	Cutis laxa, autosomal recessive, type IIC	617402	AR	3
108760	_	_	_	_	_
108770	1q21.2	Atrial standstill, digenic (GJA5/SCN5A)	108770	AD	3
108780	1p36.22	Atrial fibrillation, familial, 6	612201	AD	3
108780	1p36.22	Atrial standstill 2	615745	AR	3
108800	5p	Atrial septal defect 1	108800	AD	2
108900	5q35.1	Atrial septal defect 7, with or without AV conduction defects	108900	AD	3
108950	_	_	_	_	_
108960	_	_	_	_	_
108961	9p13.3	Acromesomelic dysplasia, Maroteaux type	602875	AR	3
108961	9p13.3	Epiphyseal chondrodysplasia, Miura type	615923	AD	3
108961	9p13.3	Short stature with nonspecific skeletal abnormalities	616255	AD	3
108962	5p13.3	?Hypertension, salt-resistant	_	_	1
108970	_	_	_	_	_
108980	_	_	_	_	_
108985	11p15.3	Sveinsson chorioretinal atrophy	108985	AD	3
108990	_	_	_	_	_
109000	_	_	_	_	_
109050	_	_	_	_	_
109090	_	_	_	_	_
109091	19p13.13	Myelofibrosis, somatic	254450	_	3
109091	19p13.13	Thrombocythemia, somatic	187950	_	3
109092	_	_	_	_	_
109100	_	_	_	_	_
109110	_	_	_	_	_
109120	_	_	_	_	_
109130	_	_	_	_	_
109135	_	_	_	_	_
109150	14q32.12	Machado-Joseph disease	109150	AD	3
109160	_	_	_	_	_
109170	_	_	_	_	_
109180	_	_	_	_	_
109190	_	_	_	_	_
109195	_	_	_	_	_
109200	3q26	Alopecia, androgenetic, 1	109200	AD	2
109270	17q21.31	Cryohydrocytosis	185020	AD	3
109270	17q21.31	Ovalocytosis, SA type	166900	AD	3
109270	17q21.31	Renal tubular acidosis, distal, AD	179800	AD	3
109270	17q21.31	Renal tubular acidosis, distal, AR	611590	AR	3
109270	17q21.31	Spherocytosis, type 4	612653	AD	3
109270	17q21.31	[Blood group, Diego]	110500	_	3
109270	17q21.31	[Blood group, Froese]	601551	_	3
109270	17q21.31	[Blood group, Swann]	601550	_	3
109270	17q21.31	[Blood group, Waldner]	112010	_	3
109270	17q21.31	[Blood group, Wright]	112050	_	3
109270	17q21.31	[Malaria, resistance to]	611162	_	3
109280	_	_	_	_	_
109300	_	_	_	_	_
109350	13q14	Gastroesophageal reflux	109350	AD	2
109390	_	_	_	_	_
109400	_	_	_	_	_
109480	19p13.3	[Blood group, OK]	111380	_	3
109500	_	_	_	_	_
109530	_	_	_	_	_
109535	20q13.12	Immunodeficiency with hyper-IgM, type 3	606843	AR	3
109540	_	_	_	_	_
109543	13q14	{Leukemia, chronic lymphocytic, susceptibility to, 2}	109543	AD	2
109545	_	_	_	_	_
109560	19q13.32	Leukemia/lymphoma, B-cell, 3	109560	_	2
109565	3q27.3	Lymphoma, B-cell	109565	_	2
109580	_	_	_	_	_
109600	_	_	_	_	_
109610	_	_	_	_	_
109630	10q25.3	[Resting heart rate]	607276	_	3
109630	10q25.3	{Congestive heart failure and beta-blocker response, modifier of}	_	_	3
109635	_	_	_	_	_
109636	_	_	_	_	_
109640	_	_	_	_	_
109650	_	_	_	_	_
109660	_	_	_	_	_
109670	_	_	_	_	_
109675	_	_	_	_	_
109684	_	_	_	_	_
109685	_	_	_	_	_
109690	5q32	Beta-2-adrenoreceptor agonist, reduced response to	_	_	3
109690	5q32	{Asthma, nocturnal, susceptibility to}	600807	AD	3
109690	5q32	{Obesity, susceptibility to}	601665	AD,AR,Mu	3
109691	8p11.23	{Obesity, susceptibility to}	601665	AD,AR,Mu	3
109700	15q21.1	?Amyloidosis, familial visceral	105200	AD	3
109700	15q21.1	Immunodeficiency 43	241600	AR	3
109710	_	_	_	_	_
109715	_	_	_	_	_
109720	3p12-q13.2	Biliary cirrhosis, primary, 1	109720	AD	2
109730	9q34.3	Aortic valve disease 1	109730	AD	3
109740	_	_	_	_	_
109750	7p13	Hyperbiliverdinemia	614156	AD,AR	3
109760	5q12.3	Periodic fever, menstrual cycle dependent	614674	AD	3
109770	_	_	_	_	_
109780	_	_	_	_	_
109800	_	_	_	_	_
109820	_	_	_	_	_
109900	_	_	_	_	_
110000	_	_	_	_	_
110050	_	_	_	_	_
110100	_	_	_	_	_
110150	_	_	_	_	_
110250	_	_	_	_	_
110300	9q34.2	[Blood group, ABO system]	616093	_	3
110310	_	_	_	_	_
110350	_	_	_	_	_
110450	_	_	_	_	_
110500	17q21.31	[Blood group, Diego]	110500	_	3
110600	12p12.3	[Blood group, Dombrock]	616060	_	3
110700	1q23.2	[Blood group, Duffy system]	110700	AD,AR	3
110720	_	_	_	_	_
110750	2q14.3	[Blood group, Gerbich]	616089	_	3
110750	2q14.3	{Malaria, resistance to}	611162	_	3
110800	_	_	_	_	_
110900	7q34	[Blood group, Kell]	110900	_	3
111000	18q12.3	[Blood group, Kidd]	111000	_	3
111100	19p13.3	[Blood group, Lewis]	_	_	3
111130	_	_	_	_	_
111150	19p13.13	Blood group--Lutheran inhibitor	111150	_	3
111200	_	_	_	_	_
111250	19p13.2	[Blood group, Landsteiner-Wiener]	111250	_	3
111300	4q31.21	[Blood group, MNSs system]	111300	_	3
111360	_	_	_	_	_
111380	19p13.3	[Blood group, OK]	111380	_	3
111400	_	_	_	_	_
111410	_	_	_	_	_
111500	_	_	_	_	_
111600	2q35	[Blood group, Langereis system]	111600	_	3
111620	1p34.2	[Blood group, Radin]	111620	_	3
111680	1p36.11	[Rh-negative blood type]	_	_	3
111690	_	_	_	_	_
111700	1p36.11	Rh-null disease, amorph type	617970	_	3
111700	1p36.11	[Blood group, Rhesus]	_	_	3
111730	_	_	_	_	_
111740	4q31.21	[Blood group, Ss]	111740	_	3
111750	1p34.2	[Blood group, Scianna system]	111750	_	3
111800	4q28-q31	[Blood group, Stoltzfus system]	111800	_	2
112000	_	_	_	_	_
112010	17q21.31	[Blood group, Waldner]	112010	_	3
112050	17q21.31	[Blood group, Wright]	112050	_	3
112100	7q22.1	[Blood group, Yt system]	112100	_	3
112200	_	_	_	_	_
112203	_	_	_	_	_
112205	19q13.2	Agammaglobulinemia 3	613501	AR	3
112210	11q12.2	Immunodeficiency, common variable, 5	613495	AR	3
112240	17q25.3	Cole-Carpenter syndrome 1	112240	AD	3
112250	9p21.3	Diaphyseal medullary stenosis with malignant fibrous histiocytoma	112250	AD	3
112260	_	_	_	_	_
112261	20p12.3	Brachydactyly, type A2	112600	AD	3
112261	20p12.3	Short stature, facial dysmorphism, and skeletal anomalies with or without cardiac anomalies	617877	AD	3
112261	20p12.3	{HFE hemochromatosis, modifier of}	235200	AR	3
112262	14q22.2	Microphthalmia, syndromic 6	607932	AD	3
112262	14q22.2	Orofacial cleft 11	600625	_	3
112263	_	_	_	_	_
112264	8p21.3	Osteogenesis imperfecta, type XIII	614856	AR	3
112265	_	_	_	_	_
112266	_	_	_	_	_
112267	_	_	_	_	_
112270	_	_	_	_	_
112300	_	_	_	_	_
112310	3p14.3	Boomerang dysplasia	112310	AD	3
112350	_	_	_	_	_
112370	_	_	_	_	_
112410	12p12.2	Hypertension and brachydactyly syndrome	112410	AD	3
112430	_	_	_	_	_
112440	_	_	_	_	_
112450	_	_	_	_	_
112500	2q35	Brachydactyly, type A1	112500	AD	3
112600	_	_	_	_	_
112700	_	_	_	_	_
112800	_	_	_	_	_
112900	_	_	_	_	_
112910	_	_	_	_	_
113000	9q22.31	Brachydactyly, type B1	113000	AD	3
113100	20q11.22	Brachydactyly, type C	113100	AD	3
113200	2q31.1	Brachydactyly, type D	113200	AD	3
113300	2q31.1	Brachydactyly, type E	113300	AD	3
113301	_	_	_	_	_
113310	_	_	_	_	_
113400	_	_	_	_	_
113450	_	_	_	_	_
113470	_	_	_	_	_
113475	_	_	_	_	_
113477	_	_	_	_	_
113480	_	_	_	_	_
113500	12q24.11	Brachyolmia type 3	113500	AD	3
113503	_	_	_	_	_
113505	_	_	_	_	_
113508	_	_	_	_	_
113510	_	_	_	_	_
113520	12p12.1	?Hyperleucinemia-isoleucinemia or hypervalinemia	_	_	1
113530	19q13.33	?Hypervalinemia or hyperleucine-isoleucinemia	_	_	1
113600	_	_	_	_	_
113610	_	_	_	_	_
113620	6p24.3	Branchiooculofacial syndrome	113620	AD	3
113630	_	_	_	_	_
113640	_	_	_	_	_
113650	8q13.3	Branchiootorenal syndrome 1, with or without cataracts	113650	AD	3
113660	_	_	_	_	_
113670	_	_	_	_	_
113700	_	_	_	_	_
113703	_	_	_	_	_
113705	17q21.31	Fanconi anemia, complementation group S	617883	AR	3
113705	17q21.31	{Breast-ovarian cancer, familial, 1}	604370	AD,Mu	3
113705	17q21.31	{Pancreatic cancer, susceptibility to, 4}	614320	_	3
113710	_	_	_	_	_
113720	_	_	_	_	_
113721	17p13.3	Breast cancer	_	_	1
113725	_	_	_	_	_
113730	_	_	_	_	_
113750	_	_	_	_	_
113800	_	_	_	_	_
113810	6p12.1	?Neuropathy, hereditary sensory and autonomic, type VI	614653	AR	3
113810	6p12.1	Epidermolysis bullosa simplex, autosomal recessive 2	615425	AR	3
113811	10q25.1	Epidermolysis bullosa, junctional, localisata variant	226650	AR	3
113811	10q25.1	Epidermolysis bullosa, junctional, non-Herlitz type	226650	AR	3
113811	10q25.1	Epithelial recurrent erosion dystrophy	122400	AD	3
113900	_	_	_	_	_
113950	_	_	_	_	_
113955	_	_	_	_	_
113960	_	_	_	_	_
113970	8q24.21	Burkitt lymphoma, somatic	113970	_	3
113995	_	_	_	_	_
114000	17q21.33	Caffey disease	114000	AD	3
114010	2p23.3	Epileptic encephalopathy, early infantile, 50	616457	AR	3
114019	16q24.3	Mental retardation, autosomal dominant 3	612580	_	3
114020	_	_	_	_	_
114021	16q22.1	Ectodermal dysplasia, ectrodactyly, and macular dystrophy	225280	AR	3
114021	16q22.1	Hypotrichosis, congenital, with juvenile macular dystrophy	601553	AR	3
114025	2p12	Cortical dysplasia, complex, with other brain malformations 9	618174	AR	3
114030	_	_	_	_	_
114050	_	_	_	_	_
114051	_	_	_	_	_
114065	_	_	_	_	_
114070	_	_	_	_	_
114078	5q32	?Mental retardation, autosomal recessive 63	618095	AR	3
114078	5q32	Mental retardation, autosomal dominant 53	617798	AD	3
114080	_	_	_	_	_
114085	_	_	_	_	_
114090	5q15	Peeling skin with leukonychia, acral punctate keratoses, cheilitis, and knuckle pads	616295	AR	3
114100	_	_	_	_	_
114105	4q24	Arthrogryposis, cleft palate, craniosynostosis, and impaired intellectual development	618265	AD	3
114105	4q24	Epileptic encephalopathy, infantile or early childhood, 1	617711	AD	3
114106	_	_	_	_	_
114107	_	_	_	_	_
114110	_	_	_	_	_
114120	_	_	_	_	_
114130	_	_	_	_	_
114131	7q21.3	{Osteoporosis, postmenopausal, susceptibility}	166710	AD	3
114140	_	_	_	_	_
114150	_	_	_	_	_
114160	_	_	_	_	_
114170	_	_	_	_	_
114180	14q32.11	Long QT syndrome 14	616247	AD	3
114180	14q32.11	Ventricular tachycardia, catecholaminergic polymorphic, 4	614916	AD	3
114181	_	_	_	_	_
114182	2p21	Long QT syndrome 15	616249	AD	3
114183	_	_	_	_	_
114184	_	_	_	_	_
114190	_	_	_	_	_
114200	3q11.2-q13.12	Camptodactyly 1	114200	AD	2
114204	_	_	_	_	_
114205	12p13.33	Brugada syndrome 3	611875	_	3
114205	12p13.33	Long QT syndrome 8	618447	_	3
114205	12p13.33	Timothy syndrome	601005	AD	3
114206	3p21.1	Primary aldosteronism, seizures, and neurologic abnormalities	615474	AD	3
114206	3p21.1	Sinoatrial node dysfunction and deafness	614896	AR	3
114207	_	_	_	_	_
114208	1q32.1	Hypokalemic periodic paralysis, type 1	170400	AD	3
114208	1q32.1	{Malignant hyperthermia susceptibility 5}	601887	AD	3
114208	1q32.1	{Thyrotoxic periodic paralysis, susceptibility to, 1}	188580	AD	3
114209	_	_	_	_	_
114210	_	_	_	_	_
114212	_	_	_	_	_
114213	_	_	_	_	_
114217	_	_	_	_	_
114220	11q13.1	Spastic paraplegia 76, autosomal recessive	616907	AR	3
114230	_	_	_	_	_
114240	15q15.1	Muscular dystrophy, limb-girdle, autosomal dominant 4	618129	AD	3
114240	15q15.1	Muscular dystrophy, limb-girdle, autosomal recessive 1	253600	AR	3
114250	1q23.2	Myopathy, vacuolar, with CASQ1 aggregates	616231	AD	3
114251	1p13.1	Ventricular tachycardia, catecholaminergic polymorphic, 2	611938	AR	3
114260	_	_	_	_	_
114280	_	_	_	_	_
114290	_	_	_	_	_
114300	18p11.22-p11.21	Arthrogryposis, distal, type 3	114300	AD	3
114350	9q34.13	Leukemia, acute myeloid, somatic	601626	_	3
114350	9q34.13	Leukemia, T-cell acute lymphoblastic, somatic	613065	_	3
114350	9q34.13	{Encephalopathy, acute, infection-induced, suseptibility to, 9}	618426	AR	3
114400	_	_	_	_	_
114450	_	_	_	_	_
114480	_	_	_	_	_
114500	_	_	_	_	_
114550	_	_	_	_	_
114580	2p22.3-p21	Candidiasis, familial, 1, autosomal dominant	114580	AD	2
114600	_	_	_	_	_
114610	_	_	_	_	_
114620	_	_	_	_	_
114650	_	_	_	_	_
114700	_	_	_	_	_
114750	_	_	_	_	_
114760	17q23.1	Retinitis pigmentosa 17	600852	AD	3
114761	16q24.2	Hyperammonemia due to carbonic anhydrase VA deficiency	615751	AR	3
114770	_	_	_	_	_
114780	_	_	_	_	_
114800	_	_	_	_	_
114815	8q12.1	Cerebellar ataxia and mental retardation with or without quadrupedal locomotion 3	613227	AR	3
114830	_	_	_	_	_
114835	16q12.2	Drug metabolism, altered, CES1-related	618057	_	3
114836	_	_	_	_	_
114840	9q34.13	Maturity-onset diabetes of the young, type VIII	609812	AD	3
114841	_	_	_	_	_
114850	_	_	_	_	_
114851	_	_	_	_	_
114852	_	_	_	_	_
114855	_	_	_	_	_
114860	_	_	_	_	_
114890	_	_	_	_	_
114900	_	_	_	_	_
115000	_	_	_	_	_
115080	17p11.2	{Cardiac conduction defect, susceptibility to}	115080	AD	3
115150	7q34	Cardiofaciocutaneous syndrome	115150	AD	3
115195	1q32.1	Cardiomyopathy, hypertrophic, 2	115195	AD	3
115196	15q22.2	Cardiomyopathy, hypertrophic, 3	115196	AD	3
115197	11p11.2	Cardiomyopathy, hypertrophic, 4	115197	AD	3
115198	_	_	_	_	_
115200	1q22	Cardiomyopathy, dilated, 1A	115200	AD	3
115210	19q13.42	Cardiomyopathy, familial restrictive, 1	115210	AD	3
115250	_	_	_	_	_
115300	16q23.2	?Hypercarotenemia and vitamin A deficiency, autosomal dominant	115300	AD	3
115310	1p36.13	Paragangliomas 4	115310	AD	3
115400	_	_	_	_	_
115430	18q12.1	Carpal tunnel syndrome, familial	115430	AD	3
115435	_	_	_	_	_
115437	_	_	_	_	_
115440	20p13	Okur-Chung neurodevelopmental syndrome	617062	AD	3
115441	_	_	_	_	_
115442	_	_	_	_	_
115450	_	_	_	_	_
115460	_	_	_	_	_
115470	22q11	Cat eye syndrome	115470	AD	4
115500	11p13	Acatalasemia	614097	_	3
115501	9p23	Albinism, oculocutaneous, type III	203290	AR	3
115501	9p23	[Skin/hair/eye pigmentation, variation in, 11 (Melanesian blond hair)]	612271	_	3
115645	_	_	_	_	_
115650	14q22-q23	Cataract 32, multiple types	115650	AD	2
115660	17q24	Cataract 7	115660	AD	2
115665	1pter-p36.13	Cataract 8, multiple types	115665	AD	2
115700	2q33.3	Cataract 4, multiple types	115700	AD	3
115800	2pter-p24	Cataract 29, coralliform	115800	AD	2
115900	2q35	?Cataract 42	115900	AD	3
116100	3q27.3	Cataract 20, multiple types	116100	AD	3
116150	_	_	_	_	_
116200	1q21.2	Cataract 1, multiple types	116200	AD	3
116300	10p13	Cataract 30, pulverulent	116300	AD	3
116400	4p16.1	?Cataract 41	116400	AD	3
116600	1p36.13	Cataract 6, multiple types	116600	AD	3
116700	6p24.3-p24.2	Cataract 13 with adult i phenotype	116700	AR	3
116790	22q11.21	{Panic disorder, susceptibility to}	167870	?AD	3
116790	22q11.21	{Schizophrenia, susceptibility to}	181500	AD	3
116800	16q22.1	Cataract 5, multiple types	116800	AD	3
116805	5q31.2	Macular dystrophy, patterned, 2	608970	AD	3
116806	3p22.1	Colorectal cancer, somatic	114500	_	3
116806	3p22.1	Exudative vitreoretinopathy 7	617572	AD	3
116806	3p22.1	Hepatocellular carcinoma, somatic	114550	_	3
116806	3p22.1	Medulloblastoma, somatic	155255	_	3
116806	3p22.1	Neurodevelopmental disorder with spastic diplegia and visual defects	615075	AD	3
116806	3p22.1	Ovarian cancer, somatic	167000	_	3
116806	3p22.1	Pilomatricoma, somatic	132600	_	3
116810	8p23.1	Keratolytic winter erythema	148370	AD	4
116820	_	_	_	_	_
116830	_	_	_	_	_
116831	_	_	_	_	_
116840	11p15.5	Ceroid lipofuscinosis, neuronal, 10	610127	AR	3
116845	_	_	_	_	_
116850	_	_	_	_	_
116860	_	_	_	_	_
116870	_	_	_	_	_
116880	_	_	_	_	_
116890	_	_	_	_	_
116896	7q22.1	Global developmental delay with or without impaired intellectual development	618330	AD	3
116897	19q13.11	?Leukemia, acute myeloid	601626	AD,SMu	3
116897	19q13.11	Leukemia, acute myeloid, somatic	601626	_	3
116898	_	_	_	_	_
116899	_	_	_	_	_
116900	_	_	_	_	_
116901	_	_	_	_	_
116920	21q22.3	Leukocyte adhesion deficiency	116920	AR	3
116930	_	_	_	_	_
116935	_	_	_	_	_
116940	_	_	_	_	_
116945	3q21.3	?Deafness, autosomal dominant 70	616968	AD	3
116946	_	_	_	_	_
116947	_	_	_	_	_
116948	_	_	_	_	_
116949	_	_	_	_	_
116950	_	_	_	_	_
116951	_	_	_	_	_
116952	1p36.12	Takenouchi-Kosaki syndrome	616737	AD	3
116953	_	_	_	_	_
116954	_	_	_	_	_
116955	3q21.3	Myotonic dystrophy 2	602668	AD	3
116957	_	_	_	_	_
116960	_	_	_	_	_
117000	_	_	_	_	_
117100	11p13	Centrotemporal epilepsy	117100	IC	2
117139	_	_	_	_	_
117140	_	_	_	_	_
117141	_	_	_	_	_
117142	_	_	_	_	_
117143	4q24	?Microcephaly 13, primary, autosomal recessive	616051	AR	3
117200	_	_	_	_	_
117210	16q21	Spinocerebellar ataxia 31	117210	AD	3
117300	13q14.2	Dementia, familial Danish	117300	AD	3
117340	_	_	_	_	_
117350	_	_	_	_	_
117360	3p26.1	Spinocerebellar ataxia 29, congenital nonprogressive	117360	AD	3
117400	_	_	_	_	_
117550	5q35.3	Sotos syndrome 1	117550	AD	3
117600	_	_	_	_	_
117650	20p13	Cerebrocostomandibular syndrome	117650	AD	3
117700	3q24-q25	Cerebellar ataxia	604290	AR	3
117700	3q24-q25	Hemosiderosis, systemic, due to aceruloplasminemia	604290	AR	3
117700	3q24-q25	[Hypoceruloplasminemia, hereditary]	604290	AR	3
117800	_	_	_	_	_
117850	_	_	_	_	_
117900	_	_	_	_	_
118000	_	_	_	_	_
118005	_	_	_	_	_
118100	8q22.1	Klippel-Feil syndrome 1, autosomal dominant	118100	AD	3
118150	_	_	_	_	_
118190	2q33.1	Leukodystrophy, hypomyelinating, 4	612233	AR	3
118190	2q33.1	Spastic paraplegia 13, autosomal dominant	605280	AD	3
118200	1q23.3	Charcot-Marie-Tooth disease, type 1B	118200	AD	3
118210	1p36.22	?Charcot-Marie-Tooth disease, type 2A1	118210	AD	3
118220	17p12	Charcot-Marie-Tooth disease, type 1A	118220	AD	3
118230	_	_	_	_	_
118300	17p12	Charcot-Marie-Tooth disease, type 1E	118300	AD	3
118301	_	_	_	_	_
118330	_	_	_	_	_
118350	_	_	_	_	_
118400	4p16.3	Cherubism	118400	AD	3
118420	_	_	_	_	_
118423	2q31.1	Duane retraction syndrome 2	604356	_	3
118425	7q34	Myotonia congenita, dominant	160800	AD	3
118425	7q34	Myotonia congenita, recessive	255700	AR	3
118425	7q34	Myotonia levior, recessive	_	_	3
118430	_	_	_	_	_
118440	_	_	_	_	_
118444	_	_	_	_	_
118445	_	_	_	_	_
118450	20p12.2	Alagille syndrome 1	118450	AD	3
118455	_	_	_	_	_
118457	_	_	_	_	_
118470	16q13	Hyperalphalipoproteinemia	143470	AD	3
118470	16q13	[High density lipoprotein cholesterol level QTL 10]	143470	AD	3
118480	_	_	_	_	_
118485	15q24.1	Adrenal insufficiency, congenital, with 46XY sex reversal, partial or complete	613743	_	3
118490	10q11.23	Myasthenic syndrome, congenital, 6, presynaptic	254210	AR	3
118491	_	_	_	_	_
118493	_	_	_	_	_
118494	1q43	?Prune belly syndrome	100100	AR	3
118495	_	_	_	_	_
118496	_	_	_	_	_
118502	8p21.2	Epilepsy, nocturnal frontal lobe, type 4	610353	AD	3
118503	15q25.1	{Lung cancer susceptibility 2}	612052	_	3
118504	20q13.33	Epilepsy, nocturnal frontal lobe, 1	600513	AD	3
118504	20q13.33	{Nicotine addiction, susceptibility to}	188890	_	3
118505	15q25.1	{Lung cancer susceptibility 2}	612052	_	3
118505	15q25.1	{Nicotine dependence, susceptibility to}	612052	_	3
118507	1q21.3	Epilepsy, nocturnal frontal lobe, 3	605375	_	3
118508	_	_	_	_	_
118509	_	_	_	_	_
118510	_	_	_	_	_
118511	_	_	_	_	_
118600	5p15.2	Chondrocalcinosis 2	118600	AD	3
118610	_	_	_	_	_
118650	_	_	_	_	_
118651	_	_	_	_	_
118661	5q14.2-q14.3	Wagner syndrome 1	143200	AD	3
118670	_	_	_	_	_
118700	14q13.3	Chorea, hereditary benign	118700	AD	3
118750	_	_	_	_	_
118800	2q35	Paroxysmal nonkinesigenic dyskinesia 1	118800	AD	3
118820	_	_	_	_	_
118825	_	_	_	_	_
118830	_	_	_	_	_
118840	_	_	_	_	_
118850	_	_	_	_	_
118860	_	_	_	_	_
118865	_	_	_	_	_
118870	_	_	_	_	_
118880	_	_	_	_	_
118888	_	_	_	_	_
118890	_	_	_	_	_
118900	_	_	_	_	_
118910	_	_	_	_	_
118920	_	_	_	_	_
118930	_	_	_	_	_
118938	_	_	_	_	_
118940	_	_	_	_	_
118943	_	_	_	_	_
118945	_	_	_	_	_
118946	_	_	_	_	_
118950	_	_	_	_	_
118953	_	_	_	_	_
118955	17q23.1	Mental retardation, autosomal dominant 56	617854	AD	3
118960	_	_	_	_	_
118970	_	_	_	_	_
118980	_	_	_	_	_
118990	_	_	_	_	_
119000	_	_	_	_	_
119100	1q42.2-q43	Split-hand/foot malformation with long bone deficiency 1	119100	AD	2
119300	1q32.2	van der Woude syndrome	119300	AD	3
119500	1q32.2	Popliteal pterygium syndrome 1	119500	AD	3
119530	6p24.3	Orofacial cleft-1	119530	AD	2
119540	_	_	_	_	_
119550	_	_	_	_	_
119570	_	_	_	_	_
119580	16q22.1	Blepharocheilodontic syndrome 1	119580	AD	3
119600	_	_	_	_	_
119650	_	_	_	_	_
119800	5q31.1	Clubfoot, congenital, with or without deficiency of long bones and/or mirror-image polydactyly	119800	AD	3
119900	4q34.1	Digital clubbing, isolated congenital	119900	AR	3
119915	_	_	_	_	_
120000	_	_	_	_	_
120040	_	_	_	_	_
120050	_	_	_	_	_
120070	2q36.3	Alport syndrome 2, autosomal recessive	203780	AR	3
120070	2q36.3	Alport syndrome 3, autosomal dominant	104200	AD	3
120070	2q36.3	Hematuria, benign familial	141200	AD	3
120080	7q21.12	{Colchicine resistance}	120080	_	3
120090	13q34	Brain small vessel disease 2	614483	AD	3
120090	13q34	{Hemorrhage, intracerebral, susceptibility to}	614519	_	3
120100	1q44	Familial cold inflammatory syndrome 1	120100	AD	3
120105	_	_	_	_	_
120110	6q22.1	Metaphyseal chondrodysplasia, Schmid type	156500	AD	3
120120	3p21.31	EBD inversa	226600	AR	3
120120	3p21.31	EBD, Bart type	132000	AD	3
120120	3p21.31	EBD, localisata variant	_	_	3
120120	3p21.31	Epidermolysis bullosa dystrophica, AD	131750	AD	3
120120	3p21.31	Epidermolysis bullosa dystrophica, AR	226600	AR	3
120120	3p21.31	Epidermolysis bullosa pruriginosa	604129	AD,AR	3
120120	3p21.31	Epidermolysis bullosa, pretibial	131850	AD,AR	3
120120	3p21.31	Toenail dystrophy, isolated	607523	AD	3
120120	3p21.31	Transient bullous of the newborn	131705	AD,AR	3
120130	13q34	?Retinal arteries, tortuosity of	180000	AD	3
120130	13q34	Angiopathy, hereditary, with nephropathy, aneurysms, and muscle cramps	611773	AD	3
120130	13q34	Brain small vessel disease with or without ocular anomalies	175780	AD	3
120130	13q34	Schizencephaly	269160	_	3
120130	13q34	{Hemorrhage, intracerebral, susceptibility to}	614519	_	3
120131	2q36.3	Alport syndrome 2, autosomal recessive	203780	AR	3
120131	2q36.3	Hematuria, familial benign	141200	AD	3
120140	12q13.11	Achondrogenesis, type II or hypochondrogenesis	200610	AD	3
120140	12q13.11	Avascular necrosis of the femoral head	608805	AD	3
120140	12q13.11	Czech dysplasia	609162	AD	3
120140	12q13.11	Epiphyseal dysplasia, multiple, with myopia and deafness	132450	AD	3
120140	12q13.11	Kniest dysplasia	156550	AD	3
120140	12q13.11	Legg-Calve-Perthes disease	150600	AD	3
120140	12q13.11	Osteoarthritis with mild chondrodysplasia	604864	AD	3
120140	12q13.11	Platyspondylic skeletal dysplasia, Torrance type	151210	AD	3
120140	12q13.11	SED congenita	183900	AD	3
120140	12q13.11	SMED Strudwick type	184250	AD	3
120140	12q13.11	Spondyloepiphyseal dysplasia, Stanescu type	616583	AD	3
120140	12q13.11	Spondyloperipheral dysplasia	271700	AD	3
120140	12q13.11	Stickler sydrome, type I, nonsyndromic ocular	609508	AD	3
120140	12q13.11	Stickler syndrome, type I	108300	AD	3
120140	12q13.11	Vitreoretinopathy with phalangeal epiphyseal dysplasia	_	_	3
120150	17q21.33	Caffey disease	114000	AD	3
120150	17q21.33	Ehlers-Danlos syndrome, arthrochalasia type, 1	130060	AD	3
120150	17q21.33	Osteogenesis imperfecta, type I	166200	AD	3
120150	17q21.33	Osteogenesis imperfecta, type II	166210	AD	3
120150	17q21.33	Osteogenesis imperfecta, type III	259420	AD	3
120150	17q21.33	Osteogenesis imperfecta, type IV	166220	AD	3
120150	17q21.33	{Bone mineral density variation QTL, osteoporosis}	166710	AD	3
120160	7q21.3	Ehlers-Danlos syndrome, arthrochalasia type, 2	617821	AD	3
120160	7q21.3	Ehlers-Danlos syndrome, cardiac valvular type	225320	AR	3
120160	7q21.3	Osteogenesis imperfecta, type II	166210	AD	3
120160	7q21.3	Osteogenesis imperfecta, type III	259420	AD	3
120160	7q21.3	Osteogenesis imperfecta, type IV	166220	AD	3
120160	7q21.3	{Osteoporosis, postmenopausal}	166710	AD	3
120165	_	_	_	_	_
120170	_	_	_	_	_
120180	2q32.2	Ehlers-Danlos syndrome, vascular type	130050	AD	3
120180	2q32.2	Polymicrogyria with or without vascular-type EDS	618343	AR	3
120190	2q32.2	Ehlers-Danlos syndrome, classic type, 2	130010	AD	3
120200	11p13	?Coloboma, ocular	120200	AD	3
120210	6q13	?Epiphyseal dysplasia, multiple, 6	614135	AD	3
120210	6q13	Stickler syndrome, type IV	614134	_	3
120215	9q34.3	Ehlers-Danlos syndrome, classic type, 1	130000	AD	3
120216	_	_	_	_	_
120220	21q22.3	Bethlem myopathy 1	158810	AD,AR	3
120220	21q22.3	Ullrich congenital muscular dystrophy 1	254090	AD,AR	3
120240	21q22.3	?Myosclerosis, congenital	255600	AR	3
120240	21q22.3	Bethlem myopathy 1	158810	AD,AR	3
120240	21q22.3	Ullrich congenital muscular dystrophy 1	254090	AD,AR	3
120250	2q37.3	Bethlem myopathy 1	158810	AD,AR	3
120250	2q37.3	Dystonia 27	616411	AR	3
120250	2q37.3	Ullrich congenital muscular dystrophy 1	254090	AD,AR	3
120251	_	_	_	_	_
120252	1p34.3	Corneal dystrophy, Fuchs endothelial, 1	136800	AD	3
120252	1p34.3	Corneal dystrophy, posterior polymorphous 2	609140	AD	3
120260	1p34.2	?Stickler syndrome, type V	614284	AR	3
120260	1p34.2	Epiphyseal dysplasia, multiple, 2	600204	AD	3
120270	20q13.33	Epiphyseal dysplasia, multiple, 3, with or without myopathy	600969	AD	3
120270	20q13.33	{Intervertebral disc disease, susceptibility to}	603932	_	3
120280	1p21.1	Fibrochondrogenesis 1	228520	AR	3
120280	1p21.1	Marshall syndrome	154780	AD	3
120280	1p21.1	Stickler syndrome, type II	604841	AD	3
120280	1p21.1	{Lumbar disc herniation, susceptibility to}	603932	_	3
120290	6p21.32	Deafness, autosomal dominant 13	601868	AD	3
120290	6p21.32	Deafness, autosomal recessive 53	609706	AR	3
120290	6p21.32	Fibrochondrogenesis 2	614524	AD,AR	3
120290	6p21.32	Otospondylomegaepiphyseal dysplasia, autosomal dominant	184840	AD	3
120290	6p21.32	Otospondylomegaepiphyseal dysplasia, autosomal recessive	215150	AR	3
120300	_	_	_	_	_
120310	_	_	_	_	_
120320	6q13-q14	?Ullrich congenital muscular dystrophy 2	616470	_	3
120320	6q13-q14	Bethlem myopathy 2	616471	AD	3
120321	_	_	_	_	_
120324	_	_	_	_	_
120325	_	_	_	_	_
120326	_	_	_	_	_
120327	_	_	_	_	_
120328	21q22.3	Knobloch syndrome, type 1	267750	AR	3
120330	10q24.31	Papillorenal syndrome	120330	AD	3
120340	_	_	_	_	_
120350	10q22.1	Myasthenic syndrome, congenital, 19	616720	AR	3
120353	11q22.2	COPD, rate of decline of lung function in	606963	_	3
120353	11q22.2	{Epidermolysis bullosa dystrophica, autosomal recessive, modifier of}	226600	AR	3
120355	_	_	_	_	_
120360	16q12.2	Multicentric osteolysis, nodulosis, and arthropathy	259600	AR	3
120361	20q13.12	Metaphyseal anadysplasia 2	613073	_	3
120400	_	_	_	_	_
120420	_	_	_	_	_
120430	_	_	_	_	_
120433	11q22.1	Coloboma, ocular, with or without hearing impairment, cleft lip/palate, and/or mental retardation	120433	AD	3
120435	2p21-p16	Colorectal cancer, hereditary nonpolyposis, type 1	120435	AD	3
120436	3p22.2	Colorectal cancer, hereditary nonpolyposis, type 2	609310	_	3
120436	3p22.2	Mismatch repair cancer syndrome	276300	AR	3
120436	3p22.2	Muir-Torre syndrome	158320	AD	3
120440	_	_	_	_	_
120450	_	_	_	_	_
120460	_	_	_	_	_
120470	18q21.2	Colorectal cancer, somatic	114500	_	3
120470	18q21.2	Esophageal carcinoma, somatic	133239	_	3
120470	18q21.2	Gaze palsy, familial horizontal, with progressive scoliosis, 2	617542	AR	3
120470	18q21.2	Mirror movements 1 and/or agenesis of the corpus callosum	157600	AD	3
120500	_	_	_	_	_
120502	1q31	Branchiootic syndrome 2	120502	AD	2
120520	3q25.2	?Spinocerebellar ataxia 43	617018	AD	3
120520	3q25.2	Charcot-Marie-Tooth disease, axonal, type 2T	617017	AD,AR	3
120550	1p36.12	C1q deficiency	613652	AR	3
120560	_	_	_	_	_
120570	1p36.12	C1q deficiency	613652	AR	3
120575	1p36.12	C1q deficiency	613652	AR	3
120577	_	_	_	_	_
120580	12p13.31	C1s deficiency	613783	_	3
120580	12p13.31	Ehlers-Danlos syndrome, periodontal type, 2	617174	AD	3
120620	1q32.2	CR1 deficiency	_	_	1
120620	1q32.2	[Blood group, Knops system]	607486	_	3
120620	1q32.2	{?SLE susceptibility}	_	_	1
120620	1q32.2	{Malaria, severe, resistance to}	611162	_	3
120650	1q32.2	Immunodeficiency, common variable, 7	614699	AR	3
120650	1q32.2	{Systemic lupus erythematosus, susceptibility to, 9}	610927	_	3
120700	19p13.3	C3 deficiency	613779	AR	3
120700	19p13.3	{Hemolytic uremic syndrome, atypical, susceptibility to, 5}	612925	AD	3
120700	19p13.3	{Macular degeneration, age-related, 9}	611378	_	3
120790	11q12.1	Complement component 4, partial deficiency of	120790	AD	3
120810	6p21.33	C4a deficiency	614380	AR	3
120810	6p21.33	[Blood group, Rodgers]	614374	_	3
120820	6p21.33	C4B deficiency	614379	_	3
120830	_	_	_	_	_
120831	_	_	_	_	_
120832	_	_	_	_	_
120900	9q33.2	C5 deficiency	609536	_	3
120900	9q33.2	[Eculizumab, poor response to]	615749	AD	3
120920	1q32.2	{Hemolytic uremic syndrome, atypical, susceptibility to, 2}	612922	AD,AR	3
120930	_	_	_	_	_
120940	5p13.1	C9 deficiency	613825	_	3
120940	5p13.1	{Macular degeneration, age-related, 15, susceptibility to}	615591	_	3
120950	1p32.2	C8 deficiency, type I	613790	AR	3
120960	1p32.2	C8 deficiency, type II	613789	AR	3
120970	19q13.33	Cone-rod retinal dystrophy-2	120970	AD	3
120980	_	_	_	_	_
121000	_	_	_	_	_
121009	_	_	_	_	_
121010	_	_	_	_	_
121011	13q12.11	Bart-Pumphrey syndrome	149200	AD	3
121011	13q12.11	Deafness, autosomal dominant 3A	601544	AD	3
121011	13q12.11	Deafness, autosomal recessive 1A	220290	AR	3
121011	13q12.11	Hystrix-like ichthyosis with deafness	602540	AD	3
121011	13q12.11	Keratitis-ichthyosis-deafness syndrome	148210	AD	3
121011	13q12.11	Keratoderma, palmoplantar, with deafness	148350	AD	3
121011	13q12.11	Vohwinkel syndrome	124500	AD	3
121012	_	_	_	_	_
121013	1q21.2	Atrial fibrillation, familial, 11	614049	AD	3
121013	1q21.2	Atrial standstill, digenic (GJA5/SCN5A)	108770	AD	3
121014	6q22.31	Atrioventricular septal defect 3	600309	AD	3
121014	6q22.31	Craniometaphyseal dysplasia, autosomal recessive	218400	AR	3
121014	6q22.31	Erythrokeratodermia variabilis et progressiva 3	617525	AD	3
121014	6q22.31	Hypoplastic left heart syndrome 1	241550	AR	3
121014	6q22.31	Oculodentodigital dysplasia	164200	AD	3
121014	6q22.31	Oculodentodigital dysplasia, autosomal recessive	257850	AR	3
121014	6q22.31	Palmoplantar keratoderma with congenital alopecia	104100	AD	3
121014	6q22.31	Syndactyly, type III	186100	AD	3
121015	13q12.11	Cataract 14, multiple types	601885	AD	3
121020	_	_	_	_	_
121050	5q23.3	Contractural arachnodactyly, congenital	121050	AD	3
121070	_	_	_	_	_
121200	_	_	_	_	_
121201	8q24.22	Seizures, benign neonatal, 2	121201	AD	3
121210	8q13-q21	Febrile seizures, familial, 1	121210	AD	2
121250	_	_	_	_	_
121270	_	_	_	_	_
121300	_	_	_	_	_
121350	_	_	_	_	_
121360	16q22.1	Myeloid leukemia, acute, M4/M4Eo subtype, somatic	601626	_	1
121390	_	_	_	_	_
121400	12q21.33	Cornea plana 1, autosomal dominant	121400	AD	2
121450	_	_	_	_	_
121700	_	_	_	_	_
121800	1p36.22	Corneal dystrophy, Schnyder type	121800	AD	3
121820	5q31.1	Corneal dystrophy, epithelial basement membrane	121820	AD	3
121850	2q34	Corneal fleck dystrophy	121850	AD	3
121900	5q31.1	Corneal dystrophy, Groenouw type I	121900	AD	3
122000	20p11.23	Corneal dystrophy, posterior polymorphous, 1	122000	AD	3
122100	_	_	_	_	_
122200	5q31.1	Corneal dystrophy, lattice type I	122200	AD	3
122400	10q25.1	Epithelial recurrent erosion dystrophy	122400	AD	3
122430	_	_	_	_	_
122440	_	_	_	_	_
122450	_	_	_	_	_
122455	_	_	_	_	_
122460	_	_	_	_	_
122470	5p13.2	Cornelia de Lange syndrome 1	122470	AD	3
122480	_	_	_	_	_
122500	14q32.13	Corticosteroid-binding globulin deficiency	611489	AD,AR	3
122550	_	_	_	_	_
122559	_	_	_	_	_
122560	_	_	_	_	_
122561	_	_	_	_	_
122580	_	_	_	_	_
122600	16p11.2	Spondylocostal dysostosis 5	122600	AD,AR	3
122700	_	_	_	_	_
122720	19q13.2	Coumarin resistance	122700	AD	3
122720	19q13.2	{Lung cancer, resistance to}	211980	AD,SMu	3
122720	19q13.2	{Nicotine addiction, protection from}	188890	_	3
122750	_	_	_	_	_
122780	_	_	_	_	_
122850	_	_	_	_	_
122860	17q21.31	Craniodiaphyseal dysplasia, autosomal dominant	122860	AD	3
122880	2q36.1	Craniofacial-deafness-hand syndrome	122880	AD	3
122900	_	_	_	_	_
122920	_	_	_	_	_
123000	5p15.2	Craniometaphyseal dysplasia	123000	AD	3
123050	_	_	_	_	_
123100	7p21.1	Craniosynostosis 1	123100	AD	3
123101	5q35.2	Craniosynostosis 2	604757	AD	3
123101	5q35.2	Parietal foramina 1	168500	AD	3
123101	5q35.2	Parietal foramina with cleidocranial dysplasia	168550	AD	3
123150	_	_	_	_	_
123155	8q12.2-q21.2	?Hydrocephalus, autosomal dominant	123155	AD	2
123260	_	_	_	_	_
123270	14q32	[Creatine kinase, brain type, ectopic expression of]	123270	_	2
123280	_	_	_	_	_
123290	_	_	_	_	_
123295	_	_	_	_	_
123310	_	_	_	_	_
123320	3p25.3	Creatine phosphokinase, elevated serum	123320	AD	3
123400	_	_	_	_	_
123450	_	_	_	_	_
123500	10q26.13	Crouzon syndrome	123500	AD	3
123540	_	_	_	_	_
123550	_	_	_	_	_
123555	_	_	_	_	_
123557	_	_	_	_	_
123560	_	_	_	_	_
123570	13q13.3	Cryptophthalmos, unilateral or bilateral, isolated	123570	AR	3
123580	21q22.3	Cataract 9, multiple types	604219	AD,AR	3
123590	11q23.1	Cardiomyopathy, dilated, 1II	615184	AD	3
123590	11q23.1	Cataract 16, multiple types	613763	AD,AR	3
123590	11q23.1	Myopathy, myofibrillar, 2	608810	AD	3
123590	11q23.1	Myopathy, myofibrillar, fatal infantile hypertonic, alpha-B crystallin-related	613869	AR	3
123610	17q11.2	Cataract 10, multiple types	600881	AD	3
123620	22q11.23	Cataract 3, multiple types	601547	AD	3
123630	22q11.23	Cataract 22	609741	AD,AR	3
123631	22q12.1	Cataract 23	610425	_	3
123660	_	_	_	_	_
123670	2q33.3	Cataract 39, multiple types, autosomal dominant	615188	AD	3
123680	2q33.3	Cataract 2, multiple types	604307	AD	3
123690	2q33.3	Cataract 4, multiple types	115700	AD	3
123691	_	_	_	_	_
123695	3q29	Spondylometaphyseal dysplasia with cone-rod dystrophy	608940	AR	3
123700	7q11.23	Cutis laxa, autosomal dominant	123700	AD	3
123710	_	_	_	_	_
123720	_	_	_	_	_
123730	3q27.3	Cataract 20, multiple types	116100	AD	3
123740	16p12.2	Deafness, autosomal dominant 40	616357	AD	3
123790	10q26.13	Beare-Stevenson cutis gyrata syndrome	123790	AD	3
123803	_	_	_	_	_
123805	12p12.2	Hypertension and brachydactyly syndrome	112410	AD	3
123810	2q33.3	Histiocytoma, angiomatoid fibrous, somatic	612160	_	3
123811	_	_	_	_	_
123812	_	_	_	_	_
123825	4p12	Retinitis pigmentosa 49	613756	_	3
123828	_	_	_	_	_
123829	12q14.1	{Melanoma, cutaneous malignant, 3}	609048	AD	3
123830	_	_	_	_	_
123831	7q36.1	?Lissencephaly 7 with cerebellar hypoplasia	616342	AR	3
123832	_	_	_	_	_
123833	12p13.32	Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 3	615938	AD	3
123834	_	_	_	_	_
123835	_	_	_	_	_
123836	_	_	_	_	_
123837	_	_	_	_	_
123838	_	_	_	_	_
123839	_	_	_	_	_
123840	_	_	_	_	_
123841	15q22.31	Osteogenesis imperfecta, type IX	259440	AR	3
123842	_	_	_	_	_
123850	_	_	_	_	_
123853	_	_	_	_	_
123855	_	_	_	_	_
123856	_	_	_	_	_
123857	_	_	_	_	_
123858	_	_	_	_	_
123859	_	_	_	_	_
123860	1p34.2	Immunodeficiency 24	615897	AR	3
123864	_	_	_	_	_
123866	_	_	_	_	_
123870	11q13.1	?Mitochondrial complex IV deficiency	220110	Mi,AR	3
123875	_	_	_	_	_
123876	_	_	_	_	_
123880	_	_	_	_	_
123885	_	_	_	_	_
123886	_	_	_	_	_
123889	21q22.11	Inflammatory bowel disease 25, early onset, autosomal recessive	612567	AR	3
123889	21q22.11	{Hepatitis B virus, susceptibility to}	610424	_	3
123890	2q33.2	Autoimmune lymphoproliferative syndrome, type V	616100	AD	3
123890	2q33.2	{Celiac disease, susceptibility to, 3}	609755	_	3
123890	2q33.2	{Diabetes mellitus, insulin-dependent, 12}	601388	_	3
123890	2q33.2	{Hashimoto thyroiditis}	140300	AD	3
123890	2q33.2	{Systemic lupus erythematosus, susceptibility to}	152700	AD	3
123900	_	_	_	_	_
123910	_	_	_	_	_
123920	_	_	_	_	_
123930	19q13.2	Efavirenz, poor metabolism of	614546	_	3
123930	19q13.2	{Efavirenz central nervous system toxicity, susceptibility to}	614546	_	3
123940	12q13.13	White sponge nevus 1	193900	AD	3
123950	_	_	_	_	_
123960	_	_	_	_	_
123970	7p15.3	Thrombocytopenia 4	612004	AD	3
123980	8q24.3	Mitochondrial complex III deficiency, nuclear type 6	615453	AR	3
123995	_	_	_	_	_
123996	_	_	_	_	_
123997	_	_	_	_	_
124000	2q35	Mitochondrial complex III deficiency, nuclear type 1	124000	AR	3
124010	_	_	_	_	_
124015	7q11.23	Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis	201750	AR	3
124015	7q11.23	Disordered steroidogenesis due to cytochrome P450 oxidoreductase	613571	_	3
124020	10q23.33	Clopidogrel, impaired responsiveness to	609535	AR	3
124020	10q23.33	Mephenytoin poor metabolizer	609535	AR	3
124020	10q23.33	Omeprazole poor metabolizer	609535	AR	3
124020	10q23.33	Proguanil poor metabolizer	609535	AR	3
124030	22q13.2	{Codeine sensitivity}	608902	AR	3
124030	22q13.2	{Debrisoquine sensitivity}	608902	AR	3
124040	_	_	_	_	_
124050	_	_	_	_	_
124060	_	_	_	_	_
124070	_	_	_	_	_
124075	_	_	_	_	_
124080	8q24.3	Aldosterone to renin ratio raised	_	_	3
124080	8q24.3	Hypoaldosteronism, congenital, due to CMO I deficiency	203400	AR	3
124080	8q24.3	Hypoaldosteronism, congenital, due to CMO II deficiency	610600	AR	3
124080	8q24.3	{Low renin hypertension, susceptibility to}	_	_	3
124089	19q13.12	Mitochondrial complex IV deficiency	220110	Mi,AR	3
124090	_	_	_	_	_
124092	1q32.1	{Graft-versus-host disease, protection against}	614395	_	3
124092	1q32.1	{HIV-1, susceptibility to}	609423	_	3
124092	1q32.1	{Rheumatoid arthritis, progression of}	180300	_	3
124095	_	_	_	_	_
124097	_	_	_	_	_
124100	_	_	_	_	_
124200	12q24.11	Darier disease	124200	AD	3
124300	_	_	_	_	_
124400	_	_	_	_	_
124450	_	_	_	_	_
124480	8p21.3	Deafness, congenital, with onychodystrophy, autosomal dominant	124480	AD	3
124490	_	_	_	_	_
124500	13q12.11	Vohwinkel syndrome	124500	AD	3
124580	_	_	_	_	_
124700	_	_	_	_	_
124800	_	_	_	_	_
124900	5q31.3	Deafness, autosomal dominant 1	124900	AD	3
124910	_	_	_	_	_
124950	_	_	_	_	_
125000	_	_	_	_	_
125050	_	_	_	_	_
125100	_	_	_	_	_
125220	_	_	_	_	_
125230	_	_	_	_	_
125240	1q32.2	Complement hyperactivation, angiopathic thrombosis, and protein-losing enteropathy	226300	AR	3
125240	1q32.2	[Blood group Cromer]	613793	AR	3
125250	3q29	Optic atrophy plus syndrome	125250	AD	3
125255	12q21.33	Corneal dystrophy, congenital stromal	610048	AD	3
125260	_	_	_	_	_
125263	_	_	_	_	_
125264	6p22.3	Leukemia, acute nonlymphocytic	125264	_	2
125265	_	_	_	_	_
125270	9q32	Porphyria, acute hepatic	612740	AR	3
125270	9q32	{Lead poisoning, susceptibility to}	612740	AR	3
125280	_	_	_	_	_
125290	_	_	_	_	_
125300	_	_	_	_	_
125305	_	_	_	_	_
125310	19p13.12	Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy 1	125310	AD	3
125320	_	_	_	_	_
125350	3p21.31	Failure of tooth eruption, primary	125350	AD	3
125370	12p13.31	Dentatorubro-pallidoluysian atrophy	125370	AD	3
125400	6q27	Dentin dysplasia, type I, with microdontia and misshapen teeth	125400	AR	3
125420	4q22.1	Dentin dysplasia, type II	125420	AD	3
125440	_	_	_	_	_
125450	_	_	_	_	_
125460	_	_	_	_	_
125480	18p	{Major affective disorder 1}	125480	AD	2
125485	4q22.1	Deafness, autosomal dominant 39, with dentinogenesis	605594	AD	3
125485	4q22.1	Dentin dysplasia, type II	125420	AD	3
125485	4q22.1	Dentinogenesis imperfecta, Shields type II	125490	AD	3
125485	4q22.1	Dentinogenesis imperfecta, Shields type III	125500	AD	3
125490	4q22.1	Dentinogenesis imperfecta, Shields type II	125490	AD	3
125500	4q22.1	Dentinogenesis imperfecta, Shields type III	125500	AD	3
125505	16p13.3	{Systemic lupus erythematosus, susceptibility to}	152700	AD	3
125510	_	_	_	_	_
125520	22q11	Cayler cardiofacial syndrome	125520	AD	2
125530	_	_	_	_	_
125540	_	_	_	_	_
125550	_	_	_	_	_
125570	_	_	_	_	_
125580	_	_	_	_	_
125590	_	_	_	_	_
125595	17q21.2	Dermatopathia pigmentosa reticularis	125595	AD	3
125597	_	_	_	_	_
125600	_	_	_	_	_
125630	19p13.12	Vibratory urticaria	125630	AD	3
125635	_	_	_	_	_
125640	_	_	_	_	_
125643	_	_	_	_	_
125645	18q12.1	Arrhythmogenic right ventricular dysplasia 11	610476	AD,AR	3
125645	18q12.1	Arrhythmogenic right ventricular dysplasia 11 with mild palmoplantar keratoderma and woolly hair	610476	AD,AR	3
125647	6p24.3	Arrhythmogenic right ventricular dysplasia 8	607450	AD	3
125647	6p24.3	Cardiomyopathy, dilated, with woolly hair and keratoderma	605676	AR	3
125647	6p24.3	Dilated cardiomyopathy with woolly hair, keratoderma, and tooth agenesis	615821	AD	3
125647	6p24.3	Epidermolysis bullosa, lethal acantholytic	609638	AR	3
125647	6p24.3	Keratosis palmoplantaris striata II	612908	AD	3
125647	6p24.3	Skin fragility-woolly hair syndrome	607655	AR	3
125650	_	_	_	_	_
125660	2q35	Cardiomyopathy, dilated, 1I	604765	_	3
125660	2q35	Myopathy, myofibrillar, 1	601419	AD,AR	3
125660	2q35	Scapuloperoneal syndrome, neurogenic, Kaeser type	181400	AD	3
125670	18q12.1	Erythroderma, congenital, with palmoplantar keratoderma, hypotrichosis, and hyper IgE	615508	AR	3
125670	18q12.1	Keratosis palmoplantaris striata I, AD	148700	AD	3
125671	18q12.1	Arrhythmogenic right ventricular dysplasia 10	610193	AD	3
125671	18q12.1	Cardiomyopathy, dilated, 1BB	612877	_	3
125700	20p13	Diabetes insipidus, neurohypophyseal	125700	AD	3
125800	12q13.12	Diabetes insipidus, nephrogenic	125800	AD,AR	3
125850	20q13.12	MODY, type I	125850	AD	3
125851	7p13	MODY, type II	125851	AD	3
125852	11p15.5	Diabetes mellitus, insulin-dependent, 2	125852	AD	3
125853	_	_	_	_	_
125855	_	_	_	_	_
125860	16q22.1	{Benzene toxicity, susceptibility to}	_	_	3
125860	16q22.1	{Breast cancer, poor survival after chemotherapy for}	_	_	3
125860	16q22.1	{Leukemia, post-chemotherapy, susceptibility to}	_	_	3
125870	_	_	_	_	_
125880	_	_	_	_	_
125890	_	_	_	_	_
125900	_	_	_	_	_
125950	_	_	_	_	_
126050	_	_	_	_	_
126060	5q14.1	Megaloblastic anemia due to dihydrofolate reductase deficiency	613839	AR	3
126061	_	_	_	_	_
126063	14q24.3	Paragangliomas 7	618475	AD	3
126064	16q22.2	Miller syndrome	263750	AR	3
126065	20q13.2	Hypercalcemia, infantile, 1	143880	AR	3
126070	_	_	_	_	_
126090	10q22.1	Hyperphenylalaninemia, BH4-deficient, D	264070	AR	3
126100	_	_	_	_	_
126110	_	_	_	_	_
126140	_	_	_	_	_
126141	7q36.2	Mental retardation, autosomal dominant 33	616311	_	3
126141	7q36.2	{Ventricular fibrillation, paroxysmal familial, 2}	612956	AD	3
126150	5q31.3	{Diphtheria, susceptibility to}	_	_	1
126180	_	_	_	_	_
126190	_	_	_	_	_
126200	_	_	_	_	_
126250	_	_	_	_	_
126255	_	_	_	_	_
126300	_	_	_	_	_
126320	_	_	_	_	_
126330	_	_	_	_	_
126335	_	_	_	_	_
126337	_	_	_	_	_
126340	19q13.32	?Cerebrooculofacioskeletal syndrome 2	610756	AR	3
126340	19q13.32	Trichothiodystrophy 1, photosensitive	601675	AR	3
126340	19q13.32	Xeroderma pigmentosum, group D	278730	AR	3
126350	_	_	_	_	_
126370	_	_	_	_	_
126375	19p13.2	Cerebellar ataxia, deafness, and narcolepsy, autosomal dominant	604121	AD	3
126375	19p13.2	Neuropathy, hereditary sensory, type IE	614116	AD	3
126380	19q13.32	Cerebrooculofacioskeletal syndrome 4	610758	AR	3
126390	_	_	_	_	_
126391	_	_	_	_	_
126410	_	_	_	_	_
126420	20q12	DNA topoisomerase I, camptothecin-resistant	_	_	3
126430	17q21.2	DNA topoisomerase II, resistance to inhibition of, by amsacrine	_	_	3
126431	_	_	_	_	_
126440	_	_	_	_	_
126448	_	_	_	_	_
126449	_	_	_	_	_
126450	_	_	_	_	_
126451	3q13.31	{Essential tremor, hereditary, 1}	190300	AD	3
126451	3q13.31	{Schizophrenia, susceptibility to}	181500	AD	3
126452	11p15.5	Autonomic nervous system dysfunction	_	_	3
126452	11p15.5	[Novelty seeking personality]	601696	?AD	1
126452	11p15.5	{Attention deficit-hyperactivity disorder}	143465	AD	3
126453	4p16.1	{Attention deficit-hyperactivity disorder, susceptibility to}	143465	AD	3
126453	4p16.1	{Blepharospasm, primary benign}	606798	AD	3
126455	5p15.33	Parkinsonism-dystonia, infantile, 1	613135	AR	3
126455	5p15.33	{Nicotine dependence, protection against}	188890	_	3
126500	_	_	_	_	_
126550	_	_	_	_	_
126600	2p16.1	Doyne honeycomb degeneration of retina	126600	AD	3
126650	7q22.3-q31.1	Diarrhea 1, secretory chloride, congenital	214700	AR	3
126660	_	_	_	_	_
126700	1q31.3	Basal laminar drusen	126700	AD	3
126800	8q13	Duane retraction syndrome 1	126800	AD	2
126830	_	_	_	_	_
126840	_	_	_	_	_
126850	_	_	_	_	_
126900	16q11.1-q22	Dupuytren contracture 1	126900	AD	2
126950	_	_	_	_	_
127000	11q12.1	Kenny-Caffey syndrome, type 2	127000	AD	3
127100	_	_	_	_	_
127200	_	_	_	_	_
127300	_	_	_	_	_
127350	_	_	_	_	_
127400	1q21.3	Dyschromatosis symmetrica hereditaria	127400	AD	3
127500	6q24.2-q25.2	Dyschromatosis universalis hereditaria 1	127500	AD	2
127550	3q26.2	Dyskeratosis congenita, autosomal dominant 1	127550	AD	3
127600	4q35	Dyskeratosis, hereditary benign intraepithelial	127600	AD	2
127700	15q21.3	{Dyslexia, susceptibility to, 1}	127700	AD	3
127750	_	_	_	_	_
127800	_	_	_	_	_
127820	_	_	_	_	_
128000	_	_	_	_	_
128100	9q34.11	Dystonia-1, torsion	128100	AD	3
128101	19p13.3	Dystonia 4, torsion, autosomal dominant	128101	AD	3
128200	16p11.2	Episodic kinesigenic dyskinesia 1	128200	AD	3
128230	14q22.2	Dystonia, DOPA-responsive, with or without hyperphenylalaninemia	128230	AD,AR	3
128235	19q13.2	Dystonia-12	128235	AD	3
128239	3p21.31	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 9	616538	AR	3
128239	3p21.31	Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 9	613818	AR	3
128240	_	_	_	_	_
128260	1q32.1	Hypotrichosis 11	615059	AD	3
128290	_	_	_	_	_
128300	_	_	_	_	_
128400	_	_	_	_	_
128500	_	_	_	_	_
128600	_	_	_	_	_
128700	8q11.1-q13.3	?Preauricular fistulae, congenital	128700	AD	2
128710	_	_	_	_	_
128800	_	_	_	_	_
128900	_	_	_	_	_
128950	_	_	_	_	_
128980	_	_	_	_	_
128990	_	_	_	_	_
128992	_	_	_	_	_
129000	_	_	_	_	_
129010	10q21.3	Charcot-Marie-Tooth disease, type 1D	607678	AD	3
129010	10q21.3	Dejerine-Sottas disease	145900	AD,AR	3
129010	10q21.3	Hypomyelinating neuropathy, congenital, 1	605253	AD,AR	3
129100	_	_	_	_	_
129150	_	_	_	_	_
129190	6q14.3	Calcification of joints and arteries	211800	AR	3
129200	4q22.3	Basan syndrome	129200	AD	3
129400	3q28	Rapp-Hodgkin syndrome	129400	AD	3
129490	2q13	Ectodermal dysplasia 10A, hypohidrotic/hair/nail type, autosomal dominant	129490	AD	3
129500	13q12.11	Ectodermal dysplasia 2, Clouston type	129500	AD	3
129510	_	_	_	_	_
129540	_	_	_	_	_
129550	_	_	_	_	_
129600	15q21.1	Ectopia lentis, familial	129600	AD	3
129750	_	_	_	_	_
129810	_	_	_	_	_
129830	_	_	_	_	_
129840	_	_	_	_	_
129850	_	_	_	_	_
129900	7q11.2-q21.3	?EEC syndrome-1	129900	AD	2
129905	_	_	_	_	_
130000	9q34.3	Ehlers-Danlos syndrome, classic type, 1	130000	AD	3
130010	2q32.2	Ehlers-Danlos syndrome, classic type, 2	130010	AD	3
130020	_	_	_	_	_
130050	2q32.2	Ehlers-Danlos syndrome, vascular type	130050	AD	3
130060	17q21.33	Ehlers-Danlos syndrome, arthrochalasia type, 1	130060	AD	3
130070	5q35.3	Ehlers-Danlos syndrome, spondylodysplastic type, 1	130070	AR	3
130080	12p13.31	Ehlers-Danlos syndrome, periodontal type, 1	130080	AD	3
130090	_	_	_	_	_
130100	_	_	_	_	_
130120	_	_	_	_	_
130130	19p13.3	Neutropenia, cyclic	162800	AD	3
130130	19p13.3	Neutropenia, severe congenital 1, autosomal dominant	202700	AD	3
130135	_	_	_	_	_
130160	7q11.23	Cutis laxa, autosomal dominant	123700	AD	3
130160	7q11.23	Supravalvar aortic stenosis	185500	AD	3
130180	_	_	_	_	_
130190	_	_	_	_	_
130200	_	_	_	_	_
130300	_	_	_	_	_
130400	_	_	_	_	_
130410	19q13.41	Glutaric acidemia IIB	231680	AR	3
130500	1p35.3	Elliptocytosis-1	611804	AD,AR	3
130590	_	_	_	_	_
130591	_	_	_	_	_
130592	_	_	_	_	_
130593	_	_	_	_	_
130600	1q23.1	Elliptocytosis-2	130600	AD	3
130610	19p13.3	?Spinocerebellar ataxia 26	609306	AD	3
130620	5q33.1	Macrocytic anemia, refractory, due to 5q deletion, somatic	153550	_	3
130650	_	_	_	_	_
130660	_	_	_	_	_
130700	_	_	_	_	_
130710	_	_	_	_	_
130720	19p13.12	Lateral meningocele syndrome	130720	AD	3
130900	8q24.3	Amelogenesis imperfecta, type IIIA	130900	AD	3
130950	_	_	_	_	_
131100	11q13.1	Multiple endocrine neoplasia 1	131100	AD	3
131150	_	_	_	_	_
131170	_	_	_	_	_
131180	_	_	_	_	_
131190	_	_	_	_	_
131195	9q34.11	Telangiectasia, hereditary hemorrhagic, type 1	187300	AD	3
131200	10q26	{Endometriosis, susceptibility to, 1}	131200	AR,Mu	2
131210	_	_	_	_	_
131220	_	_	_	_	_
131222	22q13.33	Mitochondrial DNA depletion syndrome 1 (MNGIE type)	603041	AR	3
131230	4q27	{Pregnancy loss, recurrent, susceptibility to, 3}	614391	AD	3
131235	_	_	_	_	_
131240	6p24.1	Auriculocondylar syndrome 3	615706	AR	3
131240	6p24.1	Question mark ears, isolated	612798	AD	3
131240	6p24.1	{High density lipoprotein cholesterol level QTL 7}	_	_	3
131241	_	_	_	_	_
131242	20q13.32	Central hypoventilation syndrome, congenital	209880	AD	3
131242	20q13.32	Waardenburg syndrome, type 4B	613265	AD,AR	3
131242	20q13.32	{Hirschsprung disease, susceptibility to, 4}	613712	AD	3
131243	4q31.22-q31.23	Mandibulofacial dysostosis with alopecia	616367	AD	3
131243	4q31.22-q31.23	{Migraine, resistance to}	157300	AD	3
131244	13q22.3	ABCD syndrome	600501	AR	3
131244	13q22.3	Waardenburg syndrome, type 4A	277580	AD,AR	3
131244	13q22.3	{Hirschsprung disease, susceptibility to, 2}	600155	AD	3
131290	_	_	_	_	_
131300	19q13.2	Camurati-Engelmann disease	131300	AD	3
131310	_	_	_	_	_
131320	10p14	Hypoparathyroidism, sensorineural deafness, and renal dysplasia	146255	AD	3
131330	_	_	_	_	_
131340	20p13	Spinocerebellar ataxia 23	610245	AD	3
131360	_	_	_	_	_
131370	17p13.2	?Glycogen storage disease XIII	612932	AR	3
131375	_	_	_	_	_
131390	_	_	_	_	_
131398	_	_	_	_	_
131399	17q22	[Eosinophil peroxidase deficiency]	261500	AR	3
131400	5q31-q33	Eosinophilia, familial	131400	AD	2
131410	_	_	_	_	_
131430	_	_	_	_	_
131440	5q32	Myeloproliferative disorder with eosinophilia	131440	AD	4
131445	_	_	_	_	_
131450	_	_	_	_	_
131460	_	_	_	_	_
131500	_	_	_	_	_
131530	4q25	Hypomagnesemia 4, renal	611718	_	3
131550	7p11.2	?Inflammatory skin and bowel disease, neonatal, 2	616069	AR	3
131550	7p11.2	Adenocarcinoma of lung, response to tyrosine kinase inhibitor in	211980	AD,SMu	3
131550	7p11.2	Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in	211980	AD,SMu	3
131550	7p11.2	{Nonsmall cell lung cancer, susceptibility to}	211980	AD,SMu	3
131560	_	_	_	_	_
131600	_	_	_	_	_
131705	3p21.31	Transient bullous of the newborn	131705	AD,AR	3
131750	3p21.31	Epidermolysis bullosa dystrophica, AD	131750	AD	3
131760	_	_	_	_	_
131800	_	_	_	_	_
131850	3p21.31	Epidermolysis bullosa, pretibial	131850	AD,AR	3
131880	_	_	_	_	_
131900	_	_	_	_	_
131950	8q24.3	Epidermolysis bullosa simplex, Ogna type	131950	AD	3
131960	12q13.13	Epidermolysis bullosa simplex-MP	131960	AD	3
132000	3p21.31	EBD, Bart type	132000	AD	3
132090	_	_	_	_	_
132100	6p21.1	Photoparoxysmal response 1	132100	AD	2
132300	_	_	_	_	_
132350	_	_	_	_	_
132400	19p13.11	Epiphyseal dysplasia, multiple, 1	132400	AD	3
132450	12q13.11	Epiphyseal dysplasia, multiple, with myopia and deafness	132450	AD	3
132500	_	_	_	_	_
132600	_	_	_	_	_
132700	16q12.1	Cylindromatosis, familial	132700	AD	3
132800	9q22.33	{Multiple self-healing squamous epithelioma, susceptibility to}	132800	AD	3
132810	1q42.12	?Hypercholanemia, familial	607748	AR	3
132811	8p21.2-p21.1	{Hypercholesterolemia, familial, due to LDLR defect, modifier of}	143890	AD	3
132850	_	_	_	_	_
132860	_	_	_	_	_
132880	_	_	_	_	_
132890	5q15	Bosch-Boonstra-Schaaf optic atrophy syndrome	615722	AD	3
132900	16p13.11	Aortic aneurysm, familial thoracic 4	132900	AD	3
132990	_	_	_	_	_
133000	_	_	_	_	_
133020	_	_	_	_	_
133090	_	_	_	_	_
133100	_	_	_	_	_
133170	7q22.1	?Diamond-Blackfan anemia-like	617911	AR	3
133170	7q22.1	Erythrocytosis, familial, 5	617907	AD	3
133170	7q22.1	{Microvascular complications of diabetes 2}	612623	_	3
133171	19p13.2	[Erythrocytosis, familial, 1]	133100	AD	3
133180	12q13.2	{?Erythroleukemia, familial, susceptibility to}	133180	AD	3
133190	6q14.1	Spinocerebellar ataxia 34	133190	AD	3
133200	1p34.3	Erythrokeratodermia variabilis et progressiva 1	133200	AD,AR	3
133220	_	_	_	_	_
133230	_	_	_	_	_
133239	_	_	_	_	_
133240	_	_	_	_	_
133250	_	_	_	_	_
133260	_	_	_	_	_
133270	_	_	_	_	_
133280	_	_	_	_	_
133290	_	_	_	_	_
133300	_	_	_	_	_
133420	_	_	_	_	_
133430	6q25.1-q25.2	Breast cancer, somatic	114480	_	3
133430	6q25.1-q25.2	Estrogen resistance	615363	AR	3
133430	6q25.1-q25.2	{Atherosclerosis, susceptibility to}	_	_	3
133430	6q25.1-q25.2	{HDL response to hormone replacement, augmented}	_	_	3
133430	6q25.1-q25.2	{Migraine, susceptibility to}	157300	AD	3
133430	6q25.1-q25.2	{Myocardial infarction, susceptibility to}	608446	_	3
133435	_	_	_	_	_
133440	4q23	{Autism, susceptibility to, 19}	615091	_	3
133450	22q12.2	Ewing sarcoma	612219	_	3
133450	22q12.2	Neuroepithelioma	612219	_	3
133500	_	_	_	_	_
133510	2q14.3	Trichothiodystrophy 2, photosensitive	616390	AR	3
133510	2q14.3	Xeroderma pigmentosum, group B	610651	AR	3
133520	16p13.12	Fanconi anemia, complementation group Q	615272	AR	3
133520	16p13.12	Xeroderma pigmentosum, group F	278760	AR	3
133520	16p13.12	Xeroderma pigmentosum, type F/Cockayne syndrome	278760	AR	3
133520	16p13.12	XFE progeroid syndrome	610965	AR	3
133530	13q33.1	Cerebrooculofacioskeletal syndrome 3	616570	AR	3
133530	13q33.1	Xeroderma pigmentosum, group G	278780	AR	3
133530	13q33.1	Xeroderma pigmentosum, group G/Cockayne syndrome	278780	AR	3
133535	_	_	_	_	_
133540	10q11.23	Cockayne syndrome, type B	133540	AR	3
133550	9p24.2	Dicarboxylic aminoaciduria	222730	AR	3
133550	9p24.2	{?Schizophrenia susceptibility 18}	615232	_	3
133600	_	_	_	_	_
133690	_	_	_	_	_
133700	8q24.11	Exostoses, multiple, type 1	133700	AD	3
133701	11p11.2	Exostoses, multiple, type 2	133701	AD	3
133705	_	_	_	_	_
133710	_	_	_	_	_
133730	_	_	_	_	_
133740	_	_	_	_	_
133750	_	_	_	_	_
133780	_	_	_	_	_
133800	_	_	_	_	_
133900	_	_	_	_	_
134000	_	_	_	_	_
134100	_	_	_	_	_
134200	_	_	_	_	_
134300	_	_	_	_	_
134350	19p13.3	Complement factor D deficiency	613912	AR	3
134370	1q31.3	Basal laminar drusen	126700	AD	3
134370	1q31.3	Complement factor H deficiency	609814	AD,AR	3
134370	1q31.3	{Hemolytic uremic syndrome, atypical, susceptibility to, 1}	235400	AD,AR	3
134370	1q31.3	{Macular degeneration, age-related, 4}	610698	_	3
134371	1q31.3	{Hemolytic uremic syndrome, atypical, susceptibility to}	235400	AD,AR	3
134371	1q31.3	{Macular degeneration, age-related, reduced risk of}	603075	AD	3
134390	_	_	_	_	_
134400	_	_	_	_	_
134430	_	_	_	_	_
134450	_	_	_	_	_
134500	_	_	_	_	_
134510	_	_	_	_	_
134520	_	_	_	_	_
134530	_	_	_	_	_
134540	_	_	_	_	_
134570	6p25.1	Factor XIIIA deficiency	613225	AR	3
134570	6p25.1	{Myocardial infarction, protection against}	608446	_	3
134570	6p25.1	{Venous thrombosis, protection against}	188050	AD	3
134580	1q31.3	Factor XIIIB deficiency	613235	AR	3
134600	15q15.3	Fanconi renotubular syndrome 1	134600	AD	2
134610	16p13.3	Familial Mediterranean fever, AD	134610	AD	3
134629	1q22	Porokeratosis 9, multiple types	616631	AD	3
134631	_	_	_	_	_
134632	_	_	_	_	_
134633	_	_	_	_	_
134634	_	_	_	_	_
134635	_	_	_	_	_
134636	_	_	_	_	_
134637	10q23.31	Autoimmune lymphoproliferative syndrome, type IA	601859	AD	3
134637	10q23.31	Squamous cell carcinoma, burn scar-related, somatic	_	_	3
134637	10q23.31	{Autoimmune lymphoproliferative syndrome}	601859	AD	3
134638	1q24.3	Autoimmune lymphoproliferative syndrome, type IB	601859	AD	3
134638	1q24.3	{Lung cancer, susceptibility to}	211980	AD,SMu	3
134640	_	_	_	_	_
134650	_	_	_	_	_
134651	_	_	_	_	_
134660	_	_	_	_	_
134690	_	_	_	_	_
134700	_	_	_	_	_
134720	_	_	_	_	_
134750	_	_	_	_	_
134770	11q12.3	?Hemochromatosis, type 5	615517	AD	3
134780	_	_	_	_	_
134790	19q13.33	Hyperferritinemia-cataract syndrome	600886	AD	3
134790	19q13.33	L-ferritin deficiency, dominant and recessive	615604	AD,AR	3
134790	19q13.33	Neurodegeneration with brain iron accumulation 3	606159	AD	3
134795	_	_	_	_	_
134797	15q21.1	Acromicric dysplasia	102370	AD	3
134797	15q21.1	Ectopia lentis, familial	129600	AD	3
134797	15q21.1	Geleophysic dysplasia 2	614185	AD	3
134797	15q21.1	Marfan lipodystrophy syndrome	616914	AD	3
134797	15q21.1	Marfan syndrome	154700	AD	3
134797	15q21.1	MASS syndrome	604308	_	3
134797	15q21.1	Stiff skin syndrome	184900	AD	3
134797	15q21.1	Weill-Marchesani syndrome 2, dominant	608328	AD	3
134820	4q31.3	Afibrinogenemia, congenital	202400	AR	3
134820	4q31.3	Amyloidosis, familial visceral	105200	AD	3
134820	4q31.3	Dysfibrinogenemia, congenital	616004	_	3
134820	4q31.3	Hypodysfibrinogenemia, congenital	616004	_	3
134830	4q31.3	Afibrinogenemia, congenital	202400	AR	3
134830	4q31.3	Dysfibrinogenemia, congenital	616004	_	3
134830	4q31.3	Hypofibrinogenemia, congenital	202400	AR	3
134850	4q32.1	Afibrinogenemia, congenital	202400	AR	3
134850	4q32.1	Dysfibrinogenemia, congenital	616004	_	3
134850	4q32.1	Hypodysfibrinogenemia	616004	_	3
134850	4q32.1	Hypofibrinogenemia, congenital	202400	AR	3
134900	_	_	_	_	_
134920	_	_	_	_	_
134921	_	_	_	_	_
134934	4p16.3	Achondroplasia	100800	AD	3
134934	4p16.3	Bladder cancer, somatic	109800	_	3
134934	4p16.3	CATSHL syndrome	610474	AD,AR	3
134934	4p16.3	Cervical cancer, somatic	603956	_	3
134934	4p16.3	Colorectal cancer, somatic	114500	_	3
134934	4p16.3	Crouzon syndrome with acanthosis nigricans	612247	AD	3
134934	4p16.3	Hypochondroplasia	146000	AD	3
134934	4p16.3	LADD syndrome	149730	AD	3
134934	4p16.3	Muenke syndrome	602849	AD	3
134934	4p16.3	Nevus, epidermal, somatic	162900	_	3
134934	4p16.3	SADDAN	616482	AD	3
134934	4p16.3	Spermatocytic seminoma, somatic	273300	_	3
134934	4p16.3	Thanatophoric dysplasia, type I	187600	AD	3
134934	4p16.3	Thanatophoric dysplasia, type II	187601	AD	3
134935	5q35.2	{Cancer progression/metastasis}	_	_	3
135000	_	_	_	_	_
135100	2q24.1	Fibrodysplasia ossificans progressiva	135100	AD	3
135150	17p11.2	Birt-Hogg-Dube syndrome	135150	AD	3
135290	5q22.2	Desmoid disease, hereditary	135290	AD	3
135300	2p22.1	?Fibromatosis, gingival, 1	135300	AD	3
135400	17q24.2-q24.3	Hypertrichosis terminalis, generalized, with or without gingival hyperplasia	135400	AR	4
135500	1q32.2	Zimmermann-Laband syndrome 1	135500	AD	3
135550	_	_	_	_	_
135580	_	_	_	_	_
135600	2q35	Glomerulopathy with fibronectin deposits 2	601894	AD	3
135600	2q35	Plasma fibronectin deficiency	614101	AD	1
135600	2q35	Spondylometaphyseal dysplasia, corner fracture type	184255	AD	3
135610	_	_	_	_	_
135620	_	_	_	_	_
135630	_	_	_	_	_
135631	_	_	_	_	_
135700	_	_	_	_	_
135750	7q36.3	Laurin-Sandrow syndrome	135750	AD	3
135800	_	_	_	_	_
135820	22q13.31	Synpolydactyly, 3/3'4, associated with metacarpal and metatarsal synostoses	608180	AD	4
135821	_	_	_	_	_
135900	6q25.3	Coffin-Siris syndrome 1	135900	AD	3
135940	1q21.3	Ichthyosis vulgaris	146700	AD	3
135940	1q21.3	{Dermatitis, atopic, susceptibility to, 2}	605803	_	3
135950	_	_	_	_	_
136000	4q22.3	Adermatoglyphia	136000	AD	3
136100	_	_	_	_	_
136120	16q22.1	Fish-eye disease	136120	AR	3
136130	_	_	_	_	_
136131	_	_	_	_	_
136132	1q24.3	Trimethylaminuria	602079	AR	3
136140	16p11.2	Floating-Harbor syndrome	136140	AD	3
136150	_	_	_	_	_
136200	_	_	_	_	_
136300	_	_	_	_	_
136350	8p11.23	Encephalocraniocutaneous lipomatosis	613001	SMo	3
136350	8p11.23	Hartsfield syndrome	615465	AD	3
136350	8p11.23	Hypogonadotropic hypogonadism 2 with or without anosmia	147950	AD	3
136350	8p11.23	Jackson-Weiss syndrome	123150	AD	3
136350	8p11.23	Osteoglophonic dysplasia	166250	AD	3
136350	8p11.23	Pfeiffer syndrome	101600	AD	3
136350	8p11.23	Trigonocephaly 1	190440	AD	3
136351	13q12.2	Leukemia, acute lymphoblastic, somatic	613065	_	3
136351	13q12.2	Leukemia, acute myeloid, reduced survival in, somatic	601626	_	3
136351	13q12.2	Leukemia, acute myeloid, somatic	601626	_	3
136352	5q35.3	Hemangioma, capillary infantile, somatic	602089	_	3
136352	5q35.3	Lymphatic malformation 1	153100	AD	3
136400	_	_	_	_	_
136425	_	_	_	_	_
136430	11q13.4	Neurodegeneration due to cerebral folate transport deficiency	613068	AR	3
136435	2p16.3	Ovarian dysgenesis 1	233300	AR	3
136435	2p16.3	Ovarian hyperstimulation syndrome	608115	AD	3
136435	2p16.3	Ovarian response to FSH stimulation	276400	AR	3
136440	18q21.33	Erythrokeratodermia variabilis et progressiva 4	617526	AR	3
136470	_	_	_	_	_
136480	_	_	_	_	_
136490	_	_	_	_	_
136500	_	_	_	_	_
136510	_	_	_	_	_
136515	_	_	_	_	_
136520	11p13	Foveal hypoplasia 1	136520	AD	3
136530	11p14.1	Hypogonadotropic hypogonadism 24 without anosmia	229070	AR	3
136533	13q14.11	Rhabdomyosarcoma, alveolar	268220	SMu	3
136535	_	_	_	_	_
136537	_	_	_	_	_
136538	_	_	_	_	_
136539	_	_	_	_	_
136540	_	_	_	_	_
136550	6q16.2	Macular dystrophy, North Carolina type	136550	AD	3
136560	_	_	_	_	_
136570	16p12	Chromosome 16p12.1 deletion syndrome, 520kb	136570	_	4
136580	_	_	_	_	_
136590	_	_	_	_	_
136600	_	_	_	_	_
136610	_	_	_	_	_
136620	_	_	_	_	_
136630	12q13.12	Mental retardation, FRA12A type	136630	AD	3
136640	_	_	_	_	_
136650	_	_	_	_	_
136660	_	_	_	_	_
136670	_	_	_	_	_
136680	11p13	Frasier syndrome	136680	AD,SMu	3
136750	_	_	_	_	_
136760	1p13.3	Frontonasal dysplasia 1	136760	AR	3
136770	_	_	_	_	_
136800	1p34.3	Corneal dystrophy, Fuchs endothelial, 1	136800	AD	3
136820	_	_	_	_	_
136830	_	_	_	_	_
136835	_	_	_	_	_
136836	19p13.3	Fucosyltransferase 6 deficiency	613852	_	3
136840	_	_	_	_	_
136850	1q43	Fumarase deficiency	606812	AR	3
136850	1q43	Leiomyomatosis and renal cell cancer	150800	AD	3
136870	_	_	_	_	_
136880	_	_	_	_	_
136890	_	_	_	_	_
136900	22q12.3	Sorsby fundus dystrophy	136900	AD	3
136950	_	_	_	_	_
137000	_	_	_	_	_
137010	_	_	_	_	_
137020	_	_	_	_	_
137025	_	_	_	_	_
137026	_	_	_	_	_
137028	_	_	_	_	_
137030	_	_	_	_	_
137033	_	_	_	_	_
137035	11q13.2	?Epilepsy, familial temporal lobe, 8	616461	AD	3
137040	_	_	_	_	_
137050	_	_	_	_	_
137060	9p21.1	Congenital disorder of glycosylation, type IId	607091	AR	3
137061	_	_	_	_	_
137070	16p11.2	Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia	608030	_	3
137070	16p11.2	Essential tremor, hereditary, 4	614782	AD	3
137100	6p21.3	Immunoglobulin A deficiency	137100	AD,AR,IC	2
137130	_	_	_	_	_
137140	4p12	{Alcohol dependence, susceptibility to}	103780	Mu	3
137141	_	_	_	_	_
137142	_	_	_	_	_
137143	_	_	_	_	_
137150	16p13.2	GABA-transaminase deficiency	613163	AR	3
137160	5q34	Epileptic encephalopathy, early infantile, 19	615744	AD	3
137160	5q34	{Epilepsy, childhood absence, susceptibility to, 4}	611136	_	3
137160	5q34	{Epilepsy, juvenile myoclonic, susceptibility to, 5}	611136	_	3
137161	_	_	_	_	_
137162	_	_	_	_	_
137163	1p36.33	{Epilepsy, generalized, with febrile seizures plus, type 5, susceptibility to}	613060	AD	3
137163	1p36.33	{Epilepsy, idiopathic generalized, 10}	613060	AD	3
137163	1p36.33	{Epilepsy, juvenile myoclonic, susceptibility to}	613060	AD	3
137164	5q34	Epilepsy, generalized, with febrile seizures plus, type 3	607681	AD	3
137164	5q34	Epileptic encephalopathy, early infantile, 74	618396	AD	3
137164	5q34	Febrile seizures, familial, 8	607681	AD	3
137165	3p25.3	Myoclonic-atonic epilepsy	616421	AD	3
137166	_	_	_	_	_
137167	2p11.2	Pseudoxanthoma elasticum-like disorder with multiple coagulation factor deficiency	610842	_	3
137167	2p11.2	Vitamin K-dependent clotting factors, combined deficiency of, 1	277450	AR	3
137168	_	_	_	_	_
137170	_	_	_	_	_
137181	22q11.21	[Gamma-glutamyltransferase, familial high serum]	137181	_	2
137190	4p12	Epileptic encephalopathy, early infantile, 45	617153	AD	3
137192	15q12	Epileptic encephalopathy, early infantile, 43	617113	AD	3
137192	15q12	{Epilepsy, childhood absence, susceptibility to, 5}	612269	_	3
137200	5q23.3	Neuromyotonia and axonal neuropathy, autosomal recessive	137200	AR	3
137207	_	_	_	_	_
137210	_	_	_	_	_
137215	_	_	_	_	_
137216	_	_	_	_	_
137217	_	_	_	_	_
137220	_	_	_	_	_
137240	_	_	_	_	_
137241	19q13.32	[Plasma glucose, 2-hour, QTL 2]	137241	_	2
137245	1p22.3	Lymphoma, MALT, somatic	137245	_	3
137250	_	_	_	_	_
137260	_	_	_	_	_
137270	_	_	_	_	_
137280	_	_	_	_	_
137290	1p32.1	Corneal dystrophy, gelatinous drop-like	204870	AR	3
137295	3q21.3	Emberger syndrome	614038	AD	3
137295	3q21.3	Immunodeficiency 21	614172	AD	3
137295	3q21.3	{Leukemia, acute myeloid, susceptibility to}	601626	AD,SMu	3
137295	3q21.3	{Myelodysplastic syndrome, susceptibility to}	614286	_	3
137350	9q33.2	Amyloidosis, Finnish type	105120	AD	3
137357	_	_	_	_	_
137360	_	_	_	_	_
137370	_	_	_	_	_
137400	_	_	_	_	_
137440	_	_	_	_	_
137500	_	_	_	_	_
137550	_	_	_	_	_
137560	_	_	_	_	_
137570	_	_	_	_	_
137575	_	_	_	_	_
137580	11q23	Tourette syndrome	137580	AD	2
137600	4q25	Anterior segment dysgenesis 4	137600	AD	3
137700	_	_	_	_	_
137750	1q24.3	Glaucoma 1A, primary open angle	137750	AD	3
137760	10p13	Glaucoma 1, open angle, E	137760	AD	3
137763	_	_	_	_	_
137765	_	_	_	_	_
137780	17q21.31	Alexander disease	203450	AD	3
137800	_	_	_	_	_
137900	_	_	_	_	_
137920	17q12	Renal cysts and diabetes syndrome	137920	AD	3
137940	20q13.33	Hypotrichosis-lymphedema-telangiectasia-renal defect syndrome	137940	AD	3
137950	1q32	Glomerulopathy with fibronectin deposits 1	137950	AD	2
137960	2p23.3	Charcot-Marie-Tooth disease, axonal, type 2EE	618400	AR	3
137960	2p23.3	Mitochondrial DNA depletion syndrome 6 (hepatocerebral type)	256810	AR	3
138000	1p22.1	Glomuvenous malformations	138000	AD	3
138030	2q24.2	[?Hyperproglucagonemia]	_	_	1
138032	_	_	_	_	_
138033	17q25.3	{Diabetes mellitus, noninsulin-dependent}	125853	AD	3
138035	_	_	_	_	_
138040	5q31.3	Glucocorticoid resistance	615962	AD	3
138060	_	_	_	_	_
138070	_	_	_	_	_
138079	7p13	Diabetes mellitus, noninsulin-dependent, late onset	125853	AD	3
138079	7p13	Diabetes mellitus, permanent neonatal	606176	AD,AR	3
138079	7p13	Hyperinsulinemic hypoglycemia, familial, 3	602485	AD	3
138079	7p13	MODY, type II	125851	AD	3
138090	1p36.22	Cortisone reductase deficiency 1	604931	AR	3
138100	_	_	_	_	_
138110	_	_	_	_	_
138120	_	_	_	_	_
138130	10q23.2	Hyperinsulinism-hyperammonemia syndrome	606762	AD	3
138140	1p34.2	Dystonia 9	601042	AD	3
138140	1p34.2	GLUT1 deficiency syndrome 1, infantile onset, severe	606777	AD,AR	3
138140	1p34.2	GLUT1 deficiency syndrome 2, childhood onset	612126	AD	3
138140	1p34.2	Stomatin-deficient cryohydrocytosis with neurologic defects	608885	AD	3
138140	1p34.2	{Epilepsy, idiopathic generalized, susceptibility to, 12}	614847	AD	3
138150	_	_	_	_	_
138160	3q26.2	Fanconi-Bickel syndrome	227810	AR	3
138160	3q26.2	{Diabetes mellitus, noninsulin-dependent}	125853	AD	3
138170	_	_	_	_	_
138180	10q24.2	Aspartate aminotransferase, serum level of, QTL1	614419	_	3
138190	_	_	_	_	_
138200	_	_	_	_	_
138210	16q11.2	Mental retardation, autosomal recessive 49	616281	AR	3
138220	_	_	_	_	_
138230	_	_	_	_	_
138240	_	_	_	_	_
138243	_	_	_	_	_
138244	6q16.3	Mental retardation, autosomal recessive, 6	611092	AR	3
138245	_	_	_	_	_
138246	11q22.3	Neurodevelopmental disorder with or without seizures and gait abnormalities	617864	AD	3
138247	_	_	_	_	_
138248	_	_	_	_	_
138249	9q34.3	Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant	614254	AD	3
138249	9q34.3	Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal recessive	617820	AR	3
138250	10q24.1	Cutis laxa, autosomal dominant 3	616603	AD	3
138250	10q24.1	Cutis laxa, autosomal recessive, type IIIA	219150	AR	3
138250	10q24.1	Spastic paraplegia 9A, autosomal dominant	601162	AD	3
138250	10q24.1	Spastic paraplegia 9B, autosomal recessive	616586	AR	3
138251	_	_	_	_	_
138252	12p13.1	Epileptic encephalopathy, early infantile, 27	616139	AD	3
138252	12p13.1	Mental retardation, autosomal dominant 6	613970	AD	3
138253	16p13.2	Epilepsy, focal, with speech disorder and with or without mental retardation	245570	AD	3
138254	_	_	_	_	_
138270	_	_	_	_	_
138275	_	_	_	_	_
138276	_	_	_	_	_
138277	_	_	_	_	_
138280	2q32.2	?Infantile cataract, skin abnormalities, glutamate excess, and impaired intellectual development	618339	AD	3
138280	2q32.2	Epileptic encephalopathy, early infantile, 71	618328	AR	3
138280	2q32.2	Global developmental delay, progressive ataxia, and elevated glutamine	618312	_	3
138290	1q25.3	Glutamine deficiency, congenital	610015	AR	3
138292	2p13.3	Myasthenia, congenital, 12, with tubular aggregates	610542	AR	3
138295	1q41	Leukodystrophy, hypomyelinating, 15	617951	AR	3
138297	_	_	_	_	_
138300	8p12	Hemolytic anemia due to glutathione reductase deficiency	_	_	1
138319	_	_	_	_	_
138320	3p21.31	Hemolytic anemia due to glutathione peroxidase deficiency	614164	AR	1
138321	_	_	_	_	_
138322	19p13.3	Spondylometaphyseal dysplasia, Sedaghatian type	250220	AR	3
138330	_	_	_	_	_
138333	_	_	_	_	_
138335	_	_	_	_	_
138340	_	_	_	_	_
138350	_	_	_	_	_
138359	_	_	_	_	_
138360	_	_	_	_	_
138370	_	_	_	_	_
138380	_	_	_	_	_
138385	_	_	_	_	_
138390	_	_	_	_	_
138391	_	_	_	_	_
138400	_	_	_	_	_
138420	12q13.12	Hypertriglyceridemia, transient infantile	614480	AR	3
138430	2q24.1	{Diabetes, type 2, susceptibility to}	125853	AD	3
138440	_	_	_	_	_
138450	_	_	_	_	_
138470	6p21.33	?Complement factor B deficiency	615561	_	3
138470	6p21.33	{Hemolytic uremic syndrome, atypical, susceptibility to, 4}	612924	AD	3
138470	6p21.33	{Macular degeneration, age-related, 14, reduced risk of}	615489	_	3
138480	_	_	_	_	_
138491	5q33.1	Hyperekplexia 1	149400	AD,AR	3
138492	4q32.1	Hyperekplexia 2	614619	AR	3
138500	_	_	_	_	_
138550	_	_	_	_	_
138570	19q13.33	Glycogen storage disease 0, muscle	611556	AR	3
138571	12p12.1	Glycogen storage disease 0, liver	240600	AR	3
138590	_	_	_	_	_
138600	_	_	_	_	_
138610	_	_	_	_	_
138670	_	_	_	_	_
138680	3q27.3	?Alopecia-mental retardation syndrome 1	203650	AR	3
138700	_	_	_	_	_
138710	_	_	_	_	_
138720	22q11.21	Bernard-Soulier syndrome, type B	231200	AR	3
138720	22q11.21	Giant platelet disorder, isolated	231200	AR	3
138750	_	_	_	_	_
138760	16p13.3	[Glyoxalase II deficiency]	614033	AD	1
138770	_	_	_	_	_
138790	_	_	_	_	_
138800	14q32.13	Goiter, multinodular 1, with or without Sertoli-Leydig cell tumors	138800	AD	3
138850	4q13.2	Hypogonadotropic hypogonadism 7 without anosmia	146110	AR	3
138890	14q32.13	Short stature, auditory canal atresia, mandibular hypoplasia, skeletal abnormalities	602471	AR	3
138900	4q22.1	[Uric acid concentration, serum, QTL1]	138900	?AD	3
138920	_	_	_	_	_
138930	_	_	_	_	_
138945	17q21.31	Aphasia, primary progressive	607485	AD	3
138945	17q21.31	Ceroid lipofuscinosis, neuronal, 11	614706	AR	3
138945	17q21.31	Frontotemporal lobar degeneration with ubiquitin-positive inclusions	607485	AD	3
138960	_	_	_	_	_
138965	_	_	_	_	_
138970	_	_	_	_	_
138971	1p34.3	Neutropenia, severe congenital, 7, autosomal recessive	617014	AR	3
138972	_	_	_	_	_
138981	22q12.3	Surfactant metabolism dysfunction, pulmonary, 5	614370	AR	3
138990	_	_	_	_	_
139000	_	_	_	_	_
139080	_	_	_	_	_
139090	3p21.31	Gray platelet syndrome	139090	AR	3
139100	_	_	_	_	_
139110	_	_	_	_	_
139111	_	_	_	_	_
139130	12p13.31	Night blindness, congenital stationary, type 1H	617024	AR	3
139130	12p13.31	{Hypertension, essential, susceptibility to}	145500	Mu	3
139139	_	_	_	_	_
139145	_	_	_	_	_
139150	5q14.3	Basal cell carcinoma, somatic	605462	_	3
139150	5q14.3	Capillary malformation-arteriovenous malformation 1	608354	AD	3
139160	_	_	_	_	_
139180	_	_	_	_	_
139185	_	_	_	_	_
139190	20q11.23	?Isolated growth hormone deficiency due to defect in GHRF	_	_	1
139190	20q11.23	Gigantism due to GHRF hypersecretion	_	_	1
139191	7p14.3	Growth hormone deficiency, isolated, type IV	618157	_	3
139200	_	_	_	_	_
139210	18q21.2	Myhre syndrome	139210	AD	3
139220	_	_	_	_	_
139230	_	_	_	_	_
139240	_	_	_	_	_
139250	17q23.3	Growth hormone deficiency, isolated, type IA	262400	AR	3
139250	17q23.3	Growth hormone deficiency, isolated, type IB	612781	_	3
139250	17q23.3	Growth hormone deficiency, isolated, type II	173100	AD	3
139250	17q23.3	Kowarski syndrome	262650	AR	3
139255	_	_	_	_	_
139259	_	_	_	_	_
139260	_	_	_	_	_
139265	_	_	_	_	_
139270	_	_	_	_	_
139280	_	_	_	_	_
139290	_	_	_	_	_
139300	15q21.2	Aromatase excess syndrome	139300	AD	3
139310	_	_	_	_	_
139311	16q13	Epileptic encephalopathy, early infantile, 17	615473	AD	3
139311	16q13	Neurodevelopmental disorder with involuntary movements	617493	AD	3
139312	18p11.21	Dystonia 25	615073	AD	3
139313	19p13.3	Hypocalcemia, autosomal dominant 2	615361	AD	3
139313	19p13.3	Hypocalciuric hypercalcemia, type II	145981	AD	3
139314	_	_	_	_	_
139320	20q13.32	ACTH-independent macronodular adrenal hyperplasia	219080	SMu	3
139320	20q13.32	McCune-Albright syndrome, somatic, mosaic	174800	_	3
139320	20q13.32	Osseous heteroplasia, progressive	166350	AD	3
139320	20q13.32	Pituitary adenoma 3, multiple types, somatic	617686	_	3
139320	20q13.32	Pseudohypoparathyroidism Ia	103580	AD	3
139320	20q13.32	Pseudohypoparathyroidism Ib	603233	AD	3
139320	20q13.32	Pseudohypoparathyroidism Ic	612462	AD	3
139320	20q13.32	Pseudopseudohypoparathyroidism	612463	AD	3
139330	3p21.31	Night blindness, congenital stationary, autosomal dominant 3	610444	AD	3
139330	3p21.31	Night blindness, congenital stationary, type 1G	616389	AR	3
139340	1p13.3	Achromatopsia 4	613856	_	3
139350	12q13.13	Epidermolytic hyperkeratosis	113800	AD,AR	3
139350	12q13.13	Ichthyosis histrix, Curth-Macklin type	146590	AD	3
139350	12q13.13	Ichthyosis, cyclic, with epidermolytic hyperkeratosis	607602	AD	3
139350	12q13.13	Keratosis palmoplantaris striata III	607654	_	3
139350	12q13.13	Palmoplantar keratoderma, epidermolytic	144200	AD	3
139350	12q13.13	Palmoplantar keratoderma, nonepidermolytic	600962	AD	3
139360	3p21.31	Pituitary ACTH-secreting adenoma	_	_	3
139360	3p21.31	Ventricular tachycardia, idiopathic	192605	AD	3
139370	1p13.3	Auriculocondylar syndrome 1	602483	AD	3
139380	1p36.33	Leukemia, acute lymphoblastic, somatic	613065	_	3
139380	1p36.33	Mental retardation, autosomal dominant 42	616973	AD	3
139390	_	_	_	_	_
139391	_	_	_	_	_
139392	_	_	_	_	_
139393	17p12	?Neuropathy, inflammatory demyelinating	139393	?AD	3
139395	_	_	_	_	_
139396	4q32.1	Moyamoya 6 with achalasia	615750	AR	3
139397	_	_	_	_	_
139400	_	_	_	_	_
139450	1q21.3	Hair, curly	139450	AD	2
139500	_	_	_	_	_
139600	_	_	_	_	_
139605	_	_	_	_	_
139630	_	_	_	_	_
139650	_	_	_	_	_
139750	_	_	_	_	_
139800	_	_	_	_	_
139900	2p12-q22	[Handedness]	139900	AD	2
140000	7p15.2	Hand-foot-uterus syndrome	140000	AD	3
140050	_	_	_	_	_
140090	_	_	_	_	_
140100	16q22.2	[Anhaptoglobinemia]	614081	_	3
140100	16q22.2	[Hypohaptoglobinemia]	614081	_	3
140210	_	_	_	_	_
140300	8q23-q24	Hashimoto thyroiditis	140300	AD	2
140340	_	_	_	_	_
140350	12q24.31	Hawkinsinuria	140350	AD	3
140400	1q32	Progressive familial heart block, type II	140400	AD	2
140450	_	_	_	_	_
140500	_	_	_	_	_
140550	_	_	_	_	_
140555	_	_	_	_	_
140556	_	_	_	_	_
140559	_	_	_	_	_
140560	_	_	_	_	_
140570	_	_	_	_	_
140571	_	_	_	_	_
140572	_	_	_	_	_
140573	_	_	_	_	_
140574	_	_	_	_	_
140575	_	_	_	_	_
140576	_	_	_	_	_
140580	_	_	_	_	_
140581	_	_	_	_	_
140600	2p24.1	{Osteoarthritis susceptibility 2}	140600	AD	3
140700	_	_	_	_	_
140750	_	_	_	_	_
140850	_	_	_	_	_
140900	_	_	_	_	_
141000	_	_	_	_	_
141180	_	_	_	_	_
141200	_	_	_	_	_
141250	22q12.3	Heme oxygenase-1 deficiency	614034	_	3
141250	22q12.3	{Pulmonary disease, chronic obstructive, susceptibility to}	606963	_	3
141251	_	_	_	_	_
141300	_	_	_	_	_
141350	_	_	_	_	_
141400	_	_	_	_	_
141405	_	_	_	_	_
141500	_	_	_	_	_
141700	_	_	_	_	_
141749	_	_	_	_	_
141750	16pter-p13.3	Alpha-thalassemia/mental retardation syndrome, type 1	141750	AD	4
141800	16p13.3	Erythrocytosis, 7	617981	_	3
141800	16p13.3	Heinz body anemias, alpha-	140700	AD	3
141800	16p13.3	Hemoglobin H disease, nondeletional	613978	_	3
141800	16p13.3	Methemoglobinemia, alpha type	617973	_	3
141800	16p13.3	Thalassemias, alpha-	604131	_	3
141850	16p13.3	Erythrocytosis 7	617981	_	3
141850	16p13.3	Heinz body anemia	140700	AD	3
141850	16p13.3	Hemoglobin H disease, deletional and nondeletional	613978	_	3
141850	16p13.3	Thalassemia, alpha-	604131	_	3
141860	_	_	_	_	_
141900	11p15.4	Delta-beta thalassemia	141749	AD	3
141900	11p15.4	Erythrocytosis 6	617980	_	3
141900	11p15.4	Heinz body anemia	140700	AD	3
141900	11p15.4	Hereditary persistence of fetal hemoglobin	141749	AD	3
141900	11p15.4	Methmoglobinemia, beta type	617971	_	3
141900	11p15.4	Sickle cell anemia	603903	AR	3
141900	11p15.4	Thalassemia, beta	613985	_	3
141900	11p15.4	Thalassemia-beta, dominant inclusion-body	603902	_	3
141900	11p15.4	{Malaria, resistance to}	611162	_	3
141940	_	_	_	_	_
142000	11p15.4	Thalassemia due to Hb Lepore	_	_	3
142000	11p15.4	Thalassemia, delta-	_	_	3
142100	_	_	_	_	_
142200	11p15.4	Fetal hemoglobin quantitative trait locus 1	141749	AD	3
142210	_	_	_	_	_
142220	6p22.2	Rahman syndrome	617537	AD	3
142230	_	_	_	_	_
142240	_	_	_	_	_
142250	11p15.4	Cyanosis, transient neonatal	613977	AD	3
142250	11p15.4	Fetal hemoglobin quantitative trait locus 1	141749	AD	3
142270	_	_	_	_	_
142290	_	_	_	_	_
142300	_	_	_	_	_
142309	_	_	_	_	_
142310	_	_	_	_	_
142330	12q24.31	Hepatic adenoma, somatic	142330	_	3
142333	_	_	_	_	_
142335	2p16.1	[Fetal hemoglobin QTL5]	142335	AD	2
142340	15q26.1	Hernia, congenital diaphragmatic 1	142340	Mu	2
142350	_	_	_	_	_
142360	22q11.21	Thrombophilia due to heparin cofactor II deficiency	612356	AD	3
142370	_	_	_	_	_
142380	_	_	_	_	_
142385	_	_	_	_	_
142390	_	_	_	_	_
142395	_	_	_	_	_
142400	_	_	_	_	_
142408	_	_	_	_	_
142409	7q21.11	Deafness, autosomal recessive 39	608265	AR	3
142410	12q24.31	Diabetes mellitus, insulin-dependent, 20	612520	_	3
142410	12q24.31	Hepatic adenoma, somatic	142330	_	3
142410	12q24.31	MODY, type III	600496	AD	3
142410	12q24.31	Renal cell carcinoma	144700	_	3
142410	12q24.31	{Diabetes mellitus, insulin-dependent}	222100	AR	3
142410	12q24.31	{Diabetes mellitus, noninsulin-dependent, 2}	125853	AD	3
142420	_	_	_	_	_
142440	_	_	_	_	_
142445	8p12	{?Schizophrenia, susceptibility to}	603013	_	1
142450	_	_	_	_	_
142460	_	_	_	_	_
142461	1p36.12	Dyssegmental dysplasia, Silverman-Handmaker type	224410	AR	3
142461	1p36.12	Schwartz-Jampel syndrome, type 1	255800	AR	3
142470	6q22.3-q23.1	Fetal hemoglobin quantitative trait locus 2	142470	AD	2
142500	_	_	_	_	_
142510	_	_	_	_	_
142550	_	_	_	_	_
142560	_	_	_	_	_
142570	_	_	_	_	_
142580	_	_	_	_	_
142590	_	_	_	_	_
142600	10q22.1	Hemolytic anemia due to hexokinase deficiency	235700	AR	3
142600	10q22.1	Neuropathy, hereditary motor and sensory, Russe type	605285	AR	3
142600	10q22.1	Retinitis pigmentosa 79	617460	AD	3
142610	_	_	_	_	_
142620	_	_	_	_	_
142622	1p35.1	Dystonia 2, torsion, autosomal recessive	224500	AR	3
142623	_	_	_	_	_
142625	_	_	_	_	_
142630	_	_	_	_	_
142640	3q27.3	Thrombophilia due to elevated HRG	613116	AD	1
142640	3q27.3	Thrombophilia due to HRG deficiency	613116	AD	3
142660	_	_	_	_	_
142669	4q35.1	?Hip dysplasia, Beukes type	142669	AD	3
142680	12p13.31	Periodic fever, familial	142680	AD	3
142690	1q23.2	Acne inversa, familial, 1	142690	AD	3
142695	_	_	_	_	_
142700	13q22	Developmental dysplasia of the hip 1	142700	Mu	2
142701	_	_	_	_	_
142702	_	_	_	_	_
142703	_	_	_	_	_
142704	15q21.2	{Gilles de la Tourette syndrome, susceptibility to}	137580	AD	3
142705	_	_	_	_	_
142708	_	_	_	_	_
142709	_	_	_	_	_
142710	_	_	_	_	_
142711	_	_	_	_	_
142712	_	_	_	_	_
142720	_	_	_	_	_
142730	_	_	_	_	_
142750	_	_	_	_	_
142760	_	_	_	_	_
142763	_	_	_	_	_
142765	_	_	_	_	_
142770	_	_	_	_	_
142780	_	_	_	_	_
142790	_	_	_	_	_
142795	_	_	_	_	_
142800	6p22.1	{Hypersensitivity syndrome, carbamazepine-induced, susceptibility to}	608579	_	3
142810	5q31.3	Charcot-Marie-Tooth disease, axonal, type 2W	616625	AD	3
142810	5q31.3	Usher syndrome type 3B	614504	AR	3
142830	6p21.33	{Abacavir hypersensitivity, susceptibility to}	_	_	3
142830	6p21.33	{Drug-induced liver injury due to flucloxacillin}	_	_	3
142830	6p21.33	{Spondyloarthropathy, susceptibility to, 1}	106300	Mu	3
142830	6p21.33	{Stevens-Johnson syndrome, susceptibility to}	608579	_	3
142830	6p21.33	{Synovitis, chronic, susceptibility to}	_	_	3
142830	6p21.33	{Toxic epidermal necrolysis, susceptibility to}	608579	_	3
142840	6p21.33	{HIV-1 viremia, susceptibility to}	609423	_	3
142840	6p21.33	{Psoriasis susceptibility 1}	177900	Mu	3
142850	_	_	_	_	_
142855	_	_	_	_	_
142856	_	_	_	_	_
142857	6p21.32	{Multiple sclerosis, susceptibility to, 1}	126200	Mu	3
142857	6p21.32	{Sarcoidosis, susceptibility to, 1}	181000	AD	3
142858	6p21.32	{Beryllium disease, chronic, susceptibility to}	_	_	3
142860	_	_	_	_	_
142870	_	_	_	_	_
142871	6p22.1	{Asthma, susceptibility to}	600807	AD	2
142880	_	_	_	_	_
142890	_	_	_	_	_
142900	12q24.21	Holt-Oram syndrome	142900	AD	3
142910	5q13.3	[Low density lipoprotein cholesterol level QTL 3]	_	_	3
142910	5q13.3	[Statins, attenuated cholesterol lowering by]	_	_	3
142920	_	_	_	_	_
142925	_	_	_	_	_
142930	_	_	_	_	_
142940	_	_	_	_	_
142945	7q36.3	Holoprosencephaly 3	142945	AD	3
142946	18p11.31	Holoprosencephaly 4	142946	AD	3
142950	_	_	_	_	_
142951	_	_	_	_	_
142952	_	_	_	_	_
142953	_	_	_	_	_
142954	_	_	_	_	_
142955	7p15.2	Athabaskan brainstem dysgenesis syndrome	601536	_	3
142955	7p15.2	Bosley-Salih-Alorainy syndrome	601536	_	3
142956	_	_	_	_	_
142957	_	_	_	_	_
142958	7p15.2	Radioulnar synostosis with amegakaryocytic thrombocytopenia 1	605432	AD	3
142959	7p15.2	?Guttmacher syndrome	176305	AD	3
142959	7p15.2	Hand-foot-uterus syndrome	140000	AD	3
142960	_	_	_	_	_
142961	_	_	_	_	_
142962	_	_	_	_	_
142963	_	_	_	_	_
142964	_	_	_	_	_
142965	_	_	_	_	_
142966	_	_	_	_	_
142967	_	_	_	_	_
142968	17q21.32	Facial paresis, hereditary congenital, 3	614744	AR	3
142970	_	_	_	_	_
142971	_	_	_	_	_
142972	_	_	_	_	_
142973	_	_	_	_	_
142974	_	_	_	_	_
142975	_	_	_	_	_
142976	12q13.13	Ectodermal dysplasia 9, hair/nail type	614931	AR	3
142980	_	_	_	_	_
142981	_	_	_	_	_
142982	_	_	_	_	_
142983	4p16.2	Ectodermal dysplasia 3, Witkop type	189500	AD	3
142983	4p16.2	Orofacial cleft 5	608874	_	3
142983	4p16.2	Tooth agenesis, selective, 1, with or without orofacial cleft	106600	AD	3
142984	2q31.1	Charcot-Marie-Tooth disease, foot deformity of	192950	AD	3
142984	2q31.1	Vertical talus, congenital	192950	AD	3
142985	_	_	_	_	_
142986	_	_	_	_	_
142987	_	_	_	_	_
142988	_	_	_	_	_
142989	2q31.1	?Brachydactyly-syndactyly syndrome	610713	_	3
142989	2q31.1	Brachydactyly, type D	113200	AD	3
142989	2q31.1	Brachydactyly, type E	113300	AD	3
142989	2q31.1	Syndactyly, type V	186300	AD	3
142989	2q31.1	Synpolydactyly 1	186000	AD	3
142990	_	_	_	_	_
142991	_	_	_	_	_
142992	4p16.1	Oculoauricular syndrome	612109	AR	3
142993	14q24.3	Microphthalmia with coloboma 3	610092	_	3
142993	14q24.3	Microphthalmia, isolated 2	610093	_	3
142994	7q36.3	Currarino syndrome	176450	AD	3
142995	_	_	_	_	_
142996	_	_	_	_	_
143000	_	_	_	_	_
143010	_	_	_	_	_
143020	_	_	_	_	_
143023	_	_	_	_	_
143024	_	_	_	_	_
143025	_	_	_	_	_
143030	_	_	_	_	_
143040	_	_	_	_	_
143050	_	_	_	_	_
143054	6q24.2	Mental retardation, autosomal dominant 43	616977	AD	3
143055	_	_	_	_	_
143060	_	_	_	_	_
143065	_	_	_	_	_
143070	_	_	_	_	_
143080	_	_	_	_	_
143089	_	_	_	_	_
143090	_	_	_	_	_
143095	10q22.1	Spondyloepiphyseal dysplasia with congenital joint dislocations	143095	AR	3
143100	4p16.3	Huntington disease	143100	AD	3
143110	_	_	_	_	_
143150	_	_	_	_	_
143170	_	_	_	_	_
143200	5q14.2-q14.3	Wagner syndrome 1	143200	AD	3
143400	6q14.3	Congenital anomalies of kidney and urinary tract 2	143400	AD	3
143450	2p23.3	Trifunctional protein deficiency	609015	AR	3
143460	_	_	_	_	_
143465	_	_	_	_	_
143470	_	_	_	_	_
143500	2q37.1	[Gilbert syndrome]	143500	AR	3
143850	18q	Orthostatic hypotensive disorder of Streeten	143850	AD	2
143860	15q22.2	Hyperchlorhidrosis, isolated	143860	AR	3
143870	1q24.2	{Hypercalciuria, absorptive, susceptibility to}	143870	AD	3
143880	20q13.2	Hypercalcemia, infantile, 1	143880	AR	3
143890	_	_	_	_	_
144010	2p24.1	Hypercholesterolemia, familial, 2	144010	AD	3
144020	_	_	_	_	_
144050	_	_	_	_	_
144100	_	_	_	_	_
144110	14q11.2-q13	Hyperhidrosis palmaris et plantaris	144110	AD	2
144120	14q32.33	?Hyperimmunoglobulin G1 syndrome	144120	AD	2
144150	_	_	_	_	_
144190	_	_	_	_	_
144200	_	_	_	_	_
144250	8p21.3	Combined hyperlipidemia, familial	144250	AD	3
144300	_	_	_	_	_
144400	_	_	_	_	_
144600	_	_	_	_	_
144650	11q23.3	Hyperchylomicronemia, late-onset	144650	AD	3
144700	_	_	_	_	_
144750	_	_	_	_	_
144755	8p21.3	?Hyperostosis cranalis interna	144755	AD	3
144800	_	_	_	_	_
145000	1q31.2	Hyperparathyroidism, familial primary	145000	AD	3
145001	_	_	_	_	_
145100	_	_	_	_	_
145200	_	_	_	_	_
145250	12q21.32	Hyperpigmentation with or without hypopigmentation	145250	AD	3
145260	1q31-q42	Pseudohypoaldosteronism, type IIA	145260	AD	2
145270	_	_	_	_	_
145290	_	_	_	_	_
145295	_	_	_	_	_
145300	_	_	_	_	_
145350	_	_	_	_	_
145400	_	_	_	_	_
145410	22q11.23	Opitz GBBB syndrome, type II	145410	AD	3
145420	22q11.23	Hypertelorism, Teebi type	145420	AD	3
145500	_	_	_	_	_
145505	16p12.3	{?Hypertension, essential}	_	_	1
145590	_	_	_	_	_
145600	_	_	_	_	_
145650	3p24.2	Thyroid hormone resistance, selective pituitary	145650	AD	3
145680	18q12.1	[Dystransthyretinemic hyperthyroxinemia]	145680	AD	3
145700	_	_	_	_	_
145701	8q22	?Hypertrichosis universalis congenita, Ambras type	145701	AD	2
145750	11q23.3	{Hypertriglyceridemia, susceptibility to}	145750	AD	3
145800	_	_	_	_	_
145900	_	_	_	_	_
145980	3q13.3-q21.1	Hypocalciuric hypercalcemia, type I	145980	AD	3
145981	19p13.3	Hypocalciuric hypercalcemia, type II	145981	AD	3
146000	4p16.3	Hypochondroplasia	146000	AD	3
146110	4q13.2	Hypogonadotropic hypogonadism 7 without anosmia	146110	AR	3
146150	_	_	_	_	_
146160	_	_	_	_	_
146200	_	_	_	_	_
146255	10p14	Hypoparathyroidism, sensorineural deafness, and renal dysplasia	146255	AD	3
146300	_	_	_	_	_
146350	_	_	_	_	_
146390	18p	Chromosome 18p deletion syndrome	146390	AD	4
146400	_	_	_	_	_
146450	7q32.2-q36.1	Hypospadias 3, autosomal	146450	AD,Mu	2
146500	4q21.23	{Multiple system atrophy, susceptibility to}	146500	AD,AR	3
146510	7p14.1	Pallister-Hall syndrome	146510	AD	3
146520	6p21.33	Hypotrichosis 2	146520	AD	3
146530	_	_	_	_	_
146550	8p21.3	Hypotrichosis 4	146550	AD	3
146580	_	_	_	_	_
146590	12q13.13	Ichthyosis histrix, Curth-Macklin type	146590	AD	3
146600	_	_	_	_	_
146630	_	_	_	_	_
146631	_	_	_	_	_
146640	_	_	_	_	_
146650	_	_	_	_	_
146660	8q21.13	{?Epidermodysplasia verruciformis, susceptibility to, 5}	618309	AR	3
146661	5p13.2	Severe combined immunodeficiency, T-cell negative, B-cell/natural killer cell-positive type	608971	AR	3
146680	_	_	_	_	_
146690	7q32.1	Leber congenital amaurosis 11	613837	AD	3
146690	7q32.1	Retinitis pigmentosa 10	180105	AD	3
146691	3p21.31	[IMPDH2 enzyme activity, variation in]	617995	_	3
146692	_	_	_	_	_
146700	1q21.3	Ichthyosis vulgaris	146700	AD	3
146710	_	_	_	_	_
146720	_	_	_	_	_
146730	_	_	_	_	_
146731	_	_	_	_	_
146732	_	_	_	_	_
146733	_	_	_	_	_
146734	_	_	_	_	_
146735	_	_	_	_	_
146738	19p13.11	Cryptorchidism	219050	AD	3
146740	1q23.3	Immunodeficiency 20	615707	AR	3
146750	_	_	_	_	_
146760	1q21.2	[IgG receptor I, phagocytic, familial deficiency of]	_	_	3
146770	22q11.23	Agammaglobulinemia 2	613500	AR	3
146771	_	_	_	_	_
146780	_	_	_	_	_
146790	1q23.3	{Lupus nephritis, susceptibility to}	152700	AD	3
146790	1q23.3	{Malaria, severe, susceptibility to}	611162	_	3
146790	1q23.3	{Pseudomonas aeruginosa, susceptibility to chronic infection by, in cystic fibrosis}	219700	AR	3
146800	12q13.13	Ichthyosis bullosa of Siemens	146800	AD	3
146810	_	_	_	_	_
146820	_	_	_	_	_
146830	_	_	_	_	_
146840	_	_	_	_	_
146850	_	_	_	_	_
146880	6p21.32	{Celiac disease, susceptibility to}	212750	AR,Mu	3
146900	_	_	_	_	_
146910	_	_	_	_	_
146920	1q21.3	Aicardi-Goutieres syndrome 6	615010	AR	3
146920	1q21.3	Dyschromatosis symmetrica hereditaria	127400	AD	3
146928	_	_	_	_	_
146929	2q35	{AIDS, slow progression to}	609423	_	3
146930	_	_	_	_	_
146931	_	_	_	_	_
146932	_	_	_	_	_
146933	11q23.3	Inflammatory bowel disease 28, early onset, autosomal recessive	613148	AR	3
146940	_	_	_	_	_
146950	_	_	_	_	_
146960	_	_	_	_	_
146970	_	_	_	_	_
146980	_	_	_	_	_
146990	_	_	_	_	_
147000	_	_	_	_	_
147010	_	_	_	_	_
147020	14q32.33	Agammaglobulinemia 1	601495	AR	3
147040	_	_	_	_	_
147045	_	_	_	_	_
147050	_	_	_	_	_
147060	17q21.2	Hyper-IgE recurrent infection syndrome	147060	AD	3
147061	5q31.1	{?Allergy and asthma susceptibility}	147061	_	2
147070	_	_	_	_	_
147080	_	_	_	_	_
147090	_	_	_	_	_
147100	_	_	_	_	_
147110	14q32.33	IgG2 deficiency, selective	_	_	3
147120	_	_	_	_	_
147130	_	_	_	_	_
147138	11q12.1	{Atopy, susceptibility to}	147050	AD	3
147139	_	_	_	_	_
147140	_	_	_	_	_
147141	19p13.3	Agammaglobulinemia 8, autosomal dominant	616941	AD	3
147150	_	_	_	_	_
147160	_	_	_	_	_
147170	_	_	_	_	_
147180	_	_	_	_	_
147183	4p15.2	Adams-Oliver syndrome 3	614814	AD	3
147185	_	_	_	_	_
147200	2p11.2	Kappa light chain deficiency	614102	AR	3
147210	_	_	_	_	_
147220	_	_	_	_	_
147230	_	_	_	_	_
147240	_	_	_	_	_
147245	17q23.3	Agammaglobulinemia 6	612692	AR	3
147250	7q36.3	Single median maxillary central incisor	147250	AD	3
147251	_	_	_	_	_
147260	_	_	_	_	_
147263	_	_	_	_	_
147264	_	_	_	_	_
147265	3p26.1	Gillespie syndrome	206700	AD,AR	3
147265	3p26.1	Spinocerebellar ataxia 15	606658	AD	3
147265	3p26.1	Spinocerebellar ataxia 29, congenital nonprogressive	117360	AD	3
147267	6p21.31	{Diabetes, type 1, susceptibility to}	222100	AR	2
147270	_	_	_	_	_
147280	6q25.3	Hepatocellular carcinoma, somatic	114550	_	3
147290	_	_	_	_	_
147300	_	_	_	_	_
147310	_	_	_	_	_
147320	_	_	_	_	_
147330	_	_	_	_	_
147350	_	_	_	_	_
147360	_	_	_	_	_
147370	15q26.3	Insulin-like growth factor I, resistance to	270450	AD,AR	3
147380	_	_	_	_	_
147390	_	_	_	_	_
147400	_	_	_	_	_
147410	_	_	_	_	_
147420	_	_	_	_	_
147421	_	_	_	_	_
147430	14q11.2	?Marsili syndrome	147430	AD	3
147435	_	_	_	_	_
147440	12q23.2	Growth retardation with deafness and mental retardation due to IGF1 deficiency	608747	AR	3
147450	21q22.11	Amyotrophic lateral sclerosis 1	105400	AD,AR	3
147460	6q25.3	{Microvascular complications of diabetes 6}	612634	_	3
147470	11p15.5	?Growth restriction, severe, with distinctive facies	616489	AD	3
147480	18q21.31	Cholestasis, intrahepatic, of pregnancy, 1	147480	AD	3
147485	_	_	_	_	_
147490	_	_	_	_	_
147510	_	_	_	_	_
147520	20p13	Epileptic encephalopathy, early infantile, 35	616647	AR	3
147520	20p13	[Inosine triphosphatase deficiency]	613850	_	3
147521	_	_	_	_	_
147522	_	_	_	_	_
147530	_	_	_	_	_
147540	_	_	_	_	_
147545	2q36.3	{Coronary artery disease, susceptibility to}	_	_	3
147545	2q36.3	{Diabetes mellitus, noninsulin-dependent}	125853	AD	3
147553	_	_	_	_	_
147554	_	_	_	_	_
147556	2q31.1	Epidermolysis bullosa, junctional, with pyloric stenosis	226730	AR	3
147557	17q25.1	Epidermolysis bullosa of hands and feet	131800	AD	3
147557	17q25.1	Epidermolysis bullosa, junctional, non-Herlitz type	226650	AR	3
147557	17q25.1	Epidermolysis bullosa, junctional, with pyloric atresia	226730	AR	3
147558	2q24.2	Amelogenesis imperfecta, type IH	616221	AR	3
147559	_	_	_	_	_
147560	_	_	_	_	_
147561	_	_	_	_	_
147562	_	_	_	_	_
147563	_	_	_	_	_
147564	_	_	_	_	_
147565	_	_	_	_	_
147566	_	_	_	_	_
147567	_	_	_	_	_
147568	_	_	_	_	_
147569	21q22.11	Immunodeficiency 28, mycobacteriosis	614889	AR	3
147570	12q15	{AIDS, rapid progression to}	609423	_	3
147570	12q15	{Aplastic anemia}	609135	_	3
147570	12q15	{Hepatitis C virus, response to therapy of}	609532	_	3
147570	12q15	{TSC2 angiomyolipomas, renal, modifier of}	613254	AD	3
147570	12q15	{Tuberculosis, protection against}	607948	_	3
147571	1p36.33	Immunodeficiency 38	616126	AR	3
147572	_	_	_	_	_
147573	_	_	_	_	_
147574	_	_	_	_	_
147575	5q31.1	Gastric cancer, somatic	613659	_	3
147575	5q31.1	Myelodysplastic syndrome, preleukemic	_	_	3
147575	5q31.1	Myelogenous leukemia, acute	_	_	3
147575	5q31.1	Nonsmall cell lung cancer, somatic	211980	_	3
147576	_	_	_	_	_
147577	_	_	_	_	_
147578	_	_	_	_	_
147579	_	_	_	_	_
147580	_	_	_	_	_
147581	_	_	_	_	_
147582	15q25.1	?Neurodegeneration, early-onset, with choreoathetoid movements and microcytic anemia	618451	AR	3
147583	_	_	_	_	_
147584	_	_	_	_	_
147585	_	_	_	_	_
147586	_	_	_	_	_
147590	_	_	_	_	_
147610	_	_	_	_	_
147620	7p15.3	{Crohn disease-associated growth failure}	266600	Mu	3
147620	7p15.3	{Diabetes, susceptibility to},	222100	AR	3
147620	7p15.3	{Intracranial hemorrhage in brain cerebrovascular malformations, susceptibility to}	108010	AD	3
147620	7p15.3	{Kaposi sarcoma, susceptibility to}	148000	AD	3
147620	7p15.3	{Rheumatoid arthritis, systemic juvenile}	604302	_	3
147625	_	_	_	_	_
147630	8q24.3	Insulinomatosis and diabetes mellitus	147630	AD	3
147640	_	_	_	_	_
147650	15q26.1	D-2-hydroxyglutaric aciduria 2	613657	_	3
147660	9p21.3	Interferon, alpha, deficiency	_	_	1
147670	19p13.2	Diabetes mellitus, insulin-resistant, with acanthosis nigricans	610549	_	3
147670	19p13.2	Hyperinsulinemic hypoglycemia, familial, 5	609968	AD	3
147670	19p13.2	Leprechaunism	246200	AR	3
147670	19p13.2	Rabson-Mendenhall syndrome	262190	AR	3
147671	_	_	_	_	_
147678	_	_	_	_	_
147679	2q14.1	Interleukin 1 receptor antagonist deficiency	612852	AR	3
147679	2q14.1	{Gastric cancer risk after H. pylori infection}	137215	AD	3
147679	2q14.1	{Microvascular complications of diabetes 4}	612628	_	3
147680	_	_	_	_	_
147681	_	_	_	_	_
147683	5q31.1	{Allergic rhinitis, susceptibility to}	607154	_	3
147683	5q31.1	{Asthma, susceptibility to}	600807	AD	3
147684	_	_	_	_	_
147685	_	_	_	_	_
147686	_	_	_	_	_
147690	_	_	_	_	_
147700	2q34	{Glioma, susceptibility to, somatic}	137800	_	3
147710	_	_	_	_	_
147720	2q14.1	{Gastric cancer risk after H. pylori infection}	137215	AD	3
147730	10p15.1	Immunodeficiency 41 with lymphoproliferation and autoimmunity	606367	AR	3
147730	10p15.1	{Diabetes, mellitus, insulin-dependent, susceptibility to, 10}	601942	_	3
147740	_	_	_	_	_
147750	20q13.2	IVIC syndrome	147750	AD	3
147760	_	_	_	_	_
147770	_	_	_	_	_
147780	_	_	_	_	_
147781	16p12.1	{AIDS, slow progression to}	609423	_	3
147781	16p12.1	{Atopy, susceptibility to}	147050	AD	3
147790	_	_	_	_	_
147791	11q23	Jacobsen syndrome	147791	IC	4
147795	_	_	_	_	_
147796	9p24.1	Erythrocytosis, somatic	133100	_	3
147796	9p24.1	Leukemia, acute myeloid, somatic	601626	_	3
147796	9p24.1	Myelofibrosis, somatic	254450	_	3
147796	9p24.1	Polycythemia vera, somatic	263300	_	3
147796	9p24.1	Thrombocythemia 3	614521	AD,SMu	3
147796	9p24.1	{Budd-Chiari syndrome, somatic}	600880	_	3
147800	_	_	_	_	_
147810	_	_	_	_	_
147811	_	_	_	_	_
147820	_	_	_	_	_
147830	_	_	_	_	_
147840	19p13.2	{Malaria, cerebral, susceptibility to}	611162	_	3
147850	_	_	_	_	_
147851	_	_	_	_	_
147860	_	_	_	_	_
147870	_	_	_	_	_
147880	1q21.3	[Interleukin 6, serum level of, QTL]	614752	_	3
147880	1q21.3	[Interleukin-6 receptor, soluble, serum level of, QTL]	614689	_	3
147890	_	_	_	_	_
147891	17q23.2	Ischiocoxopodopatellar syndrome with or without pulmonary arterial hypertension	147891	AD	3
147892	_	_	_	_	_
147900	_	_	_	_	_
147910	19q13.33	[Kallikrein, decreased urinary activity of]	615953	_	3
147920	12q13.12	Kabuki syndrome 1	147920	AD	3
147935	_	_	_	_	_
147940	_	_	_	_	_
147950	8p11.23	Hypogonadotropic hypogonadism 2 with or without anosmia	147950	AD	3
147960	_	_	_	_	_
148000	7p15.3	{Kaposi sarcoma, susceptibility to}	148000	AD	3
148020	_	_	_	_	_
148021	_	_	_	_	_
148022	_	_	_	_	_
148030	_	_	_	_	_
148040	12q13.13	Dowling-Degos disease 1	179850	AD	3
148040	12q13.13	Epidermolysis bullosa simplex, Dowling-Meara type	131760	AD	3
148040	12q13.13	Epidermolysis bullosa simplex, Koebner type	131900	AD	3
148040	12q13.13	Epidermolysis bullosa simplex, recessive 1	601001	AR	3
148040	12q13.13	Epidermolysis bullosa simplex, Weber-Cockayne type	131800	AD	3
148040	12q13.13	Epidermolysis bullosa simplex-MCR	609352	_	3
148040	12q13.13	Epidermolysis bullosa simplex-MP	131960	AD	3
148041	12q13.13	Pachyonychia congenita 3	615726	_	3
148042	12q13.13	Pachyonychia congenita 4	615728	_	3
148043	12q13.13	Meesmann corneal dystrophy	122100	AD	3
148050	16q24.3	KBG syndrome	148050	AD	3
148059	_	_	_	_	_
148060	12q13.13	Cirrhosis, cryptogenic	215600	AR	3
148060	12q13.13	{Cirrhosis, noncryptogenic, susceptibility to}	215600	AR	3
148065	17q21.2	White sponge nevus 2	615785	AD	3
148066	17q21.2	Dermatopathia pigmentosa reticularis	125595	AD	3
148066	17q21.2	Epidermolysis bullosa simplex, Dowling-Meara type	131760	AD	3
148066	17q21.2	Epidermolysis bullosa simplex, Koebner type	131900	AD	3
148066	17q21.2	Epidermolysis bullosa simplex, recessive 1	601001	AR	3
148066	17q21.2	Epidermolysis bullosa simplex, Weber-Cockayne type	131800	AD	3
148066	17q21.2	Naegeli-Franceschetti-Jadassohn syndrome	161000	AD	3
148067	17q21.2	Pachyonychia congenita 1	167200	AD	3
148067	17q21.2	Palmoplantar keratoderma, nonepidermolytic, focal	613000	AD	3
148069	17q21.2	Pachyonychia congenita 2	167210	AD	3
148069	17q21.2	Steatocystoma multiplex	184500	AD	3
148070	12q13.13	Cirrhosis, cryptogenic	215600	AR	3
148070	12q13.13	{Cirrhosis, noncryptogenic, susceptibility to}	215600	AR	3
148080	17q21.2	Epidermolytic hyperkeratosis	113800	AD,AR	3
148080	17q21.2	Ichthyosis with confetti	609165	AD	3
148080	17q21.2	Ichthyosis, cyclic, with epidermolytic hyperkeratosis	607602	AD	3
148100	_	_	_	_	_
148180	_	_	_	_	_
148181	_	_	_	_	_
148190	11p13	Keratitis	148190	AD	3
148200	1q44	Keratoendothelitis fugax hereditaria	148200	AD	3
148210	13q12.11	Keratitis-ichthyosis-deafness syndrome	148210	AD	3
148300	20p11.21	Keratoconus 1	148300	AD	3
148350	13q12.11	Keratoderma, palmoplantar, with deafness	148350	AD	3
148360	_	_	_	_	_
148370	8p23-p22	Keratolytic winter erythema	148370	AD	2
148390	_	_	_	_	_
148500	17q25.1	Tylosis with esophageal cancer	148500	AD	3
148520	_	_	_	_	_
148600	15q23	Keratoderma, palmoplantar, punctate type IA	148600	AD	3
148700	18q12.1	Keratosis palmoplantaris striata I, AD	148700	AD	3
148730	_	_	_	_	_
148750	_	_	_	_	_
148760	10q23.33	Microcephaly with or without chorioretinopathy, lymphedema, or mental retardation	152950	AD	3
148800	_	_	_	_	_
148820	2q36.1	Waardenburg syndrome, type 3	148820	AD,AR	3
148840	_	_	_	_	_
148860	_	_	_	_	_
148870	_	_	_	_	_
148900	_	_	_	_	_
149000	8q22.3	Klippel-Trenaunay-Weber syndrome	149000	IC	2
149100	_	_	_	_	_
149200	13q12.11	Bart-Pumphrey syndrome	149200	AD	3
149300	_	_	_	_	_
149400	5q33.1	Hyperekplexia 1	149400	AD,AR	3
149500	_	_	_	_	_
149600	_	_	_	_	_
149700	1p13.1	?Lacrimal duct defect	149700	AR	3
149730	_	_	_	_	_
149750	_	_	_	_	_
150000	11p15.1	Glycogen storage disease XI	612933	AR	3
150100	12p12.1	[Lactate dehydrogenase-B deficiency]	614128	_	3
150150	_	_	_	_	_
150160	_	_	_	_	_
150170	_	_	_	_	_
150200	17q23.3	[Placental lactogen deficiency]	_	_	1
150205	_	_	_	_	_
150210	_	_	_	_	_
150220	_	_	_	_	_
150230	8q24.11-q24.13	Trichorhinophalangeal syndrome, type II	150230	AD	4
150240	7q31.1	Lissencephaly 5	615191	AR	3
150250	3p14.3	Larsen syndrome	150250	AD	3
150260	_	_	_	_	_
150270	6p21.3-p21.2	?Laryngeal adductor paralysis	150270	AD	2
150280	_	_	_	_	_
150290	_	_	_	_	_
150292	1q25.3	Epidermolysis bullosa, junctional, Herlitz type	226700	AR	3
150292	1q25.3	Epidermolysis bullosa, junctional, non-Herlitz type	226650	AR	3
150300	_	_	_	_	_
150310	1q32.2	Amelogenesis imperfecta, type IA	104530	AD	3
150310	1q32.2	Epidermolysis bullosa, junctional, Herlitz type	226700	AR	3
150310	1q32.2	Epidermolysis bullosa, junctional, non-Herlitz type	226650	AR	3
150320	18p11.31	Poretti-Boltshauser syndrome	615960	AR	3
150325	3p21.31	Nephrotic syndrome, type 5, with or without ocular abnormalities	614199	_	3
150325	3p21.31	Pierson syndrome	609049	AR	3
150330	1q22	Cardiomyopathy, dilated, 1A	115200	AD	3
150330	1q22	Charcot-Marie-Tooth disease, type 2B1	605588	AR	3
150330	1q22	Emery-Dreifuss muscular dystrophy 2, autosomal dominant	181350	AD	3
150330	1q22	Emery-Dreifuss muscular dystrophy 3, autosomal recessive	616516	AR	3
150330	1q22	Heart-hand syndrome, Slovenian type	610140	AD	3
150330	1q22	Hutchinson-Gilford progeria	176670	AD,AR	3
150330	1q22	Lipodystrophy, familial partial, type 2	151660	AD	3
150330	1q22	Malouf syndrome	212112	AD	3
150330	1q22	Mandibuloacral dysplasia	248370	AR	3
150330	1q22	Muscular dystrophy, congenital	613205	AD	3
150330	1q22	Restrictive dermopathy, lethal	275210	AR	3
150340	5q23.2	Leukodystrophy, adult-onset, autosomal dominant	169500	AD	3
150341	19p13.3	?Epilepsy, progressive myoclonic, 9	616540	AR	3
150341	19p13.3	{Lipodystrophy, partial, acquired, susceptibility to}	608709	AD	3
150360	_	_	_	_	_
150370	3p22.1	Asplenia, isolated congenital	271400	AD	3
150390	_	_	_	_	_
150400	2q35	Tooth agenesis, selective, 4	150400	AD,AR	3
150500	_	_	_	_	_
150550	_	_	_	_	_
150570	_	_	_	_	_
150571	22q13.1	{Myocardial infarction, susceptibility to}	608446	_	3
150590	_	_	_	_	_
150600	12q13.11	Legg-Calve-Perthes disease	150600	AD	3
150699	12q14.3	Leiomyoma, uterine, somatic	150699	_	1
150700	_	_	_	_	_
150800	1q43	Leiomyomatosis and renal cell cancer	150800	AD	3
150900	_	_	_	_	_
151000	_	_	_	_	_
151001	_	_	_	_	_
151020	_	_	_	_	_
151050	8q22.1	Lenz-Majewski hyperostotic dwarfism	151050	AD	3
151100	12q24.13	LEOPARD syndrome 1	151100	AD	3
151200	8q22.1	Leri pleonosteosis chromosome duplication syndrome	151200	AD	4
151210	12q13.11	Platyspondylic skeletal dysplasia, Torrance type	151210	AD	3
151250	_	_	_	_	_
151290	_	_	_	_	_
151300	_	_	_	_	_
151310	_	_	_	_	_
151350	5q32	?Infantile liver failure syndrome 1	615438	AR	3
151380	_	_	_	_	_
151385	21q22.12	Leukemia, acute myeloid	601626	AD,SMu	3
151385	21q22.12	Platelet disorder, familial, with associated myeloid malignancy	601399	AD	3
151390	_	_	_	_	_
151400	_	_	_	_	_
151410	22q11.23	Leukemia, acute lymphocytic, somatic	613065	_	3
151410	22q11.23	Leukemia, chronic myeloid, somatic	608232	_	3
151430	18q21.33	Leukemia/lymphoma, B-cell, 2	_	_	3
151440	19p13.13	Leukemia, T-cell acute lymphoblastoid	151440	_	2
151441	_	_	_	_	_
151442	_	_	_	_	_
151443	5p13.1	Stuve-Wiedemann syndrome/Schwartz-Jampel type 2 syndrome	601559	AR	3
151445	_	_	_	_	_
151450	_	_	_	_	_
151460	1q31.3-q32.1	Severe combined immunodeficiency, T cell-negative, B-cell/natural killer-cell positive	608971	AR	3
151460	1q31.3-q32.1	{Hepatitis C virus, susceptibility to}	609532	_	3
151465	_	_	_	_	_
151500	_	_	_	_	_
151510	_	_	_	_	_
151520	_	_	_	_	_
151523	_	_	_	_	_
151525	_	_	_	_	_
151530	_	_	_	_	_
151540	_	_	_	_	_
151550	_	_	_	_	_
151570	_	_	_	_	_
151580	_	_	_	_	_
151590	_	_	_	_	_
151600	3p22.2	Nail disorder, nonsyndromic congenital, 3, (leukonychia)	151600	AD,AR	3
151610	_	_	_	_	_
151620	_	_	_	_	_
151623	17p13.1	Li-Fraumeni syndrome	151623	AD	3
151625	_	_	_	_	_
151626	_	_	_	_	_
151627	_	_	_	_	_
151628	_	_	_	_	_
151630	_	_	_	_	_
151640	_	_	_	_	_
151660	1q22	Lipodystrophy, familial partial, type 2	151660	AD	3
151670	15q21.3	Hepatic lipase deficiency	614025	AR	3
151670	15q21.3	[High density lipoprotein cholesterol level QTL 12]	612797	_	3
151670	15q21.3	{Diabetes mellitus, noninsulin-dependent}	125853	AD	3
151675	_	_	_	_	_
151680	_	_	_	_	_
151690	_	_	_	_	_
151700	_	_	_	_	_
151710	_	_	_	_	_
151720	_	_	_	_	_
151730	_	_	_	_	_
151740	_	_	_	_	_
151750	19q13.2	Lipodystrophy, familial partial, type 6	615980	AR	3
151800	_	_	_	_	_
151900	_	_	_	_	_
151990	_	_	_	_	_
152100	_	_	_	_	_
152200	6q25-q26	[LPA deficiency, congenital]	_	_	3
152200	6q25-q26	{Coronary artery disease, susceptibility to}	_	_	1
152300	_	_	_	_	_
152310	_	_	_	_	_
152390	10q11.21	{Asthma, diminished response to antileukotriene treatment in}	600807	AD	3
152390	10q11.21	{Atherosclerosis, susceptibility to}	_	_	3
152391	_	_	_	_	_
152392	_	_	_	_	_
152400	_	_	_	_	_
152420	_	_	_	_	_
152422	_	_	_	_	_
152423	_	_	_	_	_
152424	11p15.4	Thalassemia, Hispanic gamma-delta-beta	613985	_	3
152425	_	_	_	_	_
152426	_	_	_	_	_
152427	7q36.1	Long QT syndrome 2	613688	AD	3
152427	7q36.1	Short QT syndrome 1	609620	_	3
152427	7q36.1	{Long QT syndrome 2, acquired, susceptibility to}	613688	AD	3
152430	4q25	[Longevity 1]	152430	_	2
152445	1q21.3	Vohwinkel syndrome with ichthyosis	604117	AD	3
152450	_	_	_	_	_
152460	_	_	_	_	_
152550	_	_	_	_	_
152600	_	_	_	_	_
152690	_	_	_	_	_
152700	_	_	_	_	_
152760	8p21.2	?Hypogonadotropic hypogonadism 12 with or without anosmia	614841	AR	3
152761	_	_	_	_	_
152780	19q13.33	Hypogonadotropic hypogonadism 23 with or without anosmia	228300	AR	3
152790	2p16.3	Leydig cell adenoma, somatic, with precocious puberty	176410	_	3
152790	2p16.3	Leydig cell hypoplasia with hypergonadotropic hypogonadism	238320	AR	3
152790	2p16.3	Leydig cell hypoplasia with pseudohermaphroditism	238320	AR	3
152790	2p16.3	Luteinizing hormone resistance, female	238320	AR	3
152790	2p16.3	Precocious puberty, male	176410	AD	3
152800	_	_	_	_	_
152900	_	_	_	_	_
152950	10q23.33	Microcephaly with or without chorioretinopathy, lymphedema, or mental retardation	152950	AD	3
153000	_	_	_	_	_
153100	5q35.3	Lymphatic malformation 1	153100	AD	3
153200	_	_	_	_	_
153240	_	_	_	_	_
153243	_	_	_	_	_
153245	4q25	Sebaceous tumors, somatic	_	_	3
153280	_	_	_	_	_
153290	_	_	_	_	_
153300	_	_	_	_	_
153310	_	_	_	_	_
153330	_	_	_	_	_
153335	_	_	_	_	_
153337	_	_	_	_	_
153340	_	_	_	_	_
153360	_	_	_	_	_
153370	_	_	_	_	_
153380	_	_	_	_	_
153390	1p35.2	?Immunodeficiency 22	615758	AR	3
153400	_	_	_	_	_
153420	_	_	_	_	_
153430	_	_	_	_	_
153432	_	_	_	_	_
153435	_	_	_	_	_
153440	6p21.33	{Leprosy, susceptibility to, 4}	610988	_	3
153440	6p21.33	{Myocardial infarction, susceptibility to}	608446	_	3
153440	6p21.33	{Psoriatic arthritis, susceptibility to}	607507	_	3
153450	12q15	Amyloidosis, renal	105200	AD	3
153454	1p36.22	Ehlers-Danlos syndrome, kyphoscoliotic type, 1	225400	AR	3
153455	5q23.1	Aortic aneurysm, familial thoracic 10	617168	AD	3
153456	15q24.1	{Exfoliation syndrome, susceptibility to}	177650	AD	3
153460	_	_	_	_	_
153470	_	_	_	_	_
153480	_	_	_	_	_
153550	5q33.1	Macrocytic anemia, refractory, due to 5q deletion, somatic	153550	_	3
153600	6p21.3	{Macroglobulinemia, Waldenstrom, susceptibility to, 1}	153600	AD	2
153615	_	_	_	_	_
153618	_	_	_	_	_
153619	_	_	_	_	_
153620	22q11.23	{Rheumatoid arthritis, systemic juvenile, susceptibility to}	604302	_	3
153622	8p22	Barrett esophagus/esophageal adenocarcinoma	614266	_	3
153630	_	_	_	_	_
153634	_	_	_	_	_
153640	_	_	_	_	_
153650	_	_	_	_	_
153670	17p13.2	Bernard-Soulier syndrome, type A2 (dominant)	153670	AD	3
153700	11q12.3	Macular dystrophy, vitelliform, 2	153700	AD	3
153800	1p22.1	{Macular degeneration, age-related, 2}	153800	AD	3
153840	_	_	_	_	_
153860	_	_	_	_	_
153870	_	_	_	_	_
153880	7p21-p15	Macular dystrophy, dominant cystoid	153880	AD	2
153890	_	_	_	_	_
153900	_	_	_	_	_
154000	_	_	_	_	_
154020	11q23.3	Hypomagnesemia 2, renal	154020	AD	3
154030	_	_	_	_	_
154040	_	_	_	_	_
154045	19q13.41	Cataract 19, multiple types	615277	AR	3
154050	12q13.3	Cataract 15, multiple types	615274	AD	3
154100	7q11.23	Epileptic encephalopathy, early infantile, 51	617339	AR	3
154200	_	_	_	_	_
154230	9p24.3	46XY sex reversal 4	154230	_	4
154235	6p24.2	Retinitis pigmentosa 62	614181	AR	3
154250	_	_	_	_	_
154270	_	_	_	_	_
154275	17q11.2-q24	{Malignant hyperthermia susceptibility 2}	154275	AD	2
154276	7q21-q22	{Malignant hyperthermia susceptibility 3}	154276	AD	2
154280	_	_	_	_	_
154300	_	_	_	_	_
154360	_	_	_	_	_
154365	_	_	_	_	_
154370	_	_	_	_	_
154400	1q21.2	Acrofacial dysostosis 1, Nager type	154400	AD	3
154500	5q32-q33	Treacher Collins syndrome 1	154500	AD	3
154540	_	_	_	_	_
154545	10q21.1	{Chronic infections, due to MBL deficiency}	614372	AD	3
154550	15q24.1-q24.2	Congenital disorder of glycosylation, type Ib	602579	AR	3
154570	_	_	_	_	_
154580	_	_	_	_	_
154582	_	_	_	_	_
154600	_	_	_	_	_
154700	15q21.1	Marfan syndrome	154700	AD	3
154705	_	_	_	_	_
154750	_	_	_	_	_
154780	1p21.1	Marshall syndrome	154780	AD	3
154790	_	_	_	_	_
154800	_	_	_	_	_
154850	_	_	_	_	_
154870	12p12.3	Keutel syndrome	245150	AR	3
154950	14q23.3	{Pheochromocytoma, susceptibility to}	171300	AD	3
155000	_	_	_	_	_
155050	_	_	_	_	_
155100	22q12.3	Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss	155100	AD	3
155120	_	_	_	_	_
155140	_	_	_	_	_
155145	_	_	_	_	_
155150	_	_	_	_	_
155200	_	_	_	_	_
155240	_	_	_	_	_
155250	_	_	_	_	_
155255	_	_	_	_	_
155310	2p13.1	Visceral myopathy	155310	AD	3
155350	_	_	_	_	_
155500	3q26.32	Macrodactyly, somatic	155500	_	3
155540	20q13.2	{Obesity, severe, susceptibility to, BMIQ9}	602025	_	3
155541	18q21.32	Obesity (BMIQ20)	618406	_	3
155541	18q21.32	{Obesity, resistence to (BMIQ20)}	618306	_	3
155550	_	_	_	_	_
155555	16q24.3	[Analgesia from kappa-opioid receptor agonist, female-specific]	613098	_	3
155555	16q24.3	[Skin/hair/eye pigmentation 2, blond hair/fair skin]	266300	AR	3
155555	16q24.3	[Skin/hair/eye pigmentation 2, red hair/fair skin]	266300	AR	3
155555	16q24.3	{Albinism, oculocutaneous, type II, modifier of}	203200	AR	3
155555	16q24.3	{Melanoma, cutaneous malignant, 5}	613099	_	3
155555	16q24.3	{UV-induced skin damage}	266300	AR	3
155600	1p36	{Melanoma, cutaneous malignant, 1}	155600	AD	2
155601	9p21.3	{Melanoma, cutaneous malignant, 2}	155601	AD	3
155700	_	_	_	_	_
155720	_	_	_	_	_
155730	_	_	_	_	_
155735	_	_	_	_	_
155740	_	_	_	_	_
155741	_	_	_	_	_
155750	_	_	_	_	_
155755	9p21.3	Melanoma and neural system tumor syndrome	155755	AD	3
155760	15q26.1	?Spondyloepiphyseal dysplasia, Kimberley type	608361	AD	3
155760	15q26.1	Short stature and advanced bone age, with or without early-onset osteoarthritis and/or osteochondritis dissecans	165800	AD	3
155760	15q26.1	Spondyloepimetaphyseal dysplasia, aggrecan type	612813	AR	3
155770	_	_	_	_	_
155800	_	_	_	_	_
155900	9p11	?Melkersson-Rosenthal syndrome	155900	AD	2
155950	_	_	_	_	_
155960	_	_	_	_	_
155970	_	_	_	_	_
155975	_	_	_	_	_
155980	_	_	_	_	_
156000	_	_	_	_	_
156100	22q12.1	Meningioma	607174	AD	3
156190	_	_	_	_	_
156200	2q23.1	Mental retardation, autosomal dominant 1	156200	AD	3
156220	_	_	_	_	_
156225	6q22.33	Muscular dystrophy, congenital, merosin deficient or partially deficient	607855	AR	3
156225	6q22.33	Muscular dystrophy, limb-girdle, autosomal recessive 23	618138	AR	3
156230	_	_	_	_	_
156232	2q24-q32	Mesomelic dysplasia, Kantaputra type	156232	AD	2
156240	_	_	_	_	_
156250	12q24.13	Metachondromatosis	156250	AD	3
156300	_	_	_	_	_
156310	_	_	_	_	_
156340	_	_	_	_	_
156349	_	_	_	_	_
156350	_	_	_	_	_
156351	_	_	_	_	_
156352	_	_	_	_	_
156353	_	_	_	_	_
156354	_	_	_	_	_
156355	_	_	_	_	_
156356	_	_	_	_	_
156357	_	_	_	_	_
156358	_	_	_	_	_
156359	_	_	_	_	_
156360	_	_	_	_	_
156400	3p21.31	Metaphyseal chondrodysplasia, Murk Jansen type	156400	AD	3
156490	17q21.33	Neuroblastoma	256700	AD,SMu	3
156491	_	_	_	_	_
156500	6q22.1	Metaphyseal chondrodysplasia, Schmid type	156500	AD	3
156510	6p21.1	Metaphyseal dysplasia with maxillary hypoplasia with or without brachydactyly	156510	AD	3
156520	_	_	_	_	_
156530	12q24.11	Metatropic dysplasia	156530	AD	3
156535	_	_	_	_	_
156536	_	_	_	_	_
156540	9p21.3	Diaphyseal medullary stenosis with malignant fibrous histiocytoma	112250	AD	3
156550	12q13.11	Kniest dysplasia	156550	AD	3
156560	12q13.3	Charcot-Marie-Tooth disease, axonal, type 2U	616280	AD	3
156560	12q13.3	Interstitial lung and liver disease	615486	AR	3
156565	_	_	_	_	_
156569	_	_	_	_	_
156570	1q43	Homocystinuria-megaloblastic anemia, cblG complementation type	250940	AR	3
156570	1q43	{Neural tube defects, folate-sensitive, susceptibility to}	601634	AR	3
156575	_	_	_	_	_
156580	_	_	_	_	_
156590	_	_	_	_	_
156600	13q32	Microcoria, congenital	156600	AD	4
156610	6p21.33	Symmetric circumferential skin creases, congenital, 1	156610	AD	3
156620	_	_	_	_	_
156700	_	_	_	_	_
156790	_	_	_	_	_
156810	_	_	_	_	_
156830	_	_	_	_	_
156845	3p13	COMMAD syndrome	617306	AR	3
156845	3p13	Tietz albinism-deafness syndrome	103500	AD	3
156845	3p13	Waardenburg syndrome, type 2A	193510	AD	3
156845	3p13	Waardenburg syndrome/ocular albinism, digenic	103470	AD	3
156845	3p13	{Melanoma, cutaneous malignant, susceptibility to, 8}	614456	_	3
156850	16p13.3	Microphthalmia with cataract 1	156850	AD	2
156900	_	_	_	_	_
157100	_	_	_	_	_
157129	_	_	_	_	_
157130	_	_	_	_	_
157132	_	_	_	_	_
157140	17q21.31	Dementia, frontotemporal, with or without parkinsonism	600274	AD	3
157140	17q21.31	Pick disease	172700	AD	3
157140	17q21.31	Supranuclear palsy, progressive	601104	AD	3
157140	17q21.31	Supranuclear palsy, progressive atypical	260540	AR	3
157140	17q21.31	{Parkinson disease, susceptibility to}	168600	AD,Mu	3
157145	10q11.22	{Prostate cancer, hereditary, 13}	611928	_	3
157147	4q23	Abetalipoproteinemia	200100	AR	3
157147	4q23	{Metabolic syndrome, protection against}	605552	AD	3
157150	_	_	_	_	_
157151	_	_	_	_	_
157160	_	_	_	_	_
157170	2p21	Holoprosencephaly 2	157170	AD	3
157200	_	_	_	_	_
157300	4q24	{Migraine with or without aura, susceptibility to, 1}	157300	AD	2
157400	_	_	_	_	_
157500	_	_	_	_	_
157550	_	_	_	_	_
157560	_	_	_	_	_
157570	_	_	_	_	_
157600	18q21.2	Mirror movements 1 and/or agenesis of the corpus callosum	157600	AD	3
157640	15q26.1	Progressive external ophthalmoplegia, autosomal dominant 1	157640	AD	3
157650	_	_	_	_	_
157655	2q33.3	Mitochondrial complex I deficiency, nuclear type 5	618226	AR	3
157660	9p13.3	Anauxetic dysplasia 1	607095	AR	3
157660	9p13.3	Cartilage-hair hypoplasia	250250	AR	3
157660	9p13.3	Metaphyseal dysplasia without hypotrichosis	250460	AR	3
157670	_	_	_	_	_
157680	_	_	_	_	_
157700	16p12.1-p11.2	Mitral valve prolapse, myxomatous 1	157700	AD	2
157800	6q15	Cardiospondylocarpofacial syndrome	157800	AD	3
157860	_	_	_	_	_
157900	13q12.2-q13	?Moebius syndrome	157900	AD,IC	2
157910	_	_	_	_	_
157920	_	_	_	_	_
157950	_	_	_	_	_
157960	_	_	_	_	_
157970	_	_	_	_	_
157975	_	_	_	_	_
157980	_	_	_	_	_
158000	_	_	_	_	_
158020	_	_	_	_	_
158030	_	_	_	_	_
158040	_	_	_	_	_
158050	_	_	_	_	_
158070	_	_	_	_	_
158100	_	_	_	_	_
158105	17q12	{Coronary artery disease, modifier of}	_	_	3
158105	17q12	{HIV-1, resistance to}	609423	_	3
158105	17q12	{Mycobacterium tuberculosis, susceptibility to}	607948	_	3
158105	17q12	{Spina bifida, susceptibility to}	182940	AD	3
158106	_	_	_	_	_
158120	_	_	_	_	_
158130	_	_	_	_	_
158150	_	_	_	_	_
158170	9p	Chromosome 9p deletion syndrome	158170	AD	4
158250	_	_	_	_	_
158270	_	_	_	_	_
158280	_	_	_	_	_
158300	17p13.1	Trismus-pseudocamptodactyly syndrome	158300	AD	3
158310	_	_	_	_	_
158320	_	_	_	_	_
158330	1p36.12	Mullerian aplasia and hyperandrogenism	158330	AD	3
158340	1q22	Medullary cystic kidney disease 1	174000	AD	3
158343	_	_	_	_	_
158345	_	_	_	_	_
158350	_	_	_	_	_
158370	_	_	_	_	_
158371	_	_	_	_	_
158372	_	_	_	_	_
158373	_	_	_	_	_
158374	_	_	_	_	_
158375	4q13.3	{Asthma, protection against}	600807	AD	3
158378	8p11.21	Basal ganglia calcification, idiopathic, 1	213600	AD	3
158380	_	_	_	_	_
158381	_	_	_	_	_
158400	_	_	_	_	_
158500	_	_	_	_	_
158580	2q12.3	Neuronopathy, distal hereditary motor, type VIIA	158580	AD	3
158590	12q24.23	Neuropathy, distal hereditary motor, type IIA	158590	AD	3
158600	14q32.31	Spinal muscular atrophy, lower extremity-predominant 1, AD	158600	AD	3
158650	_	_	_	_	_
158700	_	_	_	_	_
158800	_	_	_	_	_
158810	_	_	_	_	_
158900	4q35	Facioscapulohumeral muscular dystrophy 1	158900	AD	4
158901	18p11.32	Fascioscapulohumeral muscular dystrophy 2, digenic	158901	_	3
159000	_	_	_	_	_
159001	_	_	_	_	_
159050	_	_	_	_	_
159100	_	_	_	_	_
159300	_	_	_	_	_
159350	5q22.2	Colorectal cancer, somatic	114500	_	3
159400	_	_	_	_	_
159405	_	_	_	_	_
159410	_	_	_	_	_
159420	_	_	_	_	_
159430	_	_	_	_	_
159440	1q23.3	Charcot-Marie-Tooth disease, dominant intermediate D	607791	AD	3
159440	1q23.3	Charcot-Marie-Tooth disease, type 1B	118200	AD	3
159440	1q23.3	Charcot-Marie-Tooth disease, type 2I	607677	AD	3
159440	1q23.3	Charcot-Marie-Tooth disease, type 2J	607736	AD	3
159440	1q23.3	Dejerine-Sottas disease	145900	AD,AR	3
159440	1q23.3	Hypomyelinating neuropathy, congenital, 2	618184	AD	3
159440	1q23.3	Roussy-Levy syndrome	180800	AD	3
159455	_	_	_	_	_
159460	19q13.12	Spastic paraplegia 75, autosomal recessive	616680	AR	3
159465	6p22.1	?Narcolepsy 7	614250	AD	3
159500	_	_	_	_	_
159530	1p34.2	Myelofibrosis with myeloid metaplasia, somatic	254450	_	3
159530	1p34.2	Thrombocythemia 2	601977	AD,SMu	3
159530	1p34.2	Thrombocytopenia, congenital amegakaryocytic	604498	AR	3
159540	_	_	_	_	_
159550	7q21.2	Ataxia-pancytopenia syndrome	159550	AD	3
159552	_	_	_	_	_
159553	_	_	_	_	_
159555	11q23.3	Leukemia, myeloid/lymphoid or mixed-lineage	159555	AD	2
159555	11q23.3	Wiedemann-Steiner syndrome	605130	AD	3
159556	_	_	_	_	_
159557	_	_	_	_	_
159558	_	_	_	_	_
159559	_	_	_	_	_
159580	_	_	_	_	_
159590	_	_	_	_	_
159595	21q11.2	Leukemia, transient, of Down syndrome	159595	_	2
159600	_	_	_	_	_
159700	_	_	_	_	_
159800	_	_	_	_	_
159900	7q21.3	Dystonia-11, myoclonic	159900	AD	3
159950	8p22	Spinal muscular atrophy with progressive myoclonic epilepsy	159950	AR	3
159970	_	_	_	_	_
159980	_	_	_	_	_
159990	12q21.31	Ophthalmoplegia, external, with rib and vertebral anomalies	618155	AR	3
159991	_	_	_	_	_
160000	_	_	_	_	_
160010	_	_	_	_	_
160100	_	_	_	_	_
160120	12p13.32	Episodic ataxia/myokymia syndrome	160120	AD	3
160150	_	_	_	_	_
160200	_	_	_	_	_
160300	_	_	_	_	_
160500	14q11.2	Laing distal myopathy	160500	AD	3
160550	_	_	_	_	_
160565	11p15.4	Myopathy, tubular aggregate, 1	160565	AD	3
160570	_	_	_	_	_
160700	18p11.31	Myopia-2	160700	AD	2
160710	14q11.2	Atrial septal defect 3	614089	_	3
160710	14q11.2	Cardiomyopathy, dilated, 1EE	613252	_	3
160710	14q11.2	Cardiomyopathy, hypertrophic, 14	613251	AD	3
160710	14q11.2	{Sick sinus syndrome 3}	614090	_	3
160720	17p13.1	Arthrogryposis, distal, type 2A (Freeman-Sheldon)	193700	AD	3
160720	17p13.1	Arthrogryposis, distal, type 2B3 (Sheldon-Hall)	618436	AD	3
160720	17p13.1	Contractures, pterygia, and variable skeletal fusions syndrome 1A	178110	AD	3
160720	17p13.1	Contractures, pterygia, and variable skeletal fusions syndrome 1B	618469	AR	3
160730	_	_	_	_	_
160740	17p13.1	Proximal myopathy and ophthalmoplegia	605637	AD,AR	3
160741	17p13.1	Carney complex variant	608837	_	3
160741	17p13.1	Trismus-pseudocamptodactyly syndrome	158300	AD	3
160742	_	_	_	_	_
160745	16p13.11	Aortic aneurysm, familial thoracic 4	132900	AD	3
160750	_	_	_	_	_
160760	14q11.2	Cardiomyopathy, dilated, 1S	613426	AD	3
160760	14q11.2	Cardiomyopathy, hypertrophic, 1	192600	AD	3
160760	14q11.2	Laing distal myopathy	160500	AD	3
160760	14q11.2	Left ventricular noncompaction 5	613426	AD	3
160760	14q11.2	Myopathy, myosin storage, autosomal dominant	608358	AD	3
160760	14q11.2	Myopathy, myosin storage, autosomal recessive	255160	AR	3
160760	14q11.2	Scapuloperoneal syndrome, myopathic type	181430	AD	3
160770	17q21.32	?Atrial fibrillation, familial, 18	617280	AD	3
160775	22q12.3	Deafness, autosomal dominant 17	603622	AD	3
160775	22q12.3	Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss	155100	AD	3
160776	_	_	_	_	_
160777	15q21.2	Griscelli syndrome, type 1	214450	AR	3
160780	2q34	Myopathy, congenital, with fast-twitch (type II) fiber atrophy	618414	AR	3
160781	12q24.11	Cardiomyopathy, hypertrophic, 10	608758	AD	3
160782	_	_	_	_	_
160790	3p21.31	Cardiomyopathy, hypertrophic, 8	608751	AD,AR	3
160793	_	_	_	_	_
160794	12q23.2	Arthrogryposis, distal, type 1B	614335	AD	3
160794	12q23.2	Lethal congenital contracture syndrome 4	614915	AR	3
160795	_	_	_	_	_
160800	7q34	Myotonia congenita, dominant	160800	AD	3
160900	19q13.32	Myotonic dystrophy 1	160900	AD	3
160980	17q24.2	Carney complex, type 1	160980	AD	3
160990	_	_	_	_	_
160993	_	_	_	_	_
160994	_	_	_	_	_
160995	_	_	_	_	_
160998	6p25.2	{?Breast cancer susceptibility}	114480	AD,SMu	1
161000	17q21.2	Naegeli-Franceschetti-Jadassohn syndrome	161000	AD	3
161015	11q13.2	Mitochondrial complex I deficiency, nuclear type 4	618225	AR	3
161050	_	_	_	_	_
161070	_	_	_	_	_
161080	_	_	_	_	_
161100	_	_	_	_	_
161200	9q33.3	Nail-patella syndrome	161200	AD	3
161400	17q21.2	?Narcolepsy 1	161400	AD	3
161470	_	_	_	_	_
161480	_	_	_	_	_
161500	_	_	_	_	_
161530	_	_	_	_	_
161550	6p21.3	{Nasopharyngeal carcinoma, susceptibility to, 2}	161550	_	2
161555	_	_	_	_	_
161560	_	_	_	_	_
161561	5q33.3	Immunodeficiency 29, mycobacteriosis	614890	AR	3
161565	_	_	_	_	_
161600	_	_	_	_	_
161650	2q23.3	Nemaline myopathy 2, autosomal recessive	256030	AR	3
161700	_	_	_	_	_
161800	_	_	_	_	_
161900	1q21	Nephropathy-hypertension	161900	AD	2
161950	6q22-q23	{IgA nephropathy, susceptibility to, 1}	161950	?AD	2
162000	16p12.3	Hyperuricemic nephropathy, familial juvenile 1	162000	AD	3
162010	_	_	_	_	_
162020	_	_	_	_	_
162030	1p13.2	Neuropathy, hereditary sensory and autonomic, type V	608654	AR	3
162040	_	_	_	_	_
162060	_	_	_	_	_
162080	14q11-q12	Retinal degeneration, autosomal recessive, clumped pigment type	_	_	3
162080	14q11-q12	Retinitis pigmentosa 27	613750	AD	3
162091	_	_	_	_	_
162095	_	_	_	_	_
162096	_	_	_	_	_
162100	17q25.3	Amyotrophy, hereditary neuralgic	162100	AD	3
162150	5q15	Obesity with impaired prohormone processing	600955	AR	3
162150	5q15	{Obesity, susceptibility to, BMIQ12}	612362	_	3
162151	_	_	_	_	_
162200	17q11.2	Neurofibromatosis, type 1	162200	AD	3
162210	17q11.2	Neurofibromatosis, familial spinal	162210	AD	3
162220	_	_	_	_	_
162230	22q12.2	?{Amyotrophic lateral sclerosis, susceptibility to}	105400	AD,AR	3
162230	22q12.2	Charcot-Marie-Tooth disease, axonal, type 2CC	616924	AD	3
162240	_	_	_	_	_
162250	_	_	_	_	_
162260	_	_	_	_	_
162270	_	_	_	_	_
162280	8p21.2	Charcot-Marie-Tooth disease, dominant intermediate G	617882	AD	3
162280	8p21.2	Charcot-Marie-Tooth disease, type 1F	607734	AD,AR	3
162280	8p21.2	Charcot-Marie-Tooth disease, type 2E	607684	AD	3
162300	10q11.21	Multiple endocrine neoplasia IIB	162300	AD	3
162320	_	_	_	_	_
162321	_	_	_	_	_
162323	_	_	_	_	_
162330	12q13.3	Hypogonadotropic hypogonadism 10 with or without anosmia	614839	AR	3
162332	4q24	Hypogonadotropic hypogonadism 11 with or without anosmia	614840	AR	3
162340	_	_	_	_	_
162341	_	_	_	_	_
162350	20q13.33	Ceroid lipofuscinosis, neuronal, 4, Parry type	162350	AD	3
162360	_	_	_	_	_
162361	_	_	_	_	_
162370	_	_	_	_	_
162375	_	_	_	_	_
162380	_	_	_	_	_
162400	9q22.31	Neuropathy, hereditary sensory and autonomic, type IA	162400	AD	3
162500	17p12	Neuropathy, recurrent, with pressure palsies	162500	AD	3
162600	_	_	_	_	_
162640	_	_	_	_	_
162641	_	_	_	_	_
162642	_	_	_	_	_
162643	2q22.1	Myelokathexis, isolated	_	_	3
162643	2q22.1	WHIM syndrome	193670	AD	3
162650	_	_	_	_	_
162651	_	_	_	_	_
162660	_	_	_	_	_
162661	_	_	_	_	_
162662	19q13.33	Glaucoma 1, open angle, 1O	613100	_	3
162700	_	_	_	_	_
162800	19p13.3	Neutropenia, cyclic	162800	AD	3
162815	_	_	_	_	_
162820	7q22-qter	?Neutrophil chemotactic response, abnormal	162820	AD	2
162830	_	_	_	_	_
162860	_	_	_	_	_
162870	_	_	_	_	_
162880	_	_	_	_	_
162890	_	_	_	_	_
162900	_	_	_	_	_
163000	9q21.2	Capillary malformations, congenital, 1, somatic, mosaic	163000	_	3
163050	_	_	_	_	_
163100	_	_	_	_	_
163200	_	_	_	_	_
163260	_	_	_	_	_
163400	_	_	_	_	_
163500	4p16.3	Night blindness, congenital stationary, autosomal dominant 2	163500	AD	3
163600	_	_	_	_	_
163700	_	_	_	_	_
163728	_	_	_	_	_
163729	7q36.1	{Alzheimer disease, late-onset, susceptibility to}	104300	AD	3
163729	7q36.1	{Coronary artery spasm 1, susceptibility to}	_	_	3
163729	7q36.1	{Hypertension, pregnancy-induced}	189800	AD	3
163729	7q36.1	{Hypertension, susceptibility to}	145500	Mu	3
163729	7q36.1	{Ischemic stroke, susceptibility to}	601367	Mu	3
163729	7q36.1	{Placental abruption}	_	_	3
163730	17q11.2	{Hypertension, susceptibility to}	145500	Mu	2
163730	17q11.2	{Malaria, resistance to}	611162	_	3
163731	_	_	_	_	_
163800	15q24.1	Sick sinus syndrome 2	163800	AD	3
163850	_	_	_	_	_
163890	4q22.1	Dementia, Lewy body	127750	AD	3
163890	4q22.1	Parkinson disease 1	168601	AD	3
163890	4q22.1	Parkinson disease 4	605543	AD	3
163900	_	_	_	_	_
163905	_	_	_	_	_
163906	_	_	_	_	_
163910	_	_	_	_	_
163920	_	_	_	_	_
163950	12q24.13	Noonan syndrome 1	163950	AD	3
163955	_	_	_	_	_
163970	16q12.2	?Orthostatic intolerance	604715	_	3
163980	_	_	_	_	_
164000	_	_	_	_	_
164005	19p13.13	Marshall-Smith syndrome	602535	AD	3
164005	19p13.13	Sotos syndrome 2	614753	AD	3
164008	14q13.2	Ectodermal dysplasia and immunodeficiency 2	612132	AD	3
164009	11q13.4	Leukemia, acute promyelocytic, somatic	612376	_	3
164010	16q24.3	Pontocerebellar hypoplasia, type 8	614961	AR	3
164011	4q24	Immunodeficiency, common variable, 12	616576	AD	3
164012	10q24.32	Immunodeficiency, common variable, 10	615577	AD	3
164013	_	_	_	_	_
164014	11q13.1	?Mucocutaneous ulceration, chronic	618287	AD	3
164015	5q31.2	Amyotrophic lateral sclerosis 21	606070	AD	3
164016	_	_	_	_	_
164017	12q13.13	?Inclusion body myopathy with early-onset Paget disease without frontotemporal dementia 3	615424	AD	3
164017	12q13.13	Amyotrophic lateral sclerosis 20	615426	AD	3
164018	_	_	_	_	_
164019	_	_	_	_	_
164020	_	_	_	_	_
164021	_	_	_	_	_
164022	_	_	_	_	_
164031	_	_	_	_	_
164035	_	_	_	_	_
164040	5q35.1	Leukemia, acute myeloid, somatic	601626	_	3
164050	14q11.2	Immunodeficiency due to purine nucleoside phosphorylase deficiency	613179	AR	3
164060	_	_	_	_	_
164100	6p12	Nystagmus 2, congenital, autosomal dominant	164100	AD	2
164150	_	_	_	_	_
164160	7q32.1	Obesity, morbid, due to leptin deficiency	614962	AR	3
164170	_	_	_	_	_
164175	_	_	_	_	_
164176	_	_	_	_	_
164177	_	_	_	_	_
164180	_	_	_	_	_
164185	_	_	_	_	_
164190	_	_	_	_	_
164200	6q22.31	Oculodentodigital dysplasia	164200	AD	3
164210	14q32	Hemifacial microsomia	164210	AD	2
164220	_	_	_	_	_
164230	_	_	_	_	_
164280	2p24.3	Feingold syndrome 1	164280	AD	3
164300	14q11.2	Oculopharyngeal muscular dystrophy	164300	AD	3
164310	_	_	_	_	_
164320	_	_	_	_	_
164330	_	_	_	_	_
164340	_	_	_	_	_
164342	_	_	_	_	_
164343	_	_	_	_	_
164345	_	_	_	_	_
164350	_	_	_	_	_
164360	18q21.1	?Combined oxidative phosphorylation deficiency 22	616045	AR	3
164360	18q21.1	?Mitochondrial complex V (ATP synthase) deficiency, nuclear type 4	615228	AR	3
164400	6p22.3	Spinocerebellar ataxia 1	164400	AD	3
164500	3p14.1	Spinocerebellar ataxia 7	164500	AD	3
164600	_	_	_	_	_
164680	_	_	_	_	_
164690	1q25.2	Leukemia, acute myeloid, with eosinophilia	_	_	1
164700	_	_	_	_	_
164710	_	_	_	_	_
164720	_	_	_	_	_
164730	14q32.33	Breast cancer, somatic	114480	_	3
164730	14q32.33	Colorectal cancer, somatic	114500	_	3
164730	14q32.33	Cowden syndrome 6	615109	_	3
164730	14q32.33	Ovarian cancer, somatic	167000	_	3
164730	14q32.33	Proteus syndrome, somatic	176920	_	3
164730	14q32.33	{Schizophrenia, susceptibility to}	181500	AD	2
164731	19q13.2	Diabetes mellitus, type II	125853	AD	3
164731	19q13.2	Hypoinsulinemic hypoglycemia with hemihypertrophy	240900	AD	3
164740	_	_	_	_	_
164745	17q21.31	Omodysplasia 2	164745	AD	3
164750	1p31.3	Omphalocele due to duplication of 1p31.3	164750	IC	4
164755	_	_	_	_	_
164756	_	_	_	_	_
164757	7q34	Adenocarcinoma of lung, somatic	211980	_	3
164757	7q34	Cardiofaciocutaneous syndrome	115150	AD	3
164757	7q34	Colorectal cancer, somatic	_	_	3
164757	7q34	LEOPARD syndrome 3	613707	AD	3
164757	7q34	Melanoma, malignant, somatic	_	_	3
164757	7q34	Nonsmall cell lung cancer, somatic	_	_	3
164757	7q34	Noonan syndrome 7	613706	AD	3
164759	_	_	_	_	_
164760	3p25.2	Cardiomyopathy, dilated, 1NN	615916	AD	3
164760	3p25.2	LEOPARD syndrome 2	611554	_	3
164760	3p25.2	Noonan syndrome 5	611553	AD	3
164761	10q11.21	Central hypoventilation syndrome, congenital	209880	AD	3
164761	10q11.21	Medullary thyroid carcinoma	155240	AD	3
164761	10q11.21	Multiple endocrine neoplasia IIA	171400	AD	3
164761	10q11.21	Multiple endocrine neoplasia IIB	162300	AD	3
164761	10q11.21	Pheochromocytoma	171300	AD	3
164761	10q11.21	{Hirschsprung disease, protection against}	142623	AD	3
164761	10q11.21	{Hirschsprung disease, susceptibility to, 1}	142623	AD	3
164762	_	_	_	_	_
164765	_	_	_	_	_
164770	5q32	Brain abnormalities, neurodegeneration, and dysosteosclerosis	618476	AR	3
164770	5q32	Leukoencephalopathy, diffuse hereditary, with spheroids	221820	AD	3
164772	_	_	_	_	_
164780	1p36.33-p36.32	Shprintzen-Goldberg syndrome	182212	AD	3
164785	12q15	{Accelerated tumor formation, susceptibility to}	614401	_	3
164790	1p13.2	?RAS-associated autoimmune lymphoproliferative syndrome type IV, somatic	614470	_	3
164790	1p13.2	Colorectal cancer, somatic	114500	_	3
164790	1p13.2	Epidermal nevus, somatic	162900	_	3
164790	1p13.2	Melanocytic nevus syndrome, congenital, somatic	137550	_	3
164790	1p13.2	Neurocutaneous melanosis, somatic	249400	_	3
164790	1p13.2	Noonan syndrome 6	613224	AD	3
164790	1p13.2	Schimmelpenning-Feuerstein-Mims syndrome, somatic mosaic	163200	_	3
164790	1p13.2	Thyroid carcinoma, follicular, somatic	188470	_	3
164795	_	_	_	_	_
164800	_	_	_	_	_
164810	_	_	_	_	_
164820	12q13.12	Osteogenesis imperfecta, type XV	615220	AR	3
164820	12q13.12	{Osteoporosis, early-onset, susceptibility to, autosomal dominant}	615221	_	3
164830	_	_	_	_	_
164831	_	_	_	_	_
164840	2p24.3	Feingold syndrome 1	164280	AD	3
164850	_	_	_	_	_
164860	7q31.2	?Deafness, autosomal recessive 97	616705	AR	3
164860	7q31.2	Hepatocellular carcinoma, childhood type, somatic	114550	_	3
164860	7q31.2	Renal cell carcinoma, papillary, 1, familial and somatic	605074	_	3
164860	7q31.2	{Osteofibrous dysplasia, susceptibility to}	607278	AD	3
164865	_	_	_	_	_
164870	17q12	Adenocarcinoma of lung, somatic	211980	_	3
164870	17q12	Gastric cancer, somatic	613659	_	3
164870	17q12	Glioblastoma, somatic	137800	_	3
164870	17q12	Ovarian cancer, somatic	_	_	3
164873	_	_	_	_	_
164874	14q12	Rett syndrome, congenital variant	613454	AD	3
164875	_	_	_	_	_
164880	_	_	_	_	_
164891	_	_	_	_	_
164900	_	_	_	_	_
164905	_	_	_	_	_
164910	_	_	_	_	_
164920	4q12	Gastrointestinal stromal tumor, familial	606764	AD,IC	3
164920	4q12	Germ cell tumors, somatic	273300	_	3
164920	4q12	Leukemia, acute myeloid	601626	AD,SMu	3
164920	4q12	Mastocytosis, cutaneous	154800	AD	3
164920	4q12	Mastocytosis, systemic, somatic	154800	_	3
164920	4q12	Piebaldism	172800	AD	3
164940	_	_	_	_	_
164950	11q13.3	Deafness, congenital with inner ear agenesis, microtia, and microdontia	610706	AR	3
164951	_	_	_	_	_
164953	19p13.2-q13.3	Liposarcoma	_	_	1
164958	_	_	_	_	_
164960	_	_	_	_	_
164970	_	_	_	_	_
164975	_	_	_	_	_
164980	_	_	_	_	_
165000	_	_	_	_	_
165010	_	_	_	_	_
165020	_	_	_	_	_
165040	_	_	_	_	_
165060	_	_	_	_	_
165070	_	_	_	_	_
165080	_	_	_	_	_
165090	_	_	_	_	_
165095	_	_	_	_	_
165098	_	_	_	_	_
165110	_	_	_	_	_
165120	_	_	_	_	_
165140	_	_	_	_	_
165150	_	_	_	_	_
165160	_	_	_	_	_
165161	_	_	_	_	_
165162	_	_	_	_	_
165170	_	_	_	_	_
165180	_	_	_	_	_
165190	4q21.21	Trichomegaly	190330	AR	3
165195	_	_	_	_	_
165196	_	_	_	_	_
165199	_	_	_	_	_
165200	_	_	_	_	_
165210	_	_	_	_	_
165215	3q26.2	Radioulnar synostosis with amegakaryocytic thrombocytopenia 2	616738	AD	3
165220	12q13.3	Polydactyly, postaxial, type A8	618123	AR	3
165220	12q13.3	Polydactyly, preaxial I	174400	AR	3
165230	2q14.2	Culler-Jones syndrome	615849	AD	3
165230	2q14.2	Holoprosencephaly 9	610829	AD	3
165240	7p14.1	Greig cephalopolysyndactyly syndrome	175700	AD	3
165240	7p14.1	Pallister-Hall syndrome	146510	AD	3
165240	7p14.1	Polydactyly, postaxial, types A1 and B	174200	AD	3
165240	7p14.1	Polydactyly, preaxial, type IV	174700	AD	3
165240	7p14.1	{Hypothalamic hamartomas, somatic}	241800	_	3
165250	_	_	_	_	_
165260	_	_	_	_	_
165270	_	_	_	_	_
165280	_	_	_	_	_
165290	_	_	_	_	_
165300	19q13.32	Optic atrophy 3 with cataract	165300	AD	3
165320	2q14-q21	?Hepatocellular carcinoma	_	_	1
165330	17q21.31-q21.32	?Tetra-amelia syndrome 1	273395	AR	3
165340	_	_	_	_	_
165350	_	_	_	_	_
165360	11q23.3	?Juvenile myelomonocytic leukemia	607785	AD,SMu	3
165360	11q23.3	Noonan syndrome-like disorder with or without juvenile myelomonocytic leukemia	613563	AD	3
165370	_	_	_	_	_
165380	_	_	_	_	_
165390	_	_	_	_	_
165490	_	_	_	_	_
165500	3q29	Optic atrophy 1	165500	AD	3
165510	_	_	_	_	_
165550	11p13	Optic nerve hypoplasia	165550	AD	3
165590	_	_	_	_	_
165600	_	_	_	_	_
165630	_	_	_	_	_
165635	_	_	_	_	_
165640	2p25.1	{Colonic adenoma recurrence, reduced risk of}	114500	AD,SMu	3
165650	_	_	_	_	_
165660	_	_	_	_	_
165670	_	_	_	_	_
165680	_	_	_	_	_
165700	_	_	_	_	_
165720	2q32.1	{Osteoarthritis susceptibility 1}	165720	Mu	3
165800	15q26.1	Short stature and advanced bone age, with or without early-onset osteoarthritis and/or osteochondritis dissecans	165800	AD	3
166000	_	_	_	_	_
166200	17q21.33	Osteogenesis imperfecta, type I	166200	AD	3
166210	_	_	_	_	_
166220	_	_	_	_	_
166230	_	_	_	_	_
166240	_	_	_	_	_
166250	8p11.23	Osteoglophonic dysplasia	166250	AD	3
166260	11p14.3	Gnathodiaphyseal dysplasia	166260	AD	3
166300	20q12	Multicentric carpotarsal osteolysis syndrome	166300	AD	3
166350	20q13.32	Osseous heteroplasia, progressive	166350	AD	3
166400	_	_	_	_	_
166450	_	_	_	_	_
166490	_	_	_	_	_
166500	_	_	_	_	_
166600	16p13.3	Osteopetrosis, autosomal dominant 2	166600	AD	3
166700	_	_	_	_	_
166705	_	_	_	_	_
166710	_	_	_	_	_
166720	_	_	_	_	_
166740	_	_	_	_	_
166750	11q13	Otodental dysplasia chromosome deletion syndrome	166750	AD	4
166760	12p13.31	{Otitis media, susceptibility to}	166760	AD	3
166780	8q13.3	?Otofaciocervical syndrome	166780	AD	3
166800	15q26.1-qter	Otosclerosis 1	166800	AD	2
166900	17q21.31	Ovalocytosis, SA type	166900	AD	3
166910	_	_	_	_	_
166945	_	_	_	_	_
166950	_	_	_	_	_
166970	_	_	_	_	_
166990	_	_	_	_	_
167000	_	_	_	_	_
167030	4p16.3	?Nephrolithiasis, calcium oxalate	167030	AR	3
167040	_	_	_	_	_
167050	_	_	_	_	_
167055	_	_	_	_	_
167100	_	_	_	_	_
167200	17q21.2	Pachyonychia congenita 1	167200	AD	3
167210	17q21.2	Pachyonychia congenita 2	167210	AD	3
167220	_	_	_	_	_
167250	5q35.3	Paget disease of bone 3	167250	AD	3
167300	_	_	_	_	_
167320	9p13.3	Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia 1	167320	AD	3
167400	2q24.3	Paroxysmal extreme pain disorder	167400	AD	3
167405	_	_	_	_	_
167409	10q24.31	Glomerulosclerosis, focal segmental, 7	616002	AD	3
167409	10q24.31	Papillorenal syndrome	120330	AD	3
167410	1p36.13	Rhabdomyosarcoma 2, alveolar	268220	SMu	3
167411	20p11.22	?Otofaciocervical syndrome 2	615560	AR	3
167413	7q32.1	Diabetes mellitus, type 2	125853	AD	3
167413	7q32.1	Maturity-onset diabetes of the young, type IX	612225	_	3
167413	7q32.1	{Diabetes mellitus, ketosis-prone, susceptibility to}	612227	AD,AR	3
167414	9p13.2	{Leukemia, acute lymphoblastic, susceptibility to, 3}	615545	_	3
167415	2q14.1	Hypothyroidism, congenital, due to thyroid dysgenesis or hypoplasia	218700	AD	3
167416	14q13.3	Tooth agenesis, selective, 3	604625	AD	3
167420	1q24.2	Agnathia-otocephaly complex	202650	AD,AR	3
167500	_	_	_	_	_
167600	_	_	_	_	_
167700	_	_	_	_	_
167730	_	_	_	_	_
167750	_	_	_	_	_
167755	_	_	_	_	_
167770	_	_	_	_	_
167771	_	_	_	_	_
167780	_	_	_	_	_
167790	5q32	Pancreatitis, hereditary	167800	AD	3
167790	5q32	Tropical calcific pancreatitis	608189	AD,AR	3
167790	5q32	{Fibrocalculous pancreatic diabetes, susceptibility to}	608189	AD,AR	3
167800	_	_	_	_	_
167805	_	_	_	_	_
167850	_	_	_	_	_
167870	13q22-q32	Panic disorder syndrome 1	167870	?AD	2
167900	_	_	_	_	_
167950	_	_	_	_	_
167959	_	_	_	_	_
167960	_	_	_	_	_
168000	11q23.1	Paragangliomas 1, with or without deafness	168000	AD	3
168100	_	_	_	_	_
168200	_	_	_	_	_
168300	17q23.3	Paramyotonia congenita	168300	AD	3
168350	_	_	_	_	_
168360	_	_	_	_	_
168400	12q24.11	Parastremmatic dwarfism	168400	AD	3
168440	_	_	_	_	_
168450	11p15.3	Hypoparathyroidism, autosomal dominant	146200	AD,AR	3
168450	11p15.3	Hypoparathyroidism, autosomal recessive	146200	AD,AR	3
168460	_	_	_	_	_
168461	11q13.3	{Colorectal cancer, susceptibility to}	114500	AD,SMu	3
168461	11q13.3	{Multiple myeloma, susceptibility to}	254500	SMu	3
168461	11q13.3	{von Hippel-Lindau syndrome, modifier of}	193300	AD	3
168468	3p21.31	Chondrodysplasia, Blomstrand type	215045	AR	3
168468	3p21.31	Eiken syndrome	600002	AR	3
168468	3p21.31	Failure of tooth eruption, primary	125350	AD	3
168468	3p21.31	Metaphyseal chondrodysplasia, Murk Jansen type	156400	AD	3
168470	12p11.22	Brachydactyly, type E2	613382	AD	3
168500	5q35.2	Parietal foramina 1	168500	AD	3
168550	5q35.2	Parietal foramina with cleidocranial dysplasia	168550	AD	3
168600	_	_	_	_	_
168601	4q22.1	Parkinson disease 1	168601	AD	3
168605	2p13.1	Perry syndrome	168605	AD	3
168610	_	_	_	_	_
168710	_	_	_	_	_
168730	_	_	_	_	_
168790	_	_	_	_	_
168800	_	_	_	_	_
168810	_	_	_	_	_
168820	7q21.3	{Coronary artery disease, susceptibility to}	_	_	3
168820	7q21.3	{Coronary artery spasm 2, susceptibility to	_	_	3
168820	7q21.3	{Microvascular complications of diabetes 5}	612633	_	3
168820	7q21.3	{Organophosphate poisoning, sensitivity to}	_	_	3
168830	_	_	_	_	_
168840	_	_	_	_	_
168850	_	_	_	_	_
168860	17q21-q22	Patella aplasia or hypoplasia	168860	AD	2
168885	_	_	_	_	_
168890	_	_	_	_	_
168900	_	_	_	_	_
169000	_	_	_	_	_
169100	6p12.3	Char syndrome	169100	AD	3
169150	6p21.1	Macular dystrophy, patterned, 1	169150	AD	3
169170	_	_	_	_	_
169190	_	_	_	_	_
169200	_	_	_	_	_
169300	_	_	_	_	_
169400	1q42.12	Pelger-Huet anomaly	169400	AD	3
169500	5q23.2	Leukodystrophy, adult-onset, autosomal dominant	169500	AD	3
169545	_	_	_	_	_
169550	_	_	_	_	_
169600	3q22.1	Hailey-Hailey disease	169600	AD	3
169610	_	_	_	_	_
169615	_	_	_	_	_
169700	_	_	_	_	_
169710	_	_	_	_	_
169720	_	_	_	_	_
169730	_	_	_	_	_
169740	_	_	_	_	_
169800	_	_	_	_	_
169900	_	_	_	_	_
170000	_	_	_	_	_
170100	19q13.11	Prolidase deficiency	170100	AR	3
170200	_	_	_	_	_
170250	_	_	_	_	_
170260	6p21.32	Bare lymphocyte syndrome, type I	604571	AR	3
170261	6p21.32	Bare lymphocyte syndrome, type I, due to TAP2 deficiency	604571	AR	3
170270	_	_	_	_	_
170280	10q22.1	Aplastic anemia	609135	_	3
170280	10q22.1	Hemophagocytic lymphohistiocytosis, familial, 2	603553	AR	3
170280	10q22.1	Lymphoma, non-Hodgkin	605027	_	3
170285	17q25.1	Nephrotic syndrome, type 17	618176	AR	3
170290	15q26.1	Lipodystrophy, familial partial, type 4	613877	AD	3
170300	_	_	_	_	_
170390	17q24.3	Andersen syndrome	170390	AD	3
170400	1q32.1	Hypokalemic periodic paralysis, type 1	170400	AD	3
170500	17q23.3	Hyperkalemic periodic paralysis, type 2	170500	AD	3
170600	_	_	_	_	_
170650	11q14.2	Periodontitis 1, juvenile	170650	AR	3
170700	_	_	_	_	_
170710	12q13.12	{Amyotrophic lateral sclerosis, susceptibility to}	105400	AD,AR	3
170715	8q21.13	Charcot-Marie-Tooth disease, demyelinating, type 1G	618279	AD	3
170900	_	_	_	_	_
170950	_	_	_	_	_
170980	_	_	_	_	_
170990	_	_	_	_	_
170993	8q21.13	Peroxisome biogenesis disorder 5A (Zellweger)	614866	AR	3
170993	8q21.13	Peroxisome biogenesis disorder 5B	614867	AR	3
170995	1p21.3	?Bile acid synthesis defect, congenital, 5	616278	AR	3
170998	22q13.31	{Hyperapobetalipoproteinemia, susceptibility to}	_	_	3
171000	_	_	_	_	_
171050	7q21.12	{Colchicine resistance}	120080	_	3
171050	7q21.12	{Inflammatory bowel disease 13}	612244	_	3
171060	7q21.12	Cholestasis, intrahepatic, of pregnancy, 3	614972	AD,AR	3
171060	7q21.12	Cholestasis, progressive familial intrahepatic 3	602347	AR	3
171060	7q21.12	Gallbladder disease 1	600803	AD,AR	3
171100	_	_	_	_	_
171150	_	_	_	_	_
171190	_	_	_	_	_
171200	7q34	[Phenylthiocarbamide tasting]	171200	AD	3
171300	_	_	_	_	_
171350	_	_	_	_	_
171400	10q11.21	Multiple endocrine neoplasia IIA	171400	AD	3
171420	_	_	_	_	_
171450	_	_	_	_	_
171480	_	_	_	_	_
171490	_	_	_	_	_
171500	_	_	_	_	_
171640	19p13.2	Spondyloenchondrodysplasia with immune dysregulation	607944	AR	3
171650	11p11.2	?Lysosomal acid phosphatase deficiency	200950	AR	1
171660	_	_	_	_	_
171700	_	_	_	_	_
171720	9q34.13	{Alkaline phosphatase, plasma level of, QTL1}	171720	?AD	2
171740	_	_	_	_	_
171750	_	_	_	_	_
171760	1p36.12	Hypophosphatasia, adult	146300	AD,AR	3
171760	1p36.12	Hypophosphatasia, childhood	241510	AR	3
171760	1p36.12	Hypophosphatasia, infantile	241500	AR	3
171760	1p36.12	Odontohypophosphatasia	146300	AD,AR	3
171790	_	_	_	_	_
171800	_	_	_	_	_
171810	_	_	_	_	_
171820	_	_	_	_	_
171830	_	_	_	_	_
171833	5q13.1	?Agammaglobulinemia 7, autosomal recessive	615214	AR	3
171833	5q13.1	Immunodeficiency 36	616005	AD	3
171833	5q13.1	SHORT syndrome	269880	AD	3
171834	3q26.32	Breast cancer, somatic	114480	_	3
171834	3q26.32	CLAPO syndrome, somatic	613089	_	3
171834	3q26.32	CLOVE syndrome, somatic	612918	_	3
171834	3q26.32	Colorectal cancer, somatic	114500	_	3
171834	3q26.32	Cowden syndrome 5	615108	_	3
171834	3q26.32	Gastric cancer, somatic	613659	_	3
171834	3q26.32	Hepatocellular carcinoma, somatic	114550	_	3
171834	3q26.32	Keratosis, seborrheic, somatic	182000	_	3
171834	3q26.32	Macrodactyly, somatic	155500	_	3
171834	3q26.32	Megalencephaly-capillary malformation-polymicrogyria syndrome, somatic	602501	_	3
171834	3q26.32	Nevus, epidermal, somatic	162900	_	3
171834	3q26.32	Nonsmall cell lung cancer, somatic	211980	_	3
171834	3q26.32	Ovarian cancer, somatic	167000	_	3
171835	_	_	_	_	_
171840	_	_	_	_	_
171850	_	_	_	_	_
171860	21q22.3	Hemolytic anemia due to phosphofructokinase deficiency	_	_	1
171880	_	_	_	_	_
171885	_	_	_	_	_
171890	_	_	_	_	_
171891	_	_	_	_	_
171900	1p31.3	Congenital disorder of glycosylation, type It	614921	AR	3
172000	_	_	_	_	_
172100	6q14.1	Immunodeficiency 23	615816	AR	3
172110	_	_	_	_	_
172150	_	_	_	_	_
172200	_	_	_	_	_
172250	_	_	_	_	_
172270	_	_	_	_	_
172280	_	_	_	_	_
172290	_	_	_	_	_
172300	_	_	_	_	_
172400	19q13.11	Hemolytic anemia, nonspherocytic, due to glucose phosphate isomerase deficiency	613470	AR	3
172405	6q22.31	Cardiomyopathy, dilated, 1P	609909	_	3
172405	6q22.31	Cardiomyopathy, hypertrophic, 18	613874	AD	3
172410	_	_	_	_	_
172411	1p36.13	{?Colorectal cancer, susceptibility to}	114500	AD,SMu	3
172420	_	_	_	_	_
172425	20q13.12	[High density lipoprotein cholesterol level QTL 9]	_	_	3
172430	1p36.23	Enolase deficiency	_	_	1
172439	_	_	_	_	_
172450	_	_	_	_	_
172460	14q23.3	Combined immunodeficiency and megaloblastic anemia with or without hyperhomocysteinemia	617780	AR	3
172460	14q23.3	{Neural tube defects, folate-sensitive, susceptibility to}	601634	AR	3
172470	_	_	_	_	_
172471	16p11.2	Cirrhosis due to liver phosphorylase kinase deficiency	_	_	3
172471	16p11.2	Glycogen storage disease IXc	613027	AR	3
172480	7p11.2	Phosphoserine phosphatase deficiency	614023	AR	3
172490	16q12.1	Phosphorylase kinase deficiency of liver and muscle, autosomal recessive	261750	AR	3
172500	_	_	_	_	_
172700	_	_	_	_	_
172800	_	_	_	_	_
172850	_	_	_	_	_
172860	17p13.3	Osteogenesis imperfecta, type VI	613982	_	3
172870	1q31.3	Pigmented paravenous chorioretinal atrophy	172870	AD	3
172880	_	_	_	_	_
172900	_	_	_	_	_
173000	_	_	_	_	_
173100	17q23.3	Growth hormone deficiency, isolated, type II	173100	AD	3
173110	3p11.2	Pituitary hormone deficiency, combined, 1	613038	AD,AR	3
173120	_	_	_	_	_
173200	17q25.3	Pityriasis rubra pilaris	173200	AD	3
173310	_	_	_	_	_
173320	_	_	_	_	_
173321	6p25.2	?Deafness, autosomal recessive 91	613453	AR	3
173325	17q21.2	Arrhythmogenic right ventricular dysplasia 12	611528	AD	3
173325	17q21.2	Naxos disease	601214	AR	3
173335	6q23.2	Arterial calcification, generalized, of infancy, 1	208000	AR	3
173335	6q23.2	Cole disease	615522	AD	3
173335	6q23.2	Hypophosphatemic rickets, autosomal recessive, 2	613312	AR	3
173335	6q23.2	{Diabetes mellitus, non-insulin-dependent, susceptibility to}	125853	AD	3
173335	6q23.2	{Obesity, susceptibility to}	601665	AD,AR,Mu	3
173340	_	_	_	_	_
173350	6q26	Dysplasminogenemia	217090	AR	3
173350	6q26	Plasminogen deficiency, type I	217090	AR	3
173360	7q22.1	Plasminogen activator inhibitor-1 deficiency	613329	AD,AR	3
173360	7q22.1	{Transcription of plasminogen activator inhibitor, modulator of}	_	_	3
173370	8p11.21	Hyperfibrinolysis, familial, due to increased release of PLAT	612348	_	1
173370	8p11.21	Thrombophilia, familial, due to decreased release of PLAT	612348	_	1
173390	_	_	_	_	_
173391	_	_	_	_	_
173393	_	_	_	_	_
173395	_	_	_	_	_
173400	_	_	_	_	_
173410	5q32	Basal ganglia calcification, idiopathic, 4	615007	AD	3
173410	5q32	Kosaki overgrowth syndrome	616592	AD	3
173410	5q32	Myeloproliferative disorder with eosinophilia	131440	AD	4
173410	5q32	Myofibromatosis, infantile, 1	228550	AD	3
173410	5q32	Premature aging syndrome, Penttinen type	601812	AD	3
173420	_	_	_	_	_
173430	_	_	_	_	_
173445	_	_	_	_	_
173450	_	_	_	_	_
173460	_	_	_	_	_
173461	_	_	_	_	_
173470	17q21.32	Bleeding disorder, platelet-type, 16, autosomal dominant	187800	AD	3
173470	17q21.32	Glanzmann thrombasthenia	273800	AR	3
173470	17q21.32	Purpura, posttransfusion	_	_	3
173470	17q21.32	Thrombocytopenia, neonatal alloimmune	_	_	3
173470	17q21.32	{Myocardial infarction, susceptibility to}	608446	_	3
173490	4q12	Gastrointestinal stromal tumor, somatic or familial	606764	_	3
173490	4q12	Hypereosinophilic syndrome, idiopathic, resistant to imatinib	607685	IC,SMu	3
173500	_	_	_	_	_
173510	7q21.11	Platelet glycoprotein IV deficiency	608404	AR	3
173510	7q21.11	[Macrothrombocytopenia]	_	_	1
173510	7q21.11	{Coronary heart disease, susceptibility to, 7}	610938	_	3
173510	7q21.11	{Malaria, cerebral, reduced risk of}	611162	_	3
173510	7q21.11	{Malaria, cerebral, susceptibility to}	611162	_	3
173511	_	_	_	_	_
173515	3q21.3	Bernard-Soulier syndrome, type C	231200	AR	3
173540	_	_	_	_	_
173560	_	_	_	_	_
173570	_	_	_	_	_
173580	_	_	_	_	_
173590	_	_	_	_	_
173600	17p11.2	Pneumothorax, primary spontaneous	173600	AD	3
173610	_	_	_	_	_
173650	20p12.3	Kindler syndrome	173650	AR	3
173700	_	_	_	_	_
173750	_	_	_	_	_
173800	_	_	_	_	_
173850	_	_	_	_	_
173865	_	_	_	_	_
173870	_	_	_	_	_
173871	_	_	_	_	_
173880	_	_	_	_	_
173900	16p13.3	Polycystic kidney disease 1	173900	AD	3
173910	4q22.1	Polycystic kidney disease 2	613095	AD	3
174000	1q22	Medullary cystic kidney disease 1	174000	AD	3
174050	19p13.2	Polycystic liver disease 1	174050	AD	3
174100	_	_	_	_	_
174200	7p14.1	Polydactyly, postaxial, types A1 and B	174200	AD	3
174300	1q32.1	Orofaciodigital syndrome V	174300	AR	3
174310	_	_	_	_	_
174400	12q13.3	Polydactyly, preaxial I	174400	AR	3
174500	_	_	_	_	_
174600	_	_	_	_	_
174700	7p14.1	Polydactyly, preaxial, type IV	174700	AD	3
174750	_	_	_	_	_
174760	_	_	_	_	_
174761	19q13.33	Mandibular hypoplasia, deafness, progeroid features, and lipodystrophy syndrome	615381	AD	3
174761	19q13.33	{Colorectal cancer, susceptibility to, 10}	612591	AD	3
174762	12q24.33	FILS syndrome	615139	AR	3
174762	12q24.33	IMAGE-I syndrome	618336	AR	3
174762	12q24.33	{Colorectal cancer, susceptibility to, 12}	615083	AD	3
174763	15q26.1	Mitochondrial DNA depletion syndrome 4A (Alpers type)	203700	AR	3
174763	15q26.1	Mitochondrial DNA depletion syndrome 4B (MNGIE type)	613662	AR	3
174763	15q26.1	Mitochondrial recessive ataxia syndrome (includes SANDO and SCAE)	607459	AR	3
174763	15q26.1	Progressive external ophthalmoplegia, autosomal dominant 1	157640	AD	3
174763	15q26.1	Progressive external ophthalmoplegia, autosomal recessive 1	258450	AR	3
174770	_	_	_	_	_
174800	20q13.32	McCune-Albright syndrome, somatic, mosaic	174800	_	3
174810	18q21.33	Osteolysis, familial expansile	174810	AD	3
174880	_	_	_	_	_
174900	_	_	_	_	_
175000	_	_	_	_	_
175020	_	_	_	_	_
175050	18q21.2	Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome	175050	AD	3
175100	_	_	_	_	_
175200	19p13.3	Peutz-Jeghers syndrome	175200	AD	3
175400	_	_	_	_	_
175450	_	_	_	_	_
175500	_	_	_	_	_
175505	_	_	_	_	_
175510	_	_	_	_	_
175690	_	_	_	_	_
175700	7p14.1	Greig cephalopolysyndactyly syndrome	175700	AD	3
175750	_	_	_	_	_
175780	13q34	Brain small vessel disease with or without ocular anomalies	175780	AD	3
175800	1q21.3	Porokeratosis 1, multiple types	175800	AD	3
175850	12q24.1-q24.2	Porokeratosis 2, palmar, plantar, and disseminated	175850	AD	2
175860	_	_	_	_	_
175900	12q24.11	Porokeratosis 3, multiple types	175900	AD	3
176000	_	_	_	_	_
176010	_	_	_	_	_
176090	_	_	_	_	_
176100	_	_	_	_	_
176200	_	_	_	_	_
176240	_	_	_	_	_
176250	_	_	_	_	_
176256	_	_	_	_	_
176257	_	_	_	_	_
176258	11p15.1	Epilepsy, progressive myoclonic 7	616187	AD	3
176260	12p13.32	Episodic ataxia/myokymia syndrome	160120	AD	3
176261	21q22.12	Jervell and Lange-Nielsen syndrome 2	612347	AR	3
176261	21q22.12	Long QT syndrome 5	613695	AD	3
176262	1p13.3	Epileptic encephalopathy, early infantile, 32	616366	AD	3
176263	_	_	_	_	_
176264	19q13.33	Spinocerebellar ataxia 13	605259	AD	3
176265	_	_	_	_	_
176266	11p14.1	Microcephaly, cataracts, impaired intellectual development, and dystonia with abnormal striatum	618284	AR	3
176267	12p13.32	Atrial fibrillation, familial, 7	612240	AD	3
176268	_	_	_	_	_
176269	_	_	_	_	_
176270	_	_	_	_	_
176290	_	_	_	_	_
176300	18q12.1	Amyloidosis, hereditary, transthyretin-related	105210	AD	3
176300	18q12.1	Carpal tunnel syndrome, familial	115430	AD	3
176300	18q12.1	[Dystransthyretinemic hyperthyroxinemia]	145680	AD	3
176305	7p15.2	?Guttmacher syndrome	176305	AD	3
176310	1q23.3	Congenital anomalies of kidney and urinary tract syndrome with or without hearing loss, abnormal ears, or developmental delay	617641	AD	3
176311	_	_	_	_	_
176312	_	_	_	_	_
176385	_	_	_	_	_
176390	_	_	_	_	_
176391	_	_	_	_	_
176392	_	_	_	_	_
176393	_	_	_	_	_
176394	_	_	_	_	_
176395	_	_	_	_	_
176396	_	_	_	_	_
176397	_	_	_	_	_
176398	_	_	_	_	_
176399	_	_	_	_	_
176400	19p13.3	?Precocious puberty, central, 1	176400	AD	3
176401	_	_	_	_	_
176410	_	_	_	_	_
176420	_	_	_	_	_
176430	15q15.1	[Premature chromatid separation trait]	176430	AD	3
176440	_	_	_	_	_
176450	7q36.3	Currarino syndrome	176450	AD	3
176500	13q14.2	Dementia, familial British	176500	AD	3
176590	_	_	_	_	_
176600	_	_	_	_	_
176610	17p13.2	Amyotrophic lateral sclerosis 18	614808	_	3
176620	_	_	_	_	_
176630	_	_	_	_	_
176635	_	_	_	_	_
176636	_	_	_	_	_
176640	20p13	Cerebral amyloid angiopathy, PRNP-related	137440	AD	3
176640	20p13	Creutzfeldt-Jakob disease	123400	AD	3
176640	20p13	Gerstmann-Straussler disease	137440	AD	3
176640	20p13	Huntington disease-like 1	603218	AD	3
176640	20p13	Insomnia, fatal familial	600072	AD	3
176640	20p13	Prion disease with protracted course	606688	AD	3
176640	20p13	{Kuru, susceptibility to}	245300	_	3
176670	1q22	Hutchinson-Gilford progeria	176670	AD,AR	3
176680	_	_	_	_	_
176690	_	_	_	_	_
176700	_	_	_	_	_
176705	17q21.33	{Breast cancer, susceptibility to}	114480	AD,SMu	3
176710	_	_	_	_	_
176720	_	_	_	_	_
176730	11p15.5	Diabetes mellitus, insulin-dependent, 2	125852	AD	3
176730	11p15.5	Diabetes mellitus, permanent neonatal	606176	AD,AR	3
176730	11p15.5	Hyperproinsulinemia	616214	AD	3
176730	11p15.5	Maturity-onset diabetes of the young, type 10	613370	AD	3
176740	20p12.3	?Ataxia-telangiectasia-like disorder 2	615919	AR	3
176741	_	_	_	_	_
176760	_	_	_	_	_
176761	5p13.2	Hyperprolactinemia	615555	AD,AR	3
176761	5p13.2	Multiple fibroadenomas of the breast	615554	AD	3
176763	1p34.1	Methylmalonic aciduria and homocystinuria, cblC type, digenic	277400	AR	3
176770	_	_	_	_	_
176780	1q31	{Pelvic organ prolapse, susceptibility to, 1}	176780	AD	2
176785	_	_	_	_	_
176790	17q25.3	Cole-Carpenter syndrome 1	112240	AD	3
176793	_	_	_	_	_
176794	_	_	_	_	_
176795	_	_	_	_	_
176797	11q23.2	Leukemia, acute promyelocytic, PL2F/RARA type	_	_	3
176797	11q23.2	Skeletal defects, genital hypoplasia, and mental retardation	612447	AR	3
176800	_	_	_	_	_
176801	10q22.1	Combined SAP deficiency	611721	AR	3
176801	10q22.1	Gaucher disease, atypical	610539	_	3
176801	10q22.1	Krabbe disease, atypical	611722	AR	3
176801	10q22.1	Metachromatic leukodystrophy due to SAP-b deficiency	249900	AR	3
176802	_	_	_	_	_
176803	_	_	_	_	_
176804	14q22.1	{Asthma, aspirin-induced, susceptibility to}	208550	AR	3
176805	_	_	_	_	_
176806	_	_	_	_	_
176807	_	_	_	_	_
176820	_	_	_	_	_
176830	2p23.3	Obesity, adrenal insufficiency, and red hair due to POMC deficiency	609734	AR	3
176830	2p23.3	{Obesity, early-onset, susceptibility to}	601665	AD,AR,Mu	3
176842	_	_	_	_	_
176843	_	_	_	_	_
176844	_	_	_	_	_
176845	_	_	_	_	_
176846	_	_	_	_	_
176847	_	_	_	_	_
176851	_	_	_	_	_
176860	2q14.3	Thrombophilia due to protein C deficiency, autosomal dominant	176860	AD	3
176870	_	_	_	_	_
176871	_	_	_	_	_
176872	15q22.31	Cardiofaciocutaneous syndrome 3	615279	_	3
176873	_	_	_	_	_
176874	_	_	_	_	_
176875	_	_	_	_	_
176876	12q24.13	LEOPARD syndrome 1	151100	AD	3
176876	12q24.13	Leukemia, juvenile myelomonocytic, somatic	607785	_	3
176876	12q24.13	Metachondromatosis	156250	AD	3
176876	12q24.13	Noonan syndrome 1	163950	AD	3
176877	_	_	_	_	_
176878	_	_	_	_	_
176879	_	_	_	_	_
176880	3q11.1	Thrombophilia due to protein S deficiency, autosomal dominant	612336	AD	3
176880	3q11.1	Thrombophilia due to protein S deficiency, autosomal recessive	614514	AR	3
176882	_	_	_	_	_
176883	_	_	_	_	_
176884	_	_	_	_	_
176885	20q13.13	{Insulin resistance, susceptibility to}	125853	AD	3
176886	_	_	_	_	_
176887	_	_	_	_	_
176888	_	_	_	_	_
176889	_	_	_	_	_
176891	_	_	_	_	_
176892	_	_	_	_	_
176893	9q21.11	?Bleeding disorder, platelet-type, 19	616176	AR	3
176894	10q11.2-q21.1	Aortic aneurysm, familial thoracic 8	615436	AD	3
176895	13q34	[Protein Z deficiency]	614024	_	3
176900	_	_	_	_	_
176910	_	_	_	_	_
176911	_	_	_	_	_
176912	_	_	_	_	_
176914	_	_	_	_	_
176915	5q31.1	Neurodevelopmental disorder and language delay with or without structural brain abnormalities	618354	AD	3
176916	_	_	_	_	_
176920	14q32.33	Proteus syndrome, somatic	176920	_	3
176930	11p11.2	Dysprothrombinemia	613679	AR	3
176930	11p11.2	Hypoprothrombinemia	613679	AR	3
176930	11p11.2	Thrombophilia due to thrombin defect	188050	AD	3
176930	11p11.2	{Pregnancy loss, recurrent, susceptibility to, 2}	614390	AD	3
176930	11p11.2	{Stroke, ischemic, susceptibility to}	601367	Mu	3
176940	_	_	_	_	_
176941	19p13.2	Immunodeficiency 35	611521	AR	3
176942	_	_	_	_	_
176943	10q26.13	Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis	207410	AD	3
176943	10q26.13	Apert syndrome	101200	AD	3
176943	10q26.13	Beare-Stevenson cutis gyrata syndrome	123790	AD	3
176943	10q26.13	Bent bone dysplasia syndrome	614592	AD	3
176943	10q26.13	Craniofacial-skeletal-dermatologic dysplasia	101600	AD	3
176943	10q26.13	Craniosynostosis, nonspecific	_	_	3
176943	10q26.13	Crouzon syndrome	123500	AD	3
176943	10q26.13	Gastric cancer, somatic	613659	_	3
176943	10q26.13	Jackson-Weiss syndrome	123150	AD	3
176943	10q26.13	LADD syndrome	149730	AD	3
176943	10q26.13	Pfeiffer syndrome	101600	AD	3
176943	10q26.13	Saethre-Chotzen syndrome	101400	AD	3
176943	10q26.13	Scaphocephaly and Axenfeld-Rieger anomaly	_	_	3
176943	10q26.13	Scaphocephaly, maxillary retrusion, and mental retardation	609579	_	3
176944	_	_	_	_	_
176945	_	_	_	_	_
176946	1p36.13	Cataract 6, multiple types	116600	AD	3
176947	2q11.2	Autoimmune disease, multisystem, infantile-onset, 2	617006	AR	3
176947	2q11.2	Immunodeficiency 48	269840	AR	3
176948	_	_	_	_	_
176949	_	_	_	_	_
176950	_	_	_	_	_
176960	17q24.2	Pituitary tumor, invasive	_	_	3
176970	_	_	_	_	_
176975	_	_	_	_	_
176977	3p21.1	Autoimmune lymphoproliferative syndrome, type III	615559	AR	3
176980	19q13.42	Spinocerebellar ataxia 14	605361	AD	3
176981	_	_	_	_	_
176982	_	_	_	_	_
176990	_	_	_	_	_
176991	_	_	_	_	_
176992	_	_	_	_	_
176993	_	_	_	_	_
177000	18q21.31	Protoporphyria, erythropoietic, 1	177000	AR	3
177010	_	_	_	_	_
177015	_	_	_	_	_
177020	_	_	_	_	_
177030	_	_	_	_	_
177040	_	_	_	_	_
177045	6p21.32	?Proteasome-associated autoinflammatory syndrome 3, digenic	617591	AR	3
177046	6p21.32	Proteasome-associated autoinflammatory syndrome 1 and digenic forms	256040	AR	3
177050	_	_	_	_	_
177060	19p13.2	Polycystic liver disease 1	174050	AD	3
177061	_	_	_	_	_
177070	15q15.2	Spherocytosis, type 5	612690	_	3
177075	16q23.2	Ayme-Gripp syndrome	601088	AD	3
177075	16q23.2	Cataract 21, multiple types	610202	AD	3
177100	_	_	_	_	_
177150	_	_	_	_	_
177170	19p13.11	Pseudoachondroplasia	177170	AD	3
177200	16p12.2	Liddle syndrome 1	177200	AD	3
177300	_	_	_	_	_
177350	_	_	_	_	_
177400	3q26.1	Butyrylcholinesterase deficiency	617936	_	3
177400	3q26.1	{Apnea, postanesthetic, susceptibility to, due to BCHE deficiency}	617936	_	3
177500	_	_	_	_	_
177600	_	_	_	_	_
177650	15q24.1	{Exfoliation syndrome, susceptibility to}	177650	AD	3
177700	12q14	Glaucoma 1, open angle, P	177700	AD	4
177720	_	_	_	_	_
177735	4q31.23	Pseudohypoaldosteronism type I, autosomal dominant	177735	AD	3
177750	_	_	_	_	_
177800	_	_	_	_	_
177820	17p13.2	von Willebrand disease, platelet-type	177820	AD	3
177850	16p13.11	Pseudoxanthoma elasticum, forme fruste	177850	AD	3
177860	_	_	_	_	_
177900	6p21.33	{Psoriasis susceptibility 1}	177900	Mu	3
177980	_	_	_	_	_
177990	_	_	_	_	_
178000	_	_	_	_	_
178110	17p13.1	Contractures, pterygia, and variable skeletal fusions syndrome 1A	178110	AD	3
178200	_	_	_	_	_
178300	1p34.1-p32	Ptosis, hereditary congenital, 1	178300	AD	2
178330	_	_	_	_	_
178350	_	_	_	_	_
178370	_	_	_	_	_
178400	_	_	_	_	_
178500	_	_	_	_	_
178550	_	_	_	_	_
178600	_	_	_	_	_
178610	_	_	_	_	_
178620	8p21.3	Surfactant metabolism dysfunction, pulmonary, 2	610913	AD	3
178630	_	_	_	_	_
178635	_	_	_	_	_
178640	2p11.2	Surfactant metabolism dysfunction, pulmonary, 1	265120	AR	3
178642	10q22.3	Pulmonary fibrosis, idiopathic	178500	AD	3
178650	_	_	_	_	_
178651	_	_	_	_	_
178800	_	_	_	_	_
178900	_	_	_	_	_
178990	_	_	_	_	_
178995	_	_	_	_	_
179000	_	_	_	_	_
179010	12q	Pyloric stenosis, infantile hypertrophic 1	179010	AD,Mu	2
179020	_	_	_	_	_
179030	_	_	_	_	_
179035	17q25.3	Cutis laxa, autosomal recessive, type IIB	612940	AR	3
179035	17q25.3	Cutis laxa, autosomal recessive, type IIIB	614438	_	3
179040	_	_	_	_	_
179050	_	_	_	_	_
179060	3p14.3	Pyruvate dehydrogenase E1-beta deficiency	614111	_	3
179061	_	_	_	_	_
179080	_	_	_	_	_
179090	_	_	_	_	_
179095	5q31.1	?Male infertility	_	_	1
179200	_	_	_	_	_
179250	_	_	_	_	_
179270	_	_	_	_	_
179280	_	_	_	_	_
179300	_	_	_	_	_
179400	_	_	_	_	_
179410	11q22.3	Deafness, autosomal recessive 24	611022	AR	3
179450	6p21.3	?Ragweed sensitivity	179450	AD	2
179490	_	_	_	_	_
179500	_	_	_	_	_
179502	4q23	Lymphocytic leukemia, acute T-cell	_	_	3
179503	_	_	_	_	_
179505	_	_	_	_	_
179508	_	_	_	_	_
179509	_	_	_	_	_
179510	_	_	_	_	_
179511	_	_	_	_	_
179512	_	_	_	_	_
179513	_	_	_	_	_
179514	_	_	_	_	_
179520	_	_	_	_	_
179530	_	_	_	_	_
179540	_	_	_	_	_
179541	_	_	_	_	_
179550	_	_	_	_	_
179551	_	_	_	_	_
179555	_	_	_	_	_
179590	1p34.2	?Breasts and/or nipples, aplasia or hypoplasia of, 2	616001	AR	3
179600	_	_	_	_	_
179605	6p21.1	Choroidal dystrophy, central areolar 2	613105	AD	3
179605	6p21.1	Leber congenital amaurosis 18	608133	AD,AR	3
179605	6p21.1	Macular dystrophy, patterned, 1	169150	AD	3
179605	6p21.1	Macular dystrophy, vitelliform, 3	608161	AD	3
179605	6p21.1	Retinitis pigmentosa 7 and digenic form	608133	AD,AR	3
179605	6p21.1	Retinitis punctata albescens	136880	AD,AR	3
179610	_	_	_	_	_
179611	_	_	_	_	_
179613	_	_	_	_	_
179615	11p12	Alpha/beta T-cell lymphopenia with gamma/delta T-cell expansion, severe cytomegalovirus infection, and autoimmunity	609889	_	3
179615	11p12	Combined cellular and humoral immune defects with granulomas	233650	AR	3
179615	11p12	Omenn syndrome	603554	AR	3
179615	11p12	Severe combined immunodeficiency, B cell-negative	601457	AR	3
179616	11p12	Combined cellular and humoral immune defects with granulomas	233650	AR	3
179616	11p12	Omenn syndrome	603554	AR	3
179616	11p12	Severe combined immunodeficiency, B cell-negative	601457	AR	3
179617	15q15.1	?Fanconi anemia, complementation group R	617244	AD	3
179617	15q15.1	Mirror movements 2	614508	AD	3
179617	15q15.1	{Breast cancer, susceptibility to}	114480	AD,SMu	3
179618	_	_	_	_	_
179620	11p15.5	[Blood group, Raph]	179620	_	3
179650	_	_	_	_	_
179700	_	_	_	_	_
179710	_	_	_	_	_
179715	_	_	_	_	_
179730	_	_	_	_	_
179740	_	_	_	_	_
179755	1q23.1	Renal cell carcinoma, papillary	605074	_	3
179760	_	_	_	_	_
179770	_	_	_	_	_
179780	_	_	_	_	_
179800	17q21.31	Renal tubular acidosis, distal, AD	179800	AD	3
179820	1q32.1	Hyperuricemic nephropathy, familial juvenile 2	613092	AD	3
179820	1q32.1	Renal tubular dysgenesis	267430	AR	3
179820	1q32.1	[Hyperproreninemia]	_	_	3
179830	_	_	_	_	_
179835	_	_	_	_	_
179836	_	_	_	_	_
179837	_	_	_	_	_
179838	_	_	_	_	_
179840	_	_	_	_	_
179850	12q13.13	Dowling-Degos disease 1	179850	AD	3
179900	_	_	_	_	_
180000	13q34	?Retinal arteries, tortuosity of	180000	AD	3
180020	6q25-q26	?Retinal cone dystrophy-1	180020	AD	2
180040	1q32.3	Leber congenital amaurosis 12	610612	AR	3
180050	_	_	_	_	_
180060	_	_	_	_	_
180069	1p31.3	Leber congenital amaurosis 2	204100	AR	3
180069	1p31.3	Retinitis pigmentosa 20	613794	AR	3
180070	_	_	_	_	_
180071	5q32	Retinitis pigmentosa 43	613810	_	3
180072	4p16.3	Night blindness, congenital stationary, autosomal dominant 2	163500	AD	3
180072	4p16.3	Retinitis pigmentosa-40	613801	AR	3
180073	17q25.3	Retinitis pigmentosa 57	613582	AR	3
180080	_	_	_	_	_
180090	15q26.1	Bothnia retinal dystrophy	607475	AR	3
180090	15q26.1	Fundus albipunctatus	136880	AD,AR	3
180090	15q26.1	Newfoundland rod-cone dystrophy	607476	_	3
180090	15q26.1	Retinitis punctata albescens	136880	AD,AR	3
180100	8q11.2-q12.1	Retinitis pigmentosa 1	180100	AD,AR	3
180102	_	_	_	_	_
180103	_	_	_	_	_
180104	7p14.3	?Retinitis pigmentosa 9	180104	AD	3
180105	7q32.1	Retinitis pigmentosa 10	180105	AD	3
180190	_	_	_	_	_
180200	_	_	_	_	_
180201	_	_	_	_	_
180202	_	_	_	_	_
180203	_	_	_	_	_
180210	_	_	_	_	_
180220	3p24.2	Microphthalmia, syndromic 12	615524	AD,AR	3
180230	_	_	_	_	_
180231	_	_	_	_	_
180240	17q21.2	Leukemia, acute promyelocytic	612376	_	1
180245	_	_	_	_	_
180246	_	_	_	_	_
180247	_	_	_	_	_
180250	10q23.33	Microphthalmia, isolated, with coloboma 10	616428	AD	3
180250	10q23.33	Retinal dystrophy, iris coloboma, and comedogenic acne syndrome	615147	AR	3
180260	_	_	_	_	_
180270	_	_	_	_	_
180280	_	_	_	_	_
180290	10q11.22	?Retinitis pigmentosa 66	615233	AR	3
180295	14q32.13	Rhabdomyosarcoma, embryonal, 2	180295	_	3
180297	6p12.3	Anemia, hemolytic, Rh-null, regulator type	268150	AD	3
180297	6p12.3	Overhydrated hereditary stomatocytosis	185000	AD	3
180300	6q23	{Rheumatoid arthritis, susceptibility to}	180300	_	2
180330	_	_	_	_	_
180350	_	_	_	_	_
180360	_	_	_	_	_
180370	_	_	_	_	_
180380	3q22.1	Night blindness, congenital stationary, autosomal dominant 1	610445	_	3
180380	3q22.1	Retinitis pigmentosa 4, autosomal dominant or recessive	613731	AD,AR	3
180380	3q22.1	Retinitis punctata albescens	136880	AD,AR	3
180381	13q34	Oguchi disease-2	613411	_	3
180385	11p13	Leukemia, acute T-cell	180385	_	2
180386	_	_	_	_	_
180390	_	_	_	_	_
180410	_	_	_	_	_
180420	_	_	_	_	_
180430	2p11.2	Ribose 5-phosphate isomerase deficiency	608611	AR	3
180435	1q25.3	Prostate cancer 1	601518	AD	3
180440	_	_	_	_	_
180450	_	_	_	_	_
180451	_	_	_	_	_
180452	_	_	_	_	_
180453	_	_	_	_	_
180454	_	_	_	_	_
180460	_	_	_	_	_
180461	_	_	_	_	_
180462	_	_	_	_	_
180463	_	_	_	_	_
180464	_	_	_	_	_
180465	_	_	_	_	_
180466	_	_	_	_	_
180467	_	_	_	_	_
180468	3q29	Diamond-Blackfan anemia 5	612528	AD	3
180469	_	_	_	_	_
180470	_	_	_	_	_
180471	_	_	_	_	_
180472	15q25.2	Diamond-Blackfan anemia 4	612527	AD	3
180473	_	_	_	_	_
180474	_	_	_	_	_
180475	_	_	_	_	_
180476	_	_	_	_	_
180477	_	_	_	_	_
180478	_	_	_	_	_
180479	_	_	_	_	_
180480	_	_	_	_	_
180490	_	_	_	_	_
180500	4q25	Axenfeld-Rieger syndrome, type 1	180500	AD	3
180510	_	_	_	_	_
180520	_	_	_	_	_
180530	_	_	_	_	_
180535	_	_	_	_	_
180540	_	_	_	_	_
180550	4q25	Ring dermoid of cornea	180550	AD	3
180600	_	_	_	_	_
180610	_	_	_	_	_
180620	_	_	_	_	_
180621	_	_	_	_	_
180630	_	_	_	_	_
180640	_	_	_	_	_
180645	_	_	_	_	_
180646	_	_	_	_	_
180647	_	_	_	_	_
180660	_	_	_	_	_
180661	_	_	_	_	_
180662	_	_	_	_	_
180663	_	_	_	_	_
180664	_	_	_	_	_
180670	_	_	_	_	_
180680	_	_	_	_	_
180690	_	_	_	_	_
180691	_	_	_	_	_
180692	_	_	_	_	_
180700	3p14.3	Robinow syndrome, autosomal dominant 1	180700	AD	3
180710	_	_	_	_	_
180720	_	_	_	_	_
180721	11q12.3	Retinitis pigmentosa 7, digenic form	608133	AD,AR	3
180730	_	_	_	_	_
180740	_	_	_	_	_
180750	7p21.1	Robinow-Sorauf syndrome	180750	AD	3
180800	_	_	_	_	_
180840	_	_	_	_	_
180849	16p13.3	Rubinstein-Taybi syndrome 1	180849	AD	3
180850	_	_	_	_	_
180860	7p11.2	Silver-Russell syndrome	180860	AD	4
180870	_	_	_	_	_
180900	_	_	_	_	_
180901	19q13.2	Central core disease	117000	AD,AR	3
180901	19q13.2	King-Denborough syndrome	145600	AD	3
180901	19q13.2	Minicore myopathy with external ophthalmoplegia	255320	AR	3
180901	19q13.2	Neuromuscular disease, congenital, with uniform type 1 fiber	117000	AD,AR	3
180901	19q13.2	{Malignant hyperthermia susceptibility 1}	145600	AD	3
180902	1q43	Arrhythmogenic right ventricular dysplasia 2	600996	AD	3
180902	1q43	Ventricular tachycardia, catecholaminergic polymorphic, 1	604772	AD	3
180903	_	_	_	_	_
180910	_	_	_	_	_
180920	5p12	Aplasia of lacrimal and salivary glands	180920	AD	3
180930	_	_	_	_	_
180940	_	_	_	_	_
180950	_	_	_	_	_
180960	20q11.22	Hypermethioninemia with deficiency of S-adenosylhomocysteine hydrolase	613752	AR	3
180980	_	_	_	_	_
180989	_	_	_	_	_
180990	_	_	_	_	_
181000	6p21.32	{Sarcoidosis, susceptibility to, 1}	181000	AD	3
181010	_	_	_	_	_
181030	8q12.1	Adenomas, salivary gland pleomorphic, somatic	181030	_	3
181031	2q37.1	Oguchi disease-1	258100	AR	3
181031	2q37.1	Retinitis pigmentosa 47	613758	_	3
181035	_	_	_	_	_
181180	_	_	_	_	_
181200	_	_	_	_	_
181250	_	_	_	_	_
181270	18q11.2	Scalp-ear-nipple syndrome	181270	AD	3
181300	_	_	_	_	_
181350	1q22	Emery-Dreifuss muscular dystrophy 2, autosomal dominant	181350	AD	3
181400	2q35	Scapuloperoneal syndrome, neurogenic, Kaeser type	181400	AD	3
181405	12q24.11	Scapuloperoneal spinal muscular atrophy	181405	AD	3
181430	14q11.2	Scapuloperoneal syndrome, myopathic type	181430	AD	3
181440	_	_	_	_	_
181450	12q24.21	Ulnar-mammary syndrome	181450	AD	3
181460	5q31-q33	{Schistosoma mansoni infection, susceptibility/resistance to}	181460	AD	2
181500	_	_	_	_	_
181510	5q23-q35	{Schizophrenia}	181500	AD	2
181515	_	_	_	_	_
181520	_	_	_	_	_
181590	1p33	Microcephaly 7, primary, autosomal recessive	612703	AR	3
181600	4q22.3	Huriez syndrome	181600	AD	3
181700	_	_	_	_	_
181750	_	_	_	_	_
181800	19p13.3	Scoliosis, idiopathic 1	181800	AD	2
182000	3q26.32	Keratosis, seborrheic, somatic	182000	_	3
182090	_	_	_	_	_
182098	_	_	_	_	_
182099	_	_	_	_	_
182100	19q13.33	[Bombay phenotype, digenic]	616754	AR	3
182100	19q13.33	{Norwalk virus infection, resistance to}	_	_	3
182100	19q13.33	{Vitamin B12 plasma level QTL1}	612542	_	3
182115	_	_	_	_	_
182120	5q33.1	Osteogenesis imperfecta, type XVII	616507	AR	3
182125	2p13.2	Dystonia, dopa-responsive, due to sepiapterin reductase deficiency	612716	?AD,AR	3
182128	_	_	_	_	_
182131	_	_	_	_	_
182132	_	_	_	_	_
182133	_	_	_	_	_
182134	_	_	_	_	_
182135	13q14.2	{Alcohol dependence, susceptibility to}	103780	Mu	3
182135	13q14.2	{Anorexia nervosa, susceptibility to}	606788	_	3
182135	13q14.2	{Major depressive disorder, response to citalopram therapy in}	608516	_	3
182135	13q14.2	{Obsessive-compulsive disorder, susceptibility to}	164230	AD	3
182135	13q14.2	{Schizophrenia, susceptibility to}	181500	AD	3
182135	13q14.2	{Seasonal affective disorder, susceptibility to}	608516	_	3
182137	_	_	_	_	_
182138	17q11.2	{Anxiety-related personality traits}	607834	_	3
182138	17q11.2	{Obsessive-compulsive disorder}	164230	AD	3
182139	_	_	_	_	_
182140	_	_	_	_	_
182141	_	_	_	_	_
182143	_	_	_	_	_
182144	_	_	_	_	_
182145	_	_	_	_	_
182150	_	_	_	_	_
182160	_	_	_	_	_
182170	5q31.2	Anemia, sideroblastic, 4	182170	AD	3
182175	_	_	_	_	_
182180	_	_	_	_	_
182190	_	_	_	_	_
182200	_	_	_	_	_
182203	_	_	_	_	_
182205	_	_	_	_	_
182210	_	_	_	_	_
182212	1p36.33-p36.32	Shprintzen-Goldberg syndrome	182212	AD	3
182220	_	_	_	_	_
182230	_	_	_	_	_
182250	2q24.2	Singleton-Merten syndrome 1	182250	AD	3
182255	_	_	_	_	_
182257	_	_	_	_	_
182260	_	_	_	_	_
182265	_	_	_	_	_
182266	_	_	_	_	_
182267	_	_	_	_	_
182268	_	_	_	_	_
182269	_	_	_	_	_
182270	_	_	_	_	_
182271	_	_	_	_	_
182279	15q11.2	Prader-Willi syndrome	176270	AD	3
182280	3p23-p21	Small-cell cancer of lung	182280	AD	2
182281	_	_	_	_	_
182282	20p13	Cerebrocostomandibular syndrome	117650	AD	3
182283	17q12	{HIV infection, resistance to}	609423	_	2
182284	_	_	_	_	_
182285	_	_	_	_	_
182290	17p11.2	Smith-Magenis syndrome	182290	AD,IC	3
182305	_	_	_	_	_
182307	5p15.33	Diarrhea 8, secretory sodium, congenital	616868	AR	3
182308	_	_	_	_	_
182309	5q35.3	?Fanconi renotubular syndrome 2	613388	AR	3
182309	5q35.3	Hypercalcemia, infantile, 2	616963	AR	3
182309	5q35.3	Nephrolithiasis/osteoporosis, hypophosphatemic, 1	612286	AD	3
182310	1p13.1	Charcot-Marie-Tooth disease, axonal, type 2DD	618036	AD	3
182310	1p13.1	Hypomagnesemia, seizures, and mental retardation 2	618314	AD	3
182330	1q24.2	[Blood pressure regulation QTL]	145500	Mu	2
182331	_	_	_	_	_
182340	1q23.2	Alternating hemiplegia of childhood 1	104290	AD	3
182340	1q23.2	Migraine, familial basilar	602481	AD	3
182340	1q23.2	Migraine, familial hemiplegic, 2	602481	AD	3
182350	19q13.2	Alternating hemiplegia of childhood 2	614820	AD	3
182350	19q13.2	CAPOS syndrome	601338	AD	3
182350	19q13.2	Dystonia-12	128235	AD	3
182360	_	_	_	_	_
182370	_	_	_	_	_
182380	22q12.3	Glucose/galactose malabsorption	606824	AR	3
182381	16p11.2	Renal glucosuria	233100	AD,AR	3
182389	2q24.3	Epilepsy, generalized, with febrile seizures plus, type 2	604403	AD	3
182389	2q24.3	Epileptic encephalopathy, early infantile, 6 (Dravet syndrome)	607208	AD	3
182389	2q24.3	Febrile seizures, familial, 3A	604403	AD	3
182389	2q24.3	Migraine, familial hemiplegic, 3	609634	AD	3
182390	2q24.3	Epileptic encephalopathy, early infantile, 11	613721	AD	3
182390	2q24.3	Seizures, benign familial infantile, 3	607745	AD	3
182391	2q24.3	Epilepsy, familial focal, with variable foci 4	617935	AD	3
182391	2q24.3	Epileptic encephalopathy, early infantile, 62	617938	AD	3
182392	_	_	_	_	_
182396	_	_	_	_	_
182400	_	_	_	_	_
182410	22q11.1	?Sneddon syndrome	182410	AR	3
182450	_	_	_	_	_
182451	_	_	_	_	_
182452	_	_	_	_	_
182453	_	_	_	_	_
182454	_	_	_	_	_
182455	16p13.3	Somatostatin analog, resistance to	_	_	3
182465	21q22.11	ZTTK syndrome	617140	AD	3
182500	15q21.1	?Cataract, congenital	182500	_	2
182520	_	_	_	_	_
182530	2p22.1	?Fibromatosis, gingival, 1	135300	AD	3
182530	2p22.1	Noonan syndrome 4	610733	AD	3
182590	_	_	_	_	_
182600	14q22.1	Spastic paraplegia 3A, autosomal dominant	182600	AD	3
182601	2p22.3	Spastic paraplegia 4, autosomal dominant	182601	AD	3
182610	_	_	_	_	_
182690	_	_	_	_	_
182700	_	_	_	_	_
182790	_	_	_	_	_
182800	_	_	_	_	_
182810	9q34.11	Epileptic encephalopathy, early infantile, 5	613477	AD	3
182815	_	_	_	_	_
182820	_	_	_	_	_
182830	_	_	_	_	_
182860	1q23.1	Elliptocytosis-2	130600	AD	3
182860	1q23.1	Pyropoikilocytosis	266140	AR	3
182860	1q23.1	Spherocytosis, type 3	270970	AR	3
182870	14q23.3	Anemia, neonatal hemolytic, fatal or near-fatal	617948	_	3
182870	14q23.3	Elliptocytosis-3	617948	_	3
182870	14q23.3	Spherocytosis, type 2	616649	AD	3
182875	_	_	_	_	_
182878	_	_	_	_	_
182879	_	_	_	_	_
182880	_	_	_	_	_
182882	_	_	_	_	_
182888	16p12.3-p12.2	Oocyte maturation defect 6	618353	AR	3
182889	7q11.23	Oocyte maturation defect 3	617712	AD	3
182890	_	_	_	_	_
182891	_	_	_	_	_
182892	_	_	_	_	_
182900	8p11.21	Spherocytosis, type 1	182900	AD,AR	3
182920	5q31.2	Myopathy, spheroid body	182920	AD	3
182930	_	_	_	_	_
182940	_	_	_	_	_
182950	_	_	_	_	_
182960	7q34-q36	Neuronopathy, distal hereditary motor, type I	182960	AD	2
182970	_	_	_	_	_
182980	20q13.32	Spinal muscular atrophy, late-onset, Finkel type	182980	AD	3
182990	_	_	_	_	_
183000	_	_	_	_	_
183020	_	_	_	_	_
183050	_	_	_	_	_
183085	_	_	_	_	_
183086	19p13.13	Spinocerebellar ataxia 6	183086	AD	3
183090	_	_	_	_	_
183100	_	_	_	_	_
183250	_	_	_	_	_
183300	_	_	_	_	_
183350	_	_	_	_	_
183400	_	_	_	_	_
183500	_	_	_	_	_
183600	7q21.2-q21.3	Split hand/foot malformation 1	183600	AD	4
183700	_	_	_	_	_
183800	_	_	_	_	_
183802	_	_	_	_	_
183840	9q31-q34	{Spondyloarthropathy, susceptibility to, 2}	183840	AD	2
183849	_	_	_	_	_
183850	_	_	_	_	_
183900	12q13.11	SED congenita	183900	AD	3
184000	_	_	_	_	_
184095	12q24.11	SED, Maroteaux type	184095	AD	3
184100	12q13	Spondyloepiphyseal dysplasia tarda, autosomal dominant	184100	AD	2
184200	_	_	_	_	_
184250	12q13.11	SMED Strudwick type	184250	AD	3
184252	12q24.11	Spondylometaphyseal dysplasia, Kozlowski type	184252	AD	3
184253	_	_	_	_	_
184255	2q35	Spondylometaphyseal dysplasia, corner fracture type	184255	AD	3
184260	14q32.12	Osteochondrodysplasia	184260	AR	3
184300	_	_	_	_	_
184400	_	_	_	_	_
184420	8p23.1	Squalene synthase deficiency	618156	_	3
184429	3q26.33	Microphthalmia, syndromic 3	206900	AD	3
184429	3q26.33	Optic nerve hypoplasia and abnormalities of the central nervous system	206900	AD	3
184430	_	_	_	_	_
184450	15q21.2	Stuttering, familial persistent, 1	184450	AD	3
184460	17q22	Stapes ankylosis with broad thumbs and toes	184460	AD	3
184470	_	_	_	_	_
184500	17q21.2	Steatocystoma multiplex	184500	AD	3
184510	_	_	_	_	_
184600	3q21.1	Peeling skin syndrome 4	607936	AR	3
184601	_	_	_	_	_
184700	19p13.2	Polycystic ovary syndrome 1	184700	AD	2
184705	_	_	_	_	_
184745	12q21.32	Deafness, autosomal dominant 69, unilateral or asymmetric	616697	AD	3
184745	12q21.32	Hyperpigmentation with or without hypopigmentation	145250	AD	3
184745	12q21.32	[Skin/hair/eye pigmentation 7, blond/brown hair]	611664	_	3
184747	_	_	_	_	_
184753	_	_	_	_	_
184754	_	_	_	_	_
184755	1p32.3	?Leukoencephalopathy with dystonia and motor neuropathy	613724	AR	3
184756	_	_	_	_	_
184757	9q33.3	46, XX sex reversal 4	617480	AD	3
184757	9q33.3	46XY sex reversal 3	612965	AD	3
184757	9q33.3	Adrenocortical insufficiency	612964	AD	3
184757	9q33.3	Premature ovarian failure 7	612964	AD	3
184757	9q33.3	Spermatogenic failure 8	613957	AD	3
184800	_	_	_	_	_
184840	6p21.32	Otospondylomegaepiphyseal dysplasia, autosomal dominant	184840	AD	3
184850	_	_	_	_	_
184900	15q21.1	Stiff skin syndrome	184900	AD	3
185000	6p12.3	Overhydrated hereditary stomatocytosis	185000	AD	3
185010	_	_	_	_	_
185020	17q21.31	Cryohydrocytosis	185020	AD	3
185050	_	_	_	_	_
185069	_	_	_	_	_
185070	11p15.4	Stormorken syndrome	185070	AD	3
185100	7p22.1	{Strabismus, susceptibility to, 1}	185100	_	2
185120	_	_	_	_	_
185200	_	_	_	_	_
185250	11q22.2	{Coronary heart disease, susceptibility to, 6}	614466	_	3
185260	_	_	_	_	_
185261	_	_	_	_	_
185300	9q21.2	Sturge-Weber syndrome, somatic, mosaic	185300	_	3
185400	_	_	_	_	_
185430	_	_	_	_	_
185440	_	_	_	_	_
185450	_	_	_	_	_
185460	_	_	_	_	_
185470	1p36.13	Gastrointestinal stromal tumor	606764	AD,IC	3
185470	1p36.13	Paraganglioma and gastric stromal sarcoma	606864	_	3
185470	1p36.13	Paragangliomas 4	115310	AD	3
185470	1p36.13	Pheochromocytoma	171300	AD	3
185480	_	_	_	_	_
185490	4p15.2	[Superoxide dismutase, elevated extracellular]	_	_	3
185500	7q11.23	Supravalvar aortic stenosis	185500	AD	3
185510	_	_	_	_	_
185520	_	_	_	_	_
185535	2p21	Colorectal cancer, hereditary nonpolyposis, type 8	613244	_	3
185535	2p21	Diarrhea 5, with tufting enteropathy, congenital	613217	AR	3
185540	_	_	_	_	_
185560	_	_	_	_	_
185570	_	_	_	_	_
185580	_	_	_	_	_
185590	_	_	_	_	_
185595	_	_	_	_	_
185600	_	_	_	_	_
185605	12q21.2	Baker-Gordon syndrome	618218	AD	3
185610	_	_	_	_	_
185620	9q34.2	Charcot-Marie-Tooth disease, type 4K	616684	AR	3
185620	9q34.2	Leigh syndrome, due to COX IV deficiency	256000	Mi,AR	3
185630	_	_	_	_	_
185640	_	_	_	_	_
185641	_	_	_	_	_
185642	_	_	_	_	_
185650	_	_	_	_	_
185660	_	_	_	_	_
185700	_	_	_	_	_
185750	_	_	_	_	_
185800	17q22	Symphalangism, proximal, 1A	185800	AD	3
185860	_	_	_	_	_
185861	_	_	_	_	_
185880	12p13.31	Myasthenic syndrome, congenital, 25	618323	AR	3
185880	12p13.31	Spastic ataxia 1, autosomal dominant	108600	AD	3
185881	_	_	_	_	_
185900	2q34-q36	Syndactyly, type 1, with or without craniosynostosis	185900	AD	4
186000	2q31.1	Synpolydactyly 1	186000	AD	3
186100	6q22.31	Syndactyly, type III	186100	AD	3
186200	7q36.3	Syndactyly, type IV	186200	AD	3
186300	2q31.1	Syndactyly, type V	186300	AD	3
186350	_	_	_	_	_
186355	_	_	_	_	_
186357	1p35.2	{Obesity, association with}	601665	AD,AR,Mu	3
186360	_	_	_	_	_
186400	_	_	_	_	_
186500	17q22	Multiple synostoses syndrome 1	186500	AD	3
186550	5q31.1	Liebenberg syndrome	186550	AD	4
186570	17q22	Tarsal-carpal coalition syndrome	186570	AD	3
186575	_	_	_	_	_
186580	16q12.1	Blau syndrome	186580	AD	3
186590	_	_	_	_	_
186591	_	_	_	_	_
186600	_	_	_	_	_
186690	_	_	_	_	_
186700	_	_	_	_	_
186710	_	_	_	_	_
186711	12p13.31	Lymphoproliferative syndrome 2	615122	AR	3
186720	_	_	_	_	_
186730	_	_	_	_	_
186740	11q23.3	Immunodeficiency 17, CD3 gamma deficient	615607	AR	3
186745	_	_	_	_	_
186750	_	_	_	_	_
186760	_	_	_	_	_
186770	_	_	_	_	_
186780	1q24.2	?Immunodeficiency 25	610163	AR	3
186790	11q23.3	Immunodeficiency 19	615617	AR	3
186810	_	_	_	_	_
186820	_	_	_	_	_
186830	11q23.3	Immunodeficiency 18	615615	AR	3
186830	11q23.3	Immunodeficiency 18, SCID variant	615615	AR	3
186845	11p15.5	Immunodeficiency, common variable, 6	613496	AR	3
186850	_	_	_	_	_
186852	_	_	_	_	_
186854	_	_	_	_	_
186855	9q31.2	Leukemia, T-cell acute lymphocytic, somatic	613065	_	3
186860	2q34	Leukemia/lymphoma, T-cell	186860	_	2
186880	14q11.2	Immunodeficiency 7, TCR-alpha/beta deficient	615387	AR	3
186890	_	_	_	_	_
186910	2p11.2	CD8 deficiency, familial	608957	AR	3
186920	_	_	_	_	_
186921	11p15.4	Leukemia, T-cell acute lymphoblastic	186921	_	2
186930	_	_	_	_	_
186940	12p13.31	OKT4 epitope deficiency	613949	_	3
186945	_	_	_	_	_
186946	_	_	_	_	_
186947	_	_	_	_	_
186950	_	_	_	_	_
186960	14q32.13	Leukemia/lymphoma, T-cell	186960	_	2
186970	_	_	_	_	_
186973	5q33.3	Lymphoproliferative syndrome 1	613011	AR	3
186975	_	_	_	_	_
186977	_	_	_	_	_
186980	_	_	_	_	_
186982	_	_	_	_	_
186990	_	_	_	_	_
187000	_	_	_	_	_
187010	_	_	_	_	_
187011	17q12	{HIV-1 disease, delayed progression of}	_	_	3
187011	17q12	{HIV-1 disease, rapid progression of}	_	_	3
187020	_	_	_	_	_
187030	_	_	_	_	_
187040	1p33	Leukemia, T-cell acute lymphocytic, somatic	613065	_	3
187050	_	_	_	_	_
187100	_	_	_	_	_
187260	5q14	Telangiectasia, hereditary benign	187260	AD	2
187270	5p15.33	{Dyskeratosis congenita, autosomal dominant 2}	613989	AD,AR	3
187270	5p15.33	{Dyskeratosis congenita, autosomal recessive 4}	613989	AD,AR	3
187270	5p15.33	{Leukemia, acute myeloid}	601626	AD,SMu	3
187270	5p15.33	{Melanoma, cutaneous malignant, 9}	615134	_	3
187270	5p15.33	{Pulmonary fibrosis and/or bone marrow failure, telomere-related, 1}	614742	AD	3
187280	_	_	_	_	_
187290	_	_	_	_	_
187300	9q34.11	Telangiectasia, hereditary hemorrhagic, type 1	187300	AD	3
187310	_	_	_	_	_
187320	_	_	_	_	_
187330	_	_	_	_	_
187340	_	_	_	_	_
187350	_	_	_	_	_
187360	_	_	_	_	_
187370	2q31.3-q32.1	Arthrogryposis, distal, type 10	187370	AD	2
187380	9q33.1	Deafness, autosomal dominant 56	615629	AD	3
187390	_	_	_	_	_
187395	3p21.31	Forebrain defects	_	_	3
187400	_	_	_	_	_
187410	_	_	_	_	_
187430	_	_	_	_	_
187450	_	_	_	_	_
187500	_	_	_	_	_
187501	_	_	_	_	_
187510	_	_	_	_	_
187520	_	_	_	_	_
187550	_	_	_	_	_
187600	4p16.3	Thanatophoric dysplasia, type I	187600	AD	3
187601	4p16.3	Thanatophoric dysplasia, type II	187601	AD	3
187650	_	_	_	_	_
187680	6p22.3	{Thiopurines, poor metabolism of, 1}	610460	AR	3
187700	_	_	_	_	_
187750	_	_	_	_	_
187760	_	_	_	_	_
187770	_	_	_	_	_
187790	_	_	_	_	_
187800	_	_	_	_	_
187900	9q34.13	Bleeding disorder, platelet-type, 17	187900	AD,AR	3
187930	_	_	_	_	_
187940	_	_	_	_	_
187950	_	_	_	_	_
188000	10p12.1	Thrombocytopenia 2	188000	AD	3
188020	_	_	_	_	_
188025	11q23	?Thrombocytopenia, Paris-Trousseau type	188025	IC	4
188030	1q23.3	Thrombocytopenic purpura, autoimmune	188030	AD	1
188035	_	_	_	_	_
188040	20p11.21	Thrombophilia due to thrombomodulin defect	614486	_	3
188040	20p11.21	{Hemolytic uremic syndrome, atypical, susceptibility to, 6}	612926	AD	3
188050	_	_	_	_	_
188055	_	_	_	_	_
188060	_	_	_	_	_
188061	6q27	{Lumbar disc herniation, susceptibility to}	603932	_	3
188062	_	_	_	_	_
188070	19p13.3	{Bleeding disorder, platelet-type, 13, susceptibility to}	614009	AD	3
188100	_	_	_	_	_
188150	_	_	_	_	_
188200	_	_	_	_	_
188201	_	_	_	_	_
188230	_	_	_	_	_
188250	16q21	?Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 3	617069	AR	3
188250	16q21	Mitochondrial DNA depletion syndrome 2 (myopathic type)	609560	AR	3
188300	_	_	_	_	_
188340	_	_	_	_	_
188345	_	_	_	_	_
188350	_	_	_	_	_
188360	_	_	_	_	_
188370	_	_	_	_	_
188380	_	_	_	_	_
188390	_	_	_	_	_
188395	_	_	_	_	_
188399	_	_	_	_	_
188400	22q11.21	DiGeorge syndrome	188400	AD	3
188410	_	_	_	_	_
188411	_	_	_	_	_
188450	8q24.22	Thyroid dyshormonogenesis 3	274700	AR	3
188450	8q24.22	{Autoimmune thyroid disease, susceptibility to, 3}	608175	_	3
188455	_	_	_	_	_
188470	_	_	_	_	_
188530	_	_	_	_	_
188540	1p13.2	Hypothyroidism, congenital, nongoitrous 4	275100	AR	3
188545	8q23.1	Thyrotropin-releasing hormone resistance, generalized	_	_	3
188550	14q13.3	{Thyroid cancer, nonmedullary, 1}	188550	AD	3
188555	_	_	_	_	_
188560	_	_	_	_	_
188570	3p24.2	Thyroid hormone resistance	188570	AD	3
188580	1q32.1	{Thyrotoxic periodic paralysis, susceptibility to, 1}	188580	AD	3
188590	_	_	_	_	_
188595	_	_	_	_	_
188600	_	_	_	_	_
188700	_	_	_	_	_
188740	7q36.3	Hypoplastic or aplastic tibia with polydactyly	188740	AD	3
188770	_	_	_	_	_
188800	_	_	_	_	_
188825	_	_	_	_	_
188826	22q12.3	Sorsby fundus dystrophy	136900	AD	3
188830	17q24.2	Acrodysostosis 1, with or without hormone resistance	101800	AD	3
188830	17q24.2	Adrenocortical tumor, somatic	_	_	3
188830	17q24.2	Carney complex, type 1	160980	AD	3
188830	17q24.2	Myxoma, intracardiac	255960	AD	3
188830	17q24.2	Pigmented nodular adrenocortical disease, primary, 1	610489	AD	3
188840	2q31.2	Cardiomyopathy, dilated, 1G	604145	_	3
188840	2q31.2	Cardiomyopathy, familial hypertrophic, 9	613765	AD	3
188840	2q31.2	Muscular dystrophy, limb-girdle, autosomal recessive 10	608807	AR	3
188840	2q31.2	Myopathy, myofibrillar, 9, with early respiratory failure	603689	AD	3
188840	2q31.2	Salih myopathy	611705	AR	3
188840	2q31.2	Tibial muscular dystrophy, tardive	600334	AD	3
188850	_	_	_	_	_
188855	_	_	_	_	_
188860	_	_	_	_	_
188890	_	_	_	_	_
189000	_	_	_	_	_
189100	_	_	_	_	_
189150	_	_	_	_	_
189200	_	_	_	_	_
189230	_	_	_	_	_
189300	_	_	_	_	_
189490	_	_	_	_	_
189500	4p16.2	Ectodermal dysplasia 3, Witkop type	189500	AD	3
189600	_	_	_	_	_
189700	_	_	_	_	_
189800	2p13	Preeclampsia/eclampsia 1	189800	AD	2
189880	_	_	_	_	_
189889	_	_	_	_	_
189890	_	_	_	_	_
189901	_	_	_	_	_
189902	_	_	_	_	_
189903	_	_	_	_	_
189904	_	_	_	_	_
189905	_	_	_	_	_
189906	_	_	_	_	_
189907	17q12	Diabetes mellitus, noninsulin-dependent	125853	AD	3
189907	17q12	Renal cysts and diabetes syndrome	137920	AD	3
189907	17q12	{Renal cell carcinoma}	144700	_	3
189908	_	_	_	_	_
189909	10p11.22	Corneal dystrophy, Fuchs endothelial, 6	613270	_	3
189909	10p11.22	Corneal dystrophy, posterior polymorphous, 3	609141	_	3
189910	_	_	_	_	_
189911	_	_	_	_	_
189912	_	_	_	_	_
189913	_	_	_	_	_
189918	_	_	_	_	_
189919	_	_	_	_	_
189920	_	_	_	_	_
189921	_	_	_	_	_
189923	_	_	_	_	_
189930	_	_	_	_	_
189931	_	_	_	_	_
189932	_	_	_	_	_
189933	_	_	_	_	_
189940	_	_	_	_	_
189960	_	_	_	_	_
189961	_	_	_	_	_
189962	_	_	_	_	_
189963	_	_	_	_	_
189964	8p12	Trichothiodystrophy 6, nonphotosensitive	616943	AR	3
189965	_	_	_	_	_
189967	11p15.3	Sveinsson chorioretinal atrophy	108985	AD	3
189968	_	_	_	_	_
189969	_	_	_	_	_
189970	_	_	_	_	_
189971	_	_	_	_	_
189972	_	_	_	_	_
189973	_	_	_	_	_
189974	_	_	_	_	_
189980	9q34.12	Congenital heart defects and skeletal malformations syndrome	617602	AD	3
189980	9q34.12	Leukemia, Philadelphia chromosome-positive, resistant to imatinib	_	_	3
189990	6q23.3	{T-cell acute lymphoblastic leukemia}	_	_	3
190000	3q22.1	Atransferrinemia	209300	AR	3
190010	3q29	Immunodeficiency 46	616740	AR	3
190020	11p15.5	Bladder cancer, somatic	109800	_	3
190020	11p15.5	Congenital myopathy with excess of muscle spindles	218040	AD	3
190020	11p15.5	Costello syndrome	218040	AD	3
190020	11p15.5	Nevus sebaceous or woolly hair nevus, somatic	162900	_	3
190020	11p15.5	Schimmelpenning-Feuerstein-Mims syndrome, somatic mosaic	163200	_	3
190020	11p15.5	Spitz nevus or nevus spilus, somatic	137550	_	3
190020	11p15.5	Thyroid carcinoma, follicular, somatic	188470	_	3
190030	_	_	_	_	_
190040	22q13.1	Basal ganglia calcification, idiopathic, 5	615483	AD	3
190040	22q13.1	Dermatofibrosarcoma protuberans	607907	_	3
190040	22q13.1	Meningioma, SIS-related	607174	AD	3
190060	_	_	_	_	_
190070	12p12.1	Arteriovenous malformation of the brain, somatic	108010	_	3
190070	12p12.1	Bladder cancer, somatic	109800	_	3
190070	12p12.1	Breast cancer, somatic	114480	_	3
190070	12p12.1	Cardiofaciocutaneous syndrome 2	615278	_	3
190070	12p12.1	Gastric cancer, somatic	137215	_	3
190070	12p12.1	Leukemia, acute myeloid	601626	AD,SMu	3
190070	12p12.1	Lung cancer, somatic	211980	_	3
190070	12p12.1	Noonan syndrome 3	609942	AD	3
190070	12p12.1	Pancreatic carcinoma, somatic	260350	_	3
190070	12p12.1	RAS-associated autoimmune leukoproliferative disorder	614470	AD	3
190070	12p12.1	Schimmelpenning-Feuerstein-Mims syndrome, somatic mosaic	163200	_	3
190080	8q24.21	Burkitt lymphoma, somatic	113970	_	3
190090	20q11.23	?Thrombocytopenia 6	616937	AD	3
190090	20q11.23	Colon cancer, advanced, somatic	114500	_	3
190100	9q13-q21	Geniospasm	190100	AD	2
190110	_	_	_	_	_
190120	17q21.1	Hypothyroidism, congenital, nongoitrous, 6	614450	AD	3
190151	12q13.2	?Lethal congenital contractural syndrome 2	607598	AR	3
190151	12q13.2	{?Erythroleukemia, familial, susceptibility to}	133180	AD	3
190160	3p24.2	Thyroid hormone resistance	188570	AD	3
190160	3p24.2	Thyroid hormone resistance, autosomal recessive	274300	AR	3
190160	3p24.2	Thyroid hormone resistance, selective pituitary	145650	AD	3
190170	_	_	_	_	_
190180	19q13.2	Camurati-Engelmann disease	131300	AD	3
190180	19q13.2	Inflammatory bowel disease, immunodeficiency, and encephalopathy	618213	AR	3
190180	19q13.2	{Cystic fibrosis lung disease, modifier of}	219700	AR	3
190181	9q22.33	Loeys-Dietz syndrome 1	609192	AD	3
190181	9q22.33	{Multiple self-healing squamous epithelioma, susceptibility to}	132800	AD	3
190182	3p24.1	Colorectal cancer, hereditary nonpolyposis, type 6	614331	_	3
190182	3p24.1	Esophageal cancer, somatic	133239	_	3
190182	3p24.1	Loeys-Dietz syndrome 2	610168	AD	3
190190	_	_	_	_	_
190195	14q12	Ichthyosis, congenital, autosomal recessive 1	242300	AR	3
190196	_	_	_	_	_
190197	1q32.1	?Epilepsy, myoclonic, familial adult, 5	615400	AR	3
190198	9q34.3	Adams-Oliver syndrome 5	616028	AD	3
190198	9q34.3	Aortic valve disease 1	109730	AD	3
190200	_	_	_	_	_
190220	1q41	Loeys-Dietz syndrome 4	614816	AD	3
190230	14q24.3	Arrhythmogenic right ventricular dysplasia 1	107970	AD	3
190230	14q24.3	Loeys-Dietz syndrome 5	615582	AD	3
190231	_	_	_	_	_
190232	_	_	_	_	_
190300	3q13.31	{Essential tremor, hereditary, 1}	190300	AD	3
190310	_	_	_	_	_
190315	22q11.21	?Myasthenic syndrome, congenital, 23, presynaptic	618197	AR	3
190315	22q11.21	Combined D-2- and L-2-hydroxyglutaric aciduria	615182	AR	3
190320	17q21.33	Trichodontoosseous syndrome	190320	AD	3
190330	4q21.21	Trichomegaly	190330	AR	3
190340	_	_	_	_	_
190345	_	_	_	_	_
190350	8q23.3	Trichorhinophalangeal syndrome, type I	190350	AD	3
190351	8q23.3	Trichorhinophalangeal syndrome, type III	190351	AD	3
190360	_	_	_	_	_
190370	1q21.3	?Uncombable hair syndrome 3	617252	AR	3
190400	_	_	_	_	_
190410	_	_	_	_	_
190420	_	_	_	_	_
190430	_	_	_	_	_
190440	8p11.23	Trigonocephaly 1	190440	AD	3
190445	_	_	_	_	_
190450	12p13.31	Hemolytic anemia due to triosephosphate isomerase deficiency	615512	AR	3
190470	_	_	_	_	_
190500	_	_	_	_	_
190600	_	_	_	_	_
190605	_	_	_	_	_
190650	_	_	_	_	_
190680	_	_	_	_	_
190685	21q22.3	Down syndrome	190685	IC	4
190700	_	_	_	_	_
190800	_	_	_	_	_
190900	7q32.1	Colorblindness, tritan	190900	AD	3
190920	_	_	_	_	_
190930	_	_	_	_	_
190940	_	_	_	_	_
190950	_	_	_	_	_
190960	_	_	_	_	_
190970	_	_	_	_	_
190980	_	_	_	_	_
190990	9p13.3	Arthrogryposis, distal, type 1A	108120	AD	3
190990	9p13.3	Arthrogryposis, distal, type 2B4	108120	AD	3
190990	9p13.3	CAP myopathy 2	609285	AD	3
190990	9p13.3	Nemaline myopathy 4, autosomal dominant	609285	AD	3
191000	_	_	_	_	_
191010	15q22.2	Cardiomyopathy, dilated, 1Y	611878	AD	3
191010	15q22.2	Cardiomyopathy, hypertrophic, 3	115196	AD	3
191010	15q22.2	Left ventricular noncompaction 9	611878	AD	3
191020	_	_	_	_	_
191030	1q21.3	CAP myopathy 1	609284	AD,AR	3
191030	1q21.3	Myopathy, congenital, with fiber-type disproportion	255310	AD,AR	3
191030	1q21.3	Nemaline myopathy 1, autosomal dominant or recessive	609284	AD,AR	3
191039	_	_	_	_	_
191040	3p21.1	Cardiomyopathy, dilated, 1Z	611879	_	3
191040	3p21.1	Cardiomyopathy, hypertrophic, 13	613243	AD	3
191041	19q13.42	Nemaline myopathy 5, Amish type	605355	AR	3
191042	_	_	_	_	_
191043	11p15.5	Arthrogryposis, distal, type 2B1	601680	AD	3
191044	19q13.42	?Cardiomyopathy, dilated, 2A	611880	AR	3
191044	19q13.42	Cardiomyopathy, dilated, 1FF	613286	_	3
191044	19q13.42	Cardiomyopathy, familial restrictive, 1	115210	AD	3
191044	19q13.42	Cardiomyopathy, hypertrophic, 7	613690	AD	3
191045	1q32.1	Cardiomyopathy, dilated, 1D	601494	AD	3
191045	1q32.1	Cardiomyopathy, familial restrictive, 3	612422	AD	3
191045	1q32.1	Cardiomyopathy, hypertrophic, 2	115195	AD	3
191045	1q32.1	Left ventricular noncompaction 6	601494	AD	3
191050	14q32.2	Neuronopathy, distal hereditary motor, type IX	617721	_	3
191060	_	_	_	_	_
191070	4q32.1	[?Hypertryptophanemia]	600627	AR	3
191080	_	_	_	_	_
191081	_	_	_	_	_
191090	_	_	_	_	_
191091	_	_	_	_	_
191092	16p13.3	?Focal cortical dysplasia, type II, somatic	607341	_	3
191092	16p13.3	Lymphangioleiomyomatosis, somatic	606690	_	3
191092	16p13.3	Tuberous sclerosis-2	613254	AD	3
191100	9q34.13	Tuberous sclerosis-1	191100	AD	3
191110	2q35	Amyotrophic lateral sclerosis 22 with or without frontotemporal dementia	616208	AD	3
191120	_	_	_	_	_
191130	6p21.33	Cortical dysplasia, complex, with other brain malformations 6	615771	AD	3
191130	6p21.33	Symmetric circumferential skin creases, congenital, 1	156610	AD	3
191135	17q21.2	Cortical dysplasia, complex, with other brain malformations 4	615412	AD	3
191150	_	_	_	_	_
191155	_	_	_	_	_
191160	6p21.33	{Asthma, susceptibility to}	600807	AD	3
191160	6p21.33	{Dementia, vascular, susceptibility to}	_	_	3
191160	6p21.33	{Malaria, cerebral, susceptibility to}	611162	_	3
191160	6p21.33	{Migraine without aura, susceptibility to}	157300	AD	3
191160	6p21.33	{Septic shock, susceptibility to}	_	_	3
191161	_	_	_	_	_
191163	6q23.3	Autoinflammatory syndrome, familial, Behcet-like	616744	AD	3
191164	_	_	_	_	_
191170	17p13.1	Bone marrow failure syndrome 5	618165	AD	3
191170	17p13.1	Breast cancer, somatic	114480	_	3
191170	17p13.1	Hepatocellular carcinoma, somatic	114550	_	3
191170	17p13.1	Li-Fraumeni syndrome	151623	AD	3
191170	17p13.1	Nasopharyngeal carcinoma, somatic	607107	_	3
191170	17p13.1	Pancreatic cancer, somatic	260350	_	3
191170	17p13.1	{Adrenocortical carcinoma, pediatric}	202300	AD	3
191170	17p13.1	{Basal cell carcinoma 7}	614740	AD	3
191170	17p13.1	{Choroid plexus papilloma}	260500	AD	3
191170	17p13.1	{Colorectal cancer}	114500	AD,SMu	3
191170	17p13.1	{Glioma susceptibility 1}	137800	AD,SMu	3
191170	17p13.1	{Osteosarcoma}	259500	SMu	3
191175	_	_	_	_	_
191181	11q13	Cervical carcinoma	191181	_	2
191190	12p13.31	Periodic fever, familial	142680	AD	3
191190	12p13.31	{Multiple sclerosis, susceptibility to, 5}	614810	_	3
191191	_	_	_	_	_
191195	10p11.23	Lung cancer, somatic	211980	_	3
191200	_	_	_	_	_
191250	_	_	_	_	_
191270	_	_	_	_	_
191275	_	_	_	_	_
191290	11p15.5	Segawa syndrome, recessive	605407	AR	3
191305	8p23.1	Maturity-onset diabetes of the young, type 11	613375	AD	3
191306	4q12	Hemangioma, capillary infantile, somatic	602089	_	3
191306	4q12	{Hemangioma, capillary infantile, susceptibility to}	602089	AD	3
191309	_	_	_	_	_
191311	1q23.3	Spondylometaepiphyseal dysplasia, short limb-hand type	271665	AR	3
191311	1q23.3	Warburg-Cinotti syndrome	618175	AD	3
191315	1q23.1	Insensitivity to pain, congenital, with anhidrosis	256800	AR	3
191315	1q23.1	Medullary thyroid carcinoma, familial	155240	AD	3
191316	_	_	_	_	_
191317	_	_	_	_	_
191318	_	_	_	_	_
191320	_	_	_	_	_
191321	_	_	_	_	_
191325	_	_	_	_	_
191327	_	_	_	_	_
191328	_	_	_	_	_
191329	16p12.2	Mitochondrial complex III deficiency, nuclear type 5	615160	AR	3
191330	8q22.1	Mitochondrial complex III deficiency, nuclear type 3	615158	AR	3
191339	_	_	_	_	_
191340	_	_	_	_	_
191342	4p13	Spastic paraplegia 79, autosomal recessive	615491	AR	3
191342	4p13	{?Parkinson disease 5, susceptibility to}	613643	_	3
191343	_	_	_	_	_
191344	_	_	_	_	_
191350	11q23.3	Congenital disorder of glycosylation, type Ij	608093	AR	3
191350	11q23.3	Myasthenic syndrome, congenital, 13, with tubular aggregates	614750	AR	3
191390	7q22	{Inflammatory bowel disease 11}	191390	Mu	2
191400	_	_	_	_	_
191420	_	_	_	_	_
191440	_	_	_	_	_
191480	1p36.13	Uncombable hair syndrome	191480	AR	3
191482	_	_	_	_	_
191500	_	_	_	_	_
191510	_	_	_	_	_
191520	_	_	_	_	_
191523	1q23.3	{Hyperlipidemia, familial combined, susceptibility to}	602491	_	3
191525	12q24.11	Immunodeficiency with hyper IgM, type 5	608106	AR	3
191530	_	_	_	_	_
191540	1p22	[Urate oxidase deficiency]	_	_	1
191550	_	_	_	_	_
191600	_	_	_	_	_
191650	_	_	_	_	_
191700	_	_	_	_	_
191710	_	_	_	_	_
191720	_	_	_	_	_
191730	_	_	_	_	_
191740	2q37.1	Crigler-Najjar syndrome, type I	218800	AR	3
191740	2q37.1	Crigler-Najjar syndrome, type II	606785	AR	3
191740	2q37.1	Hyperbilirubinemia, familial transient neonatal	237900	AR	3
191740	2q37.1	[Bilirubin, serum level of, QTL1]	601816	_	3
191740	2q37.1	[Gilbert syndrome]	143500	AR	3
191741	_	_	_	_	_
191742	_	_	_	_	_
191743	_	_	_	_	_
191750	_	_	_	_	_
191760	_	_	_	_	_
191800	_	_	_	_	_
191810	_	_	_	_	_
191830	10p13	Renal hypodysplasia/aplasia 1	191830	AR	3
191840	10q22.2	Quebec platelet disorder	601709	AD	3
191840	10q22.2	{Alzheimer disease, late-onset, susceptibility to}	104300	AD	3
191845	16p12.3	Glomerulocystic kidney disease with hyperuricemia and isosthenuria	609886	_	3
191845	16p12.3	Hyperuricemic nephropathy, familial juvenile 1	162000	AD	3
191845	16p12.3	Medullary cystic kidney disease 2	603860	_	3
191850	_	_	_	_	_
191900	1q44	Muckle-Wells syndrome	191900	AD	3
191950	_	_	_	_	_
192000	_	_	_	_	_
192020	_	_	_	_	_
192050	_	_	_	_	_
192070	_	_	_	_	_
192090	16q22.1	Blepharocheilodontic syndrome 1	119580	AD	3
192090	16q22.1	Endometrial carcinoma, somatic	608089	_	3
192090	16q22.1	Gastric cancer, hereditary diffuse, with or without cleft lip and/or palate	137215	AD	3
192090	16q22.1	Ovarian cancer, somatic	167000	_	3
192090	16q22.1	{Breast cancer, lobular}	114480	AD,SMu	3
192090	16q22.1	{Prostate cancer, susceptibility to}	176807	AD,SMu	3
192100	_	_	_	_	_
192130	_	_	_	_	_
192132	2p13.3	Renal tubular acidosis with deafness	267300	AR	3
192150	6p21.33	Neurodevelopmental disorder with microcephaly, seizures, and cortical atrophy	617802	AR	3
192200	_	_	_	_	_
192225	_	_	_	_	_
192240	6p21.1	{Microvascular complications of diabetes 1}	603933	_	3
192300	_	_	_	_	_
192310	_	_	_	_	_
192315	3p21.31	Vasculopathy, retinal, with cerebral leukodystrophy	192315	AD	3
192320	_	_	_	_	_
192321	_	_	_	_	_
192340	20p13	Diabetes insipidus, neurohypophyseal	125700	AD	3
192350	_	_	_	_	_
192400	_	_	_	_	_
192430	22q11.21	Velocardiofacial syndrome	192430	AD	3
192445	_	_	_	_	_
192450	_	_	_	_	_
192500	_	_	_	_	_
192600	_	_	_	_	_
192605	3p21.31	Ventricular tachycardia, idiopathic	192605	AD	3
192700	_	_	_	_	_
192800	_	_	_	_	_
192900	_	_	_	_	_
192950	_	_	_	_	_
192968	_	_	_	_	_
192972	_	_	_	_	_
192974	5q11.2	?Glycoprotein Ia deficiency	614200	AD	1
192975	_	_	_	_	_
192977	9p24.2	Cerebellar hypoplasia and mental retardation with or without quadrupedal locomotion 1	224050	AR	3
193000	1p13	Vesicoureteral reflux	193000	AD	2
193001	10q25.3	?Parkinsonism-dystonia, infantile, 2	618049	AR	3
193002	_	_	_	_	_
193003	13q31-q33	Nystagmus 4, congenital, autosomal dominant	193003	AD	2
193005	_	_	_	_	_
193007	6q	Vestibulopathy, familial	193007	AD	2
193010	_	_	_	_	_
193040	_	_	_	_	_
193050	_	_	_	_	_
193060	10p13	Cataract 30, pulverulent	116300	AD	3
193065	10q22.2	Cardiomyopathy, dilated, 1W	611407	_	3
193065	10q22.2	Cardiomyopathy, hypertrophic, 15	613255	AD	3
193067	11q24.3	Bleeding disorder, platelet-type, 21	617443	AD,AR	3
193070	_	_	_	_	_
193090	_	_	_	_	_
193100	12p13.32	Hypophosphatemic rickets, autosomal dominant	193100	AD	3
193190	_	_	_	_	_
193200	6p21.3	{Vitiligo-associated multiple autoimmune disease susceptibility 6}	193200	AR	2
193210	_	_	_	_	_
193220	_	_	_	_	_
193230	2q37.1	Snowflake vitreoretinal degeneration	193230	AD	3
193235	11q13.5	Vitreoretinopathy, neovascular inflammatory	193235	AD	3
193240	_	_	_	_	_
193245	_	_	_	_	_
193250	_	_	_	_	_
193290	_	_	_	_	_
193300	_	_	_	_	_
193400	12p13.31	von Willebrand disease, type 1	193400	AD	3
193450	_	_	_	_	_
193500	2q36.1	Waardenburg syndrome, type 1	193500	AD	3
193510	3p13	Waardenburg syndrome, type 2A	193510	AD	3
193520	17q11.2	Watson syndrome	193520	AD	3
193525	_	_	_	_	_
193530	_	_	_	_	_
193670	2q22.1	WHIM syndrome	193670	AD	3
193675	_	_	_	_	_
193680	_	_	_	_	_
193700	17p13.1	Arthrogryposis, distal, type 2A (Freeman-Sheldon)	193700	AD	3
193900	12q13.13	White sponge nevus 1	193900	AD	3
194000	_	_	_	_	_
194050	7q11.23	Williams-Beuren syndrome	194050	AD	4
194070	_	_	_	_	_
194071	11p15.5	Wilms tumor 2	194071	AD,SMu	3
194072	11p13	Wilms tumor, aniridia, genitourinary anomalies and mental retardation syndrome	194072	AD,SMu	4
194080	11p13	Denys-Drash syndrome	194080	AD,SMu	3
194090	16q	Wilms tumor, type 3	194090	AD	2
194100	_	_	_	_	_
194190	4p16.3	Wolf-Hirschhorn syndrome	194190	IC	4
194200	7q36.1	Wolff-Parkinson-White syndrome	194200	?AD	3
194300	12q13.13	Woolly hair, autosomal dominant	194300	AD	3
194320	_	_	_	_	_
194350	_	_	_	_	_
194355	22q12.1	{Major affective disorder-7, susceptibility to}	612371	_	3
194360	19q13.31	?Spinocerebellar ataxia, autosomal recessive 26	617633	AR	3
194363	5q14.2	Short stature, microcephaly, and endocrine dysfunction	616541	AR	3
194364	_	_	_	_	_
194370	_	_	_	_	_
194380	16q24.3	Dehydrated hereditary stomatocytosis with or without pseudohyperkalemia and/or perinatal edema	194380	AD	3
194400	_	_	_	_	_
194450	_	_	_	_	_
194460	_	_	_	_	_
194470	_	_	_	_	_
194480	_	_	_	_	_
194490	_	_	_	_	_
194500	_	_	_	_	_
194510	_	_	_	_	_
194520	_	_	_	_	_
194521	_	_	_	_	_
194522	_	_	_	_	_
194524	_	_	_	_	_
194525	_	_	_	_	_
194526	_	_	_	_	_
194527	_	_	_	_	_
194528	_	_	_	_	_
194529	_	_	_	_	_
194530	_	_	_	_	_
194531	_	_	_	_	_
194532	_	_	_	_	_
194533	_	_	_	_	_
194534	_	_	_	_	_
194535	_	_	_	_	_
194536	_	_	_	_	_
194537	_	_	_	_	_
194538	_	_	_	_	_
194539	_	_	_	_	_
194540	_	_	_	_	_
194541	_	_	_	_	_
194542	_	_	_	_	_
194543	_	_	_	_	_
194544	_	_	_	_	_
194545	_	_	_	_	_
194546	_	_	_	_	_
194547	_	_	_	_	_
194548	_	_	_	_	_
194549	_	_	_	_	_
194550	_	_	_	_	_
194551	_	_	_	_	_
194552	_	_	_	_	_
194553	_	_	_	_	_
194554	_	_	_	_	_
194555	_	_	_	_	_
194556	_	_	_	_	_
194557	_	_	_	_	_
194558	_	_	_	_	_
194624	_	_	_	_	_
194628	_	_	_	_	_
194630	_	_	_	_	_
194631	_	_	_	_	_
194632	_	_	_	_	_
194633	_	_	_	_	_
194648	4p16.3	?Polydactyly, postaxial, type A6	615226	AR	3
195000	11q12.2	Oocyte maturation defect 1	615774	AR	3
195002	_	_	_	_	_
200100	4q23	Abetalipoproteinemia	200100	AR	3
200110	2q37.3	Ablepharon-macrostomia syndrome	200110	AD	3
200130	_	_	_	_	_
200150	9q21.2	Choreoacanthocytosis	200150	AR	3
200170	_	_	_	_	_
200300	_	_	_	_	_
200350	17q12	Acetyl-CoA carboxylase deficiency	613933	AR	1
200400	_	_	_	_	_
200440	_	_	_	_	_
200450	_	_	_	_	_
200500	7q36.3	Acheiropody	200500	AR	3
200600	14q32.12	Achondrogenesis, type IA	200600	AR	3
200610	12q13.11	Achondrogenesis, type II or hypochondrogenesis	200610	AD	3
200700	20q11.22	Chondrodysplasia, Grebe type	200700	AR	3
200710	_	_	_	_	_
200720	_	_	_	_	_
200900	_	_	_	_	_
200930	_	_	_	_	_
200950	11p11.2	?Lysosomal acid phosphatase deficiency	200950	AR	1
200970	_	_	_	_	_
200980	_	_	_	_	_
200990	_	_	_	_	_
200995	_	_	_	_	_
201000	6p12.1-p11.2	Carpenter syndrome	201000	AR	3
201020	_	_	_	_	_
201050	_	_	_	_	_
201100	8q24.3	Acrodermatitis enteropathica	201100	AR	3
201170	_	_	_	_	_
201180	_	_	_	_	_
201181	_	_	_	_	_
201200	_	_	_	_	_
201250	20q11.22	?Acromesomelic dysplasia, Hunter-Thompson type	201250	AR	3
201300	12p13.33	Neuropathy, hereditary sensory and autonomic, type II	201300	AR	3
201310	_	_	_	_	_
201400	1q24.2	Adrenocorticotropic hormone deficiency	201400	AR	3
201450	1p31.1	Acyl-CoA dehydrogenase, medium chain, deficiency of	201450	AR	3
201460	_	_	_	_	_
201470	12q24.31	Acyl-CoA dehydrogenase, short-chain, deficiency of	201470	AR	3
201475	17p13.1	VLCAD deficiency	201475	AR	3
201550	_	_	_	_	_
201710	8p11.23	Lipoid adrenal hyperplasia	201710	AR	3
201750	7q11.23	Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis	201750	AR	3
201810	1p12	Adrenal hyperplasia, congenital, due to 3-beta-hydroxysteroid dehydrogenase 2 deficiency	201810	AR	3
201910	_	_	_	_	_
202010	8q24.3	Adrenal hyperplasia, congenital, due to 11-beta-hydroxylase deficiency	202010	AR	3
202110	_	_	_	_	_
202150	_	_	_	_	_
202155	_	_	_	_	_
202200	18p11.21	Glucocorticoid deficiency, due to ACTH unresponsiveness	202200	AR	3
202300	17p13.1	{Adrenocortical carcinoma, pediatric}	202300	AD	3
202355	_	_	_	_	_
202370	12p13.31	Peroxisome biogenesis disorder 2B	202370	AR	3
202400	_	_	_	_	_
202500	_	_	_	_	_
202550	_	_	_	_	_
202600	_	_	_	_	_
202650	1q24.2	Agnathia-otocephaly complex	202650	AD,AR	3
202660	_	_	_	_	_
202700	19p13.3	Neutropenia, severe congenital 1, autosomal dominant	202700	AD	3
202900	_	_	_	_	_
203000	_	_	_	_	_
203100	11q14.3	Albinism, oculocutaneous, type IA	203100	AR	3
203200	_	_	_	_	_
203280	_	_	_	_	_
203285	_	_	_	_	_
203290	9p23	Albinism, oculocutaneous, type III	203290	AR	3
203300	10q24.2	Hermansky-Pudlak syndrome 1	203300	AR	3
203310	_	_	_	_	_
203330	_	_	_	_	_
203340	_	_	_	_	_
203400	8q24.3	Hypoaldosteronism, congenital, due to CMO I deficiency	203400	AR	3
203450	17q21.31	Alexander disease	203450	AD	3
203500	3q13.33	Alkaptonuria	203500	AR	3
203550	_	_	_	_	_
203600	_	_	_	_	_
203650	3q26.3-q27.3	Alopecia-mental retardation syndrome 1	203650	AR	2
203655	8p21.3	Alopecia universalis	203655	AR	3
203700	15q26.1	Mitochondrial DNA depletion syndrome 4A (Alpers type)	203700	AR	3
203740	7p13	Alpha-ketoglutarate dehydrogenase deficiency	203740	AR	1
203750	11q22.3	Alpha-methylacetoacetic aciduria	203750	AR	3
203760	_	_	_	_	_
203780	_	_	_	_	_
203800	2p13.1	Alstrom syndrome	203800	AR	3
204000	17p13.1	Leber congenital amaurosis 1	204000	AR	3
204100	1p31.3	Leber congenital amaurosis 2	204100	AR	3
204110	_	_	_	_	_
204200	16p12.1	Ceroid lipofuscinosis, neuronal, 3	204200	AR	3
204300	15q23	Ceroid lipofuscinosis, neuronal, Kufs type, adult onset	204300	AR	3
204400	_	_	_	_	_
204500	11p15.4	Ceroid lipofuscinosis, neuronal, 2	204500	AR	3
204600	_	_	_	_	_
204650	4q13.3	Amelogenesis imperfecta, type IC	204650	AR	3
204690	17q24.2	Amelogenesis imperfecta, type IG (enamel-renal syndrome)	204690	AR	3
204700	19q13.41	Amelogenesis imperfecta, type IIA1	204700	AR	3
204730	_	_	_	_	_
204750	10p14	2-aminoadipic 2-oxoadipic aciduria	204750	AR	3
204800	_	_	_	_	_
204850	_	_	_	_	_
204870	1p32.1	Corneal dystrophy, gelatinous drop-like	204870	AR	3
204900	_	_	_	_	_
205000	_	_	_	_	_
205100	2q33.1	Amyotrophic lateral sclerosis 2, juvenile	205100	AR	3
205200	_	_	_	_	_
205250	_	_	_	_	_
205400	9q31.1	Tangier disease	205400	AR	3
205600	_	_	_	_	_
205700	_	_	_	_	_
205900	_	_	_	_	_
205950	3p22.1	Anemia, sideroblastic, 2, pyridoxine-refractory	205950	AR	3
206000	_	_	_	_	_
206100	12q13.12	Anemia, hypochromic microcytic, with iron overload 1	206100	AR	3
206200	22q12.3	Iron-refractory iron deficiency anemia	206200	AR	3
206300	_	_	_	_	_
206400	_	_	_	_	_
206500	5q22.3	?Anencephaly	206500	AR	3
206550	_	_	_	_	_
206570	_	_	_	_	_
206600	_	_	_	_	_
206700	3p26.1	Gillespie syndrome	206700	AD,AR	3
206750	_	_	_	_	_
206780	_	_	_	_	_
206800	20p13	Anonychia congenita	206800	AR	3
206900	_	_	_	_	_
206920	14q24.2	Microphthalmia with limb anomalies	206920	AR	3
207000	_	_	_	_	_
207300	_	_	_	_	_
207410	10q26.13	Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis	207410	AD	3
207500	_	_	_	_	_
207600	_	_	_	_	_
207620	_	_	_	_	_
207700	_	_	_	_	_
207720	_	_	_	_	_
207731	_	_	_	_	_
207740	_	_	_	_	_
207750	19q13.32	Hyperlipoproteinemia, type Ib	207750	AR	3
207765	_	_	_	_	_
207770	_	_	_	_	_
207780	_	_	_	_	_
207790	_	_	_	_	_
207800	6q23.2	Argininemia	207800	AR	3
207900	7q11.21	Argininosuccinic aciduria	207900	AR	3
207950	_	_	_	_	_
208000	6q23.2	Arterial calcification, generalized, of infancy, 1	208000	AR	3
208050	20q13.12	Arterial tortuosity syndrome	208050	AR	3
208060	_	_	_	_	_
208080	_	_	_	_	_
208081	_	_	_	_	_
208085	15q26.1	Arthrogryposis, renal dysfunction, and cholestasis 1	208085	AR	3
208100	5q35.1	?Arthrogryposis multiplex congenita, neurogenic type	208100	AR	3
208110	_	_	_	_	_
208150	9q31.3	Fetal akinesia deformation sequence 1	208150	AR	3
208155	_	_	_	_	_
208158	_	_	_	_	_
208200	_	_	_	_	_
208230	_	_	_	_	_
208250	1q31.1	Camptodactyly-arthropathy-coxa vara-pericarditis syndrome	208250	AR	3
208300	_	_	_	_	_
208400	4q34.3	Aspartylglucosaminuria	208400	AR	3
208500	15q13	Short-rib thoracic dysplasia 1 with or without polydactyly	208500	AR	2
208530	19p13.11	Right atrial isomerism (Ivemark)	208530	AR	3
208540	3q22.1	Renal-hepatic-pancreatic dysplasia 1	208540	AR	3
208550	_	_	_	_	_
208600	_	_	_	_	_
208700	_	_	_	_	_
208750	_	_	_	_	_
208800	_	_	_	_	_
208850	_	_	_	_	_
208870	_	_	_	_	_
208900	11q22.3	Ataxia-telangiectasia	208900	AR	3
208905	_	_	_	_	_
208910	_	_	_	_	_
208920	9p21.1	Ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia	208920	AR	3
209000	_	_	_	_	_
209010	_	_	_	_	_
209050	_	_	_	_	_
209100	_	_	_	_	_
209300	3q22.1	Atransferrinemia	209300	AR	3
209400	_	_	_	_	_
209500	8p21.3	Atrichia with papular lesions	209500	AR	3
209600	_	_	_	_	_
209700	_	_	_	_	_
209750	_	_	_	_	_
209770	_	_	_	_	_
209800	_	_	_	_	_
209850	7q22	{Autism susceptibility 1}	209850	IC,Mu	2
209880	_	_	_	_	_
209885	2q37.3	Barber-Say syndrome	209885	AD	3
209900	_	_	_	_	_
209901	11q13.2	Bardet-Biedl syndrome 1	209900	DR,AR	3
209920	_	_	_	_	_
209930	_	_	_	_	_
209950	6q23.3	Immunodeficiency 27A, mycobacteriosis, AR	209950	AR	3
209970	_	_	_	_	_
210000	3q29	Behr syndrome	210000	AR	3
210050	_	_	_	_	_
210100	5p13.2	[Beta-aminoisobutyric acid, urinary excretion of]	210100	AR	3
210200	3q27.1	3-Methylcrotonyl-CoA carboxylase 1 deficiency	210200	AR	3
210210	5q13.2	3-Methylcrotonyl-CoA carboxylase 2 deficiency	210210	AR	3
210250	_	_	_	_	_
210300	_	_	_	_	_
210350	_	_	_	_	_
210370	4q35.1-q35.2	Bietti crystalline corneoretinal dystrophy	210370	AR	3
210400	_	_	_	_	_
210450	_	_	_	_	_
210500	_	_	_	_	_
210550	_	_	_	_	_
210600	3q23	Seckel syndrome 1	210600	AR	3
210700	_	_	_	_	_
210710	2q14.2	Microcephalic osteodysplastic primordial dwarfism, type I	210710	AR	3
210720	21q22.3	Microcephalic osteodysplastic primordial dwarfism, type II	210720	AR	3
210730	_	_	_	_	_
210740	_	_	_	_	_
210745	_	_	_	_	_
210750	_	_	_	_	_
210900	15q26.1	Bloom syndrome	210900	AR	3
211000	_	_	_	_	_
211100	19q13.33	[Bombay phenotype]	616754	AR	3
211120	_	_	_	_	_
211170	_	_	_	_	_
211180	12p13.31	Bowen-Conradi syndrome	211180	AR	3
211200	_	_	_	_	_
211350	_	_	_	_	_
211355	_	_	_	_	_
211369	_	_	_	_	_
211370	_	_	_	_	_
211380	16q21	Elsahy-Waters syndrome	211380	AR	3
211390	_	_	_	_	_
211400	_	_	_	_	_
211410	_	_	_	_	_
211420	_	_	_	_	_
211450	_	_	_	_	_
211480	_	_	_	_	_
211500	20p13	?Fazio-Londe disease	211500	AR	3
211530	20p13	Brown-Vialetto-Van Laere syndrome 1	211530	AR	3
211550	_	_	_	_	_
211600	18q21.31	Cholestasis, progressive familial intrahepatic 1	211600	AR	3
211750	3q13.1-q13.2	C syndrome	211750	AD	3
211770	_	_	_	_	_
211800	6q14.3	Calcification of joints and arteries	211800	AR	3
211890	_	_	_	_	_
211900	2q24.3	Tumoral calcinosis, hyperphosphatemic, familial, 1	211900	AR	3
211910	_	_	_	_	_
211920	_	_	_	_	_
211930	_	_	_	_	_
211960	_	_	_	_	_
211965	_	_	_	_	_
211970	_	_	_	_	_
211980	_	_	_	_	_
211990	_	_	_	_	_
212050	9q34.3	Candidiasis, familial, 2, autosomal recessive	212050	AR	3
212060	_	_	_	_	_
212065	16p13.2	Congenital disorder of glycosylation, type Ia	212065	AR	3
212066	14q21.3	Congenital disorder of glycosylation, type IIa	212066	AR	3
212067	_	_	_	_	_
212070	10q24.2	Carboxypeptidase N deficiency	212070	AR	3
212080	_	_	_	_	_
212090	_	_	_	_	_
212093	3q26.31	Cardiac valvular defect, developmental	212093	AR	3
212100	_	_	_	_	_
212110	_	_	_	_	_
212112	1q22	Malouf syndrome	212112	AD	3
212120	_	_	_	_	_
212130	_	_	_	_	_
212135	_	_	_	_	_
212138	3p21.31	Carnitine-acylcarnitine translocase deficiency	212138	AR	3
212140	5q31.1	Carnitine deficiency, systemic primary	212140	AR	3
212160	_	_	_	_	_
212200	18q21.3	Carnosinemia	212200	AR	2
212350	7q34	Sengers syndrome	212350	AR	3
212360	_	_	_	_	_
212400	_	_	_	_	_
212500	6p21.31	Cataract 46, juvenile-onset	212500	AR	3
212540	_	_	_	_	_
212550	14q23.1	Optic disc anomalies with retinal and/or macular dystrophy	212550	AR	3
212600	_	_	_	_	_
212700	_	_	_	_	_
212710	_	_	_	_	_
212720	1q41	Martsolf syndrome	212720	AR	3
212750	_	_	_	_	_
212780	11p11.2	Cenani-Lenz syndactyly syndrome	212780	AR	3
212790	_	_	_	_	_
212800	_	_	_	_	_
212835	_	_	_	_	_
212840	7p22.1	Cerebellar ataxia and hypogonadotropic hypogonadism	212840	AR	3
212850	_	_	_	_	_
212890	_	_	_	_	_
212895	_	_	_	_	_
212900	_	_	_	_	_
212905	_	_	_	_	_
213000	_	_	_	_	_
213002	_	_	_	_	_
213010	_	_	_	_	_
213100	_	_	_	_	_
213200	9q34.3	Spinocerebellar ataxia, autosomal recessive 2	213200	AR	3
213300	9q34.3	Joubert syndrome 1	213300	AR	3
213400	_	_	_	_	_
213500	_	_	_	_	_
213600	8p11.21	Basal ganglia calcification, idiopathic, 1	213600	AD	3
213700	2q35	Cerebrotendinous xanthomatosis	213700	AR	3
213820	_	_	_	_	_
213900	_	_	_	_	_
213950	_	_	_	_	_
213980	1q24.1	Craniofacial dysmorphism, skeletal anomalies, and mental retardation syndrome	213980	AR	3
214100	7q21.2	Peroxisome biogenesis disorder 1A (Zellweger)	214100	AR	3
214110	12p13.31	Peroxisome biogenesis disorder 2A (Zellweger)	214110	AR	3
214150	10q11.23	Cerebrooculofacioskeletal syndrome 1	214150	AR	3
214200	_	_	_	_	_
214290	_	_	_	_	_
214300	17q21.31	Klippel-Feil syndrome 2	214300	AR	3
214350	21q22.3	CHAND syndrome	214350	AR	3
214370	_	_	_	_	_
214380	_	_	_	_	_
214400	8q21.11	Charcot-Marie-Tooth disease, type 4A	214400	AR	3
214450	15q21.2	Griscelli syndrome, type 1	214450	AR	3
214500	1q42.3	Chediak-Higashi syndrome	214500	AR	3
214700	7q22.3-q31.1	Diarrhea 1, secretory chloride, congenital	214700	AR	3
214800	_	_	_	_	_
214900	15q	Cholestasis-lymphedema syndrome	214900	AR	2
214950	5p13.2	Bile acid synthesis defect, congenital, 4	214950	AR	3
214980	_	_	_	_	_
215030	_	_	_	_	_
215045	3p21.31	Chondrodysplasia, Blomstrand type	215045	AR	3
215050	_	_	_	_	_
215100	6q23.3	Rhizomelic chondrodysplasia punctata, type 1	215100	AR	3
215105	_	_	_	_	_
215140	1q42.12	Greenberg skeletal dysplasia	215140	AR	3
215150	6p21.32	Otospondylomegaepiphyseal dysplasia, autosomal recessive	215150	AR	3
215250	_	_	_	_	_
215300	8q24.11	Chondrosarcoma	215300	AR	3
215400	6q27	{Chordoma, susceptibility to}	215400	AD	4
215450	_	_	_	_	_
215470	19p13.2	Boucher-Neuhauser syndrome	215470	AR	3
215480	_	_	_	_	_
215500	17p13.1	?Choroidal dystrophy, central areolar 1	215500	AD	3
215510	_	_	_	_	_
215518	_	_	_	_	_
215520	_	_	_	_	_
215550	_	_	_	_	_
215600	_	_	_	_	_
215700	9q34.11	Citrullinemia	215700	AR	3
215720	_	_	_	_	_
215800	_	_	_	_	_
215850	_	_	_	_	_
216100	_	_	_	_	_
216300	_	_	_	_	_
216330	_	_	_	_	_
216340	6q21	Yunis-Varon syndrome	216340	AR	3
216360	_	_	_	_	_
216400	5q12.1	Cockayne syndrome, type A	216400	AR	3
216411	_	_	_	_	_
216550	8q22.2	Cohen syndrome	216550	AR	3
216700	_	_	_	_	_
216800	_	_	_	_	_
216820	14q11.2	?Coloboma, ocular, autosomal recessive	216820	AR	3
216900	2q11.2	Achromatopsia 2	216900	AR	3
216920	_	_	_	_	_
216950	_	_	_	_	_
217000	6p21.33	C2 deficiency	217000	AR	3
217030	4q25	Complement factor I deficiency	610984	AR	3
217030	4q25	{Hemolytic uremic syndrome, atypical, susceptibility to, 3}	612923	AD	3
217030	4q25	{Macular degeneration, age-related, 13, susceptibility to}	615439	AD	3
217050	5p13.1	C6 deficiency	612446	_	3
217050	5p13.1	Combined C6/C7 deficiency	_	_	3
217070	5p13.1	C7 deficiency	610102	_	3
217080	2q11.2	Jalili syndrome	217080	AR	3
217085	2p15	?Congenital heart defects, hamartomas of tongue, and polysyndactyly	217085	AR	3
217090	_	_	_	_	_
217095	_	_	_	_	_
217100	_	_	_	_	_
217150	_	_	_	_	_
217200	_	_	_	_	_
217300	12q21.33	Cornea plana 2, autosomal recessive	217300	AR	3
217400	20p13	Corneal endothelial dystrophy and perceptive deafness	217400	AR	3
217500	_	_	_	_	_
217520	_	_	_	_	_
217600	_	_	_	_	_
217700	20p13	Corneal endothelial dystrophy, autosomal recessive	217700	AR	3
217800	16q23.1	Macular corneal dystrophy	217800	AR	3
217980	_	_	_	_	_
217990	_	_	_	_	_
218000	15q14	Agenesis of the corpus callosum with peripheral neuropathy	218000	AR	3
218010	_	_	_	_	_
218030	16q22.1	Apparent mineralocorticoid excess	218030	AR	3
218040	_	_	_	_	_
218050	_	_	_	_	_
218090	_	_	_	_	_
218100	_	_	_	_	_
218200	_	_	_	_	_
218300	_	_	_	_	_
218330	3q21.3-q22.1	Cranioectodermal dysplasia 1	218330	AR	3
218340	12p13.31	Temtamy syndrome	218340	AR	3
218350	_	_	_	_	_
218400	6q22.31	Craniometaphyseal dysplasia, autosomal recessive	218400	AR	3
218450	_	_	_	_	_
218455	_	_	_	_	_
218500	_	_	_	_	_
218530	_	_	_	_	_
218550	_	_	_	_	_
218600	8q24.3	Baller-Gerold syndrome	218600	AR	3
218649	_	_	_	_	_
218650	_	_	_	_	_
218670	_	_	_	_	_
218700	2q14.1	Hypothyroidism, congenital, due to thyroid dysgenesis or hypoplasia	218700	AD	3
218800	2q37.1	Crigler-Najjar syndrome, type I	218800	AR	3
218900	_	_	_	_	_
219000	4q21.21	Fraser syndrome 1	219000	AR	3
219050	19p13.11	Cryptorchidism	219050	AD	3
219070	_	_	_	_	_
219080	20q13.32	ACTH-independent macronodular adrenal hyperplasia	219080	SMu	3
219090	15q21.2	Pituitary adenoma 4, ACTH-secreting, somatic	219090	_	3
219095	_	_	_	_	_
219100	14q32.12	Cutis laxa, autosomal recessive, type IA	219100	AR	3
219150	10q24.1	Cutis laxa, autosomal recessive, type IIIA	219150	AR	3
219200	12q24.31	Cutis laxa, autosomal recessive, type IIA	219200	AR	3
219250	_	_	_	_	_
219300	_	_	_	_	_
219400	_	_	_	_	_
219500	1p31.1	Cystathioninuria	219500	AR	3
219550	_	_	_	_	_
219600	_	_	_	_	_
219700	_	_	_	_	_
219721	_	_	_	_	_
219730	9q33.3	Ventriculomegaly with cystic kidney disease	219730	AR	3
219750	17p13.2	Cystinosis, ocular nonnephropathic	219750	AR	3
219800	_	_	_	_	_
219900	17p13.2	Cystinosis, late-onset juvenile or adolescent nephropathic	219900	AR	3
220100	_	_	_	_	_
220110	_	_	_	_	_
220111	2p21	Leigh syndrome, French-Canadian type	220111	AR	3
220120	3p21.2	D-glyceric aciduria	220120	AR	3
220150	11q13.1	Hypouricemia, renal	220150	AR	3
220200	3q22-q24	Dandy-Walker syndrome	220200	IC	4
220210	8q24.13	Ritscher-Schinzel syndrome 1	220210	AR	3
220219	_	_	_	_	_
220220	_	_	_	_	_
220290	_	_	_	_	_
220300	_	_	_	_	_
220400	11p15.5-p15.4	Jervell and Lange-Nielsen syndrome	220400	AR	3
220500	16p13.3	DOORS syndrome	220500	AR	3
220600	7q21.3	?Split-hand/foot malformation 1 with sensorineural hearing loss	220600	AR	3
220700	_	_	_	_	_
220800	_	_	_	_	_
220900	_	_	_	_	_
221000	_	_	_	_	_
221200	13q31.1	Deafness and myopia	221200	AR	3
221300	_	_	_	_	_
221320	_	_	_	_	_
221350	_	_	_	_	_
221400	_	_	_	_	_
221500	_	_	_	_	_
221600	_	_	_	_	_
221650	_	_	_	_	_
221700	_	_	_	_	_
221740	_	_	_	_	_
221745	_	_	_	_	_
221750	9q34.3	Pituitary hormone deficiency, combined, 3	221750	AR	3
221760	_	_	_	_	_
221770	19q13.12	Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 1	221770	AR	3
221780	_	_	_	_	_
221790	_	_	_	_	_
221800	_	_	_	_	_
221810	_	_	_	_	_
221820	5q32	Leukoencephalopathy, diffuse hereditary, with spheroids	221820	AD	3
221900	10q21.3	Persistent hyperplastic primary vitreous, autosomal recessive	221900	AR	3
221950	_	_	_	_	_
221995	_	_	_	_	_
222000	_	_	_	_	_
222100	6p21.3	{Diabetes mellitus, insulin-dependent-1}	222100	AR	2
222300	4p16.1	Wolfram syndrome 1	222300	AR	3
222350	_	_	_	_	_
222400	8p23.1	Hernia, congenital diaphragmatic 2	222400	AR	2
222448	2q31.1	Donnai-Barrow syndrome	222448	AR	3
222470	5q15	Trichohepatoenteric syndrome 1	222470	AR	3
222500	_	_	_	_	_
222600	_	_	_	_	_
222690	_	_	_	_	_
222700	14q11.2	Lysinuric protein intolerance	222700	AR	3
222730	9p24.2	Dicarboxylic aminoaciduria	222730	AR	3
222745	_	_	_	_	_
222748	8q22.3	Dihydropyrimidinuria	222748	AR	3
222760	_	_	_	_	_
222765	1q42.2	Rhizomelic chondrodysplasia punctata, type 2	222765	AR	3
222800	7q33	Erythrocytosis, familial, 8	222800	AR	3
222900	3q26.1	Sucrase-isomaltase deficiency, congenital	222900	AR	3
223000	2q21.3	Lactase deficiency, congenital	223000	AR	3
223100	2q21.3	Lactase persistence/nonpersistence	223100	AD	3
223200	_	_	_	_	_
223300	_	_	_	_	_
223320	_	_	_	_	_
223330	_	_	_	_	_
223340	_	_	_	_	_
223350	_	_	_	_	_
223360	9q34.2	Orthostatic hypotension 1, due to DBH deficiency	223360	AR	3
223370	_	_	_	_	_
223380	_	_	_	_	_
223400	_	_	_	_	_
223500	_	_	_	_	_
223540	_	_	_	_	_
223550	_	_	_	_	_
223600	_	_	_	_	_
223610	_	_	_	_	_
223800	18q21.1	Dyggve-Melchior-Clausen disease	223800	AR	3
223900	9q31.3	Dysautonomia, familial	223900	AR	3
224000	_	_	_	_	_
224050	9p24.2	Cerebellar hypoplasia and mental retardation with or without quadrupedal locomotion 1	224050	AR	3
224100	20p11.23	Dyserythropoietic anemia, congenital, type II	224100	AR	3
224120	15q15.2	Dyserythropoietic anemia, congenital, type Ia	224120	AR	3
224200	_	_	_	_	_
224230	15q14	Dyskeratosis congenita, autosomal recessive 1	224230	AR	3
224250	_	_	_	_	_
224300	_	_	_	_	_
224400	_	_	_	_	_
224410	1p36.12	Dyssegmental dysplasia, Silverman-Handmaker type	224410	AR	3
224500	1p35.1	Dystonia 2, torsion, autosomal recessive	224500	AR	3
224550	_	_	_	_	_
224570	_	_	_	_	_
224600	_	_	_	_	_
224690	1p32.3	Meier-Gorlin syndrome 1	224690	AR	3
224700	_	_	_	_	_
224750	2q35	Schopf-Schulz-Passarge syndrome	224750	AR	3
224800	_	_	_	_	_
224900	2q13	Ectodermal dysplasia 10B, hypohidrotic/hair/tooth type, autosomal recessive	224900	AR	3
225000	_	_	_	_	_
225040	_	_	_	_	_
225050	_	_	_	_	_
225060	_	_	_	_	_
225100	1q21.2	Ectopia lentis, isolated, autosomal recessive	225100	AR	3
225200	1q21.2	Ectopia lentis et pupillae	225200	AR	3
225250	5q35.1	Hypothyroidism, congenital nongoitrous, 5	225250	AD	3
225280	16q22.1	Ectodermal dysplasia, ectrodactyly, and macular dystrophy	225280	AR	3
225290	_	_	_	_	_
225300	12q13.12	Split-hand/foot malformation 6	225300	AR	3
225310	_	_	_	_	_
225320	7q21.3	Ehlers-Danlos syndrome, cardiac valvular type	225320	AR	3
225350	_	_	_	_	_
225360	_	_	_	_	_
225400	1p36.22	Ehlers-Danlos syndrome, kyphoscoliotic type, 1	225400	AR	3
225410	5q35.3	Ehlers-Danlos syndrome, dermatosparaxis type	225410	AR	3
225450	_	_	_	_	_
225500	_	_	_	_	_
225700	_	_	_	_	_
225740	_	_	_	_	_
225750	3p21.31	Aicardi-Goutieres syndrome 1, dominant and recessive	225750	AD,AR	3
225753	17q25.1	Pontocerebellar hypoplasia type 4	225753	AR	3
225755	_	_	_	_	_
225790	14q24.3	Proliferative vasculopathy and hydranencephaly-hydrocephaly syndrome	225790	AR	3
225795	_	_	_	_	_
226000	_	_	_	_	_
226100	_	_	_	_	_
226110	_	_	_	_	_
226150	_	_	_	_	_
226200	21q21.1	Enterokinase deficiency	226200	AR	3
226300	1q32.2	Complement hyperactivation, angiopathic thrombosis, and protein-losing enteropathy	226300	AR	3
226350	_	_	_	_	_
226400	17q25.3	Epidermodysplasia verruciformis	226400	AR	3
226440	_	_	_	_	_
226450	_	_	_	_	_
226500	_	_	_	_	_
226600	_	_	_	_	_
226650	_	_	_	_	_
226670	8q24.3	Epidermolysis bullosa simplex with muscular dystrophy	226670	AR	3
226700	_	_	_	_	_
226730	_	_	_	_	_
226735	_	_	_	_	_
226750	16p13.3	Kohlschutter-Tonz syndrome	226750	AR	3
226800	_	_	_	_	_
226810	_	_	_	_	_
226850	_	_	_	_	_
226900	5q32	Epiphyseal dysplasia, multiple, 4	226900	AR	3
226950	_	_	_	_	_
226960	_	_	_	_	_
226980	2p11.2	Wolcott-Rallison syndrome	226980	AR	3
226985	_	_	_	_	_
226990	16q24.1	Immunodeficiency 32B, monocyte and dendritic cell deficiency, autosomal recessive	226990	AR	3
227000	_	_	_	_	_
227010	_	_	_	_	_
227050	19q13.2	Transient erythroblastopenia of childhood	227050	AR	2
227090	_	_	_	_	_
227100	_	_	_	_	_
227150	_	_	_	_	_
227200	_	_	_	_	_
227210	_	_	_	_	_
227220	_	_	_	_	_
227240	_	_	_	_	_
227250	_	_	_	_	_
227255	_	_	_	_	_
227260	2q37.3	Focal facial dermal dysplasia 3, Setleis type	227260	AR	3
227270	_	_	_	_	_
227280	_	_	_	_	_
227290	_	_	_	_	_
227295	_	_	_	_	_
227300	18q21.32	Combined factor V and VIII deficiency	227300	AR	3
227310	_	_	_	_	_
227320	_	_	_	_	_
227330	_	_	_	_	_
227400	1q24.2	Factor V deficiency	227400	AR	3
227500	13q34	Factor VII deficiency	227500	AR	3
227600	13q34	Factor X deficiency	227600	AR	3
227645	9q22.32	Fanconi anemia, complementation group C	227645	AR	3
227646	3p25.3	Fanconi anemia, complementation group D2	227646	AR	3
227650	16q24.3	Fanconi anemia, complementation group A	227650	AR	3
227660	_	_	_	_	_
227700	_	_	_	_	_
227800	_	_	_	_	_
227810	3q26.2	Fanconi-Bickel syndrome	227810	AR	3
227850	_	_	_	_	_
228000	8p22	Farber lipogranulomatosis	228000	AR	3
228020	_	_	_	_	_
228100	_	_	_	_	_
228200	_	_	_	_	_
228250	_	_	_	_	_
228300	19q13.33	Hypogonadotropic hypogonadism 23 with or without anosmia	228300	AR	3
228355	_	_	_	_	_
228400	_	_	_	_	_
228520	1p21.1	Fibrochondrogenesis 1	228520	AR	3
228550	5q32	Myofibromatosis, infantile, 1	228550	AD	3
228560	_	_	_	_	_
228600	4q21.21	Hyaline fibromatosis syndrome	228600	AR	3
228800	_	_	_	_	_
228900	20q11.22	Du Pan syndrome	228900	AR	3
228930	3p25.1	Fuhrmann syndrome	228930	AR	3
228940	_	_	_	_	_
228960	_	_	_	_	_
228980	1p36.13	[Fleck retina, familial benign]	228980	AR	3
228990	_	_	_	_	_
229000	4q35.2	Fletcher factor (prekallikrein) deficiency	612423	AR	3
229045	_	_	_	_	_
229050	17q11.2	Folate malabsorption, hereditary	229050	AR	3
229070	11p14.1	Hypogonadotropic hypogonadism 24 without anosmia	229070	AR	3
229100	21q22.3	Glutamate formiminotransferase deficiency	229100	AR	3
229120	_	_	_	_	_
229150	_	_	_	_	_
229200	16q24.2	Brittle cornea syndrome 1	229200	AR	3
229230	_	_	_	_	_
229250	_	_	_	_	_
229300	_	_	_	_	_
229310	_	_	_	_	_
229400	_	_	_	_	_
229500	_	_	_	_	_
229600	9q31.1	Fructose intolerance, hereditary	229600	AR	3
229650	_	_	_	_	_
229700	9q22.32	Fructose-1,6-bisphosphatase deficiency	229700	AR	3
229800	2p23.3	[Fructosuria]	229800	AR	3
229850	_	_	_	_	_
229900	_	_	_	_	_
229950	_	_	_	_	_
230000	1p36.11	Fucosidosis	230000	AR	3
230200	17q25.1	Galactokinase deficiency with cataracts	230200	AR	3
230300	_	_	_	_	_
230350	1p36.11	Galactose epimerase deficiency	230350	AR	3
230400	9p13.3	Galactosemia	230400	AR	3
230430	_	_	_	_	_
230450	6p12.1	Hemolytic anemia due to gamma-glutamylcysteine synthetase deficiency	230450	AR	3
230500	3p22.3	GM1-gangliosidosis, type I	230500	AR	3
230600	3p22.3	GM1-gangliosidosis, type II	230600	AR	3
230650	3p22.3	GM1-gangliosidosis, type III	230650	AR	3
230700	_	_	_	_	_
230710	_	_	_	_	_
230740	2p13.3	GAPO syndrome	230740	AR	3
230750	_	_	_	_	_
230800	1q22	Gaucher disease, type I	230800	AR	3
230900	1q22	Gaucher disease, type II	230900	AR	3
231000	1q22	Gaucher disease, type III	231000	AR	3
231005	1q22	Gaucher disease, type IIIC	231005	AR	3
231050	9q34.2	Geleophysic dysplasia 1	231050	AR	3
231060	_	_	_	_	_
231070	1q24.2	Geroderma osteodysplasticum	231070	AR	3
231080	_	_	_	_	_
231090	19q13.42	Hydatidiform mole, recurrent, 1	231090	AR	3
231095	7q34	Ghosal hematodiaphyseal syndrome	231095	AR	3
231100	_	_	_	_	_
231200	_	_	_	_	_
231300	2p22.2	Glaucoma 3A, primary open angle, congenital, juvenile, or adult onset	231300	AR	3
231400	_	_	_	_	_
231500	_	_	_	_	_
231520	_	_	_	_	_
231530	4q25	3-hydroxyacyl-CoA dehydrogenase deficiency	231530	AR	3
231550	12q13.13	Achalasia-addisonianism-alacrimia syndrome	231550	AR	3
231610	_	_	_	_	_
231630	_	_	_	_	_
231670	19p13.13	Glutaricaciduria, type I	231670	AR	3
231675	4q32.1	Glutaric acidemia IIC	231680	AR	3
231680	_	_	_	_	_
231690	7p14.1	Glutaric aciduria III	231690	AR	3
231900	20q11.22	Hemolytic anemia due to glutathione synthetase deficiency	231900	AR	3
231950	22q11.23	?Glutathioninuria	231950	AR	3
231970	_	_	_	_	_
232000	13q32.3	Propionicacidemia	606054	AR	3
232050	3q22.3	Propionicacidemia	606054	AR	3
232200	17q21.31	Glycogen storage disease Ia	232200	AR	3
232210	_	_	_	_	_
232220	11q23.3	Glycogen storage disease Ib	232220	AR	3
232240	11q23.3	Glycogen storage disease Ic	232240	AR	3
232300	17q25.3	Glycogen storage disease II	232300	AR	3
232330	_	_	_	_	_
232400	_	_	_	_	_
232500	3p12.2	Glycogen storage disease IV	232500	AR	3
232600	11q13.1	McArdle disease	232600	AR	3
232700	14q22.1	Glycogen storage disease VI	232700	AR	3
232800	12q13.11	Glycogen storage disease VII	232800	AR	3
232900	_	_	_	_	_
233100	16p11.2	Renal glucosuria	233100	AD,AR	3
233270	_	_	_	_	_
233300	2p16.3	Ovarian dysgenesis 1	233300	AR	3
233400	5q23.1	Perrault syndrome 1	233400	AR	3
233420	12q13.12	46XY sex reversal 7	233420	AR	3
233430	_	_	_	_	_
233450	_	_	_	_	_
233500	_	_	_	_	_
233600	11q23.3	?Immunodeficiency 59 and hypoglycemia	233600	AR	3
233650	_	_	_	_	_
233670	_	_	_	_	_
233690	16q24.2	Chronic granulomatous disease, autosomal, due to deficiency of CYBA	233690	AR	3
233700	7q11.23	Chronic granulomatous disease due to deficiency of NCF-1	233700	AR	3
233710	1q25.3	Chronic granulomatous disease due to deficiency of NCF-2	233710	AR	3
233800	_	_	_	_	_
233805	_	_	_	_	_
233810	_	_	_	_	_
233910	14q22.2	Hyperphenylalaninemia, BH4-deficient, B	233910	AR	3
234000	5q35.3	Factor XII deficiency	234000	AR	3
234030	_	_	_	_	_
234050	7p14.1	Trichothiodystrophy 4, nonphotosensitive	234050	AR	3
234100	_	_	_	_	_
234200	20p13	Neurodegeneration with brain iron accumulation 1	234200	AR	3
234250	_	_	_	_	_
234280	_	_	_	_	_
234300	_	_	_	_	_
234350	_	_	_	_	_
234500	5p15.33	Hartnup disorder	234500	AR	3
234580	7q21.2	Heimler syndrome 1	234580	AR	3
234700	_	_	_	_	_
234750	_	_	_	_	_
234800	_	_	_	_	_
234810	15q15.1	Pulmonary venoocclusive disease 2	234810	AR	3
234820	_	_	_	_	_
235000	11p15	Hemihypertrophy	235000	AD	2
235200	_	_	_	_	_
235255	_	_	_	_	_
235360	_	_	_	_	_
235370	_	_	_	_	_
235400	_	_	_	_	_
235500	_	_	_	_	_
235510	18q21.32	Hennekam lymphangiectasia-lymphedema syndrome 1	235510	AR	3
235550	2q37.1	Hepatic venoocclusive disease with immunodeficiency	235550	AR	3
235555	7q33	Bile acid synthesis defect, congenital, 2	235555	AR	3
235600	_	_	_	_	_
235700	10q22.1	Hemolytic anemia due to hexokinase deficiency	235700	AR	3
235730	2q22.3	Mowat-Wilson syndrome	235730	AD	3
235735	_	_	_	_	_
235740	_	_	_	_	_
235750	_	_	_	_	_
235760	_	_	_	_	_
235800	12q23.1	[Histidinemia]	235800	AD,AR	3
235830	_	_	_	_	_
235900	_	_	_	_	_
236000	3p21.31	{Hodgkin lymphoma, susceptibility to}	236000	AR	3
236100	21q22.3	Holoprosencephaly 1	236100	AD,IC	2
236110	_	_	_	_	_
236130	_	_	_	_	_
236200	_	_	_	_	_
236250	1p36.22	Homocystinuria due to MTHFR deficiency	236250	AR	3
236270	5p15.31	Homocystinuria-megaloblastic anemia, cbl E type	236270	AR	3
236300	_	_	_	_	_
236400	_	_	_	_	_
236410	_	_	_	_	_
236450	_	_	_	_	_
236490	_	_	_	_	_
236500	10q23.33	Multinucleated neurons, anhydramnios, renal dysplasia, cerebellar hypoplasia, and hydranencephaly	236500	AR	3
236600	14q32.11-q32.12	Hydrocephalus, congenital, 1	236600	AR	3
236635	_	_	_	_	_
236640	_	_	_	_	_
236660	_	_	_	_	_
236670	9q34.13	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 1	236670	AR	3
236680	11q24.2	Hydrolethalus syndrome	236680	AR	3
236690	_	_	_	_	_
236700	20p12.2	McKusick-Kaufman syndrome	236700	AR	3
236730	10q24.2	Urofacial syndrome 1	236730	AR	3
236750	_	_	_	_	_
236792	14q21.3	L-2-hydroxyglutaric aciduria	236792	AR	3
236795	_	_	_	_	_
236800	2q22.2	?Hydroxykynureninuria	236800	AR	3
236900	_	_	_	_	_
237000	_	_	_	_	_
237100	_	_	_	_	_
237300	2q34	Carbamoylphosphate synthetase I deficiency	237300	AR	3
237310	17q21.31	N-acetylglutamate synthase deficiency	237310	AR	3
237400	_	_	_	_	_
237450	_	_	_	_	_
237500	10q24.2	Dubin-Johnson syndrome	237500	AR	3
237550	_	_	_	_	_
237800	_	_	_	_	_
237900	2q37.1	Hyperbilirubinemia, familial transient neonatal	237900	AR	3
238200	_	_	_	_	_
238300	9p24.1	Glycine encephalopathy	605899	AR	3
238310	3p21.31	Glycine encephalopathy	605899	AR	3
238320	_	_	_	_	_
238330	16q23.2	?Glycine encephalopathy	605899	AR	3
238331	7q31.1	Dihydrolipoamide dehydrogenase deficiency	246900	AR	3
238340	_	_	_	_	_
238350	_	_	_	_	_
238400	_	_	_	_	_
238500	_	_	_	_	_
238600	_	_	_	_	_
238700	7q31.32	Hyperlysinemia	238700	AR	3
238710	_	_	_	_	_
238750	_	_	_	_	_
238800	_	_	_	_	_
238950	_	_	_	_	_
238970	13q14.11	Hyperornithinemia-hyperammonemia-homocitrullinemia syndrome	238970	AR	3
239000	8q24.12	Paget disease of bone 5, juvenile-onset	239000	AR	3
239100	17q21.31	Van Buchem disease	239100	AR	3
239199	_	_	_	_	_
239200	3q13.3-q21.1	Hyperparathyroidism, neonatal	239200	AD,AR	3
239300	1p36.11	Hyperphosphatasia with mental retardation syndrome 1	239300	AR	3
239350	_	_	_	_	_
239400	_	_	_	_	_
239500	22q11.21	Hyperprolinemia, type I	239500	AR	3
239510	1p36.13	Hyperprolinemia, type II	239510	AR	3
239710	_	_	_	_	_
239711	_	_	_	_	_
239800	_	_	_	_	_
239840	_	_	_	_	_
239850	12p12.1	Hypertrichotic osteochondrodysplasia	239850	AD	3
239900	_	_	_	_	_
240000	_	_	_	_	_
240100	_	_	_	_	_
240150	_	_	_	_	_
240200	_	_	_	_	_
240300	21q22.3	Autoimmune polyendocrinopathy syndrome , type I, with or without reversible metaphyseal dysplasia	240300	AD,AR	3
240400	8p21.1	Scurvy	_	_	3
240500	17p11.2	Immunodeficiency, common variable, 2	240500	AD,AR	3
240600	12p12.1	Glycogen storage disease 0, liver	240600	AR	3
240800	11p15.1	Hypoglycemia of infancy, leucine-sensitive	240800	AD	3
240900	19q13.2	Hypoinsulinemic hypoglycemia with hemihypertrophy	240900	AD	3
240950	_	_	_	_	_
241000	_	_	_	_	_
241080	2q31.1	Woodhouse-Sakati syndrome	241080	AR	3
241090	_	_	_	_	_
241100	_	_	_	_	_
241120	_	_	_	_	_
241150	_	_	_	_	_
241200	11q24.3	Bartter syndrome, type 2	241200	AR	3
241310	_	_	_	_	_
241400	_	_	_	_	_
241410	1q42.3	Hypoparathyroidism-retardation-dysmorphism syndrome	241410	AR	3
241500	1p36.12	Hypophosphatasia, infantile	241500	AR	3
241510	1p36.12	Hypophosphatasia, childhood	241510	AR	3
241519	_	_	_	_	_
241520	4q22.1	Hypophosphatemic rickets, AR	241520	AR	3
241530	9q34.3	Hypophosphatemic rickets with hypercalciuria	241530	AR	3
241540	_	_	_	_	_
241550	6q22.31	Hypoplastic left heart syndrome 1	241550	AR	3
241600	15q21.1	Immunodeficiency 43	241600	AR	3
241750	_	_	_	_	_
241760	_	_	_	_	_
241800	7p14.1	{Hypothalamic hamartomas, somatic}	241800	_	3
241850	9q22.33	Bamforth-Lazarus syndrome	241850	AR	3
241900	_	_	_	_	_
242050	_	_	_	_	_
242100	17p13.1	Ichthyosis, congenital, autosomal recessive 2	242100	AR	3
242150	_	_	_	_	_
242170	_	_	_	_	_
242300	14q12	Ichthyosis, congenital, autosomal recessive 1	242300	AR	3
242400	_	_	_	_	_
242500	2q35	Ichthyosis, congenital, autosomal recessive 4B (harlequin)	242500	AR	3
242510	_	_	_	_	_
242520	_	_	_	_	_
242530	_	_	_	_	_
242550	_	_	_	_	_
242600	_	_	_	_	_
242650	_	_	_	_	_
242670	_	_	_	_	_
242680	_	_	_	_	_
242700	_	_	_	_	_
242800	_	_	_	_	_
242840	18q12.3-q21.1	Vici syndrome	242840	AR	3
242850	_	_	_	_	_
242860	20q11.21	Immunodeficiency-centromeric instability-facial anomalies syndrome 1	242860	AR	3
242870	_	_	_	_	_
242880	_	_	_	_	_
242890	_	_	_	_	_
242900	2q35	Schimke immunoosseous dysplasia	242900	AR	3
243000	_	_	_	_	_
243050	_	_	_	_	_
243060	19q13.43	Spermatogenic failure 5	243060	AR	3
243080	_	_	_	_	_
243095	_	_	_	_	_
243100	_	_	_	_	_
243110	_	_	_	_	_
243150	2p21	Gastrointestinal defects and immunodeficiency syndrome	243150	AR	3
243180	_	_	_	_	_
243185	_	_	_	_	_
243200	_	_	_	_	_
243300	18q21.31	Cholestasis, benign recurrent intrahepatic	243300	AR	3
243305	9q31.1	Nephronophthisis 2, infantile	602088	AR	3
243310	7p22.1	Baraitser-Winter syndrome 1	243310	AD	3
243320	_	_	_	_	_
243340	_	_	_	_	_
243400	8p22	[Acetylation, slow]	243400	AR	3
243440	_	_	_	_	_
243450	_	_	_	_	_
243500	15q15.1	Isovaleric acidemia	243500	AR	3
243600	_	_	_	_	_
243605	1q41	Stromme syndrome	243605	AR	3
243700	9p24.3	Hyper-IgE recurrent infection syndrome, autosomal recessive	243700	AR	3
243800	15q15.2	Johanson-Blizzard syndrome	243800	AR	3
243910	_	_	_	_	_
244100	_	_	_	_	_
244200	20p12.3	Hypogonadotropic hypogonadism 3 with or without anosmia	244200	AD	3
244300	_	_	_	_	_
244400	9p13.3	Ciliary dyskinesia, primary, 1, with or without situs inversus	244400	AR	3
244450	12q24.11	Kaufman oculocerebrofacial syndrome	244450	AR	3
244460	1q42.3	Kenny-Caffey syndrome, type 1	244460	AR	3
244500	_	_	_	_	_
244510	_	_	_	_	_
244600	_	_	_	_	_
244850	_	_	_	_	_
245000	11q14.2	Papillon-Lefevre syndrome	245000	AR	3
245010	11q14.2	Haim-Munk syndrome	245010	AR	3
245050	5p13.1	Succinyl CoA:3-oxoacid CoA transferase deficiency	245050	_	3
245100	_	_	_	_	_
245130	_	_	_	_	_
245150	12p12.3	Keutel syndrome	245150	AR	3
245160	_	_	_	_	_
245180	_	_	_	_	_
245190	_	_	_	_	_
245200	14q31.3	Krabbe disease	245200	AR	3
245210	_	_	_	_	_
245300	20p13	{Kuru, susceptibility to}	245300	_	3
245340	1p13.2	Erythrocyte lactate transporter defect	245340	AD	3
245348	11q23.1	Pyruvate dehydrogenase E2 deficiency	245348	AR	3
245349	11p13	Lacticacidemia due to PDX1 deficiency	245349	AR	3
245400	2p11.2	Mitochondrial DNA depletion syndrome 9 (encephalomyopathic type with methylmalonic aciduria)	245400	AR	3
245450	16q23.1	D-lactic aciduria	245450	AR	3
245480	14q11.2	Specific granule deficiency	245480	AR	3
245500	_	_	_	_	_
245550	_	_	_	_	_
245552	_	_	_	_	_
245570	16p13.2	Epilepsy, focal, with speech disorder and with or without mental retardation	245570	AD	3
245590	17q21.2	Growth hormone insensitivity with immunodeficiency	245590	_	3
245600	11q12.3	Multiple joint dislocations, short stature, craniofacial dysmorphism, with or without congenital heart defects	245600	AR	3
245650	_	_	_	_	_
245660	18q11.2	Laryngoonychocutaneous syndrome	245660	AR	3
245800	19p13.2	?Laurence-Moon syndrome	245800	AR	3
245900	16q22.1	Norum disease	245900	AR	3
246000	_	_	_	_	_
246200	19p13.2	Leprechaunism	246200	AR	3
246300	4q31.3	{Leprosy, susceptibility to}	246300	AD	3
246400	_	_	_	_	_
246450	1p36.11	HMG-CoA lyase deficiency	246450	AR	3
246470	_	_	_	_	_
246490	_	_	_	_	_
246500	_	_	_	_	_
246530	5q35.3	Leukotriene C4 synthase deficiency	614037	AR	1
246550	_	_	_	_	_
246555	_	_	_	_	_
246560	10q24	Split-hand/foot malformation 3, gene duplication syndrome	246560	AD	4
246570	_	_	_	_	_
246600	10q25.3	?Pancreatic lipase deficiency	614338	AR	3
246650	16p13.3	Lipase deficiency, combined	246650	AR	3
246700	5q31.1	Chylomicron retention disease	246700	AR	3
246800	_	_	_	_	_
246900	7q31.1	Dihydrolipoamide dehydrogenase deficiency	246900	AR	3
247100	1q21.2	Urbach-Wiethe disease	247100	AR	3
247150	_	_	_	_	_
247200	17p13.3	Miller-Dieker lissencephaly syndrome	247200	AD	4
247400	_	_	_	_	_
247410	_	_	_	_	_
247420	19q13.32	[Blood group, Lutheran null]	247420	AR	3
247430	_	_	_	_	_
247440	_	_	_	_	_
247450	_	_	_	_	_
247610	_	_	_	_	_
247630	_	_	_	_	_
247640	9p22-p21	Leukemia, acute lymphoblastic	247640	AR	2
247650	_	_	_	_	_
247800	_	_	_	_	_
247900	_	_	_	_	_
247950	_	_	_	_	_
247980	_	_	_	_	_
247990	_	_	_	_	_
248000	6p24.1	Macrocephaly/megalencephaly syndrome, autosomal recessive	248000	AR	3
248010	_	_	_	_	_
248100	_	_	_	_	_
248110	_	_	_	_	_
248190	1p34.2	Hypomagnesemia 5, renal, with ocular involvement	248190	AR	3
248200	_	_	_	_	_
248250	3q28	Hypomagnesemia 3, renal	248250	AR	3
248260	_	_	_	_	_
248300	8q24.3	Meleda disease	248300	AR	3
248310	5q31-q33	{Malaria, intensity of infection}	248310	AR	2
248340	8q24.12	3MC syndrome 3	248340	AR	3
248350	_	_	_	_	_
248360	16q23.3	Malonyl-CoA decarboxylase deficiency	248360	AR	3
248370	1q22	Mandibuloacral dysplasia	248370	AR	3
248390	6p21.1	Treacher Collins syndrome 3	248390	AR	3
248400	_	_	_	_	_
248450	9p22.3	Manitoba oculotrichoanal syndrome	248450	AR	3
248500	19p13.13	Mannosidosis, alpha-, types I and II	248500	AR	3
248510	4q24	Mannosidosis, beta	248510	AR	3
248600	_	_	_	_	_
248610	1p21.2	Maple syrup urine disease, type II	248600	AR	3
248611	6q14.1	Maple syrup urine disease, type Ib	248600	AR	3
248700	18p11.22-p11.21	?Marden-Walker syndrome	248700	AD	3
248750	_	_	_	_	_
248760	_	_	_	_	_
248770	_	_	_	_	_
248800	5q31.2	Marinesco-Sjogren syndrome	248800	AR	3
248810	_	_	_	_	_
248900	15q22.31	Mast syndrome	248900	AR	3
248910	_	_	_	_	_
248950	_	_	_	_	_
249000	17q22	Meckel syndrome 1	249000	AR	3
249100	16p13.3	Familial Mediterranean fever, AR	249100	AR	3
249210	_	_	_	_	_
249230	_	_	_	_	_
249240	_	_	_	_	_
249270	1q24.2	Thiamine-responsive megaloblastic anemia syndrome	249270	AR	3
249300	_	_	_	_	_
249310	_	_	_	_	_
249400	1p13.2	Neurocutaneous melanosis, somatic	249400	_	3
249420	5q35.1	Frank-ter Haar syndrome	249420	AR	3
249500	4q26	Mental retardation, autosomal recessive 1	249500	AR	3
249599	_	_	_	_	_
249600	_	_	_	_	_
249620	_	_	_	_	_
249630	_	_	_	_	_
249650	_	_	_	_	_
249660	_	_	_	_	_
249670	_	_	_	_	_
249700	_	_	_	_	_
249710	_	_	_	_	_
249800	_	_	_	_	_
249900	10q22.1	Metachromatic leukodystrophy due to SAP-b deficiency	249900	AR	3
250100	22q13.33	Metachromatic leukodystrophy	250100	AR	3
250215	_	_	_	_	_
250220	19p13.3	Spondylometaphyseal dysplasia, Sedaghatian type	250220	AR	3
250230	_	_	_	_	_
250250	9p13.3	Cartilage-hair hypoplasia	250250	AR	3
250300	_	_	_	_	_
250400	11q22.2	Metaphyseal dysplasia, Spahr type	250400	AR	3
250410	5q12.3	Retinitis pigmentosa with or without skeletal anomalies	250410	AR	3
250420	_	_	_	_	_
250450	_	_	_	_	_
250460	9p13.3	Metaphyseal dysplasia without hypotrichosis	250460	AR	3
250500	_	_	_	_	_
250600	_	_	_	_	_
250620	2q32.2	3-hydroxyisobutryl-CoA hydrolase deficiency	250620	AR	3
250650	_	_	_	_	_
250700	_	_	_	_	_
250790	18q22.3	Methemoglobinemia and ambiguous genitalia	250790	AR	3
250800	_	_	_	_	_
250850	_	_	_	_	_
250900	_	_	_	_	_
250940	1q43	Homocystinuria-megaloblastic anemia, cblG complementation type	250940	AR	3
250950	9q22.31	3-methylglutaconic aciduria, type I	250950	AR	3
250951	_	_	_	_	_
251000	6p12.3	Methylmalonic aciduria, mut(0) type	251000	AR	3
251100	4q31.21	Methylmalonic aciduria, vitamin B12-responsive	251100	AR	3
251110	12q24.11	Methylmalonic aciduria, vitamin B12-responsive, due to defect in synthesis of adenosylcobalamin, cblB complementation type	251110	AR	3
251120	2p13.3	Methylmalonyl-CoA epimerase deficiency	251120	AR	3
251170	12q24.11	Hyper-IgD syndrome	260920	AR	3
251170	12q24.11	Mevalonic aciduria	610377	AR	3
251170	12q24.11	Porokeratosis 3, multiple types	175900	AD	3
251190	_	_	_	_	_
251200	8p23.1	Microcephaly 1, primary, autosomal recessive	251200	AR	3
251220	_	_	_	_	_
251230	21q22.11	Microcephaly-micromelia syndrome	251230	AR	3
251240	_	_	_	_	_
251250	_	_	_	_	_
251255	18q11.2	Jawad syndrome	251255	AR	3
251260	8q21.3	Nijmegen breakage syndrome	251260	AR	3
251270	22q13.33	Microcephaly and chorioretinopathy, autosomal recessive, 1	251270	AR	3
251280	5q31.3	Microcephaly, seizures, spasticity, and brain calcification	251280	AR	3
251290	5q13.2	Pseudo-TORCH syndrome 1	251290	AR	3
251300	15q25.2	Galloway-Mowat syndrome 1	251300	AR	3
251400	_	_	_	_	_
251450	17q25.3	Desbuquois dysplasia 1	251450	AR	3
251455	_	_	_	_	_
251500	_	_	_	_	_
251505	_	_	_	_	_
251600	14q32	Microphthalmia, isolated 1	251600	AR	2
251700	_	_	_	_	_
251750	14q24.3	Microspherophakia and/or megalocornea, with ectopia lentis and with or without secondary glaucoma	251750	AR	3
251800	_	_	_	_	_
251850	18q21.1	Microvillus inclusion disease	251850	AR	3
251880	2p13.1	Mitochondrial DNA depletion syndrome 3 (hepatocerebral type)	251880	AR	3
251890	_	_	_	_	_
251900	19p13.2	Mitochondrial myopathy, episodic, with optic atrophy and reversible leukoencephalopathy	251900	AR	3
251945	_	_	_	_	_
251950	7q31.1	?Mitochondrial myopathy with lactic acidosis	251950	AR	3
252010	5q11.2	Mitochondrial complex I deficiency, nuclear type 1	252010	AR	3
252011	_	_	_	_	_
252030	_	_	_	_	_
252100	_	_	_	_	_
252150	6p21.2	Molybdenum cofactor deficiency A	252150	AR	3
252160	5q11.2	Molybdenum cofactor deficiency B	252160	AR	3
252200	_	_	_	_	_
252250	_	_	_	_	_
252270	7q	Myelodysplasia and leukemia syndrome with monosomy 7	252270	AR	4
252300	_	_	_	_	_
252320	_	_	_	_	_
252350	3p26-p24.2	Moyamoya disease	252350	AR	2
252500	12q23.2	Mucolipidosis II alpha/beta	252500	AR	3
252600	12q23.2	Mucolipidosis III alpha/beta	252600	AR	3
252605	16p13.3	Mucolipidosis III gamma	252605	AR	3
252650	19p13.2	Mucolipidosis IV	252650	AR	3
252700	_	_	_	_	_
252800	4p16.3	Mucopolysaccharidosis Ih	607014	AR	3
252800	4p16.3	Mucopolysaccharidosis Ih/s	607015	AR	3
252800	4p16.3	Mucopolysaccharidosis Is	607016	AR	3
252900	17q25.3	Mucopolysaccharidosis type IIIA (Sanfilippo A)	252900	AR	3
252920	17q21.2	Mucopolysaccharidosis type IIIB (Sanfilippo B)	252920	AR	3
252930	8p11.2-p11.1	Mucopolysaccharidosis type IIIC (Sanfilippo C)	252930	AR	3
252940	12q14.3	Mucopolysaccharidosis type IIID	252940	AR	3
253000	16q24.3	Mucopolysaccharidosis IVA	253000	AR	3
253010	3p22.3	Mucopolysaccharidosis type IVB (Morquio)	253010	AR	3
253200	5q14.1	Mucopolysaccharidosis type VI (Maroteaux-Lamy)	253200	AR	3
253220	7q11.21	Mucopolysaccharidosis VII	253220	AR	3
253230	_	_	_	_	_
253240	_	_	_	_	_
253250	17q22	Mulibrey nanism	253250	AR	3
253260	3p25.1	Biotinidase deficiency	253260	AR	3
253270	21q22.13	Holocarboxylase synthetase deficiency	253270	AR	3
253280	1p34.1	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 3	253280	AR	3
253290	_	_	_	_	_
253300	5q13.2	Spinal muscular atrophy-1	253300	AR	3
253310	9q34.11	Lethal congenital contracture syndrome 1	253310	AR	3
253320	_	_	_	_	_
253400	_	_	_	_	_
253500	_	_	_	_	_
253550	5q13.2	Spinal muscular atrophy-2	253550	AR	3
253590	_	_	_	_	_
253600	15q15.1	Muscular dystrophy, limb-girdle, autosomal recessive 1	253600	AR	3
253601	2p13.2	Muscular dystrophy, limb-girdle, autosomal recessive 2	253601	AR	3
253700	13q12.12	Muscular dystrophy, limb-girdle, autosomal recessive 5	253700	AR	3
253800	9q31.2	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4	253800	AR	3
253850	_	_	_	_	_
253900	_	_	_	_	_
254000	_	_	_	_	_
254090	_	_	_	_	_
254100	_	_	_	_	_
254110	9q33.1	Muscular dystrophy, limb-girdle, autosomal recessive 8	254110	AR	3
254120	_	_	_	_	_
254130	2p13.2	Miyoshi muscular dystrophy 1	254130	AR	3
254150	_	_	_	_	_
254190	_	_	_	_	_
254195	_	_	_	_	_
254200	_	_	_	_	_
254210	10q11.23	Myasthenic syndrome, congenital, 6, presynaptic	254210	AR	3
254300	4p16.3	Myasthenic syndrome, congenital, 10	254300	AR	3
254400	_	_	_	_	_
254450	_	_	_	_	_
254500	_	_	_	_	_
254600	17q22	Myeloperoxidase deficiency	254600	AR	3
254700	_	_	_	_	_
254770	6p12.2	{Myoclonic epilepsy, juvenile, susceptibility to, 1}	254770	AD	3
254780	_	_	_	_	_
254800	21q22.3	Epilepsy, progressive myoclonic 1A (Unverricht and Lundborg)	254800	AR	3
254900	4q21.1	Epilepsy, progressive myoclonic 4, with or without renal failure	254900	AR	3
254940	9q34.2	Carey-Fineman-Ziter syndrome	254940	AR	3
254950	_	_	_	_	_
254960	_	_	_	_	_
255100	1q21.3	Lipid storage myopathy due to flavin adenine dinucleotide synthetase deficiency	255100	AR	3
255110	1p32.3	CPT II deficiency, myopathic, stress-induced	255110	AD,AR	3
255120	11q13.3	CPT deficiency, hepatic, type IA	255120	AR	3
255125	12q23.3	Myopathy with lactic acidosis, hereditary	255125	AR	3
255140	_	_	_	_	_
255160	14q11.2	Myopathy, myosin storage, autosomal recessive	255160	AR	3
255170	_	_	_	_	_
255200	2q14.3	Centronuclear myopathy 2	255200	AR	3
255300	_	_	_	_	_
255310	_	_	_	_	_
255320	19q13.2	Minicore myopathy with external ophthalmoplegia	255320	AR	3
255500	14q22.1-q24.2	Myopia 18	255500	AR	2
255600	21q22.3	?Myosclerosis, congenital	255600	AR	3
255700	7q34	Myotonia congenita, recessive	255700	AR	3
255710	_	_	_	_	_
255800	1p36.12	Schwartz-Jampel syndrome, type 1	255800	AR	3
255900	_	_	_	_	_
255960	17q24.2	Myxoma, intracardiac	255960	AD	3
255980	_	_	_	_	_
255990	_	_	_	_	_
255995	12q13.3	Myopathy, congenital, Baily-Bloch	255995	AR	3
256000	_	_	_	_	_
256020	_	_	_	_	_
256030	2q23.3	Nemaline myopathy 2, autosomal recessive	256030	AR	3
256040	6p21.32	Proteasome-associated autoinflammatory syndrome 1 and digenic forms	256040	AR	3
256050	_	_	_	_	_
256100	2q13	Nephronophthisis 1, juvenile	256100	AR	3
256120	_	_	_	_	_
256150	_	_	_	_	_
256200	_	_	_	_	_
256300	19q13.12	Nephrotic syndrome, type 1	256300	AR	3
256340	_	_	_	_	_
256350	_	_	_	_	_
256370	11p13	Nephrotic syndrome, type 4	256370	AD	3
256450	11p15.1	Hyperinsulinemic hypoglycemia, familial, 1	256450	AD,AR	3
256500	5q32	Netherton syndrome	256500	AR	3
256520	1p12	Neu-Laxova syndrome 1	256520	AR	3
256540	20q13.12	Galactosialidosis	256540	AR	3
256550	_	_	_	_	_
256600	22q13.1	Infantile neuroaxonal dystrophy 1	256600	AR	3
256690	_	_	_	_	_
256700	_	_	_	_	_
256710	_	_	_	_	_
256720	_	_	_	_	_
256730	1p34.2	Ceroid lipofuscinosis, neuronal, 1	256730	AR	3
256731	13q22.3	Ceroid lipofuscinosis, neuronal, 5	256731	AR	3
256800	1q23.1	Insensitivity to pain, congenital, with anhidrosis	256800	AR	3
256810	2p23.3	Mitochondrial DNA depletion syndrome 6 (hepatocerebral type)	256810	AR	3
256840	5p15.2	Neuropathy, hereditary sensory, with spastic paraplegia	256840	AR	3
256850	16q23.2	Giant axonal neuropathy-1	256850	AR	3
256851	_	_	_	_	_
256855	_	_	_	_	_
256860	_	_	_	_	_
256870	_	_	_	_	_
257000	_	_	_	_	_
257050	_	_	_	_	_
257100	_	_	_	_	_
257150	_	_	_	_	_
257200	11p15.4	Niemann-Pick disease, type A	257200	AR	3
257220	_	_	_	_	_
257250	_	_	_	_	_
257270	5q35.3	Night blindness, congenital stationary (complete), 1B, autosomal recessive	257270	AR	3
257300	15q15.1	Mosaic variegated aneuploidy syndrome 1	257300	AR	3
257320	7q22.1	Lissencephaly 2 (Norman-Roberts type)	257320	AR	3
257350	_	_	_	_	_
257400	_	_	_	_	_
257500	_	_	_	_	_
257550	2q13	Oculomotor apraxia, congenital, Cogan-type	257550	AR	2
257600	_	_	_	_	_
257790	_	_	_	_	_
257800	_	_	_	_	_
257850	6q22.31	Oculodentodigital dysplasia, autosomal recessive	257850	AR	3
257910	_	_	_	_	_
257920	3q27.3	3MC syndrome 1	257920	AR	3
257950	_	_	_	_	_
257960	_	_	_	_	_
257970	_	_	_	_	_
257980	2q35	Odontoonychodermal dysplasia	257980	AR	3
258040	_	_	_	_	_
258100	2q37.1	Oguchi disease-1	258100	AR	3
258120	_	_	_	_	_
258150	_	_	_	_	_
258200	_	_	_	_	_
258300	_	_	_	_	_
258315	13q31.3-q32.1	Omodysplasia 1	258315	AR	3
258320	_	_	_	_	_
258360	_	_	_	_	_
258400	_	_	_	_	_
258450	15q26.1	Progressive external ophthalmoplegia, autosomal recessive 1	258450	AR	3
258470	_	_	_	_	_
258480	11q13.4	Opsismodysplasia	258480	AR	3
258500	8q21-q22	Optic atrophy 6	258500	AR	2
258501	19q13.32	3-methylglutaconic aciduria, type III	258501	AR	3
258650	_	_	_	_	_
258660	17p13.2	{Nonarteritic anterior ischemic optic neuropathy, susceptibility to}	258660	AR	3
258700	_	_	_	_	_
258800	_	_	_	_	_
258840	_	_	_	_	_
258850	_	_	_	_	_
258860	10q24.1	Orofaciodigital syndrome IV	258860	AR	3
258865	_	_	_	_	_
258870	10q26.13	Gyrate atrophy of choroid and retina with or without ornithinemia	258870	AR	3
258900	3q21.2	Orotic aciduria	258900	AR	3
258920	_	_	_	_	_
259050	3q13.31	Primrose syndrome	259050	AD	3
259100	_	_	_	_	_
259200	_	_	_	_	_
259250	_	_	_	_	_
259270	_	_	_	_	_
259400	_	_	_	_	_
259410	_	_	_	_	_
259420	_	_	_	_	_
259440	15q22.31	Osteogenesis imperfecta, type IX	259440	AR	3
259450	17q21.2	Bruck syndrome 1	259450	AR	3
259500	_	_	_	_	_
259550	_	_	_	_	_
259600	16q12.2	Multicentric osteolysis, nodulosis, and arthropathy	259600	AR	3
259610	_	_	_	_	_
259650	_	_	_	_	_
259660	_	_	_	_	_
259680	_	_	_	_	_
259690	_	_	_	_	_
259700	11q13.2	Osteopetrosis, autosomal recessive 1	259700	AR	3
259710	13q14.11	Osteopetrosis, autosomal recessive 2	259710	AR	3
259720	6q21	Osteopetrosis, autosomal recessive 5	259720	AR	3
259730	8q21.2	Osteopetrosis, autosomal recessive 3, with renal tubular acidosis	259730	AR	3
259750	_	_	_	_	_
259770	11q13.2	Osteoporosis-pseudoglioma syndrome	259770	AR	3
259775	7p22.3	Raine syndrome	259775	AR	3
259780	_	_	_	_	_
259900	2q37.3	Hyperoxaluria, primary, type 1	259900	AR	3
260000	9p13.2	Hyperoxaluria, primary, type II	260000	AR	3
260005	8q24.3	5-oxoprolinase deficiency	260005	AD,AR	3
260100	_	_	_	_	_
260130	_	_	_	_	_
260150	_	_	_	_	_
260200	_	_	_	_	_
260300	22q12.3	Parkinson disease 15, autosomal recessive	260300	AR	3
260350	_	_	_	_	_
260370	13q12.2	Pancreatic agenesis 1	260370	AR	3
260400	7q11.21	Shwachman-Diamond syndrome	260400	AR	3
260450	_	_	_	_	_
260470	_	_	_	_	_
260480	_	_	_	_	_
260490	_	_	_	_	_
260500	17p13.1	{Choroid plexus papilloma}	260500	AD	3
260530	_	_	_	_	_
260540	17q21.31	Supranuclear palsy, progressive atypical	260540	AR	3
260555	_	_	_	_	_
260565	17q12	PEHO syndrome	260565	AR	3
260570	_	_	_	_	_
260600	4q24	Leukodystrophy, hypomyelinating, 3	260600	AR	3
260650	_	_	_	_	_
260660	1p12	Cousin syndrome	260660	AR	3
260800	17q25.3	[Pentosuria]	260800	AR	3
260900	_	_	_	_	_
260910	_	_	_	_	_
260920	12q24.11	Hyper-IgD syndrome	260920	AR	3
260950	_	_	_	_	_
260970	_	_	_	_	_
260980	_	_	_	_	_
261000	11q12.1	Intrinsic factor deficiency	261000	AR	3
261100	_	_	_	_	_
261400	_	_	_	_	_
261500	17q22	[Eosinophil peroxidase deficiency]	261500	AR	3
261510	_	_	_	_	_
261515	5q23.1	D-bifunctional protein deficiency	261515	AR	3
261540	13q12.3	Peters-plus syndrome	261540	AR	3
261550	_	_	_	_	_
261560	_	_	_	_	_
261575	_	_	_	_	_
261590	_	_	_	_	_
261600	_	_	_	_	_
261630	4p15.32	Hyperphenylalaninemia, BH4-deficient, C	261630	AR	3
261640	11q23.1	Hyperphenylalaninemia, BH4-deficient, A	261640	AR	3
261650	14q11-q12	PEPCK deficiency, mitochondrial	261650	AR	1
261660	_	_	_	_	_
261670	7p13	Glycogen storage disease X	261670	AR	3
261680	20q13.31	?Phosphoenolpyruvate carboxykinase deficiency, cytosolic	261680	AR	3
261740	7q36.1	Glycogen storage disease of heart, lethal congenital	261740	AD	3
261750	16q12.1	Phosphorylase kinase deficiency of liver and muscle, autosomal recessive	261750	AR	3
261800	17q24.3-q25.1	Pierre Robin syndrome	261800	AR	2
261900	_	_	_	_	_
261990	11q21	?Abnormal hair, joint laxity, and developmental delay	261990	_	3
262000	2q35	Bjornstad syndrome	262000	AR	3
262020	_	_	_	_	_
262190	19p13.2	Rabson-Mendenhall syndrome	262190	AR	3
262300	8q21.3	Achromatopsia 3	262300	AR	3
262350	_	_	_	_	_
262400	17q23.3	Growth hormone deficiency, isolated, type IA	262400	AR	3
262500	5p13-p12	Laron dwarfism	262500	AR	3
262600	5q35.3	Pituitary hormone deficiency, combined, 2	262600	AR	3
262650	17q23.3	Kowarski syndrome	262650	AR	3
262700	1q25.2	Pituitary hormone deficiency, combined, 4	262700	AD	3
262710	_	_	_	_	_
262780	_	_	_	_	_
262800	_	_	_	_	_
262850	17p13.3	Alpha-2-plasmin inhibitor deficiency	262850	AR	3
262875	_	_	_	_	_
262890	12q12	Scott syndrome	262890	AR	3
262900	_	_	_	_	_
263000	_	_	_	_	_
263100	_	_	_	_	_
263200	6p12.3-p12.2	Polycystic kidney disease 4, with or without hepatic disease	263200	AR	3
263210	11q23.1	Gillessen-Kaesbach-Nishimura syndrome	263210	AR	3
263300	9p24.1	Polycythemia vera, somatic	263300	_	3
263400	3p25.3	Erythrocytosis, familial, 2	263400	AR	3
263450	13q13.3-q21	Polydactyly, postaxial, type A5	263450	AR	2
263510	_	_	_	_	_
263520	4q33	Short-rib thoracic dysplasia 6 with or without polydactyly	263520	DR,AR	3
263530	_	_	_	_	_
263540	_	_	_	_	_
263550	_	_	_	_	_
263560	_	_	_	_	_
263570	3p12.2	Polyglucosan body disease, adult form	263570	AR	3
263600	_	_	_	_	_
263610	_	_	_	_	_
263620	_	_	_	_	_
263630	_	_	_	_	_
263650	21q22.3	Popliteal pterygium syndrome, Bartsocas-Papas type	263650	AR	3
263700	10q26.2	Porphyria, congenital erythropoietic	263700	AR	3
263750	16q22.2	Miller syndrome	263750	AR	3
263800	16q13	Gitelman syndrome	263800	AR	3
264010	_	_	_	_	_
264050	_	_	_	_	_
264060	_	_	_	_	_
264070	10q22.1	Hyperphenylalaninemia, BH4-deficient, D	264070	AR	3
264080	11q22.1	?Progesterone resistance	264080	AR	2
264090	10q22.3	Wiedemann-Rautenstrauch syndrome	264090	AR	3
264110	_	_	_	_	_
264120	_	_	_	_	_
264140	_	_	_	_	_
264150	_	_	_	_	_
264160	_	_	_	_	_
264180	_	_	_	_	_
264200	_	_	_	_	_
264270	_	_	_	_	_
264300	9q22.32	Pseudohermaphroditism, male, with gynecomastia	264300	AR	3
264350	_	_	_	_	_
264420	_	_	_	_	_
264450	_	_	_	_	_
264470	17q25.1	Peroxisomal acyl-CoA oxidase deficiency	264470	AR	3
264475	_	_	_	_	_
264480	_	_	_	_	_
264500	_	_	_	_	_
264600	2p23.1	Pseudovaginal perineoscrotal hypospadias	264600	AR	3
264700	12q14.1	Vitamin D-dependent rickets, type I	264700	AR	3
264800	_	_	_	_	_
264810	_	_	_	_	_
264900	4q35.2	Factor XI deficiency, autosomal dominant	612416	_	3
264900	4q35.2	Factor XI deficiency, autosomal recessive	612416	_	3
265000	2q37.1	Escobar syndrome	265000	AR	3
265050	2p25.3	3MC syndrome 2	265050	AR	3
265100	4p15.2	Pulmonary alveolar microlithiasis	265100	AR	3
265120	2p11.2	Surfactant metabolism dysfunction, pulmonary, 1	265120	AR	3
265140	_	_	_	_	_
265150	_	_	_	_	_
265200	_	_	_	_	_
265300	_	_	_	_	_
265380	16q24.1	Alveolar capillary dysplasia with misalignment of pulmonary veins	265380	AD	3
265400	_	_	_	_	_
265430	_	_	_	_	_
265450	2q33.1-q33.2	Pulmonary venoocclusive disease 1	265450	AD	3
265500	_	_	_	_	_
265600	_	_	_	_	_
265800	1q21.3	Pycnodysostosis	265800	AR	3
265850	_	_	_	_	_
265880	_	_	_	_	_
265900	7p14.1	Pyle disease	265900	AR	3
265950	_	_	_	_	_
266100	5q23.2	Epilepsy, pyridoxine-dependent	266100	AR	3
266120	7p14.3	Anemia, hemolytic, due to UMPH1 deficiency	266120	AR	3
266130	20q11.22	Glutathione synthetase deficiency	266130	AR	3
266140	1q23.1	Pyropoikilocytosis	266140	AR	3
266150	11q13.2	Pyruvate carboxylase deficiency	266150	AR	3
266200	1q22	Pyruvate kinase deficiency	266200	AR	3
266250	_	_	_	_	_
266255	_	_	_	_	_
266265	11p11.2	Congenital disorder of glycosylation, type IIc	266265	AR	3
266270	_	_	_	_	_
266280	8q24.3	RAPADILINO syndrome	266280	AR	3
266300	_	_	_	_	_
266350	_	_	_	_	_
266400	_	_	_	_	_
266500	10p13	Refsum disease	266500	AR	3
266510	17q12	Peroxisome biogenesis disorder 3B	266510	AR	3
266600	_	_	_	_	_
266810	_	_	_	_	_
266900	2q13	Senior-Loken syndrome-1	266900	AR	3
266910	_	_	_	_	_
266920	16p13.3	Short-rib thoracic dysplasia 9 with or without polydactyly	266920	AR	3
267000	2q37.1	Perlman syndrome	267000	AR	3
267010	3q22.1	Meckel syndrome 7	267010	AR	3
267200	_	_	_	_	_
267300	2p13.3	Renal tubular acidosis with deafness	267300	AR	3
267400	_	_	_	_	_
267430	_	_	_	_	_
267450	_	_	_	_	_
267480	_	_	_	_	_
267500	1p35.1	Reticular dysgenesis	267500	AR	3
267700	9q21.3-q22	Hemophagocytic lymphohistiocytosis, familial, 1	267700	AR	2
267730	_	_	_	_	_
267740	_	_	_	_	_
267750	21q22.3	Knobloch syndrome, type 1	267750	AR	3
267760	_	_	_	_	_
267800	_	_	_	_	_
267900	_	_	_	_	_
268000	_	_	_	_	_
268010	_	_	_	_	_
268020	_	_	_	_	_
268025	_	_	_	_	_
268030	_	_	_	_	_
268040	_	_	_	_	_
268050	_	_	_	_	_
268060	_	_	_	_	_
268080	_	_	_	_	_
268100	15q23	Enhanced S-cone syndrome	268100	AR	3
268130	14q12	Revesz syndrome	268130	AD	3
268150	6p12.3	Anemia, hemolytic, Rh-null, regulator type	268150	AD	3
268200	2p25.1	Myoglobinuria, acute recurrent, autosomal recessive	268200	AR	3
268210	11p15.4	Rhabdomyosarcoma, somatic	268210	_	3
268220	_	_	_	_	_
268240	_	_	_	_	_
268250	_	_	_	_	_
268300	8p21.1	Roberts syndrome	268300	AR	3
268305	17q25.3	Robin sequence with cleft mandible and limb anomalies	268305	AR	3
268310	9q22.31	Robinow syndrome, autosomal recessive	268310	AR	3
268315	_	_	_	_	_
268320	_	_	_	_	_
268400	8q24.3	Rothmund-Thomson syndrome	268400	AR	3
268500	_	_	_	_	_
268650	_	_	_	_	_
268670	_	_	_	_	_
268700	7q31.32	Saccharopinuria	268700	AR	1
268800	5q13.3	Sandhoff disease, infantile, juvenile, and adult forms	268800	AR	3
268850	_	_	_	_	_
268900	9q34.2	[Sarcosinemia]	268900	AR	3
268950	_	_	_	_	_
269000	8p21.1	SC phocomelia syndrome	269000	AR	3
269150	18q12.3	Schinzel-Giedion midface retraction syndrome	269150	AD	3
269160	_	_	_	_	_
269200	_	_	_	_	_
269250	1p31.3	Schneckenbecken dysplasia	269250	AR	3
269300	_	_	_	_	_
269400	2p25.3	Anterior segment dysgenesis 7, with sclerocornea	269400	AR	3
269500	17q21.31	Sclerosteosis 1	269500	AR	3
269600	19q13.32	Sea-blue histiocyte disease	269600	AR	3
269630	_	_	_	_	_
269650	_	_	_	_	_
269700	11q12.3	Lipodystrophy, congenital generalized, type 2	269700	AR	3
269720	_	_	_	_	_
269800	_	_	_	_	_
269840	2q11.2	Immunodeficiency 48	269840	AR	3
269860	_	_	_	_	_
269870	_	_	_	_	_
269880	5q13.1	SHORT syndrome	269880	AD	3
269920	6q13	Sialic acid storage disorder, infantile	269920	AR	3
269921	9p13.3	Sialuria	269921	AD	3
269950	_	_	_	_	_
270050	_	_	_	_	_
270100	10q22.1	Heterotaxy, visceral, 5	270100	AD	3
270150	_	_	_	_	_
270200	17p11.2	Sjogren-Larsson syndrome	270200	AR	3
270220	_	_	_	_	_
270230	_	_	_	_	_
270240	_	_	_	_	_
270300	6p21.33	Peeling skin syndrome 1	270300	AR	3
270350	_	_	_	_	_
270400	11q13.4	Smith-Lemli-Opitz syndrome	270400	AR	3
270420	19q13.2	Diarrhea 3, secretory sodium, congenital, syndromic	270420	AR	3
270425	_	_	_	_	_
270450	15q26.3	Insulin-like growth factor I, resistance to	270450	AD,AR	3
270460	_	_	_	_	_
270500	_	_	_	_	_
270550	13q12.12	Spastic ataxia, Charlevoix-Saguenay type	270550	AR	3
270600	_	_	_	_	_
270680	_	_	_	_	_
270685	11q12.3	Silver spastic paraplegia syndrome	270685	AD	3
270700	14q24.1	Spastic paraplegia 15, autosomal recessive	270700	AR	3
270710	_	_	_	_	_
270750	1q32.1	Spastic paraplegia 23	270750	AR	3
270800	8q12.3	Spastic paraplegia 5A, autosomal recessive	270800	AR	3
270805	_	_	_	_	_
270850	_	_	_	_	_
270900	_	_	_	_	_
270950	_	_	_	_	_
270960	_	_	_	_	_
270970	1q23.1	Spherocytosis, type 3	270970	AR	3
271100	_	_	_	_	_
271109	_	_	_	_	_
271110	_	_	_	_	_
271120	_	_	_	_	_
271150	5q13.2	Spinal muscular atrophy-4	271150	AR	3
271200	_	_	_	_	_
271220	_	_	_	_	_
271225	_	_	_	_	_
271245	10q24.31	Mitochondrial DNA depletion syndrome 7 (hepatocerebral type)	271245	AR	3
271250	6p23-p21	Spinocerebellar ataxia, autosomal recessive 3	271250	AR	2
271270	_	_	_	_	_
271310	_	_	_	_	_
271320	_	_	_	_	_
271322	_	_	_	_	_
271400	3p22.1	Asplenia, isolated congenital	271400	AD	3
271500	_	_	_	_	_
271510	_	_	_	_	_
271520	_	_	_	_	_
271530	_	_	_	_	_
271550	_	_	_	_	_
271600	_	_	_	_	_
271620	_	_	_	_	_
271630	_	_	_	_	_
271640	1p36.33	Spondyloepimetaphyseal dysplasia with joint laxity, type 1, with or without fractures	271640	AR	3
271650	_	_	_	_	_
271665	1q23.3	Spondylometaepiphyseal dysplasia, short limb-hand type	271665	AR	3
271700	12q13.11	Spondyloperipheral dysplasia	271700	AD	3
271900	17p13.2	Canavan disease	271900	AR	3
271930	19q13.33	Striatonigral degeneration, infantile	271930	AR	3
271950	_	_	_	_	_
271960	_	_	_	_	_
271980	6p22.3	Succinic semialdehyde dehydrogenase deficiency	271980	AR	3
272000	_	_	_	_	_
272100	_	_	_	_	_
272120	3p22.2	{Sudden infant death syndrome, susceptibility to}	272120	AR	3
272150	_	_	_	_	_
272200	3p26.1	Multiple sulfatase deficiency	272200	AR	3
272300	12q13.2	Sulfite oxidase deficiency	272300	AR	3
272350	_	_	_	_	_
272370	_	_	_	_	_
272430	19p13.11	Cold-induced sweating syndrome 1	272430	AR	3
272440	2q14.1	Filippi syndrome	272440	AR	3
272450	_	_	_	_	_
272460	3p14.3	Spondylocarpotarsal synostosis syndrome	272460	AR	3
272480	_	_	_	_	_
272500	_	_	_	_	_
272550	_	_	_	_	_
272600	_	_	_	_	_
272620	_	_	_	_	_
272650	_	_	_	_	_
272700	_	_	_	_	_
272750	5q33.1	GM2-gangliosidosis, AB variant	272750	AR	3
272800	_	_	_	_	_
272950	_	_	_	_	_
272980	_	_	_	_	_
273000	_	_	_	_	_
273050	_	_	_	_	_
273120	_	_	_	_	_
273150	_	_	_	_	_
273250	_	_	_	_	_
273300	_	_	_	_	_
273350	_	_	_	_	_
273390	_	_	_	_	_
273395	17q21.31-q21.32	?Tetra-amelia syndrome 1	273395	AR	3
273400	_	_	_	_	_
273490	_	_	_	_	_
273600	_	_	_	_	_
273680	_	_	_	_	_
273730	_	_	_	_	_
273740	_	_	_	_	_
273750	6p21.1	3-M syndrome 1	273750	AR	3
273770	_	_	_	_	_
273800	_	_	_	_	_
273900	5p13.1	Thrombocytopenia 3	273900	AR	3
274000	1q21.1	Thrombocytopenia-absent radius syndrome	274000	AR	3
274150	9q34.2	Thrombotic thrombocytopenic purpura, familial	274150	AR	3
274180	7q34	?Thromboxane synthase deficiency	614158	AD	1
274180	7q34	Ghosal hematodiaphyseal syndrome	231095	AR	3
274190	_	_	_	_	_
274200	_	_	_	_	_
274205	_	_	_	_	_
274210	_	_	_	_	_
274230	_	_	_	_	_
274240	_	_	_	_	_
274260	_	_	_	_	_
274265	_	_	_	_	_
274270	_	_	_	_	_
274300	3p24.2	Thyroid hormone resistance, autosomal recessive	274300	AR	3
274400	19p13.11	Thyroid dyshormonogenesis 1	274400	AR	3
274500	2p25.3	Thyroid dyshormonogenesis 2A	274500	AR	3
274600	7q22.3	Pendred syndrome	274600	AR	3
274700	8q24.22	Thyroid dyshormonogenesis 3	274700	AR	3
274800	6q25.1	Thyroid dyshormonogenesis 4	274800	AR	3
274900	15q21.1	Thyroid dyshormonogenesis 5	274900	AR	3
275000	14q31	{Graves disease, susceptibility to, 1}	275000	AR	2
275100	1p13.2	Hypothyroidism, congenital, nongoitrous 4	275100	AR	3
275120	3q22.1	Thyrotropin-releasing hormone deficiency	275120	AR	1
275190	_	_	_	_	_
275200	14q31.1	Hypothyroidism, congenital, nongoitrous, 1	275200	AR	3
275210	_	_	_	_	_
275220	8q24.1	?Tibial hemimelia	275220	AR	2
275230	_	_	_	_	_
275240	_	_	_	_	_
275250	_	_	_	_	_
275300	_	_	_	_	_
275350	22q12.2	Transcobalamin II deficiency	275350	AR	3
275355	_	_	_	_	_
275360	11q23.3	Trehalase deficiency	612119	AR	3
275370	_	_	_	_	_
275400	19p13.2	Oliver-McFarlane syndrome	275400	AR	3
275450	_	_	_	_	_
275500	_	_	_	_	_
275550	_	_	_	_	_
275595	_	_	_	_	_
275600	_	_	_	_	_
275630	3p21.33	Chanarin-Dorfman syndrome	275630	AR	3
275650	_	_	_	_	_
275900	13q13.3	Troyer syndrome	275900	AR	3
276000	7q34	Pancreatitis, hereditary	167800	AD	3
276000	7q34	Trypsinogen deficiency	614044	AR	1
276100	_	_	_	_	_
276200	_	_	_	_	_
276300	_	_	_	_	_
276400	2p16.3	Ovarian response to FSH stimulation	276400	AR	3
276410	_	_	_	_	_
276500	_	_	_	_	_
276600	16q22.2	Tyrosinemia, type II	276600	AR	3
276700	15q25.1	Tyrosinemia, type I	276700	AR	3
276710	12q24.31	Tyrosinemia, type III	276710	AR	3
276800	_	_	_	_	_
276820	3p25.1	Ulna and fibula, absence of, with severe limb deficiency	276820	AR	3
276821	_	_	_	_	_
276822	_	_	_	_	_
276850	_	_	_	_	_
276880	3q21.3	?Urocanase deficiency	276880	AR	3
276900	11q13.5	Usher syndrome, type 1B	276900	AR	3
276901	_	_	_	_	_
276902	3q25.1	Usher syndrome, type 3A	276902	AR	3
276903	11q13.5	Deafness, autosomal dominant 11	601317	AD	3
276903	11q13.5	Deafness, autosomal recessive 2	600060	AR	3
276903	11q13.5	Usher syndrome, type 1B	276900	AR	3
276904	11p15.1	Usher syndrome, type 1C	276904	AR	3
276905	_	_	_	_	_
276950	_	_	_	_	_
277000	_	_	_	_	_
277100	_	_	_	_	_
277150	_	_	_	_	_
277170	5p13.2	Orofaciodigital syndrome VI	277170	AR	3
277175	_	_	_	_	_
277180	7q31.2	Congenital bilateral absence of vas deferens	277180	AR	3
277200	_	_	_	_	_
277300	19q13.2	Spondylocostal dysostosis 1, autosomal recessive	277300	AR	3
277320	_	_	_	_	_
277350	_	_	_	_	_
277380	6q13	Methylmalonic aciduria and homocystinuria, cblF type	277380	AR	3
277400	_	_	_	_	_
277410	_	_	_	_	_
277420	_	_	_	_	_
277440	12q13.11	Rickets, vitamin D-resistant, type IIA	277440	AR	3
277450	2p11.2	Vitamin K-dependent clotting factors, combined deficiency of, 1	277450	AR	3
277460	8q12.3	Ataxia with isolated vitamin E deficiency	277460	AR	3
277465	_	_	_	_	_
277470	17q25.1	Pontocerebellar hypoplasia type 2A	277470	AR	3
277480	12p13.31	von Willibrand disease, type 3	277480	AR	3
277580	13q22.3	Waardenburg syndrome, type 4A	277580	AD,AR	3
277590	7q36.1	Weaver syndrome	277590	AD	3
277600	19p13.2	Weill-Marchesani syndrome 1, recessive	277600	AR	3
277610	_	_	_	_	_
277700	8p12	Werner syndrome	277700	AR	3
277720	_	_	_	_	_
277730	_	_	_	_	_
277740	_	_	_	_	_
277900	13q14.3	Wilson disease	277900	AR	3
277950	14q11.2	?Winchester syndrome	277950	_	3
277970	_	_	_	_	_
277990	_	_	_	_	_
278000	_	_	_	_	_
278100	_	_	_	_	_
278150	_	_	_	_	_
278200	_	_	_	_	_
278205	_	_	_	_	_
278250	12q24.31	Wrinkly skin syndrome	278250	AR	3
278300	2p23.1	Xanthinuria, type I	278300	AR	3
278400	_	_	_	_	_
278600	_	_	_	_	_
278700	9q22.33	Xeroderma pigmentosum, group A	278700	AR	3
278720	3p25.1	Xeroderma pigmentosum, group C	278720	AR	3
278730	19q13.32	Xeroderma pigmentosum, group D	278730	AR	3
278740	11p11.2	Xeroderma pigmentosum, group E, DDB-negative subtype	278740	AR	3
278750	6p21.1	Xeroderma pigmentosum, variant type	278750	AR	3
278760	_	_	_	_	_
278780	_	_	_	_	_
278800	10q11.23	De Sanctis-Cacchione syndrome	278800	AR	3
278810	_	_	_	_	_
278850	17q24.3-q25.1	46XX sex reversal 2	278850	AD	4
278900	_	_	_	_	_
279000	_	_	_	_	_
280000	17p11.2	CHIME syndrome	280000	AR	3
300000	Xp22.2	Opitz GBBB syndrome, type I	300000	XLR	3
300001	_	_	_	_	_
300002	_	_	_	_	_
300003	_	_	_	_	_
300004	Xp21.3	Proud syndrome	300004	XL	3
300005	Xq28	Encephalopathy, neonatal severe	300673	XLR	3
300005	Xq28	Mental retardation, X-linked syndromic, Lubs type	300260	XLR	3
300005	Xq28	Mental retardation, X-linked, syndromic 13	300055	XLR	3
300005	Xq28	Rett syndrome	312750	XLD	3
300005	Xq28	Rett syndrome, atypical	312750	XLD	3
300005	Xq28	Rett syndrome, preserved speech variant	312750	XLD	3
300005	Xq28	{Autism susceptibility, X-linked 3}	300496	XL	3
300006	_	_	_	_	_
300007	_	_	_	_	_
300008	Xp11.23	Dent disease	300009	XLR	3
300008	Xp11.23	Hypophosphatemic rickets	300554	XLR	3
300008	Xp11.23	Nephrolithiasis, type I	310468	XLR	3
300008	Xp11.23	Proteinuria, low molecular weight, with hypercalciuric nephrocalcinosis	308990	XLR	3
300009	Xp11.23	Dent disease	300009	XLR	3
300010	_	_	_	_	_
300011	Xq21.1	Menkes disease	309400	XLR	3
300011	Xq21.1	Occipital horn syndrome	304150	XLR	3
300011	Xq21.1	Spinal muscular atrophy, distal, X-linked 3	300489	XLR	3
300012	_	_	_	_	_
300013	Xq28	?Microphthalmia, syndromic 1	309800	XL	3
300013	Xq28	Ogden syndrome	300855	XLR,XLD	3
300014	Xq28	?Spinocerebellar ataxia, X-linked 1	302500	XLR	3
300015	_	_	_	_	_
300016	_	_	_	_	_
300017	Xq28	?FG syndrome 2	300321	XL	3
300017	Xq28	Cardiac valvular dysplasia, X-linked	314400	XLR	3
300017	Xq28	Congenital short bowel syndrome	300048	XLR	3
300017	Xq28	Frontometaphyseal dysplasia 1	305620	XLR	3
300017	Xq28	Heterotopia, periventricular, 1	300049	XLD	3
300017	Xq28	Intestinal pseudoobstruction, neuronal	300048	XLR	3
300017	Xq28	Melnick-Needles syndrome	309350	XLD	3
300017	Xq28	Otopalatodigital syndrome, type I	311300	XLD	3
300017	Xq28	Otopalatodigital syndrome, type II	304120	XLD	3
300017	Xq28	Terminal osseous dysplasia	300244	XLD	3
300018	Xp21.2	46XY sex reversal 2, dosage-sensitive	300018	XL	3
300019	Xq28	Mental retardation, X-linked 3 (methylmalonic acidemia and homocysteinemia, cblX type )	309541	XLR	3
300020	_	_	_	_	_
300021	_	_	_	_	_
300022	_	_	_	_	_
300023	_	_	_	_	_
300024	_	_	_	_	_
300025	_	_	_	_	_
300026	_	_	_	_	_
300027	_	_	_	_	_
300028	_	_	_	_	_
300029	Xp11.4	Retinitis pigmentosa 3	300029	_	3
300030	Xp21.2	Deafness, X-linked 3	300030	XL	2
300031	_	_	_	_	_
300032	Xq21.1	Alpha-thalassemia myelodysplasia syndrome, somatic	300448	_	3
300032	Xq21.1	Alpha-thalassemia/mental retardation syndrome	301040	XLD	3
300032	Xq21.1	Mental retardation-hypotonic facies syndrome, X-linked	309580	XLR	3
300033	_	_	_	_	_
300034	_	_	_	_	_
300035	Xq13.1	Craniofrontonasal dysplasia	304110	XLD	3
300036	Xq28	Cerebral creatine deficiency syndrome 1	300352	XLR	3
300037	Xq26.2	Simpson-Golabi-Behmel syndrome, type 1	312870	XLR	3
300037	Xq26.2	Wilms tumor, somatic	194070	_	3
300038	_	_	_	_	_
300039	Xq21.1	Deafness, X-linked 2	304400	XLR	3
300040	Xp11.22	Cornelia de Lange syndrome 2	300590	XLD	3
300041	_	_	_	_	_
300042	_	_	_	_	_
300043	_	_	_	_	_
300044	_	_	_	_	_
300045	_	_	_	_	_
300046	Xq23-q24	Mental retardation, X-linked 23	300046	XL	2
300047	Xp11-q21	Mental retardation, X-linked 20	300047	XL	2
300048	_	_	_	_	_
300049	Xq28	Heterotopia, periventricular, 1	300049	XLD	3
300050	_	_	_	_	_
300051	_	_	_	_	_
300052	_	_	_	_	_
300053	_	_	_	_	_
300054	_	_	_	_	_
300055	Xq28	Mental retardation, X-linked, syndromic 13	300055	XLR	3
300056	Xp22.2	Linear skin defects with multiple congenital anomalies 1	309801	XLD	3
300057	_	_	_	_	_
300058	_	_	_	_	_
300059	_	_	_	_	_
300060	Xq28	Galloway-Mowat syndrome 2, X-linked	301006	XLR	3
300061	_	_	_	_	_
300062	Xp11.3-q13.3	Mental retardation, X-linked 14	300062	XL	2
300063	_	_	_	_	_
300064	_	_	_	_	_
300065	_	_	_	_	_
300066	Xp22.12	Deafness, X-linked 4	300066	XLD	3
300067	_	_	_	_	_
300068	Xq12	Androgen insensitivity	300068	XLR	3
300069	_	_	_	_	_
300070	_	_	_	_	_
300071	Xp11.23	Night blindness, congenital stationary (incomplete), 2A, X-linked	300071	XL	3
300072	Xp11.4	Mental retardation, X-linked 99	300919	XLR	3
300072	Xp11.4	Mental retardation, X-linked 99, syndromic, female-restricted	300968	XLD	3
300073	_	_	_	_	_
300074	_	_	_	_	_
300075	Xp22.12	Coffin-Lowry syndrome	303600	XLD	3
300075	Xp22.12	Mental retardation, X-linked 19	300844	XLD	3
300076	Xq26-qter	Woods-Black-Norbury syndrome	300076	XLD	2
300077	_	_	_	_	_
300078	Xq24	Mitochondrial complex I deficiency, nuclear type 12	301020	XLR	3
300079	Xq25	Lymphoproliferative syndrome, X-linked, 2	300635	XLR	3
300080	Xp11.3	TARP syndrome	311900	XLR	3
300081	_	_	_	_	_
300082	Xq	[Social cognition]	300082	XL	2
300083	_	_	_	_	_
300084	Xq13.1	Mental retardation, X-linked, syndromic 34	300967	XL	3
300085	Xq27	Cone dystrophy, progressive X-linked, 2	300085	XL	2
300086	_	_	_	_	_
300087	Xq13.2	X-inactivation, familial skewed	300087	_	3
300088	Xq22.1	Epileptic encephalopathy, early infantile, 9	300088	XL	3
300089	_	_	_	_	_
300090	Xq28	Congenital disorder of glycosylation, type Iy	300934	XLR	3
300091	_	_	_	_	_
300092	_	_	_	_	_
300093	_	_	_	_	_
300094	_	_	_	_	_
300095	Xq13.2	Allan-Herndon-Dudley syndrome	300523	XL	3
300096	Xp11.4	Mental retardation, X-linked 58	300210	XLR	3
300097	_	_	_	_	_
300098	_	_	_	_	_
300099	_	_	_	_	_
300100	_	_	_	_	_
300101	_	_	_	_	_
300102	_	_	_	_	_
300103	_	_	_	_	_
300104	Xq28	Mental retardation, X-linked 41	300849	XLD	3
300105	Xp22.11	Mental retardation, X-linked, Snyder-Robinson type	309583	XLR	3
300106	Xq28	Spondyloepimetaphyseal dysplasia, X-linked	300106	XLR	3
300107	_	_	_	_	_
300108	Xq21.33	?Premature ovarian failure 2A	300511	XLD	3
300109	_	_	_	_	_
300110	Xp11.23	Aland Island eye disease	300600	XL	3
300110	Xp11.23	Cone-rod dystrophy, X-linked, 3	300476	XLR	3
300110	Xp11.23	Night blindness, congenital stationary (incomplete), 2A, X-linked	300071	XL	3
300111	_	_	_	_	_
300112	_	_	_	_	_
300113	_	_	_	_	_
300114	Xp22.2	Raynaud-Claes syndrome	300114	XLD	3
300115	Xp11.3-p11.21	Mental retardation, X-linked 50	300115	XL	2
300116	_	_	_	_	_
300117	_	_	_	_	_
300118	_	_	_	_	_
300119	_	_	_	_	_
300120	Xq28	Hypospadias 2, X-linked	300758	XLR	3
300121	Xq23	Lissencephaly, X-linked	300067	XL	3
300121	Xq23	Subcortical laminal heterotopia, X-linked	300067	XL	3
300122	_	_	_	_	_
300123	Xq27.1	Mental retardation, X-linked, with isolated growth hormone deficiency	300123	_	3
300124	_	_	_	_	_
300125	Xq	{Migraine, familial typical, susceptibility to, 2}	300125	XL	2
300126	Xq28	Dyskeratosis congenita, X-linked	305000	XLR	3
300127	Xq12	Mental retardation, X-linked, with cerebellar hypoplasia and distinctive facial appearance	300486	XLR	3
300128	Xp11.3	Kabuki syndrome 2	300867	XLD	3
300129	_	_	_	_	_
300130	_	_	_	_	_
300131	Xq23	Bone mineral density QTL18, osteoporosis	300910	XLD	3
300132	_	_	_	_	_
300133	_	_	_	_	_
300134	_	_	_	_	_
300135	Xq13.3	Anemia, sideroblastic, with ataxia	301310	XLR	3
300136	Xp11	{Diabetes mellitus, insulin-dependent, X-linked}	300136	_	2
300137	Xq26.1	Hypothyroidism, central, and testicular enlargement	300888	XLR	3
300138	Xq28	?Mental retardation, X-linked, syndromic 32	300886	XLR	3
300139	Xq13.1	Corpus callosum, agenesis of, with mental retardation, ocular coloboma and micrognathia	300472	XLR	3
300140	_	_	_	_	_
300141	_	_	_	_	_
300142	Xq23	Mental retardation, X-linked 30/47	300558	XLR	3
300143	Xp21.3-p21.2	Mental retardation, X-linked 21/34	300143	XLR	3
300144	Xq24	{Parkinson disease, age of onset, modifier}	168600	AD,Mu	3
300145	Xq26.1	{Angioedema induced by ACE inhibitors, susceptibility to}	300909	_	3
300146	_	_	_	_	_
300147	Xq27-q28	{Prostate cancer, hereditary, X-linked 1}	300147	_	2
300148	Xp22.11	MEHMO syndrome	300148	XLR	3
300149	_	_	_	_	_
300150	_	_	_	_	_
300151	_	_	_	_	_
300152	_	_	_	_	_
300153	_	_	_	_	_
300154	_	_	_	_	_
300155	Xq26-q27	Retinitis pigmentosa 24	300155	_	2
300156	_	_	_	_	_
300157	Xq23	Mental retardation, X-linked 63	300387	XLD	3
300158	_	_	_	_	_
300159	_	_	_	_	_
300160	Xp11.4	Mental retardation, X-linked 102	300958	XLR,XLD	3
300161	Xp22.11	MEHMO syndrome	300148	XLR	3
300162	_	_	_	_	_
300163	Xq26.3	?Uruguay faciocardiomusculoskeletal syndrome	300280	XLR	3
300163	Xq26.3	Emery-Dreifuss muscular dystrophy 6, X-linked	300696	XLR	3
300163	Xq26.3	Myopathy, X-linked, with postural muscle atrophy	300696	XLR	3
300163	Xq26.3	Reducing body myopathy, X-linked 1a, severe, infantile or early childhood onset	300717	XLD	3
300163	Xq26.3	Reducing body myopathy, X-linked 1b, with late childhood or adult onset	300718	XL	3
300163	Xq26.3	Scapuloperoneal myopathy, X-linked dominant	300695	XLD	3
300164	_	_	_	_	_
300165	_	_	_	_	_
300166	Xp11.4	Microphthalmia, syndromic 2	300166	XLD	3
300167	_	_	_	_	_
300168	Xq26.2	Keipert syndrome	301026	XLR	3
300169	Xq26.1	Combined oxidative phosphorylation deficiency 6	300816	XLR	3
300169	Xq26.1	Cowchock syndrome	310490	XLR	3
300169	Xq26.1	Deafness, X-linked 5	300614	XLR	3
300170	Xp22.2	?Retinitis pigmentosa 23	300424	XLR	3
300170	Xp22.2	Joubert syndrome 10	300804	XLR	3
300170	Xp22.2	Orofaciodigital syndrome I	311200	XLD	3
300170	Xp22.2	Simpson-Golabi-Behmel syndrome, type 2	300209	XLR	3
300171	_	_	_	_	_
300172	Xp11.4	FG syndrome 4	300422	_	3
300172	Xp11.4	Mental retardation and microcephaly with pontine and cerebellar hypoplasia	300749	XLD	3
300172	Xp11.4	Mental retardation, with or without nystagmus	300422	_	3
300173	_	_	_	_	_
300174	_	_	_	_	_
300175	_	_	_	_	_
300176	_	_	_	_	_
300177	_	_	_	_	_
300178	_	_	_	_	_
300179	Xq25-q26	X inactivation, familial skewed, 2	300179	_	2
300180	Xp22.33	Chondrodysplasia punctata, X-linked recessive	302950	XLR	3
300181	_	_	_	_	_
300182	_	_	_	_	_
300183	_	_	_	_	_
300184	_	_	_	_	_
300185	_	_	_	_	_
300186	_	_	_	_	_
300187	_	_	_	_	_
300188	Xq13.1	Lujan-Fryns syndrome	309520	XLR	3
300188	Xq13.1	Ohdo syndrome, X-linked	300895	XLR	3
300188	Xq13.1	Opitz-Kaveggia syndrome	305450	XLR	3
300189	Xq13.1	Mental retardation, X-linked 90	300850	XLR	3
300190	_	_	_	_	_
300191	_	_	_	_	_
300192	Xp11.22	?Sarcoma, synovial	300813	_	3
300193	Xq28	?Microphthalmia, syndromic 13	300915	XL	3
300194	Xq22.3	Alport syndrome, mental retardation, midface hypoplasia, and elliptocytosis	300194	_	4
300195	Xq23	Midface hypoplasia, hearing impairment, elliptocytosis, and nephrocalcinosis	300990	XLR	3
300196	_	_	_	_	_
300197	Xq28	Immunodeficiency 47	300972	XLR	3
300198	_	_	_	_	_
300199	Xq26.3	?Mental retardation, X-linked, syndromic 11, Shashi type	300238	XLR	3
300200	Xp21.2	Adrenal hypoplasia, congenital	300200	XLR	3
300201	_	_	_	_	_
300202	Xp22.2	Spondyloepiphyseal dysplasia tarda	313400	XLR	3
300203	Xp22.13	Epileptic encephalopathy, early infantile, 2	300672	XLD	3
300204	Xq22.3	?Mental retardation, X-linked 101	300928	XLR	3
300205	Xp11.23	Chondrodysplasia punctata, X-linked dominant	302960	XLD	3
300205	Xp11.23	MEND syndrome	300960	XLR	3
300206	Xp21.3-p21.2	Mental retardation, X-linked 21/34	300143	XLR	3
300207	_	_	_	_	_
300208	_	_	_	_	_
300209	Xp22.2	Simpson-Golabi-Behmel syndrome, type 2	300209	XLR	3
300210	Xp11.4	Mental retardation, X-linked 58	300210	XLR	3
300211	Xp22.3	Episodic muscle weakness, X-linked	300211	_	2
300212	_	_	_	_	_
300213	_	_	_	_	_
300214	_	_	_	_	_
300215	_	_	_	_	_
300216	_	_	_	_	_
300217	_	_	_	_	_
300218	Xp11.3-q22	Mental retardation, X-linked syndromic 7	300218	_	2
300219	_	_	_	_	_
300220	_	_	_	_	_
300221	Xpter-p22.32	{Hodgkin disease susceptibility, pseudoautosomal}	300221	_	2
300222	_	_	_	_	_
300223	_	_	_	_	_
300224	_	_	_	_	_
300225	_	_	_	_	_
300226	Xp22.12	Deafness, X-linked 4	300066	XLD	3
300227	_	_	_	_	_
300228	Xq27	Testicular germ cell tumor	300228	_	2
300229	_	_	_	_	_
300230	_	_	_	_	_
300231	Xq26.3	Mental retardation, X-linked syndromic, Christianson type	300243	XLD	3
300232	_	_	_	_	_
300233	_	_	_	_	_
300234	_	_	_	_	_
300235	_	_	_	_	_
300236	_	_	_	_	_
300237	_	_	_	_	_
300238	Xq26.3	?Mental retardation, X-linked, syndromic 11, Shashi type	300238	XLR	3
300239	_	_	_	_	_
300240	_	_	_	_	_
300241	_	_	_	_	_
300242	_	_	_	_	_
300243	Xq26.3	Mental retardation, X-linked syndromic, Christianson type	300243	XLD	3
300244	Xq28	Terminal osseous dysplasia	300244	XLD	3
300245	Xq24-q27.1	Ptosis, hereditary congenital 2	300245	XLD	2
300246	_	_	_	_	_
300247	Xp11.22	Ovarian dysgenesis 2	300510	XL	3
300247	Xp11.22	Premature ovarian failure 4	300510	XL	3
300248	Xq28	Ectodermal dysplasia and immunodeficiency 1	300291	_	3
300248	Xq28	Ectodermal, dysplasia, anhidrotic, lymphedema and immunodeficiency	300301	_	3
300248	Xq28	Immunodeficiency 33	300636	XLR	3
300248	Xq28	Immunodeficiency, isolated	300584	_	3
300248	Xq28	Incontinentia pigmenti	308300	XLD	3
300248	Xq28	Invasive pneumococcal disease, recurrent isolated, 2	300640	_	3
300249	_	_	_	_	_
300250	_	_	_	_	_
300251	_	_	_	_	_
300252	_	_	_	_	_
300253	_	_	_	_	_
300254	_	_	_	_	_
300255	Xq13.1	Mental retardation, X-linked 106	300997	XLR	3
300256	Xp11.22	HSD10 mitochondrial disease	300438	XLD	3
300257	Xq24	Danon disease	300257	XLD	3
300258	_	_	_	_	_
300259	Xq	{Mycobacterium tuberculosis, susceptibility, X-linked}	300259	_	2
300260	Xq28	Mental retardation, X-linked syndromic, Lubs type	300260	XLR	3
300261	Xq28	Mental retardation syndrome, X-linked, Armfield type	300261	XLR	2
300262	Xq13.2	Mental retardation, X-linked syndromic, Abidi type	300262	_	2
300263	Xp11.22	Mental retardation syndrome, X-linked, Siderius type	300263	XLR	3
300264	Xp11.21	Amyotrophic lateral sclerosis 15, with or without frontotemporal dementia	300857	XLD	3
300265	Xq26.3	Congenital heart defects, nonsyndromic, 1, X-linked	306955	XLR	3
300265	Xq26.3	Heterotaxy, visceral, 1, X-linked	306955	XLR	3
300265	Xq26.3	VACTERL association, X-linked	314390	XLR	3
300266	Xq11.2	Spastic paraplegia 16, X-linked, complicated	300266	XLR	2
300267	_	_	_	_	_
300268	_	_	_	_	_
300269	Xq13.1	Cornelia de Lange syndrome 5	300882	XLD	3
300270	_	_	_	_	_
300271	Xq28	Mental retardation, X-linked 72	300271	XLR	3
300272	Xp11.23	?Chondrodysplasia with platyspondyly, distinctive brachydactyly, hydrocephaly, and microphthalmia	300863	XLD	3
300273	Xp22	Goiter, multinodular, 2	300273	XLD	2
300274	_	_	_	_	_
300275	Xq28	CHILD syndrome	308050	XLD	3
300275	Xq28	CK syndrome	300831	XLR	3
300276	_	_	_	_	_
300277	_	_	_	_	_
300278	Xp11.4	Night blindness, congenital stationary (complete), 1A, X-linked	310500	XLR	3
300279	_	_	_	_	_
300280	Xq26.3	?Uruguay faciocardiomusculoskeletal syndrome	300280	XLR	3
300281	_	_	_	_	_
300282	_	_	_	_	_
300283	_	_	_	_	_
300284	_	_	_	_	_
300285	_	_	_	_	_
300286	_	_	_	_	_
300287	_	_	_	_	_
300288	_	_	_	_	_
300289	_	_	_	_	_
300290	_	_	_	_	_
300291	Xq28	Ectodermal dysplasia and immunodeficiency 1	300291	_	3
300292	Xp11.23	Immunodysregulation, polyendocrinopathy, and enteropathy, X-linked	304790	XLR	3
300293	_	_	_	_	_
300294	Xp22.12	?Olmsted syndrome, X-linked	300918	XLR	3
300294	Xp22.12	IFAP syndrome with or without BRESHECK syndrome	308205	XLR	3
300294	Xp22.12	Keratosis follicularis spinulosa decalvans, X-linked	308800	XLR	3
300294	Xp22.12	Osteogenesis imperfecta, type XIX	301014	XLR	3
300295	_	_	_	_	_
300296	_	_	_	_	_
300297	_	_	_	_	_
300298	Xq24	Mental retardation, X-linked, syndromic 14	300676	XLR	3
300299	Xp11.23	Neutropenia, severe congenital, X-linked	300299	XLR	3
300300	Xq22.1	Agammaglobulinemia, X-linked 1	300755	XLR	3
300300	Xq22.1	Isolated growth hormone deficiency, type III, with agammaglobulinemia	307200	XLR	3
300301	Xq28	Ectodermal, dysplasia, anhidrotic, lymphedema and immunodeficiency	300301	_	3
300302	_	_	_	_	_
300303	_	_	_	_	_
300304	Xq24	Mental retardation, X-linked, syndromic 15 (Cabezas type)	300354	XLR	3
300305	_	_	_	_	_
300306	Xq24	{Obesity, susceptibility to, BMIQ11}	300306	_	2
300307	Xq21.1	?Abruzzo-Erickson syndrome	302905	XL	3
300307	Xq21.1	Cleft palate with ankyloglossia	303400	XL	3
300308	_	_	_	_	_
300309	_	_	_	_	_
300310	Xp22.12	?Immunodeficiency 61	300310	XLR	3
300311	Xq13.1	Spermatogenic failure, X-linked, 2	309120	XLR	3
300312	_	_	_	_	_
300313	_	_	_	_	_
300314	_	_	_	_	_
300315	_	_	_	_	_
300316	_	_	_	_	_
300317	_	_	_	_	_
300318	_	_	_	_	_
300319	_	_	_	_	_
300320	_	_	_	_	_
300321	Xq28	?FG syndrome 2	300321	XL	3
300322	Xq26.2-q26.3	Lesch-Nyhan syndrome	300322	XLR	3
300323	Xq26.2-q26.3	HPRT-related gout	300323	XLR	3
300324	Xq22.2-q26	Mental retardation, X-linked 53	300324	XLR	2
300325	_	_	_	_	_
300326	_	_	_	_	_
300327	_	_	_	_	_
300328	_	_	_	_	_
300329	_	_	_	_	_
300330	_	_	_	_	_
300331	Chr.X	Thrombocythemia, X-linked	300331	XLR	2
300332	_	_	_	_	_
300333	_	_	_	_	_
300334	_	_	_	_	_
300335	_	_	_	_	_
300336	Xq13.1	{Asperger syndrome susceptibility, X-linked 1}	300494	IC,Mu,XL	3
300336	Xq13.1	{Autism susceptibility, X-linked 1}	300425	XL	3
300337	_	_	_	_	_
300338	_	_	_	_	_
300339	_	_	_	_	_
300340	_	_	_	_	_
300341	_	_	_	_	_
300342	_	_	_	_	_
300343	_	_	_	_	_
300344	_	_	_	_	_
300345	Chr.X	Microphthalmia with coloboma 1	300345	_	2
300346	_	_	_	_	_
300347	_	_	_	_	_
300348	_	_	_	_	_
300349	_	_	_	_	_
300350	Xq23	Megalocornea 1, X-linked	309300	XLR	3
300351	Xp11	{Graves disease, susceptibility to, X-linked}	300351	_	2
300352	Xq28	Cerebral creatine deficiency syndrome 1	300352	XLR	3
300353	_	_	_	_	_
300354	Xq24	Mental retardation, X-linked, syndromic 15 (Cabezas type)	300354	XLR	3
300355	Xp22.2	Mental retardation, X-linked 73	300355	XLR	2
300356	Xq22.1	Mohr-Tranebjaerg syndrome	304700	XLR	3
300357	_	_	_	_	_
300358	_	_	_	_	_
300359	_	_	_	_	_
300360	_	_	_	_	_
300361	_	_	_	_	_
300362	_	_	_	_	_
300363	_	_	_	_	_
300364	_	_	_	_	_
300365	_	_	_	_	_
300366	_	_	_	_	_
300367	Xp11.23	Thrombocytopenia, X-linked, with or without dyserythropoietic anemia	300367	XLR	3
300368	Xp11.3	Intellectual developmental disorder, X-linked 108	301024	XLR	3
300369	_	_	_	_	_
300370	_	_	_	_	_
300371	Xq28	Adrenoleukodystrophy	300100	XLR	3
300371	Xq28	Adrenomyeloneuropathy, adult	300100	XLR	3
300372	Xq26	Mental retardation, X-linked 42	300372	_	2
300373	Xq11.2	Osteopathia striata with cranial sclerosis	300373	XLD	3
300374	Xp22.12	?Immunodeficiency 61	300310	XLR	3
300375	_	_	_	_	_
300376	Xp21.2-p21.1	Becker muscular dystrophy	300376	XLR	3
300377	Xp21.2-p21.1	Becker muscular dystrophy	300376	XLR	3
300377	Xp21.2-p21.1	Cardiomyopathy, dilated, 3B	302045	XL	3
300377	Xp21.2-p21.1	Duchenne muscular dystrophy	310200	XLR	3
300378	Xq24-q25	Radial ray deficiency	300378	_	2
300379	Xq13.2	Tonne-Kalscheuer syndrome	300978	XL	3
300380	_	_	_	_	_
300381	_	_	_	_	_
300382	Xp21.3	Epileptic encephalopathy, early infantile, 1	308350	XLR	3
300382	Xp21.3	Hydranencephaly with abnormal genitalia	300215	XL	3
300382	Xp21.3	Lissencephaly, X-linked 2	300215	XL	3
300382	Xp21.3	Mental retardation, X-linked 29 and others	300419	XLR	3
300382	Xp21.3	Partington syndrome	309510	XLR	3
300382	Xp21.3	Proud syndrome	300004	XL	3
300383	Xp11.23	Properdin deficiency, X-linked	312060	XLR	3
300384	Xq28	Emery-Dreifuss muscular dystrophy 1, X-linked	310300	XLR	3
300385	_	_	_	_	_
300386	Xq26.3	Immunodeficiency, X-linked, with hyper-IgM	308230	XLR	3
300387	Xq23	Mental retardation, X-linked 63	300387	XLD	3
300388	Xq27.2-q28	Polymicrogyria, bilateral perisylvian	300388	XLD	2
300389	_	_	_	_	_
300390	Xq21.2	Choroideremia	303100	XLD	3
300391	Xp22.2	Amelogenesis imperfecta, type 1E	301200	XLD	3
300392	Xp11.23	Neutropenia, severe congenital, X-linked	300299	XLR	3
300392	Xp11.23	Thrombocytopenia, X-linked	313900	XLR	3
300392	Xp11.23	Thrombocytopenia, X-linked, intermittent	313900	XLR	3
300392	Xp11.23	Wiskott-Aldrich syndrome	301000	XLR	3
300393	Xq26.3	Pituitary adenoma 2, GH-secreting	300943	XL	3
300394	Xq28	Barth syndrome	302060	XLR	3
300395	Xq25	Mental retardation, X-linked 12/35	300957	XLR	3
300396	_	_	_	_	_
300397	_	_	_	_	_
300398	Xq28	Deafness, dystonia, and cerebral hypomyelination	300475	XLR	3
300399	_	_	_	_	_
300400	Xq13.1	Severe combined immunodeficiency, X-linked	300400	XLR	3
300401	Xq22.2	Pelizaeus-Merzbacher disease	312080	XLR	3
300401	Xq22.2	Spastic paraplegia 2, X-linked	312920	XLR	3
300402	_	_	_	_	_
300403	Xp11.3	?Mitochondrial complex I deficiency, nuclear type 30	301021	XL	3
300403	Xp11.3	Linear skin defects with multiple congenital anomalies 3	300952	XLD	3
300404	_	_	_	_	_
300405	_	_	_	_	_
300406	Xp22.3	FG syndrome 3	300406	_	2
300407	_	_	_	_	_
300408	_	_	_	_	_
300409	_	_	_	_	_
300410	_	_	_	_	_
300411	_	_	_	_	_
300412	_	_	_	_	_
300413	_	_	_	_	_
300414	Xq26.2	Borjeson-Forssman-Lehmann syndrome	301900	XLR	3
300415	Xq28	Myotubular myopathy, X-linked	310400	XLR	3
300416	_	_	_	_	_
300417	_	_	_	_	_
300418	_	_	_	_	_
300419	Xp21.3	Mental retardation, X-linked 29 and others	300419	XLR	3
300420	_	_	_	_	_
300421	_	_	_	_	_
300422	_	_	_	_	_
300423	Xp11.4	Mental retardation, X-linked, syndromic, Hedera type	300423	XLR	3
300424	Xp22.2	?Retinitis pigmentosa 23	300424	XLR	3
300425	Xq13.1	{Autism susceptibility, X-linked 1}	300425	XL	3
300426	_	_	_	_	_
300427	Xp22.32-p22.31	Mental retardation, X-linked	300495	IC,Mu,XL	3
300427	Xp22.32-p22.31	{Asperger syndrome susceptibility, X-linked 2}	300497	XL	3
300427	Xp22.32-p22.31	{Autism susceptibility, X-linked 2}	300495	IC,Mu,XL	3
300428	Xp22.3	Mental retardation, X-linked 2	300428	XL	2
300429	Xq11.1	Epileptic encephalopathy, early infantile, 8	300607	XLR	3
300430	_	_	_	_	_
300431	_	_	_	_	_
300432	_	_	_	_	_
300433	Xp11.2-q12	Mental retardation, X-linked 81	300433	XLR	2
300434	Xp11.22	Stocco dos Santos X-linked mental retardation syndrome	300434	XL	3
300435	_	_	_	_	_
300436	Xq25-q26	Mental retardation, X-linked 46	300436	XLR	2
300437	_	_	_	_	_
300438	Xp11.22	HSD10 mitochondrial disease	300438	XLD	3
300439	_	_	_	_	_
300440	_	_	_	_	_
300441	_	_	_	_	_
300442	_	_	_	_	_
300443	_	_	_	_	_
300444	_	_	_	_	_
300445	_	_	_	_	_
300446	_	_	_	_	_
300447	_	_	_	_	_
300448	Xq21.1	Alpha-thalassemia myelodysplasia syndrome, somatic	300448	_	3
300449	_	_	_	_	_
300450	_	_	_	_	_
300451	Xq13.1	Ectodermal dysplasia 1, hypohidrotic, X-linked	305100	XLR	3
300451	Xq13.1	Tooth agenesis, selective, X-linked 1	313500	XLD	3
300452	_	_	_	_	_
300453	_	_	_	_	_
300454	Xq12-q21.3	Mental retardation, X-linked 77	300454	XLR	2
300455	Xp11.4	Retinitis pigmentosa, X-linked, and sinorespiratory infections, with or without deafness	300455	_	3
300456	_	_	_	_	_
300457	Xp22.2-p22.1	Cataract 40, X-linked	302200	XL	3
300457	Xp22.2-p22.1	Nance-Horan syndrome	302350	XLD	3
300458	_	_	_	_	_
300459	_	_	_	_	_
300460	Xq22.1	Epileptic encephalopathy, early infantile, 9	300088	XL	3
300461	Xp11.4	Ornithine transcarbamylase deficiency	311250	XLR	3
300462	_	_	_	_	_
300463	Xp11.23	Renpenning syndrome	309500	XLR	3
300464	Xq23-q26	{Coronary heart disease, susceptibility to, 3}	300464	_	2
300465	_	_	_	_	_
300466	_	_	_	_	_
300467	_	_	_	_	_
300468	_	_	_	_	_
300469	_	_	_	_	_
300470	Xp11.21	Bartter syndrome, type 5, antenatal, transient	300971	XLR	3
300471	Chr.X	Cubitus valgus with mental retardation and unusual facies	300471	XLR	2
300472	Xq13.1	Corpus callosum, agenesis of, with mental retardation, ocular coloboma and micrognathia	300472	XLR	3
300473	Xp21.2	46XY sex reversal 2, dosage-sensitive	300018	XL	3
300473	Xp21.2	Adrenal hypoplasia, congenital	300200	XLR	3
300474	Xp21.2	Glycerol kinase deficiency	307030	XLR	3
300475	Xq28	Deafness, dystonia, and cerebral hypomyelination	300475	XLR	3
300476	Xp11.23	Cone-rod dystrophy, X-linked, 3	300476	XLR	3
300477	_	_	_	_	_
300478	_	_	_	_	_
300479	_	_	_	_	_
300480	_	_	_	_	_
300481	Xp21.1-p11.4	Chronic granulomatous disease, X-linked	306400	XLR	3
300481	Xp21.1-p11.4	Immunodeficiency 34, mycobacteriosis, X-linked	300645	XLR	3
300482	_	_	_	_	_
300483	_	_	_	_	_
300484	Chr.X	Orofaciodigital syndrome VIII	300484	XLR	2
300485	Xp11.4	Microphthalmia, syndromic 2	300166	XLD	3
300486	Xq12	Mental retardation, X-linked, with cerebellar hypoplasia and distinctive facial appearance	300486	XLR	3
300487	_	_	_	_	_
300488	Xp21.3	{Menopause, natural, age at, QTL1}	300488	XLD	2
300489	Xq21.1	Spinal muscular atrophy, distal, X-linked 3	300489	XLR	3
300490	Xq25	Lymphoproliferative syndrome, X-linked, 1	308240	XLR	3
300491	Xp11.3-p11.2	Epilepsy, X-linked, with variable learning disabilities and behavior disorders	300491	XLR,XLD	3
300492	_	_	_	_	_
300493	_	_	_	_	_
300494	Xq13.1	{Asperger syndrome susceptibility, X-linked 1}	300494	IC,Mu,XL	3
300495	_	_	_	_	_
300496	Xq28	{Autism susceptibility, X-linked 3}	300496	XL	3
300497	Xp22.32-p22.31	{Asperger syndrome susceptibility, X-linked 2}	300497	XL	3
300498	Xp11.3-p11.21	Mental retardation,X-linked 45	300498	XL	2
300499	Xp11.23	Mental retardation, X-linked 9/44	309549	XLR	3
300500	Xp22.2	Ocular albinism, type I, Nettleship-Falls type	300500	XL	3
300501	_	_	_	_	_
300502	Xp22.12	Pyruvate dehydrogenase E1-alpha deficiency	312170	XLD	3
300503	_	_	_	_	_
300504	_	_	_	_	_
300505	Xp11.3-q22.3	Mental retardation, X-linked 84	300505	XLR	2
300506	_	_	_	_	_
300507	_	_	_	_	_
300508	_	_	_	_	_
300509	Xq27.3	{Dyslexia, susceptibility to, 9}	300509	_	2
300510	_	_	_	_	_
300511	Xq21.33	?Premature ovarian failure 2A	300511	XLD	3
300512	_	_	_	_	_
300513	_	_	_	_	_
300514	Xp22.2	Fanconi anemia, complementation group B	300514	XLR	3
300515	Xp22.2	Fanconi anemia, complementation group B	300514	XLR	3
300516	Xq27.1	?Hemolytic anemia, congenital, X-linked	301015	XLR	3
300517	_	_	_	_	_
300518	Xq24-q25	Mental retardation, X-linked 82	300518	XLR	2
300519	Chr.X	Mental retardation, X-linked, syndromic, Martin-Probst type	300519	XLR	2
300520	_	_	_	_	_
300521	Xq13.1	?Mental retardation, X-linked 100	300923	XLR	3
300522	Xp11.22	Mental retardation, X-linked 1/78	309530	XLD	3
300523	Xq13.2	Allan-Herndon-Dudley syndrome	300523	XL	3
300524	Xq13.3	Mental retardation, X-linked 98	300912	XLD	3
300525	_	_	_	_	_
300526	Xp11.23	Neurodegeneration with brain iron accumulation 5	300894	XLD	3
300527	_	_	_	_	_
300528	_	_	_	_	_
300529	_	_	_	_	_
300530	_	_	_	_	_
300531	_	_	_	_	_
300532	_	_	_	_	_
300533	_	_	_	_	_
300534	Xp11.22	Mental retardation, X-linked, syndromic, Claes-Jensen type	300534	XLR	3
300535	Xq26.1	Dent disease 2	300555	XLR	3
300535	Xq26.1	Lowe syndrome	309000	XLR	3
300536	Xq27	[Bone mineral density QTL 4]	300536	_	2
300537	_	_	_	_	_
300538	Xq28	Diabetes insipidus, nephrogenic	304800	XLR	3
300538	Xq28	Nephrogenic syndrome of inappropriate antidiuresis	300539	XLR	3
300539	Xq28	Nephrogenic syndrome of inappropriate antidiuresis	300539	XLR	3
300540	_	_	_	_	_
300541	_	_	_	_	_
300542	_	_	_	_	_
300543	_	_	_	_	_
300544	_	_	_	_	_
300545	Xq26.2	?Paganini-Miozzo syndrome	301025	XLR	3
300546	Xp11.22	Aarskog-Scott syndrome	305400	XLR	3
300546	Xp11.22	Mental retardation, X-linked syndromic 16	305400	XLR	3
300547	_	_	_	_	_
300548	_	_	_	_	_
300549	_	_	_	_	_
300550	Xp22.11	Hypophosphatemic rickets, X-linked dominant	307800	XLD	3
300551	_	_	_	_	_
300552	Xp22.2	Opitz GBBB syndrome, type I	300000	XLR	3
300553	Xq21.1	Mental retardation, X-linked 93	300659	XLR	3
300554	Xp11.23	Hypophosphatemic rickets	300554	XLR	3
300555	Xq26.1	Dent disease 2	300555	XLR	3
300556	Xp11.4	?Parkinsonism with spasticity, X-linked	300911	XLR	3
300556	Xp11.4	Mental retardation, X-linked, syndromic, Hedera type	300423	XLR	3
300557	Xq21-q25	{Parkinson disease 12}	300557	_	2
300558	Xq23	Mental retardation, X-linked 30/47	300558	XLR	3
300559	Xq13.1	Muscle glycogenosis	300559	XLR	3
300560	Xp11.22	Mental retardation syndrome, X-linked, Siderius type	300263	XLR	3
300561	_	_	_	_	_
300562	_	_	_	_	_
300563	_	_	_	_	_
300564	_	_	_	_	_
300565	_	_	_	_	_
300566	_	_	_	_	_
300567	_	_	_	_	_
300568	_	_	_	_	_
300569	_	_	_	_	_
300570	_	_	_	_	_
300571	_	_	_	_	_
300572	Xp22.13	Congenital bilateral absence of vas deferens, X-linked	300985	XL	3
300573	_	_	_	_	_
300574	_	_	_	_	_
300575	_	_	_	_	_
300576	Xq13.3	?Mental retardation, X-linked 91	300577	XLD	3
300577	Xq13.3	?Mental retardation, X-linked 91	300577	XLD	3
300578	Xp11.3	Chromosome Xp11.3 deletion syndrome	300578	XLR	4
300579	Xp11.22	Stocco dos Santos X-linked mental retardation syndrome	300434	XL	3
300580	Xq13.1-q22.1	Myopathy, congenital, with fiber-type disproportion, X-linked	300580	XLD	2
300581	Xq22.3	FG syndrome 5	300581	_	2
300582	_	_	_	_	_
300583	_	_	_	_	_
300584	Xq28	Immunodeficiency, isolated	300584	_	3
300585	_	_	_	_	_
300586	_	_	_	_	_
300587	_	_	_	_	_
300588	_	_	_	_	_
300589	Xp11.4	Nystagmus 5, congenital, X-linked	300589	XLD	2
300590	Xp11.22	Cornelia de Lange syndrome 2	300590	XLD	3
300591	Xq24-q25	{Stature QTL 6}	300591	_	2
300592	_	_	_	_	_
300593	_	_	_	_	_
300594	_	_	_	_	_
300595	_	_	_	_	_
300596	_	_	_	_	_
300597	_	_	_	_	_
300598	_	_	_	_	_
300599	_	_	_	_	_
300600	Xp11.23	Aland Island eye disease	300600	XL	3
300601	_	_	_	_	_
300602	_	_	_	_	_
300603	Xq21.1	?Premature ovarian failure 2B	300604	XLR	3
300604	Xq21.1	?Premature ovarian failure 2B	300604	XLR	3
300605	Xq28	Retinitis pigmentosa 34	300605	_	2
300606	_	_	_	_	_
300607	Xq11.1	Epileptic encephalopathy, early infantile, 8	300607	XLR	3
300608	_	_	_	_	_
300609	_	_	_	_	_
300610	Xq22.1	Mental retardation, X-linked, syndromic, Bain type	300986	XLD	3
300611	Xq24	Tn polyagglutination syndrome, somatic	300622	_	3
300612	_	_	_	_	_
300613	Xq23-q27.2	Myopia 13	300613	_	2
300614	Xq26.1	Deafness, X-linked 5	300614	XLR	3
300615	_	_	_	_	_
300616	_	_	_	_	_
300617	_	_	_	_	_
300618	_	_	_	_	_
300619	_	_	_	_	_
300620	_	_	_	_	_
300621	_	_	_	_	_
300622	Xq24	Tn polyagglutination syndrome, somatic	300622	_	3
300623	Xq27.3	Fragile X tremor/ataxia syndrome	300623	XLD	3
300624	Xq27.3	Fragile X syndrome	300624	XLD	3
300625	_	_	_	_	_
300626	_	_	_	_	_
300627	_	_	_	_	_
300628	Xq26.2	Nystagmus 1, congenital, X-linked	310700	XL	3
300628	Xq26.2	Nystagmus, infantile periodic alternating, X-linked	310700	XL	3
300629	Xp22.2	Mental retardation, X-linked syndromic 5	304340	XLR	3
300630	_	_	_	_	_
300631	_	_	_	_	_
300632	_	_	_	_	_
300633	Xq12	Hypospadias 1, X-linked	300633	XLR	3
300634	_	_	_	_	_
300635	Xq25	Lymphoproliferative syndrome, X-linked, 2	300635	XLR	3
300636	Xq28	Immunodeficiency 33	300636	XLR	3
300637	_	_	_	_	_
300638	_	_	_	_	_
300639	_	_	_	_	_
300640	Xq28	Invasive pneumococcal disease, recurrent isolated, 2	300640	_	3
300641	_	_	_	_	_
300642	Xq22.1	?Rolandic epilepsy, mental retardation, and speech dyspraxia	300643	_	3
300643	Xq22.1	?Rolandic epilepsy, mental retardation, and speech dyspraxia	300643	_	3
300644	Xq22.1	Fabry disease	301500	XL	3
300644	Xq22.1	Fabry disease, cardiac variant	301500	XL	3
300645	Xp21.1-p11.4	Immunodeficiency 34, mycobacteriosis, X-linked	300645	XLR	3
300646	Xq26.1	Mental retardation, X-linked syndromic, Raymond type	300799	_	3
300647	Xq11.2	Osteopathia striata with cranial sclerosis	300373	XLD	3
300648	_	_	_	_	_
300649	_	_	_	_	_
300650	Xp22.3	Ocular albinism with sensorineural deafness	300650	XL	2
300651	Xp11.23	Focal dermal hypoplasia	305600	XLD	3
300652	Xp11.3-q12	Angio serpiginosum	300652	XLD	2
300653	Xq21.1	Phosphoglycerate kinase 1 deficiency	300653	XLR	3
300654	_	_	_	_	_
300655	_	_	_	_	_
300656	_	_	_	_	_
300657	_	_	_	_	_
300658	Xp11.3	Exudative vitreoretinopathy 2, X-linked	305390	_	3
300658	Xp11.3	Norrie disease	310600	XLR	3
300659	Xq21.1	Mental retardation, X-linked 93	300659	XLR	3
300660	Xq25-q27	Leukoencephalopathy with metaphyseal chondrodysplasia	300660	XLR	2
300661	_	_	_	_	_
300662	_	_	_	_	_
300663	_	_	_	_	_
300664	_	_	_	_	_
300665	_	_	_	_	_
300666	_	_	_	_	_
300667	_	_	_	_	_
300668	_	_	_	_	_
300669	_	_	_	_	_
300670	_	_	_	_	_
300671	_	_	_	_	_
300672	Xp22.13	Epileptic encephalopathy, early infantile, 2	300672	XLD	3
300673	Xq28	Encephalopathy, neonatal severe	300673	XLR	3
300674	_	_	_	_	_
300675	_	_	_	_	_
300676	Xq24	Mental retardation, X-linked, syndromic 14	300676	XLR	3
300677	_	_	_	_	_
300678	_	_	_	_	_
300679	Xp21	Chromosome Xp21 deletion syndrome	300679	_	4
300680	_	_	_	_	_
300681	_	_	_	_	_
300682	_	_	_	_	_
300683	_	_	_	_	_
300684	_	_	_	_	_
300685	_	_	_	_	_
300686	_	_	_	_	_
300687	_	_	_	_	_
300688	_	_	_	_	_
300689	_	_	_	_	_
300690	_	_	_	_	_
300691	_	_	_	_	_
300692	_	_	_	_	_
300693	_	_	_	_	_
300694	_	_	_	_	_
300695	Xq26.3	Scapuloperoneal myopathy, X-linked dominant	300695	XLD	3
300696	_	_	_	_	_
300697	Xp11.22	Mental retardation, X-linked syndromic, Turner type	309590	XL	3
300698	_	_	_	_	_
300699	Xq25	Mental retardation, X-linked 94	300699	XLR	3
300700	Xq24-q26	Albinism-deafness syndrome	300700	XL	2
300701	_	_	_	_	_
300702	_	_	_	_	_
300703	Xq25-q27.1	Spinocerebellar ataxia, X-linked 5	300703	XLR	2
300704	Xp11.22	{Prostate cancer, hereditary, X-linked 2}	300704	_	2
300705	Xp11.22	Xp11.22 microduplication syndrome	300705	_	4
300706	_	_	_	_	_
300707	Xq28	STAR syndrome	300707	XLD	3
300708	Xq28	STAR syndrome	300707	XLD	3
300709	Xq12-q21.31	Mental retardation, X-linked, syndromic 9	300709	_	2
300710	Xq11-q12	Alopecia, androgenetic, 2	300710	_	2
300711	Xq23	Pyloric stenosis, infantile hypertrophic, 4	300711	_	2
300712	Xq26-q27	?Craniofacioskeletal syndrome	300712	XLR,XLD	2
300713	_	_	_	_	_
300714	_	_	_	_	_
300715	Xq21.1	Immunodeficiency, X-linked, with magnesium defect, Epstein-Barr virus infection and neoplasia	300853	_	3
300716	Chr.X	Mental retardation, X-linked 95	300716	XLD	2
300717	Xq26.3	Reducing body myopathy, X-linked 1a, severe, infantile or early childhood onset	300717	XLD	3
300718	Xq26.3	Reducing body myopathy, X-linked 1b, with late childhood or adult onset	300718	XL	3
300719	Chr.X	Deafness, cataract, retinitis pigmentosa, and sperm abnormalities	300719	XLR	2
300720	_	_	_	_	_
300721	_	_	_	_	_
300722	_	_	_	_	_
300723	_	_	_	_	_
300724	Xp22.12	Mental retardation, X-linked, syndromic, Houge type	301008	XL	3
300725	_	_	_	_	_
300726	_	_	_	_	_
300727	_	_	_	_	_
300728	_	_	_	_	_
300729	_	_	_	_	_
300730	_	_	_	_	_
300731	_	_	_	_	_
300732	_	_	_	_	_
300733	_	_	_	_	_
300734	_	_	_	_	_
300735	_	_	_	_	_
300736	_	_	_	_	_
300737	_	_	_	_	_
300738	_	_	_	_	_
300739	_	_	_	_	_
300740	_	_	_	_	_
300741	_	_	_	_	_
300742	_	_	_	_	_
300743	_	_	_	_	_
300744	_	_	_	_	_
300745	_	_	_	_	_
300746	Xq27.1	Hemophilia B	306900	XLR	3
300746	Xq27.1	Thrombophilia, X-linked, due to factor IX defect	300807	_	3
300746	Xq27.1	{Deep venous thrombosis, protection against}	300807	_	3
300746	Xq27.1	{Warfarin sensitivity}	122700	AD	3
300747	Xp22.31	Ichthyosis, X-linked	308100	XLR	3
300748	_	_	_	_	_
300749	Xp11.4	Mental retardation and microcephaly with pontine and cerebellar hypoplasia	300749	XLD	3
300750	Xq24-q25	Spastic paraplegia 34, X-linked	300750	XLR	2
300751	Xp11.21	Anemia, sideroblastic, 1	300751	XLR	3
300752	Xp11.21	Protoporphyria, erythropoietic, X-linked	300752	XL	3
300753	_	_	_	_	_
300754	_	_	_	_	_
300755	Xq22.1	Agammaglobulinemia, X-linked 1	300755	XLR	3
300756	Xq21.3	{Alzheimer disease 16}	300756	_	2
300757	Xp11.3	Retinitis pigmentosa 2	312600	XL	3
300758	Xq28	Hypospadias 2, X-linked	300758	XLR	3
300759	_	_	_	_	_
300760	_	_	_	_	_
300761	_	_	_	_	_
300762	_	_	_	_	_
300763	_	_	_	_	_
300764	_	_	_	_	_
300765	_	_	_	_	_
300766	_	_	_	_	_
300767	_	_	_	_	_
300768	_	_	_	_	_
300769	_	_	_	_	_
300770	Xp22.33	Surfactant metabolism dysfunction, pulmonary, 4	300770	_	3
300771	_	_	_	_	_
300772	_	_	_	_	_
300773	_	_	_	_	_
300774	Xq28	?Waisman syndrome	311510	XLR	3
300774	Xq28	Mental retardation, X-linked 72	300271	XLR	3
300775	_	_	_	_	_
300776	Xq23	?Congenital disorder of glycosylation, type Is	300884	XLD	3
300776	Xq23	Epileptic encephalopathy, early infantile, 36	300884	XLD	3
300777	Xq28	{Autism, susceptibility to, X-linked 6}	300872	XLR	3
300778	Xp22.3	Corneal dystrophy, Lisch epithelial	300778	XLD	2
300779	Xq25	Corneal dystrophy, endothelial, X-linked	300779	XLD	2
300780	_	_	_	_	_
300781	_	_	_	_	_
300782	_	_	_	_	_
300783	_	_	_	_	_
300784	_	_	_	_	_
300785	_	_	_	_	_
300786	_	_	_	_	_
300787	_	_	_	_	_
300788	_	_	_	_	_
300789	_	_	_	_	_
300790	_	_	_	_	_
300791	_	_	_	_	_
300792	_	_	_	_	_
300793	_	_	_	_	_
300794	_	_	_	_	_
300795	_	_	_	_	_
300796	_	_	_	_	_
300797	_	_	_	_	_
300798	Xp22.13	Glycogen storage disease, type IXa1	306000	XLR	3
300798	Xp22.13	Glycogen storage disease, type IXa2	306000	XLR	3
300799	Xq26.1	Mental retardation, X-linked syndromic, Raymond type	300799	_	3
300800	_	_	_	_	_
300801	Xp11.23-p11.22	Chromosome Xp11.23-p11.22 duplication syndrome	300801	XLD	4
300802	Xp11.23	Mental retardation, X-linked 96	300802	XLR	3
300803	Xq21.1	Mental retardation, X-linked 97	300803	XL	3
300804	Xp22.2	Joubert syndrome 10	300804	XLR	3
300805	_	_	_	_	_
300806	Xq28	Mental retardation, X-linked, FRAXE type	309548	XLR	3
300807	_	_	_	_	_
300808	Xp22.2	Nystagmus 6, congenital, X-linked	300814	_	3
300808	Xp22.2	Ocular albinism, type I, Nettleship-Falls type	300500	XL	3
300809	Xq28	{Systemic lupus erythematosus, susceptibility to, 15}	300809	_	2
300810	_	_	_	_	_
300811	_	_	_	_	_
300812	_	_	_	_	_
300813	_	_	_	_	_
300814	Xp22.2	Nystagmus 6, congenital, X-linked	300814	_	3
300815	Xq28	Chromosome Xq28 duplication syndrome	300815	_	4
300816	Xq26.1	Combined oxidative phosphorylation deficiency 6	300816	XLR	3
300817	_	_	_	_	_
300818	Xp22.2	Paroxysmal nocturnal hemoglobinuria, somatic	300818	_	3
300819	_	_	_	_	_
300820	_	_	_	_	_
300821	Xq28	Blue cone monochromacy	303700	XLR	3
300821	Xq28	Colorblindness, deutan	303800	XL	3
300822	Xq28	Blue cone monochromacy	303700	XLR	3
300822	Xq28	Colorblindness, protan	303900	XL	3
300823	Xq28	Mucopolysaccharidosis II	309900	XLR	3
300824	_	_	_	_	_
300825	_	_	_	_	_
300826	Xq25	Neurodevelopmental disorder, X-linked, with craniofacial abnormalities	301022	XL	3
300827	Xq21.1	Metacarpal 4-5 fusion	309630	XLR	3
300828	Xp22.11	{Autism, susceptibility to, X-linked 4}	300830	XLR	3
300829	_	_	_	_	_
300830	Xp22.11	{Autism, susceptibility to, X-linked 4}	300830	XLR	3
300831	Xq28	CK syndrome	300831	XLR	3
300832	_	_	_	_	_
300833	Xq26.3	46XX sex reversal 3	300833	XLD	4
300834	Xp11.4	Macular degeneration, X-linked atrophic	300834	XLR	3
300835	Xp11.23	Anemia, X-linked, with/without neutropenia and/or platelet abnormalities	300835	XLR	3
300836	Xp22.31	Hypogonadotropic hypogonadism 1 with or without anosmia (Kallmann syndrome 1)	308700	XLR	3
300837	_	_	_	_	_
300838	Xp22.2	Mental retardation, X-linked 104	300983	XL	3
300839	Xp22.13	Retinoschisis	312700	XLR	3
300840	_	_	_	_	_
300841	Xq28	Hemophilia A	306700	XLR	3
300842	Xp21.1	McLeod syndrome with or without chronic granulomatous disease	300842	XL	3
300843	Xq28	Bornholm eye disease	300843	XLR	2
300844	Xp22.12	Mental retardation, X-linked 19	300844	XLD	3
300845	Xq28	Moyamoya disease 4	300845	XLR	4
300846	_	_	_	_	_
300847	Xq28	{Autism, susceptibility to, X-linked 5}	300847	_	3
300848	Xp11.3	Mental retardation, X-linked 89	300848	XLD	2
300849	Xq28	Mental retardation, X-linked 41	300849	XLD	3
300850	Xq13.1	Mental retardation, X-linked 90	300850	XLR	3
300851	Xp11.3	Mental retardation, X-linked 92	300851	XLR	2
300852	Xq24	Mental retardation, X-linked 88	300852	XL	2
300853	Xq21.1	Immunodeficiency, X-linked, with magnesium defect, Epstein-Barr virus infection and neoplasia	300853	_	3
300854	Xp11.23	Renal cell carcinoma, papillary, 1	300854	_	3
300855	Xq28	Ogden syndrome	300855	XLR,XLD	3
300856	Xp11.22	{Hypospadias 4, X-linked, susceptibility to}	300856	_	2
300857	Xp11.21	Amyotrophic lateral sclerosis 15, with or without frontotemporal dementia	300857	XLD	3
300858	Xp21.1-p11.23	Mental retardation, X-linked, syndromic 17	300858	XLR	2
300859	Xp11.23	Ritscher-Schinzel syndrome 2	300963	XLR	3
300860	Xq24	Mental retardation, X-linked syndromic, Nascimento-type	300860	XLR	3
300861	Xq21.33-q23	Mental retardation, X-linked, syndromic, Chudley-Schwartz type	300861	XLR	2
300862	_	_	_	_	_
300863	Xp11.23	?Chondrodysplasia with platyspondyly, distinctive brachydactyly, hydrocephaly, and microphthalmia	300863	XLD	3
300864	Chr.X	Cerebral-cerebellar-coloboma syndrome, X-linked	300864	XLR	2
300865	_	_	_	_	_
300866	_	_	_	_	_
300867	Xp11.3	Kabuki syndrome 2	300867	XLD	3
300868	Xp22.2	Multiple congenital anomalies-hypotonia-seizures syndrome 2	300868	XLR	3
300869	Xq27.3-q28	Chromosome Xq27.3-q28 duplication syndrome	300869	XLR	4
300870	Xp22	Aneurysm, intracranial berry, 5	300870	_	2
300871	_	_	_	_	_
300872	Xq28	{Autism, susceptibility to, X-linked 6}	300872	XLR	3
300873	_	_	_	_	_
300874	_	_	_	_	_
300875	_	_	_	_	_
300876	_	_	_	_	_
300877	_	_	_	_	_
300878	_	_	_	_	_
300879	_	_	_	_	_
300880	_	_	_	_	_
300881	_	_	_	_	_
300882	Xq13.1	Cornelia de Lange syndrome 5	300882	XLD	3
300883	_	_	_	_	_
300884	_	_	_	_	_
300885	Xq21.1	Linear skin defects with multiple congenital anomalies 2	300887	XLD	3
300886	Xq28	?Mental retardation, X-linked, syndromic 32	300886	XLR	3
300887	Xq21.1	Linear skin defects with multiple congenital anomalies 2	300887	XLD	3
300888	Xq26.1	Hypothyroidism, central, and testicular enlargement	300888	XLR	3
300889	_	_	_	_	_
300890	_	_	_	_	_
300891	_	_	_	_	_
300892	_	_	_	_	_
300893	_	_	_	_	_
300894	Xp11.23	Neurodegeneration with brain iron accumulation 5	300894	XLD	3
300895	Xq13.1	Ohdo syndrome, X-linked	300895	XLR	3
300896	Xp11.23	Congenital disorder of glycosylation, type IIm	300896	SMo,XLD	3
300897	Xq11.2	Wieacker-Wolff syndrome	314580	XLR	3
300898	_	_	_	_	_
300899	_	_	_	_	_
300900	_	_	_	_	_
300901	_	_	_	_	_
300902	_	_	_	_	_
300903	_	_	_	_	_
300904	_	_	_	_	_
300905	Xp22.11	?Charcot-Marie-Tooth disease, X-linked dominant, 6	300905	XLD	3
300906	Xp22.11	?Charcot-Marie-Tooth disease, X-linked dominant, 6	300905	XLD	3
300907	_	_	_	_	_
300908	Xq28	Hemolytic anemia, G6PD deficient (favism)	300908	XLD	3
300909	Xq26.1	{Angioedema induced by ACE inhibitors, susceptibility to}	300909	_	3
300910	Xq23	Bone mineral density QTL18, osteoporosis	300910	XLD	3
300911	Xp11.4	?Parkinsonism with spasticity, X-linked	300911	XLR	3
300912	Xq13.3	Mental retardation, X-linked 98	300912	XLD	3
300913	Xq28	Myopathy, X-linked, with excessive autophagy	310440	XLR	3
300914	Xq22.3	?Deafness, X-linked 6	300914	XLR	3
300915	Xq28	?Microphthalmia, syndromic 13	300915	XL	3
300916	_	_	_	_	_
300917	_	_	_	_	_
300918	Xp22.12	?Olmsted syndrome, X-linked	300918	XLR	3
300919	Xp11.4	Mental retardation, X-linked 99	300919	XLR	3
300920	_	_	_	_	_
300921	_	_	_	_	_
300922	_	_	_	_	_
300923	Xq13.1	?Mental retardation, X-linked 100	300923	XLR	3
300924	_	_	_	_	_
300925	_	_	_	_	_
300926	_	_	_	_	_
300927	_	_	_	_	_
300928	Xq22.3	?Mental retardation, X-linked 101	300928	XLR	3
300929	_	_	_	_	_
300930	_	_	_	_	_
300931	_	_	_	_	_
300932	Xq22.3	[Thyroxine-binding globulin QTL]	300932	XL	3
300933	Xq22.3	Ciliary dyskinesia, primary, 36, X-linked	300991	XLR	3
300934	Xq28	Congenital disorder of glycosylation, type Iy	300934	XLR	3
300935	_	_	_	_	_
300936	_	_	_	_	_
300937	_	_	_	_	_
300938	_	_	_	_	_
300939	_	_	_	_	_
300940	_	_	_	_	_
300941	_	_	_	_	_
300942	Xq26.3	Chromosome Xq26.3 duplication syndrome	300942	XLD	4
300943	Xq26.3	Pituitary adenoma 2, GH-secreting	300943	XL	3
300944	_	_	_	_	_
300945	Xp11.22	?Diamond-Blackfan anemia 14 with mandibulofacial dysostosis	300946	XLR	3
300946	Xp11.22	?Diamond-Blackfan anemia 14 with mandibulofacial dysostosis	300946	XLR	3
300947	_	_	_	_	_
300948	_	_	_	_	_
300949	_	_	_	_	_
300950	_	_	_	_	_
300951	Xq24	?Trichothiodystrophy 5, nonphotosensitive	300953	XLD	3
300952	Xp11.3	Linear skin defects with multiple congenital anomalies 3	300952	XLD	3
300953	Xq24	?Trichothiodystrophy 5, nonphotosensitive	300953	XLD	3
300954	_	_	_	_	_
300955	_	_	_	_	_
300956	_	_	_	_	_
300957	Xq25	Mental retardation, X-linked 12/35	300957	XLR	3
300958	Xp11.4	Mental retardation, X-linked 102	300958	XLR,XLD	3
300959	_	_	_	_	_
300960	Xp11.23	MEND syndrome	300960	XLR	3
300961	_	_	_	_	_
300962	_	_	_	_	_
300963	Xp11.23	Ritscher-Schinzel syndrome 2	300963	XLR	3
300964	Xq12	Wilson-Turner syndrome	309585	XLR	3
300965	_	_	_	_	_
300966	Xq13.1	Mental retardation, X-linked, syndromic 33	300966	XLR	3
300967	Xq13.1	Mental retardation, X-linked, syndromic 34	300967	XL	3
300968	Xp11.4	Mental retardation, X-linked 99, syndromic, female-restricted	300968	XLD	3
300969	Xq22.1	?Deafness, X-linked 7	301018	XLR	3
300970	_	_	_	_	_
300971	Xp11.21	Bartter syndrome, type 5, antenatal, transient	300971	XLR	3
300972	Xq28	Immunodeficiency 47	300972	XLR	3
300973	_	_	_	_	_
300974	_	_	_	_	_
300975	Xp11.23	Mental retardation, X-linked 105	300984	XLR	3
300976	_	_	_	_	_
300977	_	_	_	_	_
300978	Xq13.2	Tonne-Kalscheuer syndrome	300978	XL	3
300979	Xq25	Xq25 duplication syndrome	300979	XL	4
300980	Xp22.11	Mental retardation, X-linked 103	300982	XLR	3
300981	_	_	_	_	_
300982	Xp22.11	Mental retardation, X-linked 103	300982	XLR	3
300983	Xp22.2	Mental retardation, X-linked 104	300983	XL	3
300984	Xp11.23	Mental retardation, X-linked 105	300984	XLR	3
300985	Xp22.13	Congenital bilateral absence of vas deferens, X-linked	300985	XL	3
300986	Xq22.1	Mental retardation, X-linked, syndromic, Bain type	300986	XLD	3
300987	_	_	_	_	_
300988	Xq12	Immunodeficiency 50	300988	XLR	3
300989	Xq28	Meester-Loeys syndrome	300989	XL	3
300990	Xq23	Midface hypoplasia, hearing impairment, elliptocytosis, and nephrocalcinosis	300990	XLR	3
300991	Xq22.3	Ciliary dyskinesia, primary, 36, X-linked	300991	XLR	3
300992	_	_	_	_	_
300993	_	_	_	_	_
300994	_	_	_	_	_
300995	_	_	_	_	_
300996	_	_	_	_	_
300997	Xq13.1	Mental retardation, X-linked 106	300997	XLR	3
300998	Xq28	Mental retardation, X-linked, syndromic, 35	300998	XLR	3
300999	_	_	_	_	_
301000	Xp11.23	Wiskott-Aldrich syndrome	301000	XLR	3
301001	_	_	_	_	_
301002	_	_	_	_	_
301003	_	_	_	_	_
301004	_	_	_	_	_
301005	_	_	_	_	_
301006	Xq28	Galloway-Mowat syndrome 2, X-linked	301006	XLR	3
301007	_	_	_	_	_
301008	Xp22.12	Mental retardation, X-linked, syndromic, Houge type	301008	XL	3
301009	_	_	_	_	_
301010	Xq13.1	Myopia 26, X-linked, female-limited	301010	XL	3
301011	_	_	_	_	_
301012	Xq24	?Mental retardation, X-linked 107	301013	XL	3
301013	Xq24	?Mental retardation, X-linked 107	301013	XL	3
301014	Xp22.12	Osteogenesis imperfecta, type XIX	301014	XLR	3
301015	Xq27.1	?Hemolytic anemia, congenital, X-linked	301015	XLR	3
301016	_	_	_	_	_
301017	_	_	_	_	_
301018	Xq22.1	?Deafness, X-linked 7	301018	XLR	3
301019	_	_	_	_	_
301020	Xq24	Mitochondrial complex I deficiency, nuclear type 12	301020	XLR	3
301021	Xp11.3	?Mitochondrial complex I deficiency, nuclear type 30	301021	XL	3
301022	Xq25	Neurodevelopmental disorder, X-linked, with craniofacial abnormalities	301022	XL	3
301023	_	_	_	_	_
301024	Xp11.3	Intellectual developmental disorder, X-linked 108	301024	XLR	3
301025	Xq26.2	?Paganini-Miozzo syndrome	301025	XLR	3
301026	Xq26.2	Keipert syndrome	301026	XLR	3
301027	_	_	_	_	_
301040	Xq21.1	Alpha-thalassemia/mental retardation syndrome	301040	XLD	3
301050	Xq22.3	Alport syndrome 1, X-linked	301050	XLD	3
301090	_	_	_	_	_
301100	_	_	_	_	_
301200	Xp22.2	Amelogenesis imperfecta, type 1E	301200	XLD	3
301201	Xq22-q28	?Amelogenesis imperfecta, type IE, X-linked 2	301201	XL	2
301220	Xp22.1-p21.3	Pigmentary disorder, reticulate, with systemic manifestations, X-linked	301220	XLR	3
301300	Xp11.21	Anemia, sideroblastic, 1	300751	XLR	3
301300	Xp11.21	Protoporphyria, erythropoietic, X-linked	300752	XL	3
301310	Xq13.3	Anemia, sideroblastic, with ataxia	301310	XLR	3
301410	_	_	_	_	_
301500	_	_	_	_	_
301590	Xq27-q28	?Microphthalmia, syndromic 4	301590	XLR	2
301700	_	_	_	_	_
301770	Xq13.1	Myopia 26, X-linked, female-limited	301010	XL	3
301780	_	_	_	_	_
301790	_	_	_	_	_
301800	_	_	_	_	_
301810	_	_	_	_	_
301815	_	_	_	_	_
301820	_	_	_	_	_
301830	Xp11.3	Spinal muscular atrophy, X-linked 2, infantile	301830	XLR	3
301835	Xq22.3	Arts syndrome	301835	XLR	3
301840	_	_	_	_	_
301845	Xq24-q27	Bazex syndrome	301845	XLD	2
301850	_	_	_	_	_
301870	Xq28	Meester-Loeys syndrome	300989	XL	3
301870	Xq28	Spondyloepimetaphyseal dysplasia, X-linked	300106	XLR	3
301880	_	_	_	_	_
301900	Xq26.2	Borjeson-Forssman-Lehmann syndrome	301900	XLR	3
301940	_	_	_	_	_
301950	_	_	_	_	_
302000	_	_	_	_	_
302020	_	_	_	_	_
302030	_	_	_	_	_
302045	Xp21.2-p21.1	Cardiomyopathy, dilated, 3B	302045	XL	3
302060	Xq28	Barth syndrome	302060	XLR	3
302200	Xp22.2-p22.1	Cataract 40, X-linked	302200	XL	3
302300	_	_	_	_	_
302350	Xp22.2-p22.1	Nance-Horan syndrome	302350	XLD	3
302380	_	_	_	_	_
302400	_	_	_	_	_
302500	Xq28	?Spinocerebellar ataxia, X-linked 1	302500	XLR	3
302600	_	_	_	_	_
302650	_	_	_	_	_
302700	_	_	_	_	_
302800	Xq13.1	Charcot-Marie-Tooth neuropathy, X-linked dominant, 1	302800	XLD	3
302801	Xp22.2	Charcot-Marie-Tooth neuropathy, X-linked recessive, 2	302801	XLR	2
302802	Xq26	Charcot-Marie-Tooth neuropathy, X-linked recessive, 3	302802	XLR	4
302803	_	_	_	_	_
302900	_	_	_	_	_
302905	Xq21.1	?Abruzzo-Erickson syndrome	302905	XL	3
302910	Xp22.2	Raynaud-Claes syndrome	300114	XLD	3
302920	_	_	_	_	_
302940	_	_	_	_	_
302950	Xp22.33	Chondrodysplasia punctata, X-linked recessive	302950	XLR	3
302960	Xp11.23	Chondrodysplasia punctata, X-linked dominant	302960	XLD	3
303100	Xq21.2	Choroideremia	303100	XLD	3
303110	Xq21	Choroideremia, deafness, and mental retardation	303110	XLR	4
303350	_	_	_	_	_
303400	Xq21.1	Cleft palate with ankyloglossia	303400	XL	3
303600	Xp22.12	Coffin-Lowry syndrome	303600	XLD	3
303630	Xq22.3	Alport syndrome 1, X-linked	301050	XLD	3
303631	Xq22.3	?Deafness, X-linked 6	300914	XLR	3
303650	_	_	_	_	_
303700	_	_	_	_	_
303800	Xq28	Colorblindness, deutan	303800	XL	3
303900	Xq28	Colorblindness, protan	303900	XL	3
304000	_	_	_	_	_
304020	Xp11.4	Cone-rod dystrophy, X-linked, 1	304020	XL	3
304030	_	_	_	_	_
304040	Xq13.1	Charcot-Marie-Tooth neuropathy, X-linked dominant, 1	302800	XLD	3
304050	Xp22	Aicardi syndrome	304050	XLD	2
304100	Xq28	Corpus callosum, partial agenesis of	304100	XLR	3
304110	Xq13.1	Craniofrontonasal dysplasia	304110	XLD	3
304120	Xq28	Otopalatodigital syndrome, type II	304120	XLD	3
304150	Xq21.1	Occipital horn syndrome	304150	XLR	3
304200	_	_	_	_	_
304300	_	_	_	_	_
304340	Xp22.2	Mental retardation, X-linked syndromic 5	304340	XLR	3
304350	_	_	_	_	_
304400	Xq21.1	Deafness, X-linked 2	304400	XLR	3
304500	Xq22.3	Deafness, X-linked 1	304500	XL	3
304590	_	_	_	_	_
304600	_	_	_	_	_
304700	Xq22.1	Mohr-Tranebjaerg syndrome	304700	XLR	3
304730	Xq24-qter	Dermoids of cornea	304730	XL	2
304750	_	_	_	_	_
304790	Xp11.23	Immunodysregulation, polyendocrinopathy, and enteropathy, X-linked	304790	XLR	3
304800	Xq28	Diabetes insipidus, nephrogenic	304800	XLR	3
304900	_	_	_	_	_
304930	_	_	_	_	_
304950	_	_	_	_	_
304990	_	_	_	_	_
305000	Xq28	Dyskeratosis congenita, X-linked	305000	XLR	3
305050	_	_	_	_	_
305100	Xq13.1	Ectodermal dysplasia 1, hypohidrotic, X-linked	305100	XLR	3
305200	_	_	_	_	_
305300	_	_	_	_	_
305350	_	_	_	_	_
305360	_	_	_	_	_
305370	_	_	_	_	_
305371	Xp11.23	Anemia, X-linked, with/without neutropenia and/or platelet abnormalities	300835	XLR	3
305371	Xp11.23	Leukemia, megakaryoblastic, with or without Down syndrome, somatic	190685	_	3
305371	Xp11.23	Thrombocytopenia with beta-thalassemia, X-linked	314050	XLR	3
305371	Xp11.23	Thrombocytopenia, X-linked, with or without dyserythropoietic anemia	300367	XLR	3
305390	Xp11.3	Exudative vitreoretinopathy 2, X-linked	305390	_	3
305400	_	_	_	_	_
305423	_	_	_	_	_
305424	_	_	_	_	_
305425	_	_	_	_	_
305435	Xp22.2	Fetal hemoglobin quantitative trait locus 3	305435	XL	2
305450	Xq13.1	Opitz-Kaveggia syndrome	305450	XLR	3
305550	_	_	_	_	_
305600	Xp11.23	Focal dermal hypoplasia	305600	XLD	3
305620	Xq28	Frontometaphyseal dysplasia 1	305620	XLR	3
305645	_	_	_	_	_
305650	_	_	_	_	_
305660	_	_	_	_	_
305670	_	_	_	_	_
305690	_	_	_	_	_
305700	_	_	_	_	_
305800	_	_	_	_	_
305900	Xq28	Hemolytic anemia, G6PD deficient (favism)	300908	XLD	3
305900	Xq28	{Resistance to malaria due to G6PD deficiency}	611162	_	3
305910	_	_	_	_	_
305915	Xq25	Mental retardation, X-linked 94	300699	XLR	3
305920	_	_	_	_	_
305980	_	_	_	_	_
305990	_	_	_	_	_
306000	_	_	_	_	_
306100	_	_	_	_	_
306190	_	_	_	_	_
306250	Xp22.33	Surfactant metabolism dysfunction, pulmonary, 4	300770	_	3
306300	_	_	_	_	_
306400	Xp21.1-p11.4	Chronic granulomatous disease, X-linked	306400	XLR	3
306480	_	_	_	_	_
306500	_	_	_	_	_
306600	_	_	_	_	_
306700	Xq28	Hemophilia A	306700	XLR	3
306800	_	_	_	_	_
306900	Xq27.1	Hemophilia B	306900	XLR	3
306930	_	_	_	_	_
306950	_	_	_	_	_
306955	_	_	_	_	_
306960	_	_	_	_	_
306970	_	_	_	_	_
306980	_	_	_	_	_
306990	_	_	_	_	_
306995	Xq28	[?Homosexuality, male]	306995	XL	2
307000	_	_	_	_	_
307010	_	_	_	_	_
307030	Xp21.2	Glycerol kinase deficiency	307030	XLR	3
307150	Xq27.1	Hypertrichosis, congenital generalized	307150	XLD	4
307200	Xq22.1	Isolated growth hormone deficiency, type III, with agammaglobulinemia	307200	XLR	3
307300	_	_	_	_	_
307500	_	_	_	_	_
307600	_	_	_	_	_
307700	Xq27.1	Hypoparathyroidism, X-linked	307700	XL	4
307800	Xp22.11	Hypophosphatemic rickets, X-linked dominant	307800	XLD	3
307810	_	_	_	_	_
307830	_	_	_	_	_
308000	Xq26.2-q26.3	HPRT-related gout	300323	XLR	3
308000	Xq26.2-q26.3	Lesch-Nyhan syndrome	300322	XLR	3
308050	Xq28	CHILD syndrome	308050	XLD	3
308100	Xp22.31	Ichthyosis, X-linked	308100	XLR	3
308200	_	_	_	_	_
308205	Xp22.12	IFAP syndrome with or without BRESHECK syndrome	308205	XLR	3
308210	_	_	_	_	_
308220	_	_	_	_	_
308230	Xq26.3	Immunodeficiency, X-linked, with hyper-IgM	308230	XLR	3
308240	Xq25	Lymphoproliferative syndrome, X-linked, 1	308240	XLR	3
308250	_	_	_	_	_
308280	_	_	_	_	_
308290	_	_	_	_	_
308300	Xq28	Incontinentia pigmenti	308300	XLD	3
308310	_	_	_	_	_
308350	Xp21.3	Epileptic encephalopathy, early infantile, 1	308350	XLR	3
308370	_	_	_	_	_
308380	Xq13.1	Combined immunodeficiency, X-linked, moderate	312863	XLR	3
308380	Xq13.1	Severe combined immunodeficiency, X-linked	300400	XLR	3
308385	_	_	_	_	_
308400	_	_	_	_	_
308500	_	_	_	_	_
308600	_	_	_	_	_
308700	Xp22.31	Hypogonadotropic hypogonadism 1 with or without anosmia (Kallmann syndrome 1)	308700	XLR	3
308750	_	_	_	_	_
308800	Xp22.12	Keratosis follicularis spinulosa decalvans, X-linked	308800	XLR	3
308830	_	_	_	_	_
308840	Xq28	Corpus callosum, partial agenesis of	304100	XLR	3
308840	Xq28	CRASH syndrome	303350	XLR	3
308840	Xq28	Hydrocephalus due to aqueductal stenosis	307000	XLR	3
308840	Xq28	Hydrocephalus with congenital idiopathic intestinal pseudoobstruction	307000	XLR	3
308840	Xq28	Hydrocephalus with Hirschsprung disease	307000	XLR	3
308840	Xq28	MASA syndrome	303350	XLR	3
308850	_	_	_	_	_
308905	Xp11	{Leber optic atrophy, susceptibility to}	308905	XL	2
308930	_	_	_	_	_
308940	_	_	_	_	_
308950	_	_	_	_	_
308960	_	_	_	_	_
308980	_	_	_	_	_
308990	Xp11.23	Proteinuria, low molecular weight, with hypercalciuric nephrocalcinosis	308990	XLR	3
309000	Xq26.1	Lowe syndrome	309000	XLR	3
309050	_	_	_	_	_
309060	Xq24	Danon disease	300257	XLD	3
309100	_	_	_	_	_
309120	Xq13.1	Spermatogenic failure, X-linked, 2	309120	XLR	3
309150	_	_	_	_	_
309200	Xq28	{?Major affective disorder 2}	309200	XLD	2
309300	Xq23	Megalocornea 1, X-linked	309300	XLR	3
309350	Xq28	Melnick-Needles syndrome	309350	XLD	3
309400	Xq21.1	Menkes disease	309400	XLR	3
309470	_	_	_	_	_
309480	_	_	_	_	_
309490	_	_	_	_	_
309500	Xp11.23	Renpenning syndrome	309500	XLR	3
309510	Xp21.3	Partington syndrome	309510	XLR	3
309520	Xq13.1	Lujan-Fryns syndrome	309520	XLR	3
309530	Xp11.22	Mental retardation, X-linked 1/78	309530	XLD	3
309540	_	_	_	_	_
309541	Xq28	Mental retardation, X-linked 3 (methylmalonic acidemia and homocysteinemia, cblX type )	309541	XLR	3
309545	Xp11	?Mental retardation, X-linked, syndromic 12	309545	XL	2
309548	Xq28	Mental retardation, X-linked, FRAXE type	309548	XLR	3
309549	Xp11.23	Mental retardation, X-linked 9/44	309549	XLR	3
309550	Xq27.3	Fragile X syndrome	300624	XLD	3
309550	Xq27.3	Fragile X tremor/ataxia syndrome	300623	XLD	3
309550	Xq27.3	Premature ovarian failure 1	311360	XL	3
309555	Xq26	Gustavson syndrome	309555	XL	2
309560	_	_	_	_	_
309580	Xq21.1	Mental retardation-hypotonic facies syndrome, X-linked	309580	XLR	3
309583	Xp22.11	Mental retardation, X-linked, Snyder-Robinson type	309583	XLR	3
309585	Xq12	Wilson-Turner syndrome	309585	XLR	3
309590	Xp11.22	Mental retardation, X-linked syndromic, Turner type	309590	XL	3
309600	_	_	_	_	_
309605	_	_	_	_	_
309610	Xp11-q21	Prieto syndrome	309610	XLR	2
309620	Xq28	Mental retardation-skeletal dysplasia	309620	XL	2
309630	Xq21.1	Metacarpal 4-5 fusion	309630	XLR	3
309640	_	_	_	_	_
309645	_	_	_	_	_
309660	_	_	_	_	_
309700	_	_	_	_	_
309800	Xq28	?Microphthalmia, syndromic 1	309800	XL	3
309801	Xp22.2	Linear skin defects with multiple congenital anomalies 1	309801	XLD	3
309840	_	_	_	_	_
309845	Xq12	Immunodeficiency 50	300988	XLR	3
309850	Xp11.3	Brunner syndrome	300615	XLR	3
309850	Xp11.3	{Antisocial behavior}	300615	XLR	3
309860	_	_	_	_	_
309900	Xq28	Mucopolysaccharidosis II	309900	XLR	3
309930	_	_	_	_	_
309950	_	_	_	_	_
310000	_	_	_	_	_
310095	_	_	_	_	_
310200	Xp21.2-p21.1	Duchenne muscular dystrophy	310200	XLR	3
310300	Xq28	Emery-Dreifuss muscular dystrophy 1, X-linked	310300	XLR	3
310305	_	_	_	_	_
310310	_	_	_	_	_
310350	_	_	_	_	_
310370	_	_	_	_	_
310400	Xq28	Myotubular myopathy, X-linked	310400	XLR	3
310440	Xq28	Myopathy, X-linked, with excessive autophagy	310440	XLR	3
310450	_	_	_	_	_
310460	Xq28	Myopia-1	310460	XLR	2
310465	_	_	_	_	_
310468	Xp11.23	Nephrolithiasis, type I	310468	XLR	3
310470	_	_	_	_	_
310490	Xq26.1	Cowchock syndrome	310490	XLR	3
310500	Xp11.4	Night blindness, congenital stationary (complete), 1A, X-linked	310500	XLR	3
310600	Xp11.3	Norrie disease	310600	XLR	3
310650	_	_	_	_	_
310700	_	_	_	_	_
310800	_	_	_	_	_
310900	_	_	_	_	_
310980	_	_	_	_	_
310990	_	_	_	_	_
311000	_	_	_	_	_
311010	_	_	_	_	_
311020	_	_	_	_	_
311030	_	_	_	_	_
311040	_	_	_	_	_
311050	Xp11.4-p11.21	Optic atrophy 2, X-linked	311050	XL	2
311070	Xq22.3	Charcot-Marie-Tooth disease, X-linked recessive, 5	311070	XLR	3
311100	_	_	_	_	_
311150	_	_	_	_	_
311200	Xp22.2	Orofaciodigital syndrome I	311200	XLD	3
311240	_	_	_	_	_
311241	_	_	_	_	_
311250	Xp11.4	Ornithine transcarbamylase deficiency	311250	XLR	3
311280	_	_	_	_	_
311300	Xq28	Otopalatodigital syndrome, type I	311300	XLD	3
311350	_	_	_	_	_
311360	Xq27.3	Premature ovarian failure 1	311360	XL	3
311400	_	_	_	_	_
311450	_	_	_	_	_
311510	Xq28	?Waisman syndrome	311510	XLR	3
311550	_	_	_	_	_
311601	_	_	_	_	_
311700	_	_	_	_	_
311750	_	_	_	_	_
311770	Xp22.2	Multiple congenital anomalies-hypotonia-seizures syndrome 2	300868	XLR	3
311770	Xp22.2	Paroxysmal nocturnal hemoglobinuria, somatic	300818	_	3
311790	_	_	_	_	_
311800	Xq21.1	Phosphoglycerate kinase 1 deficiency	300653	XLR	3
311810	_	_	_	_	_
311850	Xq22.3	Arts syndrome	301835	XLR	3
311850	Xq22.3	Charcot-Marie-Tooth disease, X-linked recessive, 5	311070	XLR	3
311850	Xq22.3	Deafness, X-linked 1	304500	XL	3
311850	Xq22.3	Gout, PRPS-related	300661	XLR	3
311850	Xq22.3	Phosphoribosylpyrophosphate synthetase superactivity	300661	XLR	3
311860	_	_	_	_	_
311870	Xq13.1	Muscle glycogenosis	300559	XLR	3
311895	_	_	_	_	_
311900	Xp11.3	TARP syndrome	311900	XLR	3
312000	Xq27.1	Panhypopituitarism, X-linked	312000	XL	3
312030	_	_	_	_	_
312040	Xp22.1-p21.3	Pigmentary disorder, reticulate, with systemic manifestations, X-linked	301220	XLR	3
312060	Xp11.23	Properdin deficiency, X-linked	312060	XLR	3
312070	_	_	_	_	_
312080	Xq22.2	Pelizaeus-Merzbacher disease	312080	XLR	3
312090	_	_	_	_	_
312095	_	_	_	_	_
312100	_	_	_	_	_
312150	_	_	_	_	_
312170	Xp22.12	Pyruvate dehydrogenase E1-alpha deficiency	312170	XLD	3
312173	Xq28	Mental retardation, X-linked, syndromic, 35	300998	XLR	3
312173	Xq28	{Autism, susceptibility to, X-linked 5}	300847	_	3
312180	Xq24	Mental retardation, X-linked syndromic, Nascimento-type	300860	XLR	3
312190	_	_	_	_	_
312200	_	_	_	_	_
312210	_	_	_	_	_
312300	Xq12	Androgen insensitivity, partial, with or without breast cancer	312300	XLR	3
312390	_	_	_	_	_
312400	_	_	_	_	_
312420	_	_	_	_	_
312450	_	_	_	_	_
312500	_	_	_	_	_
312530	_	_	_	_	_
312550	_	_	_	_	_
312600	Xp11.3	Retinitis pigmentosa 2	312600	XL	3
312610	Xp11.4	Cone-rod dystrophy, X-linked, 1	304020	XL	3
312610	Xp11.4	Macular degeneration, X-linked atrophic	300834	XLR	3
312610	Xp11.4	Retinitis pigmentosa 3	300029	_	3
312610	Xp11.4	Retinitis pigmentosa, X-linked, and sinorespiratory infections, with or without deafness	300455	_	3
312612	Xp21.3-p21.2	?Retinitis pigmentosa, X-linked recessive, 6	312612	XL	2
312700	Xp22.13	Retinoschisis	312700	XLR	3
312750	_	_	_	_	_
312760	_	_	_	_	_
312780	_	_	_	_	_
312800	_	_	_	_	_
312820	Xp11.23	?Sarcoma, synovial	300813	_	3
312830	_	_	_	_	_
312840	_	_	_	_	_
312860	_	_	_	_	_
312861	_	_	_	_	_
312863	Xq13.1	Combined immunodeficiency, X-linked, moderate	312863	XLR	3
312865	Xp22.33	Langer mesomelic dysplasia	249700	_	3
312865	Xp22.33	Leri-Weill dyschondrosteosis	127300	_	3
312865	Xp22.33	Short stature, idiopathic familial	300582	_	3
312870	Xq26.2	Simpson-Golabi-Behmel syndrome, type 1	312870	XLR	3
312890	_	_	_	_	_
312900	_	_	_	_	_
312910	_	_	_	_	_
312920	Xq22.2	Spastic paraplegia 2, X-linked	312920	XLR	3
313000	Xp22.33	Turner syndrome-associated neurocognitive phenotype	313000	?XLR	2
313000	Xp22.33	[Visuospatial/perceptual abilities]	313000	?XLR	2
313020	_	_	_	_	_
313100	_	_	_	_	_
313200	Xq12	Spinal and bulbar muscular atrophy of Kennedy	313200	XLR	3
313350	Xq26	Split hand/foot malformation 2	313350	XL	2
313400	Xp22.2	Spondyloepiphyseal dysplasia tarda	313400	XLR	3
313420	_	_	_	_	_
313430	Xq27.1	Mental retardation, X-linked, with isolated growth hormone deficiency	300123	_	3
313430	Xq27.1	Panhypopituitarism, X-linked	312000	XL	3
313440	Xp11.3-p11.2	Epilepsy, X-linked, with variable learning disabilities and behavior disorders	300491	XLR,XLD	3
313450	_	_	_	_	_
313460	_	_	_	_	_
313470	_	_	_	_	_
313475	Xp11.23	Mental retardation, X-linked 96	300802	XLR	3
313480	_	_	_	_	_
313490	_	_	_	_	_
313500	Xq13.1	Tooth agenesis, selective, X-linked 1	313500	XLD	3
313550	_	_	_	_	_
313650	Xq13.1	Dystonia-Parkinsonism, X-linked	314250	XLR	3
313650	Xq13.1	Mental retardation, X-linked, syndromic 33	300966	XLR	3
313680	_	_	_	_	_
313700	Xq12	Androgen insensitivity	300068	XLR	3
313700	Xq12	Androgen insensitivity, partial, with or without breast cancer	312300	XLR	3
313700	Xq12	Hypospadias 1, X-linked	300633	XLR	3
313700	Xq12	Spinal and bulbar muscular atrophy of Kennedy	313200	XLR	3
313700	Xq12	{Prostate cancer, susceptibility to}	176807	AD,SMu	3
313850	Xq25-q26.1	Thoracoabdominal syndrome	313850	XL	2
313900	_	_	_	_	_
314000	_	_	_	_	_
314050	Xp11.23	Thrombocytopenia with beta-thalassemia, X-linked	314050	XLR	3
314100	_	_	_	_	_
314200	Xq22.3	[Thyroxine-binding globulin QTL]	300932	XL	3
314240	_	_	_	_	_
314250	Xq13.1	Dystonia-Parkinsonism, X-linked	314250	XLR	3
314300	Xq28	Goeminne TKCR syndrome	314300	XL	2
314310	Xp11.23	Renal cell carcinoma, papillary, 1	300854	_	3
314320	_	_	_	_	_
314350	_	_	_	_	_
314360	_	_	_	_	_
314370	Xp11.3	Spinal muscular atrophy, X-linked 2, infantile	301830	XLR	3
314375	Xp11.23	Congenital disorder of glycosylation, type IIm	300896	SMo,XLD	3
314380	_	_	_	_	_
314390	Xq26.3	VACTERL association, X-linked	314390	XLR	3
314400	Xq28	Cardiac valvular dysplasia, X-linked	314400	XLR	3
314500	_	_	_	_	_
314550	_	_	_	_	_
314555	_	_	_	_	_
314560	_	_	_	_	_
314570	_	_	_	_	_
314580	Xq11.2	Wieacker-Wolff syndrome	314580	XLR	3
314600	_	_	_	_	_
314670	Xq13.2	X-inactivation, familial skewed	300087	_	3
314690	Xp11.22	Mental retardation, X-linked, syndromic, Claes-Jensen type	300534	XLR	3
314700	Xpter-p22.32	[Blood group, XG system]	_	_	3
314705	_	_	_	_	_
314800	_	_	_	_	_
314850	Xp21.1	McLeod syndrome with or without chronic granulomatous disease	300842	XL	3
314900	_	_	_	_	_
314920	_	_	_	_	_
314940	_	_	_	_	_
314960	_	_	_	_	_
314980	_	_	_	_	_
314990	Xq21.1	Mental retardation, X-linked 97	300803	XL	3
314993	_	_	_	_	_
314995	_	_	_	_	_
314997	_	_	_	_	_
314998	_	_	_	_	_
315000	_	_	_	_	_
400000	_	_	_	_	_
400001	_	_	_	_	_
400002	_	_	_	_	_
400003	Yq11.223	?Sertoli-cell-only syndrome	_	_	1
400004	Chr.Y	Retinitis pigmentosa, Y-linked	400004	YL	2
400005	Yq11.221	Spermatogenic failure, Y-linked, 2	415000	YL	3
400006	_	_	_	_	_
400007	_	_	_	_	_
400008	_	_	_	_	_
400009	_	_	_	_	_
400010	_	_	_	_	_
400011	_	_	_	_	_
400012	_	_	_	_	_
400013	_	_	_	_	_
400014	_	_	_	_	_
400015	_	_	_	_	_
400016	_	_	_	_	_
400017	_	_	_	_	_
400018	_	_	_	_	_
400019	_	_	_	_	_
400020	Yp11.2	Langer mesomelic dysplasia	249700	_	3
400020	Yp11.2	Leri-Weill dyschondrosteosis	127300	_	3
400020	Yp11.2	Short stature, idiopathic familial	300582	_	3
400021	_	_	_	_	_
400022	_	_	_	_	_
400023	_	_	_	_	_
400024	_	_	_	_	_
400025	_	_	_	_	_
400026	_	_	_	_	_
400027	_	_	_	_	_
400028	_	_	_	_	_
400029	_	_	_	_	_
400030	_	_	_	_	_
400031	_	_	_	_	_
400032	_	_	_	_	_
400033	Yp11.2	?Deafness, Y-linked 2	400047	YL	3
400034	_	_	_	_	_
400035	_	_	_	_	_
400036	_	_	_	_	_
400037	_	_	_	_	_
400038	_	_	_	_	_
400039	_	_	_	_	_
400040	_	_	_	_	_
400041	_	_	_	_	_
400042	Yq11	Spermatogenic failure, Y-linked, 1	400042	_	4
400043	Chr.Y	Deafness, Y-linked 1	400043	YL	2
400044	Yp11.2	46XY sex reversal 1	400044	YL	3
400045	Yp11.2	46XX sex reversal 1	400045	XLD	4
400046	_	_	_	_	_
400047	Yp11.2	?Deafness, Y-linked 2	400047	YL	3
402500	_	_	_	_	_
403000	_	_	_	_	_
410000	_	_	_	_	_
415000	Yq11.221	Spermatogenic failure, Y-linked, 2	415000	YL	3
424000	_	_	_	_	_
424500	_	_	_	_	_
425000	_	_	_	_	_
425500	Yq	?Hairy ears, Y-linked	425500	YL	2
426000	_	_	_	_	_
430000	_	_	_	_	_
450000	_	_	_	_	_
465000	_	_	_	_	_
470000	_	_	_	_	_
475000	_	_	_	_	_
480000	Yp11.2	46XX sex reversal 1	400045	XLD	4
480000	Yp11.2	46XY sex reversal 1	400044	YL	3
480100	_	_	_	_	_
488000	_	_	_	_	_
489000	_	_	_	_	_
489500	_	_	_	_	_
490000	_	_	_	_	_
500000	_	_	_	_	_
500001	_	_	_	_	_
500002	_	_	_	_	_
500003	_	_	_	_	_
500004	_	_	_	_	_
500005	_	_	_	_	_
500006	_	_	_	_	_
500007	_	_	_	_	_
500008	_	_	_	_	_
500009	_	_	_	_	_
500010	_	_	_	_	_
500011	_	_	_	_	_
500014	_	_	_	_	_
500015	_	_	_	_	_
502000	_	_	_	_	_
502500	_	_	_	_	_
510000	_	_	_	_	_
515000	_	_	_	_	_
516000	_	_	_	_	_
516001	_	_	_	_	_
516002	_	_	_	_	_
516003	_	_	_	_	_
516004	_	_	_	_	_
516005	_	_	_	_	_
516006	_	_	_	_	_
516020	_	_	_	_	_
516030	_	_	_	_	_
516040	_	_	_	_	_
516050	_	_	_	_	_
516060	_	_	_	_	_
516070	_	_	_	_	_
520000	_	_	_	_	_
520100	_	_	_	_	_
530000	_	_	_	_	_
535000	_	_	_	_	_
540000	_	_	_	_	_
545000	_	_	_	_	_
550000	_	_	_	_	_
550500	_	_	_	_	_
550900	_	_	_	_	_
551000	_	_	_	_	_
551200	_	_	_	_	_
551500	_	_	_	_	_
553000	_	_	_	_	_
555000	_	_	_	_	_
556500	_	_	_	_	_
557000	_	_	_	_	_
560000	_	_	_	_	_
561000	_	_	_	_	_
561010	_	_	_	_	_
580000	22q13.31	{Deafness, mitochondrial, modifier of}	580000	Mi	3
590000	_	_	_	_	_
590005	_	_	_	_	_
590010	_	_	_	_	_
590015	_	_	_	_	_
590020	_	_	_	_	_
590025	_	_	_	_	_
590030	_	_	_	_	_
590035	_	_	_	_	_
590040	_	_	_	_	_
590045	_	_	_	_	_
590050	_	_	_	_	_
590055	_	_	_	_	_
590060	_	_	_	_	_
590065	_	_	_	_	_
590070	_	_	_	_	_
590075	_	_	_	_	_
590080	_	_	_	_	_
590085	_	_	_	_	_
590090	_	_	_	_	_
590095	_	_	_	_	_
590100	_	_	_	_	_
590105	_	_	_	_	_
598500	_	_	_	_	_
600000	_	_	_	_	_
600001	18q11.2	Pancreatic agenesis and congenital heart defects	600001	AD	3
600002	3p21.31	Eiken syndrome	600002	AR	3
600003	10p12.33-p12.31	Brugada syndrome 4	611876	_	3
600004	_	_	_	_	_
600005	16p13.13	Bare lymphocyte syndrome, type II, complementation group A	209920	AR	3
600005	16p13.13	{Rheumatoid arthritis, susceptibility to}	180300	_	3
600006	_	_	_	_	_
600007	_	_	_	_	_
600008	11q23.2	Homocysteine plasma level	600008	_	2
600009	_	_	_	_	_
600010	_	_	_	_	_
600011	7q22.1	Capillary malformation-arteriovenous malformation 2	618196	AD	3
600011	7q22.1	Lymphatic malformation 7	617300	AD	3
600012	_	_	_	_	_
600013	14q32.2	Gabriele-de Vries syndrome	617557	AD	3
600014	9p24.3	Nicolaides-Baraitser syndrome	601358	AD	3
600015	_	_	_	_	_
600016	12q12	?Myopathy, congenital, Compton-North	612540	AR	3
600017	_	_	_	_	_
600018	_	_	_	_	_
600019	17q23.3	Orthostatic hypotension 2	618182	AR	3
600020	10q25.2	Neurofibrosarcoma, somatic	_	_	3
600020	10q25.2	Prostate cancer, somatic	176807	_	3
600021	_	_	_	_	_
600022	_	_	_	_	_
600023	16q21	Elsahy-Waters syndrome	211380	AR	3
600024	1q42.12	?Reynolds syndrome	613471	AD	3
600024	1q42.12	Greenberg skeletal dysplasia	215140	AR	3
600024	1q42.12	Pelger-Huet anomaly	169400	AD	3
600024	1q42.12	Pelger-Huet anomaly with mild skeletal anomalies	618019	_	3
600025	_	_	_	_	_
600026	_	_	_	_	_
600027	_	_	_	_	_
600028	7q21.3	?Split-hand/foot malformation 1 with sensorineural hearing loss	220600	AR	3
600029	_	_	_	_	_
600030	_	_	_	_	_
600031	1q32.1	[Chitotriosidase deficiency]	614122	AR	3
600032	_	_	_	_	_
600033	_	_	_	_	_
600034	_	_	_	_	_
600035	10q26.11	Schizencephaly	269160	_	3
600036	_	_	_	_	_
600037	14q22.3	Microphthalmia, syndromic 5	610125	AD	3
600037	14q22.3	Pituitary hormone deficiency, combined, 6	613986	AD	3
600037	14q22.3	Retinal dystrophy, early-onset, with or without pituitary dysfunction	610125	AD	3
600038	_	_	_	_	_
600039	_	_	_	_	_
600040	19q13.33	Colorectal cancer, somatic	114500	_	3
600040	19q13.33	T-cell acute lymphoblastic leukemia, somatic	613065	_	3
600041	_	_	_	_	_
600042	_	_	_	_	_
600043	_	_	_	_	_
600044	3q27.1	Thrombocythemia 1	187950	AD	3
600045	_	_	_	_	_
600046	9q31.1	HDL deficiency, type 2	604091	_	3
600046	9q31.1	Tangier disease	205400	AR	3
600047	_	_	_	_	_
600048	_	_	_	_	_
600049	3q26	Myelodysplasia syndrome-1	_	_	3
600050	_	_	_	_	_
600051	_	_	_	_	_
600052	_	_	_	_	_
600053	2q11.2	Achromatopsia 2	216900	AR	3
600054	_	_	_	_	_
600055	_	_	_	_	_
600056	_	_	_	_	_
600057	_	_	_	_	_
600058	_	_	_	_	_
600059	17p13.3	Retinitis pigmentosa 13	600059	AD	3
600060	11q13.5	Deafness, autosomal recessive 2	600060	AR	3
600061	_	_	_	_	_
600062	_	_	_	_	_
600063	_	_	_	_	_
600064	_	_	_	_	_
600065	21q22.3	Leukocyte adhesion deficiency	116920	AR	3
600066	_	_	_	_	_
600067	_	_	_	_	_
600068	_	_	_	_	_
600069	_	_	_	_	_
600070	_	_	_	_	_
600071	_	_	_	_	_
600072	20p13	Insomnia, fatal familial	600072	AD	3
600073	2q31.1	Donnai-Barrow syndrome	222448	AR	3
600074	_	_	_	_	_
600075	6q27	Spinocerebellar ataxia 17	607136	AD	3
600075	6q27	{Parkinson disease, susceptibility to}	168600	AD,Mu	3
600076	_	_	_	_	_
600077	_	_	_	_	_
600078	_	_	_	_	_
600079	7q11.23	Colon cancer, somatic	114500	_	3
600080	_	_	_	_	_
600081	11p15.2	Rickets due to defect in vitamin D 25-hydroxylation	600081	AR	3
600082	_	_	_	_	_
600083	_	_	_	_	_
600084	_	_	_	_	_
600085	_	_	_	_	_
600086	_	_	_	_	_
600087	_	_	_	_	_
600088	_	_	_	_	_
600089	6p21.3	?Diabetes mellitus, insulin-dependent, neonatal	600089	AR	2
600090	_	_	_	_	_
600091	_	_	_	_	_
600092	_	_	_	_	_
600093	_	_	_	_	_
600094	_	_	_	_	_
600095	_	_	_	_	_
600096	_	_	_	_	_
600097	_	_	_	_	_
600098	11p15.2	Ovarian carcinoma	_	_	3
600099	_	_	_	_	_
600100	_	_	_	_	_
600101	1p34.2	Deafness, autosomal dominant 2A	600101	AD	3
600102	_	_	_	_	_
600103	_	_	_	_	_
600104	1q32.1	Myasthenic syndrome, congenital, 7, presynaptic	616040	AD	3
600105	1q31.3	Retinitis pigmentosa-12	600105	AR	3
600106	_	_	_	_	_
600107	_	_	_	_	_
600108	11q22.2	Metaphyseal anadysplasia 1	602111	AD	3
600108	11q22.2	Metaphyseal dysplasia, Spahr type	250400	AR	3
600108	11q22.2	Spondyloepimetaphyseal dysplasia, Missouri type	602111	AD	3
600109	_	_	_	_	_
600110	6q14.1	Stargardt disease 3	600110	AD	3
600111	5p13.2	Episodic ataxia, type 6	612656	AD	3
600112	14q32.31	Charcot-Marie-Tooth disease, axonal, type 20	614228	AD	3
600112	14q32.31	Mental retardation, autosomal dominant 13	614563	AD	3
600112	14q32.31	Spinal muscular atrophy, lower extremity-predominant 1, AD	158600	AD	3
600113	_	_	_	_	_
600114	_	_	_	_	_
600115	_	_	_	_	_
600116	6q26	Parkinson disease, juvenile, type 2	600116	AR	3
600117	_	_	_	_	_
600118	2q21.3	Warburg micro syndrome 1	600118	AR	3
600119	17q21.33	Muscular dystrophy, limb-girdle, autosomal recessive 3	608099	AR	3
600120	_	_	_	_	_
600121	2q31.2	Rhizomelic chondrodysplasia punctata, type 3	600121	AR	3
600122	_	_	_	_	_
600123	_	_	_	_	_
600124	7p15.2	?Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	615422	_	3
600125	_	_	_	_	_
600126	_	_	_	_	_
600127	_	_	_	_	_
600128	_	_	_	_	_
600129	5q11.2-q12.1	Acrodysostosis 2, with or without hormone resistance	614613	AD	3
600130	_	_	_	_	_
600131	8q24	Epilepsy, childhood absence, 1	600131	AD	2
600132	6p21.31	Retinitis pigmentosa 14	600132	AR	3
600133	6q21	Cardiomyopathy, dilated, 1JJ	615235	AD	3
600134	_	_	_	_	_
600135	_	_	_	_	_
600136	_	_	_	_	_
600137	_	_	_	_	_
600138	19q13.42	Retinitis pigmentosa 11	600138	AD	3
600139	_	_	_	_	_
600140	16p13.3	Menke-Hennekam syndrome 1	618332	_	3
600140	16p13.3	Rubinstein-Taybi syndrome 1	180849	AD	3
600141	_	_	_	_	_
600142	10q26.13	CARASIL syndrome	600142	AR	3
600143	8p23.3	Ceroid lipofuscinosis, neuronal, 8	600143	AR	3
600144	12p11.23	?Anhidrosis, isolated, with normal sweat glands	106190	AR	3
600145	1p13.1	Caudal regression syndrome	600145	AD	3
600146	_	_	_	_	_
600147	17q21.31	Klippel-Feil syndrome 2	214300	AR	3
600148	_	_	_	_	_
600149	_	_	_	_	_
600150	10q22.3	?Cerebellar atrophy, developmental delay, and seizures	617643	AR	3
600150	10q22.3	Paroxysmal nonkinesigenic dyskinesia, 3, with or without generalized epilepsy	609446	AD	3
600151	3q11.2	Bardet-Biedl syndrome 3	600151	AR	3
600152	_	_	_	_	_
600153	_	_	_	_	_
600154	14q24.1	Glycosylphosphatidylinositol biosynthesis defect 17	618010	AR	3
600155	13q22.3	{Hirschsprung disease, susceptibility to, 2}	600155	AD	3
600156	9q31	{Hirschsprung disease, susceptibility to, 5}	600156	AD	2
600157	_	_	_	_	_
600158	_	_	_	_	_
600159	_	_	_	_	_
600160	9p21.3	Melanoma and neural system tumor syndrome	155755	AD	3
600160	9p21.3	Orolaryngeal cancer, multiple	_	_	3
600160	9p21.3	Pancreatic cancer/melanoma syndrome	606719	AD	3
600160	9p21.3	{Melanoma, cutaneous malignant, 2}	155601	AD	3
600161	_	_	_	_	_
600162	_	_	_	_	_
600163	3p22.2	Atrial fibrillation, familial, 10	614022	AD	3
600163	3p22.2	Brugada syndrome 1	601144	AD	3
600163	3p22.2	Cardiomyopathy, dilated, 1E	601154	AD	3
600163	3p22.2	Heart block, nonprogressive	113900	AD	3
600163	3p22.2	Heart block, progressive, type IA	113900	AD	3
600163	3p22.2	Long QT syndrome-3	603830	AD	3
600163	3p22.2	Sick sinus syndrome 1	608567	AR	3
600163	3p22.2	Ventricular fibrillation, familial, 1	603829	_	3
600163	3p22.2	{Sudden infant death syndrome, susceptibility to}	272120	AR	3
600164	_	_	_	_	_
600165	11p	Nanophthalmos-1	600165	AD	2
600166	_	_	_	_	_
600167	_	_	_	_	_
600168	3p21.31	{Nasopharyngeal carcinoma, susceptibility to, 3}	617075	AD	3
600169	_	_	_	_	_
600170	9p13.3	[Blood group GIL]	607457	_	3
600171	_	_	_	_	_
600172	_	_	_	_	_
600173	19p13.11	SCID, autosomal recessive, T-negative/B-positive type	600802	AR	3
600174	_	_	_	_	_
600175	12q24.11	Spinal muscular atrophy, distal, congenital nonprogressive	600175	AD	3
600176	_	_	_	_	_
600177	_	_	_	_	_
600178	_	_	_	_	_
600179	17p13.1	?Choroidal dystrophy, central areolar 1	215500	AD	3
600179	17p13.1	Cone-rod dystrophy 6	601777	AD,AR	3
600179	17p13.1	Leber congenital amaurosis 1	204000	AR	3
600180	_	_	_	_	_
600181	_	_	_	_	_
600182	_	_	_	_	_
600183	_	_	_	_	_
600184	9q34.11	?Neurodegeneration with brain iron accumulation 8	617917	AR	3
600185	13q13.1	Fanconi anemia, complementation group D1	605724	AR	3
600185	13q13.1	Wilms tumor	194070	AD,SMu	3
600185	13q13.1	{Breast cancer, male, susceptibility to}	114480	AD,SMu	3
600185	13q13.1	{Breast-ovarian cancer, familial, 2}	612555	AD	3
600185	13q13.1	{Glioblastoma 3}	613029	AR	3
600185	13q13.1	{Medulloblastoma}	155255	AD,AR	3
600185	13q13.1	{Pancreatic cancer 2}	613347	_	3
600185	13q13.1	{Prostate cancer}	176807	AD,SMu	3
600186	_	_	_	_	_
600187	_	_	_	_	_
600188	_	_	_	_	_
600189	_	_	_	_	_
600190	_	_	_	_	_
600191	_	_	_	_	_
600192	18q11.2	Sarcoma, synovial	_	_	1
600193	1p21-p13.3	Waardenburg syndrome, type 2B	600193	AD	2
600194	12q13.13	Ichthyosis bullosa of Siemens	146800	AD	3
600195	9p21.2	Venous malformations, multiple cutaneous and mucosal	600195	AD	3
600196	_	_	_	_	_
600197	_	_	_	_	_
600198	_	_	_	_	_
600199	_	_	_	_	_
600200	_	_	_	_	_
600201	20q11.22	[Skin/hair/eye pigmentation 9, brown/nonbrown eyes]	611742	_	3
600201	20q11.22	[Skin/hair/eye pigmentation 9, dark/light hair]	611742	_	3
600202	6p22-p21	{Dyslexia, susceptibility to, 2}	600202	AD	2
600203	_	_	_	_	_
600204	1p34.2	Epiphyseal dysplasia, multiple, 2	600204	AD	3
600205	_	_	_	_	_
600206	12p12.3	?Deafness, autosomal recessive 102	615974	AR	3
600207	_	_	_	_	_
600208	_	_	_	_	_
600209	19p	Exostoses, multiple, type 3	600209	AD	2
600210	_	_	_	_	_
600211	6p21.1	Cleidocranial dysplasia	119600	AD	3
600211	6p21.1	Cleidocranial dysplasia, forme fruste, dental anomalies only	119600	AD	3
600211	6p21.1	Cleidocranial dysplasia, forme fruste, with brachydactyly	119600	AD	3
600211	6p21.1	Metaphyseal dysplasia with maxillary hypoplasia with or without brachydactyly	156510	AD	3
600212	_	_	_	_	_
600213	_	_	_	_	_
600214	_	_	_	_	_
600215	_	_	_	_	_
600216	_	_	_	_	_
600217	_	_	_	_	_
600218	_	_	_	_	_
600219	_	_	_	_	_
600220	16q23.3	Autoinflammation, antibody deficiency, and immune dysregulation syndrome	614878	AD	3
600220	16q23.3	Familial cold autoinflammatory syndrome 3	614468	AD	3
600221	9p21.2	Glaucoma 3, primary congenital, E	617272	AD	3
600221	9p21.2	Venous malformations, multiple cutaneous and mucosal	600195	AD	3
600222	_	_	_	_	_
600223	16q22.1	Spinocerebellar ataxia 4	600223	AD	2
600224	11q13.2	Spinocerebellar ataxia 5	600224	AD	3
600225	14q22.2	Dystonia, DOPA-responsive, with or without hyperphenylalaninemia	128230	AD,AR	3
600225	14q22.2	Hyperphenylalaninemia, BH4-deficient, B	233910	AR	3
600226	_	_	_	_	_
600227	_	_	_	_	_
600228	12p13.31	?Liddle syndrome 3	618126	AD	3
600228	12p13.31	Bronchiectasis with or without elevated sweat chloride 2	613021	AD	3
600228	12p13.31	Pseudohypoaldosteronism, type I	264350	AR	3
600229	2p14	Spastic tetraplegia, thin corpus callosum, and progressive microcephaly	616657	AR	3
600230	_	_	_	_	_
600231	12q13.12	Palmoplantar keratoderma, Bothnian type	600231	AD	3
600232	5q34	Epileptic encephalopathy, infantile or early childhood, 2	617829	AD	3
600233	_	_	_	_	_
600234	1p12	HMG-CoA synthase-2 deficiency	605911	AR	3
600235	19q13.11	Atrial fibrillation, familial, 13	615377	AD	3
600235	19q13.11	Brugada syndrome 5	612838	_	3
600235	19q13.11	Cardiac conduction defect, nonspecific	612838	_	3
600235	19q13.11	Epilepsy, generalized, with febrile seizures plus, type 1	604233	AD	3
600235	19q13.11	Epileptic encephalopathy, early infantile, 52	617350	AR	3
600236	1q41	Stromme syndrome	243605	AR	3
600237	_	_	_	_	_
600238	20p13	?Uncombable hair syndrome 2	617251	AR	3
600239	_	_	_	_	_
600240	_	_	_	_	_
600241	_	_	_	_	_
600242	_	_	_	_	_
600243	_	_	_	_	_
600244	2q37.3	{Multiple sclerosis, disease progression, modifier of}	126200	Mu	3
600244	2q37.3	{Systemic lupus erythematosus, susceptibility to, 2}	605218	_	3
600245	_	_	_	_	_
600246	_	_	_	_	_
600247	_	_	_	_	_
600248	_	_	_	_	_
600249	_	_	_	_	_
600250	_	_	_	_	_
600251	22q11.23	?Facial clefting, oblique, 1	600251	AD	3
600252	_	_	_	_	_
600253	7p21.1	?Retinitis pigmentosa 85	618345	AR	3
600254	_	_	_	_	_
600255	_	_	_	_	_
600256	_	_	_	_	_
600257	8q12.2-q21.2	Bor-Duane hydrocephalus contiguous gene syndrome	600257	AD	4
600258	_	_	_	_	_
600259	7p22.1	Colorectal cancer, hereditary nonpolyposis, type 4	614337	_	3
600259	7p22.1	Mismatch repair cancer syndrome	276300	AR	3
600260	_	_	_	_	_
600261	_	_	_	_	_
600262	_	_	_	_	_
600263	6q23.3	{H. pylori infection, susceptibility to}	600263	_	3
600264	_	_	_	_	_
600265	_	_	_	_	_
600266	2q35	{Buruli ulcer, susceptibility to}	610446	_	3
600266	2q35	{Mycobacterium tuberculosis, susceptibility to infection by}	607948	_	3
600267	_	_	_	_	_
600268	_	_	_	_	_
600269	_	_	_	_	_
600270	_	_	_	_	_
600271	18q12.1	?Hypotrichosis and recurrent skin vesicles	613102	AR	3
600272	_	_	_	_	_
600273	16p13.3	Polycystic kidney disease, infantile severe, with tuberous sclerosis	600273	AD	4
600274	_	_	_	_	_
600275	1p12	Alagille syndrome 2	610205	AD	3
600275	1p12	Hajdu-Cheney syndrome	102500	AD	3
600276	19p13.12	?Myofibromatosis, infantile 2	615293	AD	3
600276	19p13.12	Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy 1	125310	AD	3
600276	19p13.12	Lateral meningocele syndrome	130720	AD	3
600277	_	_	_	_	_
600278	_	_	_	_	_
600279	1q23.2	Peroxisome biogenesis disorder 12A (Zellweger)	614886	AR	3
600280	_	_	_	_	_
600281	20q13.12	Fanconi renotubular syndrome 4, with maturity-onset diabetes of the young	616026	AD	3
600281	20q13.12	MODY, type I	125850	AD	3
600281	20q13.12	{Diabetes mellitus, noninsulin-dependent}	125853	AD	3
600282	_	_	_	_	_
600283	_	_	_	_	_
600284	_	_	_	_	_
600285	_	_	_	_	_
600286	22q11.21	Polymicrogyria, perisylvian, with cerebellar hypoplasia and arthrogryposis	616531	AR	3
600287	7p14.3	Charcot-Marie-Tooth disease, type 2D	601472	AD	3
600287	7p14.3	Neuropathy, distal hereditary motor, type VA	600794	AD	3
600288	_	_	_	_	_
600289	_	_	_	_	_
600290	_	_	_	_	_
600291	2p23.3	{Obesity, susceptibility to, BMIQ19}	617885	AR	3
600292	_	_	_	_	_
600293	3q21.1	Dyskinesia, familial, with facial myokymia	606703	AD	3
600294	12q13.12	?Lethal congenital contracture syndrome 8	616287	AR	3
600295	_	_	_	_	_
600296	_	_	_	_	_
600297	_	_	_	_	_
600298	_	_	_	_	_
600299	_	_	_	_	_
600300	11p13	Epileptic encephalopathy, early infantile, 41	617105	AD	3
600301	10q26.13	2-methylbutyrylglycinuria	610006	AR	3
600302	_	_	_	_	_
600303	_	_	_	_	_
600304	_	_	_	_	_
600305	_	_	_	_	_
600306	_	_	_	_	_
600307	_	_	_	_	_
600308	_	_	_	_	_
600309	6q22.31	Atrioventricular septal defect 3	600309	AD	3
600310	19p13.11	Epiphyseal dysplasia, multiple, 1	132400	AD	3
600310	19p13.11	Pseudoachondroplasia	177170	AD	3
600311	_	_	_	_	_
600312	_	_	_	_	_
600313	_	_	_	_	_
600314	_	_	_	_	_
600315	1p36.33	?Immunodeficiency 16	615593	AR	3
600316	17p11.2	Deafness, autosomal recessive 3	600316	AR	3
600317	_	_	_	_	_
600318	15q26	{Diabetes mellitus, insulin-dependent, 3}	600318	_	2
600319	11q13	{Diabetes mellitus, insulin-dependent, 4}	600319	_	2
600320	6q25.1	{Diabetes mellitus, insulin-dependent, 5}	600320	_	3
600321	2q31	{Diabetes mellitus, insulin-dependent, 7}	600321	_	2
600322	20p12.2	?Myasthenic syndrome, congenital, 18	616330	AD	3
600323	_	_	_	_	_
600324	_	_	_	_	_
600325	_	_	_	_	_
600326	_	_	_	_	_
600327	_	_	_	_	_
600328	_	_	_	_	_
600329	_	_	_	_	_
600330	_	_	_	_	_
600331	_	_	_	_	_
600332	1q41	Rippling muscle disease-1	600332	AD	2
600333	_	_	_	_	_
600334	2q31.2	Tibial muscular dystrophy, tardive	600334	AD	3
600335	_	_	_	_	_
600336	10q11.23	Myasthenic syndrome, congenital, 21, presynaptic	617239	AR	3
600337	_	_	_	_	_
600338	_	_	_	_	_
600339	_	_	_	_	_
600340	_	_	_	_	_
600341	_	_	_	_	_
600342	10q23.1	Retinitis pigmentosa 44	613769	_	3
600343	_	_	_	_	_
600344	_	_	_	_	_
600345	_	_	_	_	_
600346	17q12	Turnpenny-Fry syndrome	618371	AD	3
600347	_	_	_	_	_
600348	14q32.2	Band heterotopia	600348	AR	3
600349	_	_	_	_	_
600350	_	_	_	_	_
600351	_	_	_	_	_
600352	_	_	_	_	_
600353	_	_	_	_	_
600354	5q13.2	Spinal muscular atrophy-1	253300	AR	3
600354	5q13.2	Spinal muscular atrophy-2	253550	AR	3
600354	5q13.2	Spinal muscular atrophy-3	253400	AR	3
600354	5q13.2	Spinal muscular atrophy-4	271150	AR	3
600355	_	_	_	_	_
600356	_	_	_	_	_
600357	_	_	_	_	_
600358	_	_	_	_	_
600359	11q24.3	Bartter syndrome, type 2	241200	AR	3
600360	_	_	_	_	_
600361	4q34.3-q35.2	Hereditary motor and sensory neuropathy V	600361	AD	2
600362	_	_	_	_	_
600363	15q11.2	Spastic paraplegia 6, autosomal dominant	600363	AD	3
600364	6p21.1	Cone dystrophy-3	602093	AD	3
600364	6p21.1	Cone-rod dystrophy 14	602093	AD	3
600365	_	_	_	_	_
600366	_	_	_	_	_
600367	_	_	_	_	_
600368	_	_	_	_	_
600369	_	_	_	_	_
600370	12q23.1	Mitochondrial phosphate carrier deficiency	610773	_	3
600371	_	_	_	_	_
600372	_	_	_	_	_
600373	19p13.3	CODAS syndrome	600373	AR	3
600374	15q24.1	Bardet-Biedl syndrome 4	615982	AR	3
600375	7q36.1	?Fanconi anemia, complementation group U	617247	AR	3
600376	12q13.13	Telangiectasia, hereditary hemorrhagic, type 2	600376	AD	3
600377	_	_	_	_	_
600378	_	_	_	_	_
600379	_	_	_	_	_
600380	_	_	_	_	_
600381	_	_	_	_	_
600382	_	_	_	_	_
600383	8q13	Mesomelia-synostoses syndrome	600383	AD	4
600384	_	_	_	_	_
600385	_	_	_	_	_
600386	_	_	_	_	_
600387	_	_	_	_	_
600388	_	_	_	_	_
600389	_	_	_	_	_
600390	_	_	_	_	_
600391	_	_	_	_	_
600392	_	_	_	_	_
600393	_	_	_	_	_
600394	_	_	_	_	_
600395	_	_	_	_	_
600396	_	_	_	_	_
600397	20q13.13	Epileptic encephalopathy, early infantile, 26	616056	AD	3
600398	_	_	_	_	_
600399	_	_	_	_	_
600400	_	_	_	_	_
600401	_	_	_	_	_
600402	_	_	_	_	_
600403	_	_	_	_	_
600404	_	_	_	_	_
600405	_	_	_	_	_
600406	_	_	_	_	_
600407	_	_	_	_	_
600408	_	_	_	_	_
600409	_	_	_	_	_
600410	_	_	_	_	_
600411	_	_	_	_	_
600412	_	_	_	_	_
600413	_	_	_	_	_
600414	12p13.31	Peroxisome biogenesis disorder 2A (Zellweger)	214110	AR	3
600414	12p13.31	Peroxisome biogenesis disorder 2B	202370	AR	3
600414	12p13.31	Rhizomelic chondrodysplasia punctata, type 5	616716	AR	3
600415	8q12.3	Ataxia with isolated vitamin E deficiency	277460	AR	3
600416	_	_	_	_	_
600417	10q24.32-q24.33	Spastic paraplegia 45, autosomal recessive	613162	AR	3
600418	_	_	_	_	_
600419	_	_	_	_	_
600420	_	_	_	_	_
600421	_	_	_	_	_
600422	_	_	_	_	_
600423	1p36.12	?Hirschsprung disease, cardiac defects, and autonomic dysfunction	613870	AD	3
600423	1p36.12	{Hypertension, essential, susceptibility to}	145500	Mu	3
600424	_	_	_	_	_
600425	_	_	_	_	_
600426	_	_	_	_	_
600427	_	_	_	_	_
600428	_	_	_	_	_
600429	6p24.3-p24.2	Adult i phenotype without cataract	110800	AD	3
600429	6p24.3-p24.2	Cataract 13 with adult i phenotype	116700	AR	3
600429	6p24.3-p24.2	[Blood group, Ii]	110800	AD	3
600430	2q37	Chromosome 2q37 deletion syndrome	600430	AD	4
600431	_	_	_	_	_
600432	_	_	_	_	_
600433	_	_	_	_	_
600434	_	_	_	_	_
600435	_	_	_	_	_
600436	_	_	_	_	_
600437	_	_	_	_	_
600438	10q21.1	?Mitochondrial DNA depletion syndrome 15 (hepatocerebral type)	617156	AR	3
600439	_	_	_	_	_
600440	_	_	_	_	_
600441	_	_	_	_	_
600442	12q13.12	Palmoplantar keratoderma, Bothnian type	600231	AD	3
600443	_	_	_	_	_
600444	_	_	_	_	_
600445	_	_	_	_	_
600446	_	_	_	_	_
600447	_	_	_	_	_
600448	_	_	_	_	_
600449	_	_	_	_	_
600450	10p15.1	46XY sex reversal 8	614279	AR	3
600451	10p15.1	{46XY sex reversal 8, modifier of}	614279	AR	3
600452	_	_	_	_	_
600453	_	_	_	_	_
600454	_	_	_	_	_
600455	_	_	_	_	_
600456	9q21.33	Epileptic encephalopathy, early infantile, 58	617830	AD	3
600456	9q21.33	Obesity, hyperphagia, and developmental delay	613886	AD	3
600457	_	_	_	_	_
600458	_	_	_	_	_
600459	_	_	_	_	_
600460	_	_	_	_	_
600461	_	_	_	_	_
600462	12q24.33	Myopathy, lactic acidosis, and sideroblastic anemia 1	600462	AR	3
600463	15q26.3	Microphthalmia, isolated 8	615113	AR	3
600464	_	_	_	_	_
600465	10q21.2	?Mental retardation, autosomal recessive, 37	615493	AR	3
600466	_	_	_	_	_
600467	3q13.1	{Malignant hyperthermia susceptibility 4}	600467	AD	2
600468	_	_	_	_	_
600469	_	_	_	_	_
600470	3q24	Craniosynostosis 6	616602	AD	3
600471	_	_	_	_	_
600472	_	_	_	_	_
600473	5q31.3	Mental retardation, autosomal dominant 31	616158	AD	3
600474	_	_	_	_	_
600475	_	_	_	_	_
600476	_	_	_	_	_
600477	_	_	_	_	_
600478	6p21.33	Trichohepatoenteric syndrome 2	614602	AR	3
600479	_	_	_	_	_
600480	15q21.3	Craniosynostosis 3	615314	AD	3
600481	_	_	_	_	_
600482	_	_	_	_	_
600483	10q24.32	Hypogonadotropic hypogonadism 6 with or without anosmia	612702	AD	3
600484	_	_	_	_	_
600485	_	_	_	_	_
600486	_	_	_	_	_
600487	_	_	_	_	_
600488	_	_	_	_	_
600489	_	_	_	_	_
600490	_	_	_	_	_
600491	_	_	_	_	_
600492	2q31.2	Immunodeficiency, developmental delay, and hypohomocysteinemia	617744	AD	3
600493	_	_	_	_	_
600494	_	_	_	_	_
600495	3q27.1	{Parkinson disease 18}	614251	AD	3
600496	12q24.31	MODY, type III	600496	AD	3
600497	_	_	_	_	_
600498	_	_	_	_	_
600499	_	_	_	_	_
600500	_	_	_	_	_
600501	13q22.3	ABCD syndrome	600501	AR	3
600502	11q13.3	Charcot-Marie-Tooth disease, axonal, type 2S	616155	AR	3
600502	11q13.3	Neuronopathy, distal hereditary motor, type VI	604320	AR	3
600503	_	_	_	_	_
600504	_	_	_	_	_
600505	_	_	_	_	_
600506	_	_	_	_	_
600507	_	_	_	_	_
600508	_	_	_	_	_
600509	11p15.1	Diabetes mellitus, noninsulin-dependent	125853	AD	3
600509	11p15.1	Diabetes mellitus, permanent neonatal	606176	AD,AR	3
600509	11p15.1	Diabetes mellitus, transient neonatal 2	610374	_	3
600509	11p15.1	Hyperinsulinemic hypoglycemia, familial, 1	256450	AD,AR	3
600509	11p15.1	Hypoglycemia of infancy, leucine-sensitive	240800	AD	3
600510	7q35-q36	Pigment dispersion syndrome	600510	AD	2
600511	6p23	{Schizophrenia}	181500	AD	2
600512	10q23.33	Epilepsy, familial temporal lobe, 1	600512	AD	3
600513	20q13.33	Epilepsy, nocturnal frontal lobe, 1	600513	AD	3
600514	7q22.1	Lissencephaly 2 (Norman-Roberts type)	257320	AR	3
600514	7q22.1	{Epilepsy, familial temporal lobe, 7}	616436	AD	3
600515	3q25.1	Bleeding disorder, platelet-type, 8	609821	AR	3
600516	_	_	_	_	_
600517	_	_	_	_	_
600518	_	_	_	_	_
600519	_	_	_	_	_
600520	_	_	_	_	_
600521	3q27.3	3MC syndrome 1	257920	AR	3
600522	1q31.1	Gastrointestinal ulceration, recurrent, with dysfunctional platelets	618372	AR	3
600523	12q13.12	Anemia, hypochromic microcytic, with iron overload 1	206100	AR	3
600524	_	_	_	_	_
600525	17q21.33	Amelogenesis imperfecta, type IV	104510	AD	3
600525	17q21.33	Trichodontoosseous syndrome	190320	AD	3
600526	_	_	_	_	_
600527	_	_	_	_	_
600528	11q13.3	CPT deficiency, hepatic, type IA	255120	AR	3
600529	9q22.31	3-methylglutaconic aciduria, type I	250950	AR	3
600530	_	_	_	_	_
600531	_	_	_	_	_
600532	18p11.22	Mitochondrial complex I deficiency, nuclear type 7	618229	AR	3
600533	1q23.2	Neural tube defects	182940	AD	3
600534	_	_	_	_	_
600535	_	_	_	_	_
600536	12q13.2	Muscular dystrophy, congenital, due to ITGA7 deficiency	613204	AR	3
600537	_	_	_	_	_
600538	_	_	_	_	_
600539	_	_	_	_	_
600540	_	_	_	_	_
600541	_	_	_	_	_
600542	9q31.1	Chondrosarcoma, extraskeletal myxoid	612237	_	3
600543	2q34	Amyotrophic lateral sclerosis 19	615515	AD	3
600544	_	_	_	_	_
600545	_	_	_	_	_
600546	_	_	_	_	_
600547	_	_	_	_	_
600548	5q31.2	Anemia, sideroblastic, 4	182170	AD	3
600548	5q31.2	Even-plus syndrome	616854	AR	3
600549	_	_	_	_	_
600550	_	_	_	_	_
600551	_	_	_	_	_
600552	_	_	_	_	_
600553	_	_	_	_	_
600554	_	_	_	_	_
600555	2q32.2	Immunodeficiency 31A, mycobacteriosis, autosomal dominant	614892	AD	3
600555	2q32.2	Immunodeficiency 31B, mycobacterial and viral infections, autosomal recessive	613796	AR	3
600555	2q32.2	Immunodeficiency 31C, autosomal dominant	614162	AD	3
600556	12q13.3	Immunodeficiency 44	616636	AR	3
600557	_	_	_	_	_
600558	2q32.2-q32.3	{Systemic lupus erythematosus, susceptibility to, 11}	612253	_	3
600559	_	_	_	_	_
600560	_	_	_	_	_
600561	_	_	_	_	_
600562	_	_	_	_	_
600563	_	_	_	_	_
600564	_	_	_	_	_
600565	2p16.3	Pitt-Hopkins-like syndrome 2	614325	AR	3
600565	2p16.3	{Schizophrenia, susceptibility to, 17}	614332	_	3
600566	_	_	_	_	_
600567	_	_	_	_	_
600568	_	_	_	_	_
600569	_	_	_	_	_
600570	3q27.1	Hyperaldosteronism, familial, type II	605635	AD	3
600570	3q27.1	Leukoencephalopathy with ataxia	615651	AR	3
600570	3q27.1	{Epilepsy, idiopathic generalized, susceptibility to, 11}	607628	AD	3
600570	3q27.1	{Epilepsy, juvenile absence, susceptibility to, 2}	607628	AD	3
600570	3q27.1	{Epilepsy, juvenile myoclonic, susceptibility to, 8}	607628	AD	3
600571	4q12	Fibromatosis, gingival, 5	617626	AD	3
600571	4q12	{Wilms tumor 6, susceptibility to}	616806	_	3
600572	_	_	_	_	_
600573	_	_	_	_	_
600574	22q11.21	Noonan syndrome 10	616564	AD	3
600574	22q11.21	Noonan syndrome 2	605275	AR	3
600574	22q11.21	{Schwannomatosis-2, susceptibility to}	615670	AD	3
600575	_	_	_	_	_
600576	8p23.1	?Testicular anomalies with or without congenital heart disease	615542	AD	3
600576	8p23.1	Atrial septal defect 2	607941	AD	3
600576	8p23.1	Atrioventricular septal defect 4	614430	AD	3
600576	8p23.1	Tetralogy of Fallot	187500	AD	3
600576	8p23.1	Ventricular septal defect 1	614429	AD	3
600577	9q34.3	Pituitary hormone deficiency, combined, 3	221750	AR	3
600578	_	_	_	_	_
600579	12p12.3	Nephrotic syndrome, type 6	614196	AR	3
600580	_	_	_	_	_
600581	_	_	_	_	_
600582	8q12.3	Traboulsi syndrome	601552	AR	3
600583	_	_	_	_	_
600584	5q35.1	Atrial septal defect 7, with or without AV conduction defects	108900	AD	3
600584	5q35.1	Conotruncal heart malformations, variable	217095	_	3
600584	5q35.1	Hypoplastic left heart syndrome 2	614435	AD	3
600584	5q35.1	Hypothyroidism, congenital nongoitrous, 5	225250	AD	3
600584	5q35.1	Tetralogy of Fallot	187500	AD	3
600584	5q35.1	Ventricular septal defect 3	614432	AD	3
600585	_	_	_	_	_
600586	_	_	_	_	_
600587	_	_	_	_	_
600588	_	_	_	_	_
600589	_	_	_	_	_
600590	2p23.2	Noonan syndrome-like disorder with loose anagen hair 2	617506	AD	3
600591	_	_	_	_	_
600592	_	_	_	_	_
600593	4p16	Craniosynostosis, Adelaide type	600593	?AD	2
600594	_	_	_	_	_
600595	_	_	_	_	_
600596	_	_	_	_	_
600597	_	_	_	_	_
600598	_	_	_	_	_
600599	19p13.13	Blood group--Lutheran inhibitor	111150	_	3
600599	19p13.13	Dyserythropoietic anemia, congenital, type IV	613673	AD	3
600599	19p13.13	[Hereditary persistence of fetal hemoglobin]	613566	_	3
600600	_	_	_	_	_
600601	_	_	_	_	_
600602	_	_	_	_	_
600603	_	_	_	_	_
600604	_	_	_	_	_
600605	_	_	_	_	_
600606	_	_	_	_	_
600607	_	_	_	_	_
600608	5q31.1	Myopia 25, autosomal dominant	617238	AD	3
600609	_	_	_	_	_
600610	_	_	_	_	_
600611	_	_	_	_	_
600612	_	_	_	_	_
600613	_	_	_	_	_
600614	_	_	_	_	_
600615	_	_	_	_	_
600616	_	_	_	_	_
600617	8p11.23	Lipoid adrenal hyperplasia	201710	AR	3
600618	12p13.2	Leukemia, acute myeloid, somatic	601626	_	3
600618	12p13.2	Thrombocytopenia 5	616216	AD	3
600619	_	_	_	_	_
600620	_	_	_	_	_
600621	_	_	_	_	_
600622	_	_	_	_	_
600623	_	_	_	_	_
600624	18q21.1-q21.3	Cone-rod retinal dystrophy-1	600624	AD	2
600625	14q22.2	Orofacial cleft 11	600625	_	3
600626	_	_	_	_	_
600627	4q32.1	[?Hypertryptophanemia]	600627	AR	3
600628	_	_	_	_	_
600629	_	_	_	_	_
600630	10q11.23	UV-sensitive syndrome 1	600630	AR	3
600631	13q13-q14.3	Enuresis, nocturnal, 1	600631	AD	2
600632	11q25	Ovarian cancer, somatic	167000	_	3
600633	_	_	_	_	_
600634	_	_	_	_	_
600635	14q13.3	Chorea, hereditary benign	118700	AD	3
600635	14q13.3	Choreoathetosis, hypothyroidism, and neonatal respiratory distress	610978	AD	3
600635	14q13.3	{Thyroid cancer, nonmedullary, 1}	188550	AD	3
600636	_	_	_	_	_
600637	_	_	_	_	_
600638	16q24.3	Fibrosis of extraocular muscles, congenital, 3A	600638	AD	3
600639	_	_	_	_	_
600640	_	_	_	_	_
600641	_	_	_	_	_
600642	_	_	_	_	_
600643	_	_	_	_	_
600644	11q23.3	Cleft lip/palate-ectodermal dysplasia syndrome	225060	AR	3
600644	11q23.3	Orofacial cleft 7	225060	AR	3
600645	_	_	_	_	_
600646	_	_	_	_	_
600647	_	_	_	_	_
600648	_	_	_	_	_
600649	1p32.3	CPT II deficiency, infantile	600649	AR	3
600650	1p32.3	CPT II deficiency, infantile	600649	AR	3
600650	1p32.3	CPT II deficiency, lethal neonatal	608836	AR	3
600650	1p32.3	CPT II deficiency, myopathic, stress-induced	255110	AD,AR	3
600650	1p32.3	{Encephalopathy, acute, infection-induced, 4, susceptibility to}	614212	AD,AR	3
600651	_	_	_	_	_
600652	19q13.33	Deafness, autosomal dominant 4A	600652	AD	3
600653	_	_	_	_	_
600654	_	_	_	_	_
600655	_	_	_	_	_
600656	_	_	_	_	_
600657	_	_	_	_	_
600658	_	_	_	_	_
600659	_	_	_	_	_
600660	15q26.3	{Coronary artery disease, autosomal dominant, 1}	608320	AD	3
600661	_	_	_	_	_
600662	5q14.3	Chromosome 5q14.3 deletion syndrome	613443	AD	4
600662	5q14.3	Mental retardation, stereotypic movements, epilepsy, and/or cerebral malformations	613443	AD	3
600663	_	_	_	_	_
600664	10q24.31	Cocoon syndrome	613630	_	3
600665	_	_	_	_	_
600666	11q12.3	Polycystic kidney disease 3	600666	AD	3
600667	17q21.31	Omodysplasia 2	164745	AD	3
600668	8q	Chondrocalcinosis with early-onset osteoarthritis	600668	AD	2
600669	8q24	{Epilepsy, idiopathic generalized, susceptibility to, 1}	600669	AD	2
600670	_	_	_	_	_
600671	_	_	_	_	_
600672	_	_	_	_	_
600673	17q21.31	Neurodegeneration, childhood-onset, with brain atrophy	617672	AD	3
600674	_	_	_	_	_
600675	14q32.33	{Breast cancer, susceptibility to}	114480	AD,SMu	3
600675	14q32.33	{Melanoma, cutaneous malignant, 6}	613972	_	3
600676	_	_	_	_	_
600677	_	_	_	_	_
600678	2p16.3	Colorectal cancer, hereditary nonpolyposis, type 5	614350	AD	3
600678	2p16.3	Mismatch repair cancer syndrome	276300	AR	3
600678	2p16.3	{Endometrial cancer, familial}	608089	_	3
600679	_	_	_	_	_
600680	_	_	_	_	_
600681	17q24.3	Andersen syndrome	170390	AD	3
600681	17q24.3	Atrial fibrillation, familial, 9	613980	AD	3
600681	17q24.3	Short QT syndrome 3	609622	_	3
600682	1p13.2	Erythrocyte lactate transporter defect	245340	AD	3
600682	1p13.2	Hyperinsulinemic hypoglycemia, familial, 7	610021	AD	3
600682	1p13.2	Monocarboxylate transporter 1 deficiency	616095	AD,AR	3
600683	_	_	_	_	_
600684	_	_	_	_	_
600685	_	_	_	_	_
600686	_	_	_	_	_
600687	_	_	_	_	_
600688	_	_	_	_	_
600689	_	_	_	_	_
600690	_	_	_	_	_
600691	_	_	_	_	_
600692	11p15.5	Arthrogryposis, distal, type 2B2	618435	AD	3
600693	_	_	_	_	_
600694	_	_	_	_	_
600695	_	_	_	_	_
600696	_	_	_	_	_
600697	_	_	_	_	_
600698	12q14.3	Leiomyoma, uterine, somatic	150699	_	1
600699	_	_	_	_	_
600700	3q27-q28	Leukemia, acute myeloid	601626	AD,SMu	3
600700	3q27-q28	Lipoma	_	_	3
600701	6p21.31	{Diabetes mellitus, noninsulin-dependent, susceptibility to}	125853	AD	3
600702	12q13.13	?Myoclonus, familial, 2	618364	AD	3
600702	12q13.13	Cognitive impairment with or without cerebellar ataxia	614306	AD	3
600702	12q13.13	Epileptic encephalopathy, early infantile, 13	614558	AD	3
600702	12q13.13	Seizures, benign familial infantile, 5	617080	AD	3
600703	_	_	_	_	_
600704	_	_	_	_	_
600705	_	_	_	_	_
600706	_	_	_	_	_
600707	_	_	_	_	_
600708	_	_	_	_	_
600709	9q22.31	Growth retardation, impaired intellectual development, hypotonia, and hepatopathy	617093	AR	3
600710	_	_	_	_	_
600711	_	_	_	_	_
600712	9q21.32	Au-Kline syndrome	616580	AD	3
600713	1q32.2	Cortisone reductase deficiency 2	614662	AD	3
600714	_	_	_	_	_
600715	_	_	_	_	_
600716	1p13.2	{Diabetes, type 1, susceptibility to}	222100	AR	3
600716	1p13.2	{Rheumatoid arthritis, susceptibility to}	180300	_	3
600716	1p13.2	{Systemic lupus erythematosus susceptibility to}	152700	AD	3
600717	_	_	_	_	_
600718	_	_	_	_	_
600719	_	_	_	_	_
600720	_	_	_	_	_
600721	2q37.3	D-2-hydroxyglutaric aciduria	600721	AR	3
600722	1p34.2	Ceroid lipofuscinosis, neuronal, 1	256730	AR	3
600723	_	_	_	_	_
600724	16q21	Retinitis pigmentosa 45	613767	AR	3
600725	7q36.3	Holoprosencephaly 3	142945	AD	3
600725	7q36.3	Microphthalmia with coloboma 5	611638	AD	3
600725	7q36.3	Schizencephaly	269160	_	3
600725	7q36.3	Single median maxillary central incisor	147250	AD	3
600726	2q35	Acrocapitofemoral dysplasia	607778	AR	3
600726	2q35	Brachydactyly, type A1	112500	AD	3
600727	1p31.3	Brain malformations with or without urinary tract defects	613735	AD	3
600728	9p23-p22	Macrocephaly, acquired, with impaired intellectual development	618286	AD	3
600729	_	_	_	_	_
600730	_	_	_	_	_
600731	_	_	_	_	_
600732	_	_	_	_	_
600733	13q12.2	MODY, type IV	606392	_	3
600733	13q12.2	Pancreatic agenesis 1	260370	AR	3
600733	13q12.2	{Diabetes mellitus, type II, susceptibility to}	125853	AD	3
600734	11q24.3	Hyperaldosteronism, familial, type III	613677	AD	3
600734	11q24.3	Long QT syndrome 13	613485	AD	3
600735	_	_	_	_	_
600736	_	_	_	_	_
600737	_	_	_	_	_
600738	_	_	_	_	_
600739	_	_	_	_	_
600740	19q13.32	Hypocalciuric hypercalcemia, type III	600740	AD	3
600741	_	_	_	_	_
600742	_	_	_	_	_
600743	_	_	_	_	_
600744	_	_	_	_	_
600745	_	_	_	_	_
600746	_	_	_	_	_
600747	17q23.2	Vertebral anomalies and variable endocrine and T-cell dysfunction	618223	AD	3
600748	_	_	_	_	_
600749	14q11.2	Specific granule deficiency	245480	AR	3
600750	_	_	_	_	_
600751	_	_	_	_	_
600752	_	_	_	_	_
600753	_	_	_	_	_
600754	14q11.2	?Winchester syndrome	277950	_	3
600755	3p25.2	{Schizophrenia, susceptibility to}	181500	AD	3
600756	_	_	_	_	_
600757	19q13	Orofacial cleft 3	600757	?AD	2
600758	_	_	_	_	_
600759	1q42.13	Alzheimer disease-4	606889	AD	3
600759	1q42.13	Cardiomyopathy, dilated, 1V	613697	AD	3
600760	16p12.2	Bronchiectasis with or without elevated sweat chloride 1	211400	AD	3
600760	16p12.2	Liddle syndrome 1	177200	AD	3
600760	16p12.2	Pseudohypoaldosteronism, type I	264350	AR	3
600761	16p12.2	Bronchiectasis with or without elevated sweat chloride 3	613071	AD	3
600761	16p12.2	Liddle syndrome 2	618114	AD	3
600761	16p12.2	Pseudohypoaldosteronism, type I	264350	AR	3
600762	_	_	_	_	_
600763	_	_	_	_	_
600764	_	_	_	_	_
600765	_	_	_	_	_
600766	_	_	_	_	_
600767	_	_	_	_	_
600768	_	_	_	_	_
600769	_	_	_	_	_
600770	11p15.5	{Pulmonary fibrosis, idiopathic, susceptibility to}	178500	AD	3
600771	_	_	_	_	_
600772	_	_	_	_	_
600773	_	_	_	_	_
600774	1p13.3	Mental retardation, autosomal recessive 60	617432	AR	3
600775	19q13.2	Craniosynostosis 4	600775	AD	3
600776	_	_	_	_	_
600777	_	_	_	_	_
600778	12p13.1	Multiple endocrine neoplasia, type IV	610755	AD	3
600779	_	_	_	_	_
600780	_	_	_	_	_
600781	_	_	_	_	_
600782	_	_	_	_	_
600783	5q31.3	?Perrault syndrome 2	614926	AR	3
600784	_	_	_	_	_
600785	_	_	_	_	_
600786	_	_	_	_	_
600787	_	_	_	_	_
600788	_	_	_	_	_
600789	_	_	_	_	_
600790	6q14-q16.2	Chorioretinal atrophy, progressive bifocal	600790	AD	2
600791	_	_	_	_	_
600792	14q12	Deafness, autosomal recessive 5	600792	AR	2
600793	_	_	_	_	_
600794	_	_	_	_	_
600795	3p11.2	Dementia, familial, nonspecific	600795	AD	3
600796	_	_	_	_	_
600797	13q34	{Diabetes mellitus, noninsulin-dependent}	125853	AD	3
600798	_	_	_	_	_
600799	2q33.1-q33.2	Pulmonary hypertension, familial primary, 1, with or without HHT	178600	AD	3
600799	2q33.1-q33.2	Pulmonary hypertension, primary, fenfluramine or dexfenfluramine-associated	178600	AD	3
600799	2q33.1-q33.2	Pulmonary venoocclusive disease 1	265450	AD	3
600800	_	_	_	_	_
600801	_	_	_	_	_
600802	19p13.11	SCID, autosomal recessive, T-negative/B-positive type	600802	AR	3
600803	7q21.12	Gallbladder disease 1	600803	AD,AR	3
600804	11q14.3	{Diabetes mellitus, type 2, susceptibility to}	125853	AD	3
600805	18q11.2	Epidermolysis bullosa, generalized atrophic benign	226650	AR	3
600805	18q11.2	Epidermolysis bullosa, junctional, Herlitz type	226700	AR	3
600805	18q11.2	Laryngoonychocutaneous syndrome	245660	AR	3
600806	_	_	_	_	_
600807	_	_	_	_	_
600808	12q13-q21	Enuresis, nocturnal, 2	600808	AD	2
600809	_	_	_	_	_
600810	20p12.3-p12.2	Auriculocondylar syndrome 2	614669	AD,AR	3
600811	11p11.2	Xeroderma pigmentosum, group E, DDB-negative subtype	278740	AR	3
600812	_	_	_	_	_
600813	_	_	_	_	_
600814	11q21	Ataxia-telangiectasia-like disorder 1	604391	AR	3
600815	_	_	_	_	_
600816	_	_	_	_	_
600817	_	_	_	_	_
600818	_	_	_	_	_
600819	_	_	_	_	_
600820	11q23.3	Short stature, rhizomelic, with microcephaly, micrognathia, and developmental delay	617164	AD	3
600821	_	_	_	_	_
600822	_	_	_	_	_
600823	_	_	_	_	_
600824	11p15.1	?Cardiomyopathy, dilated, 1M	607482	_	3
600824	11p15.1	Cardiomyopathy, hypertrophic, 12	612124	AD	3
600825	15q22.2	Intellectual developmental disorder with or without epilepsy or cerebellar ataxia	618060	AD	3
600826	_	_	_	_	_
600827	10q23.33	Cone dystrophy 4	613093	AR	3
600828	_	_	_	_	_
600829	11q13.4	Opsismodysplasia	258480	AR	3
600830	_	_	_	_	_
600831	_	_	_	_	_
600832	_	_	_	_	_
600833	_	_	_	_	_
600834	_	_	_	_	_
600835	10q11.21	{AIDS, resistance to}	609423	_	3
600836	2q35	?Cataract 42	115900	AD	3
600837	5p13.2	Central hypoventilation syndrome	209880	AD	3
600837	5p13.2	{Hirschsprung disease, susceptibility to, 3}	613711	AD	3
600837	5p13.2	{Pheochromocytoma, modifier of}	171300	AD	3
600838	17q11.2	T-cell immunodeficiency, congenital alopecia, and nail dystrophy	601705	AR	3
600839	15q21.1	Bartter syndrome, type 1	601678	AR	3
600840	_	_	_	_	_
600841	_	_	_	_	_
600842	2p23.3	[Fasting plasma glucose level QTL 5]	613463	_	3
600843	_	_	_	_	_
600844	12q24.33	Deafness, autosomal dominant 41	608224	AD	3
600845	_	_	_	_	_
600846	_	_	_	_	_
600847	_	_	_	_	_
600848	_	_	_	_	_
600849	_	_	_	_	_
600850	22q11.21	{Schizophrenia, susceptibility to, 4}	600850	AD	3
600851	_	_	_	_	_
600852	17q23.1	Retinitis pigmentosa 17	600852	AD	3
600853	5q33.1	Mental retardation, autosomal recessive 46	616116	AR	3
600854	_	_	_	_	_
600855	21q22.13	Mental retardation, autosomal dominant 7	614104	AD	3
600856	11p15.4	Beckwith-Wiedemann syndrome	130650	AD	3
600856	11p15.4	IMAGE syndrome	614732	AD	3
600857	5p15.33	Cardiomyopathy, dilated, 1GG	613642	_	3
600857	5p15.33	Leigh syndrome	256000	Mi,AR	3
600857	5p15.33	Mitochondrial respiratory chain complex II deficiency	252011	AR	3
600857	5p15.33	Paragangliomas 5	614165	AD	3
600858	7q36.1	Cardiomyopathy, hypertrophic 6	600858	AD	3
600859	7p22.1	Leukodystrophy, hypomyelinating, 17	618006	AR	3
600860	_	_	_	_	_
600861	_	_	_	_	_
600862	_	_	_	_	_
600863	_	_	_	_	_
600864	17q25.3	Advanced sleep-phase syndrome, familial, 2	615224	AD	3
600865	_	_	_	_	_
600866	_	_	_	_	_
600867	_	_	_	_	_
600868	_	_	_	_	_
600869	_	_	_	_	_
600870	_	_	_	_	_
600871	1p22.1	?Neutropenia, nonimmune chronic idiopathic, of adults	607847	AD	3
600871	1p22.1	?Neutropenia, severe congenital 2, autosomal dominant	613107	AD	3
600872	_	_	_	_	_
600873	_	_	_	_	_
600874	_	_	_	_	_
600875	_	_	_	_	_
600876	_	_	_	_	_
600877	21q22.13	Keppen-Lubinsky syndrome	614098	AD	3
600878	_	_	_	_	_
600879	_	_	_	_	_
600880	_	_	_	_	_
600881	17q11.2	Cataract 10, multiple types	600881	AD	3
600882	3q21.3	Charcot-Marie-Tooth disease, type 2B	600882	AD	3
600883	6q25-q27	{Diabetes mellitus, insulin-dependent, 8}	600883	_	2
600884	9q13	Cardiomyopathy, dilated 1B	600884	AD	2
600885	_	_	_	_	_
600886	19q13.33	Hyperferritinemia-cataract syndrome	600886	AD	3
600887	5q14.1	Endometrial carcinoma, somatic	608089	_	3
600887	5q14.1	Familial adenomatous polyposis 4	617100	AR	3
600888	_	_	_	_	_
600889	_	_	_	_	_
600890	2p23.3	Fatty liver, acute, of pregnancy	609016	AR	3
600890	2p23.3	HELLP syndrome, maternal, of pregnancy	609016	AR	3
600890	2p23.3	LCHAD deficiency	609016	AR	3
600890	2p23.3	Trifunctional protein deficiency	609015	AR	3
600891	_	_	_	_	_
600892	_	_	_	_	_
600893	_	_	_	_	_
600894	_	_	_	_	_
600895	_	_	_	_	_
600896	_	_	_	_	_
600897	1q21.2	Cataract 1, multiple types	116200	AD	3
600898	2p25.2	Mental retardation, autosomal dominant 27	615866	AD	3
600899	8q11.21	Immunodeficiency 26, with or without neurologic abnormalities	615966	AR	3
600900	4q12	Muscular dystrophy, limb-girdle, autosomal recessive 4	604286	AR	3
600901	6p21.31	Fanconi anemia, complementation group E	600901	AR	3
600902	_	_	_	_	_
600903	_	_	_	_	_
600904	_	_	_	_	_
600905	_	_	_	_	_
600906	_	_	_	_	_
600907	_	_	_	_	_
600908	_	_	_	_	_
600909	21q22.3	Cataract 44	616509	AR	3
600909	21q22.3	Hypotrichosis 14	618275	AR	3
600910	_	_	_	_	_
600911	_	_	_	_	_
600912	_	_	_	_	_
600913	_	_	_	_	_
600914	_	_	_	_	_
600915	_	_	_	_	_
600916	_	_	_	_	_
600917	7q31.1	Insulin resistance, severe, digenic	125853	AD	3
600918	_	_	_	_	_
600919	_	_	_	_	_
600920	22q11.21	Van den Ende-Gupta syndrome	600920	AR	3
600921	13q12.11	Multiple synostoses syndrome 3	612961	AD	3
600922	3q21.1	Aortic aneurysm, familial thoracic 7	613780	AD	3
600923	1q23.3	Porphyria variegata	176200	AD	3
600924	16p13.3	Myopathy, mitochondrial progressive, with congenital cataract, hearing loss, and developmental delay	613076	_	3
600925	11p11.2	Colon cancer, somatic	114500	_	3
600926	_	_	_	_	_
600927	_	_	_	_	_
600928	16p13.3	Epilepsy, familial focal, with variable foci 3	617118	AD	3
600929	22q12.1	Cataract 17, multiple types	611544	AD,AR	3
600930	_	_	_	_	_
600931	_	_	_	_	_
600932	_	_	_	_	_
600933	_	_	_	_	_
600934	_	_	_	_	_
600935	_	_	_	_	_
600936	5q34	{Breast cancer, susceptibility to}	114480	AD,SMu	3
600937	11p15.1	Diabetes mellitus, transient neonatal, 3	610582	AD	3
600937	11p15.1	Diabetes, permanent neonatal, with or without neurologic features	606176	AD,AR	3
600937	11p15.1	Hyperinsulinemic hypoglycemia, familial, 2	601820	AR	3
600937	11p15.1	Maturity-onset diabetes of the young, type 13	616329	AD	3
600937	11p15.1	{Diabetes mellitus, type 2, susceptibility to}	125853	AD	3
600938	_	_	_	_	_
600939	9p13.3	Craniosynostosis and dental anomalies	614188	AR	3
600940	_	_	_	_	_
600941	_	_	_	_	_
600942	_	_	_	_	_
600943	11q13.5	Osteogenesis imperfecta, type X	613848	AR	3
600943	11q13.5	{Preterm premature rupture of the membranes, susceptibility to}	610504	_	3
600944	19p13.13	Neurodevelopmental disorder with seizures and speech and walking impairment	618480	_	3
600945	_	_	_	_	_
600946	5p13-p12	Growth hormone insensitivity, partial	604271	AD	3
600946	5p13-p12	Increased responsiveness to growth hormone	604271	AD	3
600946	5p13-p12	Laron dwarfism	262500	AR	3
600946	5p13-p12	{Hypercholesterolemia, familial, modifier of}	143890	AD	3
600947	_	_	_	_	_
600948	_	_	_	_	_
600949	_	_	_	_	_
600950	_	_	_	_	_
600951	_	_	_	_	_
600952	_	_	_	_	_
600953	_	_	_	_	_
600954	_	_	_	_	_
600955	5q15	Obesity with impaired prohormone processing	600955	AR	3
600956	12q13.13	Persistent Mullerian duct syndrome, type II	261550	AR	3
600957	19p13.3	Persistent Mullerian duct syndrome, type I	261550	AR	3
600958	11p11.2	Cardiomyopathy, dilated, 1MM	615396	AD	3
600958	11p11.2	Cardiomyopathy, hypertrophic, 4	115197	AD	3
600958	11p11.2	Left ventricular noncompaction 10	615396	AD	3
600959	_	_	_	_	_
600960	9q34.11	Mental retardation, autosomal dominant 58	618106	AD	3
600961	_	_	_	_	_
600962	12q13.13	Palmoplantar keratoderma, nonepidermolytic	600962	AD	3
600963	19q13.32	Branchiootorenal syndrome 2	610896	_	3
600964	_	_	_	_	_
600965	4p16.1	Deafness, autosomal dominant 6/14/38	600965	AD	3
600966	_	_	_	_	_
600967	_	_	_	_	_
600968	16q13	Gitelman syndrome	263800	AR	3
600969	20q13.33	Epiphyseal dysplasia, multiple, 3, with or without myopathy	600969	AD	3
600970	6q14.1	Deafness, autosomal dominant 22	606346	AD	3
600970	6q14.1	Deafness, autosomal dominant 22, with hypertrophic cardiomyopathy	606346	AD	3
600970	6q14.1	Deafness, autosomal recessive 37	607821	AR	3
600971	3p21.31	Deafness, autosomal recessive 6	600971	AR	3
600972	5q32	Achondrogenesis Ib	600972	AR	3
600973	_	_	_	_	_
600974	9q21.13	Deafness, autosomal recessive 7	600974	AR	3
600975	1p36.2-p36.1	Glaucoma 3, primary infantile, B	600975	AR	2
600976	_	_	_	_	_
600977	17p13.2-p13.1	Cone-rod dystrophy 5	600977	AD	3
600978	_	_	_	_	_
600979	_	_	_	_	_
600980	4q22.1	Hypophosphatemic rickets, AR	241520	AR	3
600981	_	_	_	_	_
600982	5q11.2	46XY sex reversal 6	613762	AD	3
600983	4q31.23	Hypertension, early-onset, autosomal dominant, with exacerbation in pregnancy	605115	_	3
600983	4q31.23	Pseudohypoaldosteronism type I, autosomal dominant	177735	AD	3
600984	_	_	_	_	_
600985	6p21.33-p21.32	Ehlers-Danlos syndrome, classic-like, 1	606408	AR	3
600985	6p21.33-p21.32	Vesicoureteral reflux 8	615963	AD	3
600986	_	_	_	_	_
600987	15q14	Cleft palate, cardiac defects, and mental retardation	600987	AD	3
600988	_	_	_	_	_
600989	_	_	_	_	_
600990	_	_	_	_	_
600991	_	_	_	_	_
600992	_	_	_	_	_
600993	18q21.2	Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome	175050	AD	3
600993	18q21.2	Myhre syndrome	139210	AD	3
600993	18q21.2	Pancreatic cancer, somatic	260350	_	3
600993	18q21.2	Polyposis, juvenile intestinal	174900	AD	3
600994	7p15.3	Deafness, autosomal dominant 5	600994	AD	3
600995	1q25.2	Nephrotic syndrome, type 2	600995	AR	3
600996	1q43	Arrhythmogenic right ventricular dysplasia 2	600996	AD	3
600997	1p36.12	?Bleeding disorder, platelet-type, 22	618462	AR	3
600997	1p36.12	{Prostate cancer/brain cancer susceptibility, somatic}	603688	_	3
600998	9q21.2	Capillary malformations, congenital, 1, somatic, mosaic	163000	_	3
600998	9q21.2	Sturge-Weber syndrome, somatic, mosaic	185300	_	3
600999	_	_	_	_	_
601000	_	_	_	_	_
601001	_	_	_	_	_
601002	20q11.22	Glutathione synthetase deficiency	266130	AR	3
601002	20q11.22	Hemolytic anemia due to glutathione synthetase deficiency	231900	AR	3
601003	16p11.2	Brody myopathy	601003	AR	3
601004	_	_	_	_	_
601005	12p13.33	Timothy syndrome	601005	AD	3
601006	_	_	_	_	_
601007	1p31.3	Obesity, morbid, due to leptin receptor deficiency	614963	AR	3
601008	_	_	_	_	_
601009	_	_	_	_	_
601010	_	_	_	_	_
601011	19p13.13	Epileptic encephalopathy, early infantile, 42	617106	AD	3
601011	19p13.13	Episodic ataxia, type 2	108500	AD	3
601011	19p13.13	Migraine, familial hemiplegic, 1	141500	AD	3
601011	19p13.13	Migraine, familial hemiplegic, 1, with progressive cerebellar ataxia	141500	AD	3
601011	19p13.13	Spinocerebellar ataxia 6	183086	AD	3
601012	_	_	_	_	_
601013	1q25.3	Epileptic encephalopathy, early infantile, 69	618285	AD	3
601014	_	_	_	_	_
601015	14q24.3	Niemann-pick disease, type C2	607625	AR	3
601016	_	_	_	_	_
601017	20q11.21	Long QT syndrome 12	612955	AD	3
601018	_	_	_	_	_
601019	1p34.1	Glycine encephalopathy with normal serum glycine	617301	AR	3
601020	_	_	_	_	_
601021	_	_	_	_	_
601022	6p21.33	{Rheumatoid arthritis, susceptibility to}	180300	_	3
601023	9p13.3	Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	613954	_	3
601023	9p13.3	Charcot-Marie-Tooth disease, type 2Y	616687	AD	3
601023	9p13.3	Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia 1	167320	AD	3
601024	_	_	_	_	_
601025	_	_	_	_	_
601026	_	_	_	_	_
601027	_	_	_	_	_
601028	_	_	_	_	_
601029	_	_	_	_	_
601030	_	_	_	_	_
601031	_	_	_	_	_
601032	_	_	_	_	_
601033	_	_	_	_	_
601034	_	_	_	_	_
601035	_	_	_	_	_
601036	_	_	_	_	_
601037	_	_	_	_	_
601038	_	_	_	_	_
601039	_	_	_	_	_
601040	12q24.31	[High density lipoprotein cholesterol level QTL6]	610762	_	3
601041	_	_	_	_	_
601042	1p34.2	Dystonia 9	601042	AD	3
601043	_	_	_	_	_
601044	_	_	_	_	_
601045	11q12.1	Blepharocheilodontic syndrome 2	617681	AD	3
601046	_	_	_	_	_
601047	7q31.2	?Lipodystrophy, congenital generalized, type 3	612526	AR	3
601047	7q31.2	Lipodystrophy, familial partial, type 7	606721	AD	3
601047	7q31.2	Pulmonary hypertension, primary, 3	615343	AD	3
601048	_	_	_	_	_
601049	_	_	_	_	_
601050	_	_	_	_	_
601051	_	_	_	_	_
601052	_	_	_	_	_
601053	_	_	_	_	_
601054	_	_	_	_	_
601055	_	_	_	_	_
601056	_	_	_	_	_
601057	_	_	_	_	_
601058	_	_	_	_	_
601059	_	_	_	_	_
601060	_	_	_	_	_
601061	_	_	_	_	_
601062	_	_	_	_	_
601063	_	_	_	_	_
601064	_	_	_	_	_
601065	16q22.1	Charcot-Marie-Tooth disease, axonal, type 2N	613287	AD	3
601065	16q22.1	Epileptic encephalopathy, early infantile, 29	616339	AR	3
601066	_	_	_	_	_
601067	_	_	_	_	_
601068	8q24.11-q24.12	Epilepsy, familial adult myoclonic, 1	601068	AD	3
601069	_	_	_	_	_
601070	_	_	_	_	_
601071	_	_	_	_	_
601072	21q22.3	Deafness, autosomal recessive 8/10	601072	AR	3
601073	_	_	_	_	_
601074	_	_	_	_	_
601075	_	_	_	_	_
601076	_	_	_	_	_
601077	_	_	_	_	_
601078	_	_	_	_	_
601079	_	_	_	_	_
601080	_	_	_	_	_
601081	_	_	_	_	_
601082	_	_	_	_	_
601083	_	_	_	_	_
601084	_	_	_	_	_
601085	_	_	_	_	_
601086	_	_	_	_	_
601087	_	_	_	_	_
601088	16q23.2	Ayme-Gripp syndrome	601088	AD	3
601089	16q24.1	Alveolar capillary dysplasia with misalignment of pulmonary veins	265380	AD	3
601090	6p25.3	Anterior segment dysgenesis 3, multiple subtypes	601631	AD	3
601090	6p25.3	Axenfeld-Rieger syndrome, type 3	602482	AD	3
601091	_	_	_	_	_
601092	_	_	_	_	_
601093	5q35.1	Enlarged vestibular aqueduct	600791	AR	3
601094	1p33	Anterior segment dysgenesis 2, multiple subtypes	610256	AR	3
601094	1p33	Cataract 34, multiple types	612968	_	3
601094	1p33	{Aortic aneurysm, familial thoracic 11, susceptibility to}	617349	AD	3
601095	_	_	_	_	_
601096	_	_	_	_	_
601097	17p12	?Neuropathy, inflammatory demyelinating	139393	?AD	3
601097	17p12	Charcot-Marie-Tooth disease, type 1A	118220	AD	3
601097	17p12	Charcot-Marie-Tooth disease, type 1E	118300	AD	3
601097	17p12	Dejerine-Sottas disease	145900	AD,AR	3
601097	17p12	Neuropathy, recurrent, with pressure palsies	162500	AD	3
601097	17p12	Roussy-Levy syndrome	180800	AD	3
601098	16p13.13	Charcot-Marie-Tooth disease, type 1C	601098	AD	3
601099	_	_	_	_	_
601100	_	_	_	_	_
601101	5q31.3-q32	Telangiectasia, hereditary hemorrhagic, type 3	601101	_	2
601102	_	_	_	_	_
601103	12p13.31	Aortic aneurysm, familial thoracic 9	616166	AD	3
601104	17q21.31	Supranuclear palsy, progressive	601104	AD	3
601105	1q21.3	Pycnodysostosis	265800	AR	3
601106	_	_	_	_	_
601107	10q24.2	Dubin-Johnson syndrome	237500	AR	3
601108	_	_	_	_	_
601109	_	_	_	_	_
601110	3q27.1	Congenital disorder of glycosylation, type Id	601110	AR	3
601111	_	_	_	_	_
601112	_	_	_	_	_
601113	_	_	_	_	_
601114	_	_	_	_	_
601115	_	_	_	_	_
601116	_	_	_	_	_
601117	_	_	_	_	_
601118	_	_	_	_	_
601119	19p13.3	Perrault syndrome 3	614129	AR	3
601120	_	_	_	_	_
601121	_	_	_	_	_
601122	_	_	_	_	_
601123	_	_	_	_	_
601124	_	_	_	_	_
601125	_	_	_	_	_
601126	_	_	_	_	_
601127	_	_	_	_	_
601128	_	_	_	_	_
601129	10q23.33	{Drug metabolism, altered, CYP2C8-related}	618018	_	3
601130	10q23.33	Tolbutamide poor metabolizer	_	_	3
601130	10q23.33	Warfarin sensitivity	122700	AD	3
601131	_	_	_	_	_
601132	_	_	_	_	_
601133	_	_	_	_	_
601134	11q24.2	?Congenital disorder of glycosylation, type Iw	615596	AR	3
601135	_	_	_	_	_
601136	_	_	_	_	_
601137	_	_	_	_	_
601138	_	_	_	_	_
601139	_	_	_	_	_
601140	_	_	_	_	_
601141	_	_	_	_	_
601142	_	_	_	_	_
601143	2p13.1	Neuropathy, distal hereditary motor, type VIIB	607641	AD	3
601143	2p13.1	Perry syndrome	168605	AD	3
601143	2p13.1	{Amyotrophic lateral sclerosis, susceptibility to}	105400	AD,AR	3
601144	3p22.2	Brugada syndrome 1	601144	AD	3
601145	21q22.3	Epilepsy, progressive myoclonic 1A (Unverricht and Lundborg)	254800	AR	3
601146	20q11.22	?Acromesomelic dysplasia, Hunter-Thompson type	201250	AR	3
601146	20q11.22	Brachydactyly, type A1, C	615072	AD,AR	3
601146	20q11.22	Brachydactyly, type A2	112600	AD	3
601146	20q11.22	Brachydactyly, type C	113100	AD	3
601146	20q11.22	Chondrodysplasia, Grebe type	200700	AR	3
601146	20q11.22	Du Pan syndrome	228900	AR	3
601146	20q11.22	Multiple synostoses syndrome 2	610017	AD	3
601146	20q11.22	Symphalangism, proximal, 1B	615298	_	3
601146	20q11.22	{Osteoarthritis-5}	612400	_	3
601147	8q22.1	Klippel-Feil syndrome 1, autosomal dominant	118100	AD	3
601147	8q22.1	Leber congenital amaurosis 17	615360	AR	3
601147	8q22.1	Microphthalmia with coloboma 6, digenic	613703	AD	3
601147	8q22.1	Microphthalmia, isolated 4	613094	_	3
601147	8q22.1	Multiple synostoses syndrome 4	617898	AD	3
601148	_	_	_	_	_
601149	_	_	_	_	_
601150	12p11.21	Warsaw breakage syndrome	613398	AR	3
601151	_	_	_	_	_
601152	1p36.22	Hereditary motor and sensory neuropathy VIA	601152	AD	3
601153	_	_	_	_	_
601154	3p22.2	Cardiomyopathy, dilated, 1E	601154	AD	3
601155	_	_	_	_	_
601156	17q12	{Asthma, susceptibility to}	600807	AD	3
601156	17q12	{HIV1, resistance to}	609423	_	3
601157	_	_	_	_	_
601158	_	_	_	_	_
601159	_	_	_	_	_
601160	_	_	_	_	_
601161	_	_	_	_	_
601162	10q24.1	Spastic paraplegia 9A, autosomal dominant	601162	AD	3
601163	_	_	_	_	_
601164	_	_	_	_	_
601165	_	_	_	_	_
601166	_	_	_	_	_
601167	_	_	_	_	_
601168	_	_	_	_	_
601169	_	_	_	_	_
601170	_	_	_	_	_
601171	_	_	_	_	_
601172	_	_	_	_	_
601173	_	_	_	_	_
601174	_	_	_	_	_
601175	_	_	_	_	_
601176	1p22.1	{Myocardial infarction, susceptibility to}	608446	_	3
601177	_	_	_	_	_
601178	_	_	_	_	_
601179	_	_	_	_	_
601180	_	_	_	_	_
601181	2q13	{Encephalopathy, acute, infection-induced, 3, susceptibility to}	608033	AD	3
601182	_	_	_	_	_
601183	_	_	_	_	_
601184	13q32.1	?Ataxia, combined cerebellar and peripheral, with hearing loss and diabetes mellitus	616192	AR	3
601185	_	_	_	_	_
601186	_	_	_	_	_
601187	_	_	_	_	_
601188	10pter-q11	Prostate adenocarcinoma	601188	_	2
601189	_	_	_	_	_
601190	12p12.3	Achromatopsia 6	610024	AD,AR	3
601190	12p12.3	Retinal cone dystrophy 3	610024	AD,AR	3
601191	_	_	_	_	_
601192	1p36.13	[Fleck retina, familial benign]	228980	AR	3
601193	_	_	_	_	_
601194	4p14	{Leprosy, protection against}	613223	_	3
601194	4p14	{Leprosy, susceptibility to, 5}	613223	_	3
601195	_	_	_	_	_
601196	_	_	_	_	_
601197	11p15.4	?Retinal dystrophy and obesity	616188	AR	3
601198	_	_	_	_	_
601199	3q13.3-q21.1	Hyperparathyroidism, neonatal	239200	AD,AR	3
601199	3q13.3-q21.1	Hypocalcemia, autosomal dominant	601198	AD	3
601199	3q13.3-q21.1	Hypocalcemia, autosomal dominant, with Bartter syndrome	601198	AD	3
601199	3q13.3-q21.1	Hypocalciuric hypercalcemia, type I	145980	AD	3
601199	3q13.3-q21.1	{Epilepsy idiopathic generalized, susceptibility to, 8}	612899	_	3
601200	14q32.13	Pleuropulmonary blastoma	601200	AD	3
601201	_	_	_	_	_
601202	17p13	Cataract 24, anterior polar	601202	AD	2
601203	_	_	_	_	_
601204	_	_	_	_	_
601205	14q23.1	Branchiootic syndrome 3	608389	AD	3
601205	14q23.1	Deafness, autosomal dominant 23	605192	AD	3
601206	_	_	_	_	_
601207	_	_	_	_	_
601208	14q24.3-q31	{Diabetes mellitus, insulin-dependent, 11}	601208	_	2
601209	_	_	_	_	_
601210	_	_	_	_	_
601211	_	_	_	_	_
601212	_	_	_	_	_
601213	_	_	_	_	_
601214	17q21.2	Naxos disease	601214	AR	3
601215	3q23	?Cutaneous telangiectasia and cancer syndrome, familial	614564	AD	3
601215	3q23	Seckel syndrome 1	210600	AR	3
601216	11q13.1	Dental anomalies and short stature	601216	AR	3
601217	_	_	_	_	_
601218	_	_	_	_	_
601219	_	_	_	_	_
601220	_	_	_	_	_
601221	_	_	_	_	_
601222	_	_	_	_	_
601223	_	_	_	_	_
601224	11p11.2	Potocki-Shaffer syndrome	601224	_	4
601225	_	_	_	_	_
601226	_	_	_	_	_
601227	_	_	_	_	_
601228	15q15.3-q22.1	Polyposis syndrome, mixed hereditary 1	601228	AD	4
601228	15q15.3-q22.1	{Colorectal cancer, susceptibility to, 4}	601228	AD	4
601229	_	_	_	_	_
601230	_	_	_	_	_
601231	1p36.22	Focal cortical dysplasia, type II, somatic	607341	_	3
601231	1p36.22	Smith-Kingsmore syndrome	616638	AD	3
601232	_	_	_	_	_
601233	_	_	_	_	_
601234	_	_	_	_	_
601235	_	_	_	_	_
601236	_	_	_	_	_
601237	_	_	_	_	_
601238	19p13.3	Ataxia, cerebellar, Cayman type	601238	AR	3
601239	18q12.1	Left ventricular noncompaction 1, with or without congenital heart defects	604169	AD	3
601240	19p13.3	Cerebral creatine deficiency syndrome 2	612736	AR	3
601241	_	_	_	_	_
601242	_	_	_	_	_
601243	17p11.2	?Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 5	618098	AR	3
601243	17p11.2	Microcephaly, growth restriction, and increased sister chromatid exchange 2	618097	AR	3
601244	_	_	_	_	_
601245	_	_	_	_	_
601246	_	_	_	_	_
601247	14q21.3	Noonan syndrome 9	616559	AD	3
601248	2q14.3	Centronuclear myopathy 2	255200	AR	3
601249	_	_	_	_	_
601250	_	_	_	_	_
601251	_	_	_	_	_
601252	_	_	_	_	_
601253	3p25.3	Cardiomyopathy, familial hypertrophic	192600	AD	3
601253	3p25.3	Creatine phosphokinase, elevated serum	123320	AD	3
601253	3p25.3	Long QT syndrome 9	611818	AD	3
601253	3p25.3	Myopathy, distal, Tateyama type	614321	AD	3
601253	3p25.3	Rippling muscle disease 2	606072	AD	3
601254	_	_	_	_	_
601255	2q37.3	Mental retardation, autosomal dominant 9	614255	AD	3
601255	2q37.3	Neuropathy, hereditary sensory, type IIC	614213	AR	3
601255	2q37.3	Spastic paraplegia 30, autosomal recessive	610357	AR	3
601256	_	_	_	_	_
601257	_	_	_	_	_
601258	_	_	_	_	_
601259	4q13.3	Amelogenesis imperfecta, type IF	616270	AR	3
601260	_	_	_	_	_
601261	_	_	_	_	_
601262	_	_	_	_	_
601263	19p13.3	Cardiofaciocutaneous syndrome 4	615280	_	3
601264	_	_	_	_	_
601265	10q22.1	Heterotaxy, visceral, 5	270100	AD	3
601266	_	_	_	_	_
601267	3p21.31	{HIV infection, susceptibility/resistance to}	_	_	3
601268	_	_	_	_	_
601269	17p13.2	Combined oxidative phosphorylation deficiency 33	617713	AR	3
601270	_	_	_	_	_
601271	_	_	_	_	_
601272	_	_	_	_	_
601273	_	_	_	_	_
601274	_	_	_	_	_
601275	_	_	_	_	_
601276	_	_	_	_	_
601277	2q35	Ichthyosis, congenital, autosomal recessive 4A	601277	AR	3
601278	_	_	_	_	_
601279	_	_	_	_	_
601280	13q13.3	Cerebellar, ocular, craniofacial, and genital syndrome	618479	AR	3
601281	_	_	_	_	_
601282	8q24.3	?Epidermolysis bullosa simplex with nail dystrophy	616487	AR	3
601282	8q24.3	Epidermolysis bullosa simplex with muscular dystrophy	226670	AR	3
601282	8q24.3	Epidermolysis bullosa simplex with pyloric atresia	612138	AR	3
601282	8q24.3	Epidermolysis bullosa simplex, Ogna type	131950	AD	3
601282	8q24.3	Muscular dystrophy, limb-girdle, autosomal recessive 17	613723	AR	3
601283	2q37.3	{Diabetes mellitus, noninsulin-dependent 1}	601283	_	3
601284	12q13.13	Telangiectasia, hereditary hemorrhagic, type 2	600376	AD	3
601285	_	_	_	_	_
601286	_	_	_	_	_
601287	5q33.2-q33.3	Muscular dystrophy, limb-girdle, autosomal recessive 6	601287	AR	3
601288	8q22.3	Popov-Chang syndrome	618428	AD	3
601289	_	_	_	_	_
601290	_	_	_	_	_
601291	_	_	_	_	_
601292	_	_	_	_	_
601293	_	_	_	_	_
601294	_	_	_	_	_
601295	13q33.1	Bile acid malabsorption, primary	613291	AR	3
601296	9q31.3	Fetal akinesia deformation sequence 1	208150	AR	3
601296	9q31.3	Myasthenic syndrome, congenital, 9, associated with acetylcholine receptor deficiency	616325	AR	3
601297	_	_	_	_	_
601298	_	_	_	_	_
601299	10q23.2	Juvenile polyposis syndrome, infantile form	174900	AD	3
601299	10q23.2	Polyposis syndrome, hereditary mixed, 2	610069	_	3
601299	10q23.2	Polyposis, juvenile intestinal	174900	AD	3
601300	12q13.13	Pancreatic cancer, somatic	_	_	3
601301	_	_	_	_	_
601302	_	_	_	_	_
601303	_	_	_	_	_
601304	_	_	_	_	_
601305	_	_	_	_	_
601306	_	_	_	_	_
601307	_	_	_	_	_
601308	_	_	_	_	_
601309	9q22.32	Basal cell carcinoma, somatic	605462	_	3
601309	9q22.32	Basal cell nevus syndrome	109400	AD	3
601309	9q22.32	Holoprosencephaly 7	610828	AD	3
601310	_	_	_	_	_
601311	_	_	_	_	_
601312	_	_	_	_	_
601313	16p13.3	Polycystic kidney disease 1	173900	AD	3
601314	5q23.3	Neuromyotonia and axonal neuropathy, autosomal recessive	137200	AR	3
601315	_	_	_	_	_
601316	6q23.2	Deafness, autosomal dominant 10	601316	AD	3
601317	11q13.5	Deafness, autosomal dominant 11	601317	AD	3
601318	2q34	{Diabetes mellitus, insulin-dependent, 13}	601318	_	2
601319	_	_	_	_	_
601320	_	_	_	_	_
601321	17q11.2	Neurofibromatosis-Noonan syndrome	601321	AD	3
601322	_	_	_	_	_
601323	_	_	_	_	_
601324	_	_	_	_	_
601325	_	_	_	_	_
601326	_	_	_	_	_
601327	11q23.3	Atrial fibrillation, familial, 14	615378	AD	3
601328	_	_	_	_	_
601329	_	_	_	_	_
601330	12p12.3	Diarrhea 6	614616	AD	3
601330	12p12.3	Meconium ileus	614665	AR	3
601331	10q21.1	{Renal dysplasia, cystic, susceptibility to}	601331	AD	3
601332	_	_	_	_	_
601333	_	_	_	_	_
601334	_	_	_	_	_
601335	_	_	_	_	_
601336	2p13.1	Congenital disorder of glycosylation, type IIb	606056	AR	3
601337	_	_	_	_	_
601338	19q13.2	CAPOS syndrome	601338	AD	3
601339	_	_	_	_	_
601340	_	_	_	_	_
601341	_	_	_	_	_
601342	_	_	_	_	_
601343	_	_	_	_	_
601344	_	_	_	_	_
601345	_	_	_	_	_
601346	_	_	_	_	_
601347	_	_	_	_	_
601348	_	_	_	_	_
601349	6q21	Microphthalmia, syndromic 8	601349	?AD	2
601350	_	_	_	_	_
601351	_	_	_	_	_
601352	_	_	_	_	_
601353	_	_	_	_	_
601354	_	_	_	_	_
601355	_	_	_	_	_
601356	_	_	_	_	_
601357	_	_	_	_	_
601358	9p24.3	Nicolaides-Baraitser syndrome	601358	AD	3
601359	_	_	_	_	_
601360	_	_	_	_	_
601361	_	_	_	_	_
601362	10p14-p13	DiGeorge syndrome/velocardiofacial syndrome complex-2	601362	_	2
601363	17q12-q21	Wilms tumor, type 4	601363	AD	2
601364	_	_	_	_	_
601365	1p36.33	Robinow syndrome, autosomal dominant 2	616331	AD	3
601366	_	_	_	_	_
601367	_	_	_	_	_
601368	3q27.1	Robinow syndrome, autosomal dominant 3	616894	AD	3
601369	14q12	Deafness, autosomal dominant 9	601369	AD	3
601370	_	_	_	_	_
601371	_	_	_	_	_
601372	_	_	_	_	_
601373	3p21.31	{Diabetes mellitus, insulin-dependent, 22}	612522	_	3
601373	3p21.31	{Hepatitis C virus, resistance to}	609532	_	3
601373	3p21.31	{HIV infection, susceptibility/resistance to}	_	_	3
601373	3p21.31	{West nile virus, susceptibility to}	610379	_	3
601374	_	_	_	_	_
601375	_	_	_	_	_
601376	_	_	_	_	_
601377	_	_	_	_	_
601378	_	_	_	_	_
601379	_	_	_	_	_
601380	_	_	_	_	_
601381	_	_	_	_	_
601382	11q21	Charcot-Marie-Tooth disease, type 4B1	601382	AR	3
601383	_	_	_	_	_
601384	_	_	_	_	_
601385	8p22	Mental retardation, autosomal recessive 7	611093	AR	3
601386	_	_	_	_	_
601387	_	_	_	_	_
601388	2q33.2	{Diabetes mellitus, insulin-dependent, 12}	601388	_	3
601389	_	_	_	_	_
601390	11p15.4	Van Maldergem syndrome 1	601390	AR	3
601391	_	_	_	_	_
601392	_	_	_	_	_
601393	_	_	_	_	_
601394	_	_	_	_	_
601395	17q11.2	{HIV/AIDS, susceptibility to}	609423	_	3
601396	_	_	_	_	_
601397	6q27	Sacral agenesis with vertebral anomalies	615709	AR	3
601397	6q27	{Neural tube defects, susceptibility to}	182940	AD	3
601398	_	_	_	_	_
601399	21q22.12	Platelet disorder, familial, with associated myeloid malignancy	601399	AD	3
601400	_	_	_	_	_
601401	_	_	_	_	_
601402	3q25.32	Leukemia, acute myeloid	601626	AD,SMu	1
601403	_	_	_	_	_
601404	14q32.11	Amelogenesis imperfecta, hypomaturation type, IIA6	617217	AR	3
601405	1p36.21	{Pancreatitis, chronic, susceptibility to}	167800	AD	3
601406	12q24.31	B-cell non-Hodgkin lymphoma, high-grade	_	_	3
601407	12q24.2	Diabetes mellitus, noninsulin-dependent, 2	601407	_	2
601408	8p11.21	Mental retardation, autosomal dominant 32	616268	AD	3
601409	_	_	_	_	_
601410	6q24	{Diabetes mellitus, transient neonatal, 1}	601410	AD	4
601411	5q33.2-q33.3	Cardiomyopathy, dilated, 1L	606685	_	3
601411	5q33.2-q33.3	Muscular dystrophy, limb-girdle, autosomal recessive 6	601287	AR	3
601412	1q21-q23	Deafness, autosomal dominant 7	601412	AD	2
601413	_	_	_	_	_
601414	1q21.2	Retinitis pigmentosa 18	601414	AD	3
601415	_	_	_	_	_
601416	_	_	_	_	_
601417	_	_	_	_	_
601418	_	_	_	_	_
601419	2q35	Myopathy, myofibrillar, 1	601419	AD,AR	3
601420	_	_	_	_	_
601421	16q23.1	?Charcot-Marie-Tooth disease, recessive intermediate, B	613641	AR	3
601421	16q23.1	Deafness, autosomal recessive 89	613916	AR	3
601422	_	_	_	_	_
601423	_	_	_	_	_
601424	5p13.1	Succinyl CoA:3-oxoacid CoA transferase deficiency	245050	_	3
601425	_	_	_	_	_
601426	_	_	_	_	_
601427	_	_	_	_	_
601428	2q14.2	Microcephalic osteodysplastic primordial dwarfism, type I	210710	AR	3
601428	2q14.2	Roifman syndrome	616651	AR	3
601429	_	_	_	_	_
601430	_	_	_	_	_
601431	_	_	_	_	_
601432	_	_	_	_	_
601433	_	_	_	_	_
601434	_	_	_	_	_
601435	_	_	_	_	_
601436	_	_	_	_	_
601437	_	_	_	_	_
601438	_	_	_	_	_
601439	12p12.1	Atrial fibrillation, familial, 12	614050	AD	3
601439	12p12.1	Cardiomyopathy, dilated, 1O	608569	_	3
601439	12p12.1	Hypertrichotic osteochondrodysplasia	239850	AD	3
601440	17q22	Nephrotic syndrome, type 7	615008	AR	3
601440	17q22	{Hemolytic uremic syndrome, atypical, susceptibility to, 7}	615008	AR	3
601441	_	_	_	_	_
601442	_	_	_	_	_
601443	14q13.1	Nemaline myopathy 7, autosomal recessive	610687	AR	3
601444	_	_	_	_	_
601445	8q24.13	?Mitochondrial complex I deficiency, nuclear type 24	618245	AR	3
601446	_	_	_	_	_
601447	_	_	_	_	_
601448	_	_	_	_	_
601449	_	_	_	_	_
601450	_	_	_	_	_
601451	_	_	_	_	_
601452	_	_	_	_	_
601453	_	_	_	_	_
601454	4q	{Psoriasis susceptibility 3}	601454	_	2
601455	8q24.22	Charcot-Marie-Tooth disease, type 4D	601455	AR	3
601456	_	_	_	_	_
601457	_	_	_	_	_
601458	12p13.2-q24.1	{Inflammatory bowel disease 2}	601458	_	2
601459	_	_	_	_	_
601460	3q22.1-q22.2	Hypertrophic osteoarthropathy, primary, autosomal recessive 2	614441	AR	3
601461	_	_	_	_	_
601462	2q31.1	Myasthenic syndrome, congenital, 1A, slow-channel	601462	AD	3
601463	_	_	_	_	_
601464	_	_	_	_	_
601465	2p13.1	Mitochondrial DNA depletion syndrome 3 (hepatocerebral type)	251880	AR	3
601465	2p13.1	Portal hypertension, noncirrhotic	617068	AR	3
601465	2p13.1	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 4	617070	AR	3
601466	_	_	_	_	_
601467	_	_	_	_	_
601468	_	_	_	_	_
601469	_	_	_	_	_
601470	3p22.2	{Coronary artery disease, resistance to}	607339	_	3
601470	3p22.2	{Macular degeneration, age-related, 12}	613784	_	3
601470	3p22.2	{Rapid progression to AIDS from HIV1 infection}	609423	_	3
601471	3q21-q22	Facial paresis, hereditary congenital, 1	601471	AD	2
601472	7p14.3	Charcot-Marie-Tooth disease, type 2D	601472	AD	3
601473	_	_	_	_	_
601474	_	_	_	_	_
601475	_	_	_	_	_
601476	_	_	_	_	_
601477	_	_	_	_	_
601478	_	_	_	_	_
601479	15q22.2	Glomerulosclerosis, focal segmental, 6	614131	AR	3
601480	_	_	_	_	_
601481	_	_	_	_	_
601482	_	_	_	_	_
601483	_	_	_	_	_
601484	_	_	_	_	_
601485	16p11.2	Generalized epilepsy with febrile seizures plus, type 9	616172	AD	3
601486	3p24.3	{Spermatogenic failure, susceptibility to}	_	_	3
601487	3p25.2	Carotid intimal medial thickness 1	609338	_	3
601487	3p25.2	Insulin resistance, severe, digenic	604367	AD	3
601487	3p25.2	Lipodystrophy, familial partial, type 3	604367	AD	3
601487	3p25.2	Obesity, severe	601665	AD,AR,Mu	3
601487	3p25.2	[Obesity, resistance to]	_	_	3
601487	3p25.2	{Diabetes, type 2}	125853	AD	3
601488	22q12.3	?Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type III	613960	AR	3
601489	16p13.3	Acid-labile subunit, deficiency of	615961	_	3
601490	_	_	_	_	_
601491	_	_	_	_	_
601492	3p21.31	?Mucopolysaccharidosis type IX	601492	AR	3
601493	_	_	_	_	_
601494	_	_	_	_	_
601495	14q32.33	Agammaglobulinemia 1	601495	AR	3
601496	_	_	_	_	_
601497	_	_	_	_	_
601498	6p21.1	Heimler syndrome 2	616617	AR	3
601498	6p21.1	Peroxisome biogenesis disorder 4A (Zellweger)	614862	AR	3
601498	6p21.1	Peroxisome biogenesis disorder 4B	614863	AD,AR	3
601499	13q14	Rieger syndrome, type 2	601499	AD	2
601500	7q32.1	Basal cell carcinoma, somatic	605462	_	3
601500	7q32.1	Curry-Jones syndrome, somatic mosaic	601707	_	3
601501	16q11.2	{Parkinson disease 17}	614203	AD	3
601502	_	_	_	_	_
601503	_	_	_	_	_
601504	_	_	_	_	_
601505	_	_	_	_	_
601506	_	_	_	_	_
601507	_	_	_	_	_
601508	_	_	_	_	_
601509	_	_	_	_	_
601510	_	_	_	_	_
601511	_	_	_	_	_
601512	_	_	_	_	_
601513	3q28-q29	Epileptic encephalopathy, early infantile, 47	617166	AD	3
601514	_	_	_	_	_
601515	13q33.1	Spinocerebellar ataxia 27	609307	AD	3
601516	_	_	_	_	_
601517	12q24.12	Spinocerebellar ataxia 2	183090	AD	3
601517	12q24.12	{Amyotrophic lateral sclerosis, susceptibility to, 13}	183090	AD	3
601517	12q24.12	{Parkinson disease, late-onset, susceptibility to}	168600	AD,Mu	3
601518	1q25.3	Prostate cancer 1	601518	AD	3
601519	_	_	_	_	_
601520	_	_	_	_	_
601521	_	_	_	_	_
601522	_	_	_	_	_
601523	_	_	_	_	_
601524	_	_	_	_	_
601525	1q32.1	{Asthma-related traits, susceptibility to, 7}	611960	_	3
601525	1q32.1	{Schizophrenia, susceptibility to}	181500	AD	3
601526	_	_	_	_	_
601527	12q21.31	?Frontonasal dysplasia 3	613456	_	3
601528	4q34.3	Lymphatic malformation 4	615907	AD	3
601529	_	_	_	_	_
601530	5q35.3	Frontotemporal dementia and/or amyotrophic lateral sclerosis 3	616437	AD	3
601530	5q35.3	Myopathy, distal, with rimmed vacuoles	617158	AD	3
601530	5q35.3	Neurodegeneration with ataxia, dystonia, and gaze palsy, childhood-onset	617145	AR	3
601530	5q35.3	Paget disease of bone 3	167250	AD	3
601531	_	_	_	_	_
601532	_	_	_	_	_
601533	_	_	_	_	_
601534	_	_	_	_	_
601535	_	_	_	_	_
601536	_	_	_	_	_
601537	_	_	_	_	_
601538	5q35.3	Pituitary hormone deficiency, combined, 2	262600	AR	3
601539	7q21.2	Peroxisome biogenesis disorder 1B (NALD/IRD)	601539	AR	3
601540	_	_	_	_	_
601541	_	_	_	_	_
601542	4q25	Anterior segment dysgenesis 4	137600	AD	3
601542	4q25	Axenfeld-Rieger syndrome, type 1	180500	AD	3
601542	4q25	Ring dermoid of cornea	180550	AD	3
601543	11q23.3	Deafness, autosomal dominant 8/12	601543	AD	3
601544	13q12.11	Deafness, autosomal dominant 3A	601544	AD	3
601545	17p13.3	Lissencephaly 1	607432	AD	3
601545	17p13.3	Subcortical laminar heterotopia	607432	AD	3
601546	_	_	_	_	_
601547	22q11.23	Cataract 3, multiple types	601547	AD	3
601548	2p16.1	Doyne honeycomb degeneration of retina	126600	AD	3
601549	_	_	_	_	_
601550	17q21.31	[Blood group, Swann]	601550	_	3
601551	17q21.31	[Blood group, Froese]	601551	_	3
601552	8q12.3	Traboulsi syndrome	601552	AR	3
601553	16q22.1	Hypotrichosis, congenital, with juvenile macular dystrophy	601553	AR	3
601554	_	_	_	_	_
601555	_	_	_	_	_
601556	6p22.3	Spinocerebellar ataxia 1	164400	AD	3
601557	_	_	_	_	_
601558	_	_	_	_	_
601559	5p13.1	Stuve-Wiedemann syndrome/Schwartz-Jampel type 2 syndrome	601559	AR	3
601560	_	_	_	_	_
601561	_	_	_	_	_
601562	_	_	_	_	_
601563	_	_	_	_	_
601564	7q34	{Pancreatitis, chronic, protection against}	167800	AD	3
601565	16q24.1	Immunodeficiency 32A, mycobacteriosis, autosomal dominant	614893	AD	3
601565	16q24.1	Immunodeficiency 32B, monocyte and dendritic cell deficiency, autosomal recessive	226990	AR	3
601566	13q34	Squamous cell carcinoma, head and neck, somatic	275355	_	3
601567	18q21.32	Combined factor V and VIII deficiency	227300	AR	3
601568	10q25.1-q25.2	Cerebral palsy, spastic quadriplegic, 3	617008	AR	3
601569	_	_	_	_	_
601570	3p25.1	Fuhrmann syndrome	228930	AR	3
601570	3p25.1	Ulna and fibula, absence of, with severe limb deficiency	276820	AR	3
601571	_	_	_	_	_
601572	_	_	_	_	_
601573	7q36.1	Weaver syndrome	277590	AD	3
601574	17q12	Chondrosarcoma, extraskeletal myxoid	612237	_	1
601575	_	_	_	_	_
601576	_	_	_	_	_
601577	_	_	_	_	_
601578	_	_	_	_	_
601579	_	_	_	_	_
601580	_	_	_	_	_
601581	_	_	_	_	_
601582	_	_	_	_	_
601583	7p14.1	{Wilms tumor susceptibility-5}	601583	AD,SMu	3
601584	_	_	_	_	_
601585	_	_	_	_	_
601586	_	_	_	_	_
601587	_	_	_	_	_
601588	_	_	_	_	_
601589	_	_	_	_	_
601590	_	_	_	_	_
601591	_	_	_	_	_
601592	11p11.2	Fetal akinesia deformation sequence 2	618388	_	3
601592	11p11.2	Myasthenic syndrome, congenital, 11, associated with acetylcholine receptor deficiency	616326	AR	3
601593	2q35	{Breast cancer, susceptibility to}	114480	AD,SMu	3
601594	_	_	_	_	_
601595	_	_	_	_	_
601596	5q32	Charcot-Marie-Tooth disease, type 4C	601596	AR	3
601597	_	_	_	_	_
601598	_	_	_	_	_
601599	_	_	_	_	_
601600	_	_	_	_	_
601601	6p12.3	Char syndrome	169100	AD	3
601601	6p12.3	Patent ductus arteriosus 2	617035	AD	3
601602	_	_	_	_	_
601603	_	_	_	_	_
601604	19p13.11	Immunodeficiency 30	614891	AR	3
601605	_	_	_	_	_
601606	16q12.1	Trichoepithelioma, multiple familial, 1	601606	AD	3
601607	22q11.23	Coffin-Siris syndrome 3	614608	AD	3
601607	22q11.23	Rhabdoid tumors, somatic	609322	_	3
601607	22q11.23	{Rhabdoid tumor predisposition syndrome 1}	609322	AD	3
601607	22q11.23	{Schwannomatosis-1, susceptibility to}	162091	AD	3
601608	_	_	_	_	_
601609	4q25	3-hydroxyacyl-CoA dehydrogenase deficiency	231530	AR	3
601609	4q25	Hyperinsulinemic hypoglycemia, familial, 4	609975	AR	3
601610	_	_	_	_	_
601611	_	_	_	_	_
601612	_	_	_	_	_
601613	_	_	_	_	_
601614	17p13.1	Mirror movements 4	618264	AD	3
601615	16p13.3	Surfactant metabolism dysfunction, pulmonary, 3	610921	AR	3
601616	_	_	_	_	_
601617	12q13.2	Fundus albipunctatus	136880	AD,AR	3
601618	20q13.33	Hypotrichosis-lymphedema-telangiectasia syndrome	607823	AR	3
601618	20q13.33	Hypotrichosis-lymphedema-telangiectasia-renal defect syndrome	137940	AD	3
601619	_	_	_	_	_
601620	12q24.21	Holt-Oram syndrome	142900	AD	3
601621	12q24.21	Ulnar-mammary syndrome	181450	AD	3
601622	7p21.1	Craniosynostosis 1	123100	AD	3
601622	7p21.1	Robinow-Sorauf syndrome	180750	AD	3
601622	7p21.1	Saethre-Chotzen syndrome with or without eyelid anomalies	101400	AD	3
601622	7p21.1	Sweeney-Cox syndrome	617746	AD	3
601623	15q11.2	Angelman syndrome	105830	AD	3
601624	_	_	_	_	_
601625	_	_	_	_	_
601626	_	_	_	_	_
601627	5q13.2	{Spinal muscular atrophy, type III, modifier of}	253400	AR	3
601628	_	_	_	_	_
601629	_	_	_	_	_
601630	_	_	_	_	_
601631	6p25.3	Anterior segment dysgenesis 3, multiple subtypes	601631	AD	3
601632	_	_	_	_	_
601633	_	_	_	_	_
601634	_	_	_	_	_
601635	_	_	_	_	_
601636	_	_	_	_	_
601637	_	_	_	_	_
601638	_	_	_	_	_
601639	19p13.12	Cushing syndrome, ACTH-independent adrenal, somatic	615830	_	3
601640	_	_	_	_	_
601641	3p14.3	Bile acid synthesis defect, congenital, 6	617308	AR	3
601642	_	_	_	_	_
601643	_	_	_	_	_
601644	_	_	_	_	_
601645	_	_	_	_	_
601646	6p21.1	Mental retardation, autosomal dominant 35	616355	AD	3
601647	_	_	_	_	_
601648	_	_	_	_	_
601649	_	_	_	_	_
601650	11q12.2	Paragangliomas 2	601650	AD	3
601651	_	_	_	_	_
601652	1q24.3	Glaucoma 1A, primary open angle	137750	AD	3
601653	8q13.3	?Otofaciocervical syndrome	166780	AD	3
601653	8q13.3	Anterior segment anomalies with or without cataract	602588	AD	3
601653	8q13.3	Branchiootic syndrome 1	602588	AD	3
601653	8q13.3	Branchiootorenal syndrome 1, with or without cataracts	113650	AD	3
601654	_	_	_	_	_
601655	_	_	_	_	_
601656	18q11.2	Atrial septal defect 9	614475	AD	3
601656	18q11.2	Atrioventricular septal defect 5	614474	AD	3
601656	18q11.2	Pancreatic agenesis and congenital heart defects	600001	AD	3
601656	18q11.2	Persistent truncus arteriosus	217095	_	3
601656	18q11.2	Tetralogy of Fallot	187500	AD	3
601657	_	_	_	_	_
601658	_	_	_	_	_
601659	_	_	_	_	_
601660	_	_	_	_	_
601661	_	_	_	_	_
601662	_	_	_	_	_
601663	14q23.2-q23.3	?Ovarian dysgenesis 8	618187	AD	3
601664	2q11.2	Retinitis pigmentosa 33	610359	AD	3
601665	_	_	_	_	_
601666	6q21	{Diabetes mellitus, insulin-dependent, 15}	601666	_	2
601667	_	_	_	_	_
601668	_	_	_	_	_
601669	_	_	_	_	_
601670	_	_	_	_	_
601671	11q13.1	Coffin-Siris syndrome 7	618027	AD	3
601672	_	_	_	_	_
601673	_	_	_	_	_
601674	_	_	_	_	_
601675	19q13.32	Trichothiodystrophy 1, photosensitive	601675	AR	3
601676	1p31	Acute insulin response	601676	_	2
601677	_	_	_	_	_
601678	15q21.1	Bartter syndrome, type 1	601678	AR	3
601679	_	_	_	_	_
601680	11p15.5	Arthrogryposis, distal, type 2B1	601680	AD	3
601681	_	_	_	_	_
601682	3q21-q24	Glaucoma 1C, primary open angle	601682	AD	2
601683	16p12.3	?Coenzyme Q10 deficiency, primary, 8	616733	AR	3
601684	_	_	_	_	_
601685	_	_	_	_	_
601686	_	_	_	_	_
601687	17q21.2	Meesmann corneal dystrophy	122100	AD	3
601688	4q34.1	Cranioosteoarthropathy	259100	AR	3
601688	4q34.1	Digital clubbing, isolated congenital	119900	AR	3
601688	4q34.1	Hypertrophic osteoarthropathy, primary, autosomal recessive 1	259100	AR	3
601689	18q11.2	?Spermatogenic failure 13	615841	AR	3
601690	6p12.3	Platelet-activating factor acetylhydrolase deficiency	614278	AR	3
601690	6p12.3	{Asthma, susceptibility to}	600807	AD	3
601690	6p12.3	{Atopy, susceptibility to}	147050	AD	3
601691	1p22.1	Cone-rod dystrophy 3	604116	_	3
601691	1p22.1	Fundus flavimaculatus	248200	AR	3
601691	1p22.1	Retinal dystrophy, early-onset severe	248200	AR	3
601691	1p22.1	Retinitis pigmentosa 19	601718	AR	3
601691	1p22.1	Stargardt disease 1	248200	AR	3
601691	1p22.1	{Macular degeneration, age-related, 2}	153800	AD	3
601692	5q31.1	Corneal dystrophy, Avellino type	607541	AD	3
601692	5q31.1	Corneal dystrophy, epithelial basement membrane	121820	AD	3
601692	5q31.1	Corneal dystrophy, Groenouw type I	121900	AD	3
601692	5q31.1	Corneal dystrophy, lattice type I	122200	AD	3
601692	5q31.1	Corneal dystrophy, lattice type IIIA	608471	AD	3
601692	5q31.1	Corneal dystrophy, Reis-Bucklers type	608470	_	3
601692	5q31.1	Corneal dystrophy, Thiel-Behnke type	602082	AD	3
601693	11q13.4	{Obesity, susceptibility to, BMIQ4}	607447	_	3
601694	2p21	[Leptin serum levels QTL1]	601694	_	2
601695	_	_	_	_	_
601696	11p15.5	[Novelty seeking personality]	601696	?AD	1
601697	18q22.1	Peeling skin syndrome 5	617115	AR	3
601698	_	_	_	_	_
601699	20q13.13	Hypertension, essential	145500	Mu	3
601700	_	_	_	_	_
601701	_	_	_	_	_
601702	_	_	_	_	_
601703	_	_	_	_	_
601704	_	_	_	_	_
601705	17q11.2	T-cell immunodeficiency, congenital alopecia, and nail dystrophy	601705	AR	3
601706	_	_	_	_	_
601707	7q32.1	Curry-Jones syndrome, somatic mosaic	601707	_	3
601708	_	_	_	_	_
601709	10q22.2	Quebec platelet disorder	601709	AD	3
601710	_	_	_	_	_
601711	_	_	_	_	_
601712	_	_	_	_	_
601713	_	_	_	_	_
601714	_	_	_	_	_
601715	_	_	_	_	_
601716	_	_	_	_	_
601717	19p13.2	Hemophagocytic lymphohistiocytosis, familial, 5	613101	_	3
601718	1p22.1	Retinitis pigmentosa 19	601718	AR	3
601719	17q23.2	Ischiocoxopodopatellar syndrome with or without pulmonary arterial hypertension	147891	AD	3
601720	_	_	_	_	_
601721	_	_	_	_	_
601722	_	_	_	_	_
601723	_	_	_	_	_
601724	2q31.3	Maturity-onset diabetes of the young 6	606394	_	3
601724	2q31.3	{Diabetes mellitus, noninsulin-dependent}	125853	AD	3
601725	17q12	Epileptic encephalopathy, early infantile, 72	618374	AD	3
601726	_	_	_	_	_
601727	_	_	_	_	_
601728	10q23.31	Cowden syndrome 1	158350	AD	3
601728	10q23.31	Lhermitte-Duclos syndrome	158350	AD	3
601728	10q23.31	Macrocephaly/autism syndrome	605309	AD	3
601728	10q23.31	Prostate cancer, somatic	176807	_	3
601728	10q23.31	{Glioma susceptibility 2}	613028	_	3
601728	10q23.31	{Meningioma}	607174	AD	3
601729	_	_	_	_	_
601730	1q24.3	Glycosylphosphatidylinositol biosynthesis defect 16	617816	AR	3
601731	2q35	AICA-ribosiduria due to ATIC deficiency	608688	AR	3
601732	_	_	_	_	_
601733	_	_	_	_	_
601734	12q13.2	Coffin-Siris syndrome 8	618362	AD	3
601735	_	_	_	_	_
601736	17q23.3	Specific granule deficiency 2	617475	AR	3
601737	_	_	_	_	_
601738	_	_	_	_	_
601739	_	_	_	_	_
601740	15q14	Cleft palate, cardiac defects, and mental retardation	600987	AD	3
601741	_	_	_	_	_
601742	_	_	_	_	_
601743	5p13.1	Amyloidosis, primary localized cutaneous, 1	105250	AD	3
601744	_	_	_	_	_
601745	_	_	_	_	_
601746	11q23.3	?Immunodeficiency 59 and hypoglycemia	233600	AR	3
601747	_	_	_	_	_
601748	_	_	_	_	_
601749	1p22.1	Glomuvenous malformations	138000	AD	3
601750	_	_	_	_	_
601751	_	_	_	_	_
601752	10q24.1	Spastic paraplegia 64, autosomal recessive	615683	AR	3
601753	_	_	_	_	_
601754	_	_	_	_	_
601755	_	_	_	_	_
601756	2q24.3	Tumoral calcinosis, hyperphosphatemic, familial, 1	211900	AR	3
601757	6q23.3	Peroxisome biogenesis disorder 9B	614879	AR	3
601757	6q23.3	Rhizomelic chondrodysplasia punctata, type 1	215100	AR	3
601758	17q12	Peroxisome biogenesis disorder 3A (Zellweger)	614859	AR	3
601758	17q12	Peroxisome biogenesis disorder 3B	266510	AR	3
601759	_	_	_	_	_
601760	_	_	_	_	_
601761	_	_	_	_	_
601762	2q33.1	Autoimmune lymphoproliferative syndrome, type II	603909	AD	3
601762	2q33.1	Gastric cancer, somatic	613659	_	3
601762	2q33.1	Lymphoma, non-Hodgkin, somatic	605027	_	3
601763	2q33.1	?Autoimmune lymphoproliferative syndrome, type IIB	607271	AR	3
601763	2q33.1	Hepatocellular carcinoma, somatic	114550	_	3
601763	2q33.1	{Breast cancer, protection against}	114480	AD,SMu	3
601763	2q33.1	{Lung cancer, protection against}	211980	AD,SMu	3
601764	19q	Seizures, benign familial infantile, 1	601764	AD	2
601765	_	_	_	_	_
601766	_	_	_	_	_
601767	_	_	_	_	_
601768	19p13.3	Leukemia, acute myeloid	601626	AD,SMu	1
601769	12q13.11	?Osteoporosis, involutional	166710	AD	1
601769	12q13.11	Rickets, vitamin D-resistant, type IIA	277440	AR	3
601770	_	_	_	_	_
601771	2p22.2	Anterior segment dysgenesis 6, multiple subtypes	617315	_	3
601771	2p22.2	Glaucoma 3A, primary open angle, congenital, juvenile, or adult onset	231300	AR	3
601772	_	_	_	_	_
601773	_	_	_	_	_
601774	_	_	_	_	_
601775	_	_	_	_	_
601776	15q15.1	Ehlers-Danlos syndrome, musculocontractural type 1	601776	AR	3
601777	17p13.1	Cone-rod dystrophy 6	601777	AD,AR	3
601778	_	_	_	_	_
601779	_	_	_	_	_
601780	15q23	Ceroid lipofuscinosis, neuronal, 6	601780	AR	3
601781	_	_	_	_	_
601782	_	_	_	_	_
601783	_	_	_	_	_
601784	_	_	_	_	_
601785	16p13.2	Congenital disorder of glycosylation, type Ia	212065	AR	3
601786	_	_	_	_	_
601787	_	_	_	_	_
601788	2q32.2	Muscle hypertrophy	614160	_	3
601789	2p15	Peroxisome biogenesis disorder 11A (Zellweger)	614883	AR	3
601789	2p15	Peroxisome biogenesis disorder 11B	614885	AR	3
601790	_	_	_	_	_
601791	1p36.22	Peroxisome biogenesis disorder 13A (Zellweger)	614887	AR	3
601792	_	_	_	_	_
601793	_	_	_	_	_
601794	_	_	_	_	_
601795	_	_	_	_	_
601796	_	_	_	_	_
601797	_	_	_	_	_
601798	_	_	_	_	_
601799	_	_	_	_	_
601800	_	_	_	_	_
601801	_	_	_	_	_
601802	3p14.3	Growth hormone deficiency with pituitary anomalies	182230	AD,AR	3
601802	3p14.3	Pituitary hormone deficiency, combined, 5	182230	AD,AR	3
601802	3p14.3	Septooptic dysplasia	182230	AD,AR	3
601803	12p	Pallister-Killian syndrome	601803	SMo	4
601804	_	_	_	_	_
601805	_	_	_	_	_
601806	2q21.3	Lactase persistence/nonpersistence	223100	AD	3
601807	12q13.2	Cavitary optic disc anomalies	611543	AD	3
601808	18q	Chromosome 18q deletion syndrome	601808	AD	4
601809	_	_	_	_	_
601810	10q21.3	?Seckel syndrome 8	615807	AR	3
601810	10q21.3	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 6	615156	AD	3
601811	_	_	_	_	_
601812	5q32	Premature aging syndrome, Penttinen type	601812	AD	3
601813	11q13.2	Exudative vitreoretinopathy 4	601813	AD,AR	3
601814	11q23.3	Hypomagnesemia 2, renal	154020	AD	3
601815	1p12	Phosphoglycerate dehydrogenase deficiency	601815	AR	3
601816	2q37.1	[Bilirubin, serum level of, QTL1]	601816	_	3
601817	_	_	_	_	_
601818	_	_	_	_	_
601819	17q24.2	Neurodevelopmental disorder with dysmorphic facies and distal limb anomalies	617755	AD	3
601820	11p15.1	Hyperinsulinemic hypoglycemia, familial, 2	601820	AR	3
601821	_	_	_	_	_
601822	_	_	_	_	_
601823	_	_	_	_	_
601824	_	_	_	_	_
601825	19p13.3	Mitochondrial complex I deficiency, nuclear type 3	618224	AR	3
601826	_	_	_	_	_
601827	_	_	_	_	_
601828	_	_	_	_	_
601829	_	_	_	_	_
601830	_	_	_	_	_
601831	_	_	_	_	_
601832	_	_	_	_	_
601833	_	_	_	_	_
601834	_	_	_	_	_
601835	_	_	_	_	_
601836	_	_	_	_	_
601837	13q33.3	LIG4 syndrome	606593	AR	3
601837	13q33.3	{Multiple myeloma, resistance to}	254500	SMu	3
601838	_	_	_	_	_
601839	_	_	_	_	_
601840	_	_	_	_	_
601841	_	_	_	_	_
601842	_	_	_	_	_
601843	19p13.11	Thyroid dyshormonogenesis 1	274400	AR	3
601844	17q21.2	Pseudohypoaldosteronism, type IIB	614491	AD	3
601845	_	_	_	_	_
601846	19p13.3	Muscular dystrophy with rimmed vacuoles	601846	AD	2
601847	2q31.1	Cholestasis, progressive familial intrahepatic 2	601847	AR	3
601848	_	_	_	_	_
601849	_	_	_	_	_
601850	_	_	_	_	_
601851	_	_	_	_	_
601852	_	_	_	_	_
601853	_	_	_	_	_
601854	_	_	_	_	_
601855	19q13.2	?Immunodeficiency 62	618459	AR	3
601856	_	_	_	_	_
601857	_	_	_	_	_
601858	_	_	_	_	_
601859	_	_	_	_	_
601860	5q23.1	D-bifunctional protein deficiency	261515	AR	3
601860	5q23.1	Perrault syndrome 1	233400	AR	3
601861	13q13.3	Bare lymphocyte syndrome, type II, complementation group D	209920	AR	3
601862	_	_	_	_	_
601863	1q21.3	Bare lymphocyte syndrome, type II, complementation group C	209920	AR	3
601863	1q21.3	Bare lymphocyte syndrome, type II, complementation group E	209920	AR	3
601864	_	_	_	_	_
601865	3q24	Bruck syndrome 2	609220	AR	3
601866	_	_	_	_	_
601867	_	_	_	_	_
601868	6p21.32	Deafness, autosomal dominant 13	601868	AD	3
601869	19p13.3	Deafness, autosomal recessive 15	601869	AR	3
601870	_	_	_	_	_
601871	_	_	_	_	_
601872	_	_	_	_	_
601873	12q13.3	Spastic paraplegia 26, autosomal recessive	609195	AR	3
601874	_	_	_	_	_
601875	_	_	_	_	_
601876	_	_	_	_	_
601877	_	_	_	_	_
601878	_	_	_	_	_
601879	_	_	_	_	_
601880	_	_	_	_	_
601881	18q21.32	Microphthalmia, isolated 3	611038	AR	3
601882	_	_	_	_	_
601883	_	_	_	_	_
601884	11q13.2	[Bone mineral density variability 1]	601884	AD	3
601885	13q12.11	Cataract 14, multiple types	601885	AD	3
601886	_	_	_	_	_
601887	1q32.1	{Malignant hyperthermia susceptibility 5}	601887	AD	3
601888	5p	{Malignant hyperthermia susceptibility 6}	601888	_	2
601889	_	_	_	_	_
601890	_	_	_	_	_
601891	_	_	_	_	_
601892	_	_	_	_	_
601893	5p15.2	Mental retardation, autosomal dominant 44	617061	AD	3
601894	2q35	Glomerulopathy with fibronectin deposits 2	601894	AD	3
601895	_	_	_	_	_
601896	14q32.32	{?Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 5}	614849	_	3
601897	3q21.2	Global developmental delay, absent or hypoplastic corpus callosum, and dysmorphic facies	617260	AD	3
601898	3q26.31	Growth hormone deficiency, isolated partial	615925	AD,AR	3
601899	_	_	_	_	_
601900	6p25.3	[Skin/hair/eye pigmentation, variation in, 8]	611724	_	3
601901	_	_	_	_	_
601902	1p32.3	Meier-Gorlin syndrome 1	224690	AR	3
601903	4q13.2	{Bone mineral density QTL 12, osteoporosis}	612560	_	3
601904	_	_	_	_	_
601905	_	_	_	_	_
601906	12q13.12	Split-hand/foot malformation 6	225300	AR	3
601906	12q13.12	Tooth agenesis, selective, 8	617073	AD	3
601907	_	_	_	_	_
601908	_	_	_	_	_
601909	_	_	_	_	_
601910	_	_	_	_	_
601911	17q21.33	?Orofacial cleft 15	616788	AD	3
601912	2q33.1	?Orofacial cleft 10	613705	IC	3
601913	_	_	_	_	_
601914	_	_	_	_	_
601915	_	_	_	_	_
601916	_	_	_	_	_
601917	_	_	_	_	_
601918	5q31.1	?Premature ovarian failure 14	618014	AR	3
601919	_	_	_	_	_
601920	20p12.2	?Deafness, congenital heart defects, and posterior embryotoxon	617992	_	3
601920	20p12.2	Alagille syndrome 1	118450	AD	3
601920	20p12.2	Tetralogy of Fallot	187500	AD	3
601921	_	_	_	_	_
601922	_	_	_	_	_
601923	_	_	_	_	_
601924	1q23.2	{Autoimmune interstitial lung, joint, and kidney disease}	616414	AD	3
601925	17q25.3	Nephrotic syndrome, type 8	615244	AR	3
601926	_	_	_	_	_
601927	_	_	_	_	_
601928	12q13.13	Monilethrix	158000	AD	3
601929	_	_	_	_	_
601930	_	_	_	_	_
601931	_	_	_	_	_
601932	_	_	_	_	_
601933	12q23.3	{Delayed sleep phase disorder, susceptibility to}	614163	AD	3
601934	_	_	_	_	_
601935	_	_	_	_	_
601936	_	_	_	_	_
601937	_	_	_	_	_
601938	_	_	_	_	_
601939	_	_	_	_	_
601940	_	_	_	_	_
601941	18q21	{Diabetes mellitus, insulin-dependent, 6}	601941	_	2
601942	10p15.1	{Diabetes, mellitus, insulin-dependent, susceptibility to, 10}	601942	_	3
601943	_	_	_	_	_
601944	_	_	_	_	_
601945	_	_	_	_	_
601946	_	_	_	_	_
601947	_	_	_	_	_
601948	_	_	_	_	_
601949	2q23.3	Episodic ataxia, type 5	613855	AD	3
601949	2q23.3	{Epilepsy, idiopathic generalized, susceptibility to, 9}	607682	AD	3
601949	2q23.3	{Epilepsy, juvenile myoclonic, susceptibility to, 6}	607682	AD	3
601950	_	_	_	_	_
601951	_	_	_	_	_
601952	13q12.3	Keratosis linearis with ichthyosis congenita and sclerosing keratoderma	601952	AR	3
601953	_	_	_	_	_
601954	17q12	Muscular dystrophy, limb-girdle, autosomal recessive 7	601954	AR	3
601955	_	_	_	_	_
601956	_	_	_	_	_
601957	_	_	_	_	_
601958	_	_	_	_	_
601959	_	_	_	_	_
601960	_	_	_	_	_
601961	_	_	_	_	_
601962	6p21.32	Bare lymphocyte syndrome, type I	604571	AR	3
601963	_	_	_	_	_
601964	_	_	_	_	_
601965	_	_	_	_	_
601966	_	_	_	_	_
601967	_	_	_	_	_
601968	1p13.2	Diarrhea 9	618168	AR	3
601969	_	_	_	_	_
601970	_	_	_	_	_
601971	_	_	_	_	_
601972	9q21.13	{Epilepsy, idiopathic generalized, susceptibility to, 15}	618357	AD	3
601973	_	_	_	_	_
601974	_	_	_	_	_
601975	1q32.1	Ectodermal dysplasia/skin fragility syndrome	604536	_	3
601976	_	_	_	_	_
601977	1p34.2	Thrombocythemia 2	601977	AD,SMu	3
601978	9p13.3	?Amyotrophic lateral sclerosis 16, juvenile	614373	AR	3
601978	9p13.3	?Spinal muscular atrophy, distal, autosomal recessive, 2	605726	AR	3
601979	_	_	_	_	_
601980	_	_	_	_	_
601981	_	_	_	_	_
601982	3p25.3	Renal cell carcinoma, clear cell, somatic	144700	_	3
601983	_	_	_	_	_
601984	_	_	_	_	_
601985	_	_	_	_	_
601986	_	_	_	_	_
601987	_	_	_	_	_
601988	_	_	_	_	_
601989	_	_	_	_	_
601990	_	_	_	_	_
601991	_	_	_	_	_
601992	9p23-p11	Friedreich ataxia 2	601992	AR	2
601993	_	_	_	_	_
601994	_	_	_	_	_
601995	_	_	_	_	_
601996	_	_	_	_	_
601997	_	_	_	_	_
601998	_	_	_	_	_
601999	_	_	_	_	_
602000	_	_	_	_	_
602001	_	_	_	_	_
602002	_	_	_	_	_
602003	_	_	_	_	_
602004	_	_	_	_	_
602005	_	_	_	_	_
602006	_	_	_	_	_
602007	_	_	_	_	_
602008	_	_	_	_	_
602009	_	_	_	_	_
602010	_	_	_	_	_
602011	3p25	?Pancreatic endocrine tumors	_	_	1
602012	_	_	_	_	_
602013	_	_	_	_	_
602014	9q21.13	Hypomagnesemia 1, intestinal	602014	AR	3
602015	_	_	_	_	_
602016	_	_	_	_	_
602017	_	_	_	_	_
602018	_	_	_	_	_
602019	_	_	_	_	_
602020	_	_	_	_	_
602021	_	_	_	_	_
602022	_	_	_	_	_
602023	1p36.13	Bartter syndrome, type 3	607364	AR	3
602023	1p36.13	Bartter syndrome, type 4b, digenic	613090	DR	3
602024	1p36.13	Bartter syndrome, type 4b, digenic	613090	DR	3
602025	20q13.2	{Obesity, severe, susceptibility to, BMIQ9}	602025	_	3
602026	10p13	Refsum disease	266500	AR	3
602027	_	_	_	_	_
602028	_	_	_	_	_
602029	_	_	_	_	_
602030	_	_	_	_	_
602031	_	_	_	_	_
602032	12q13.13	Ectodermal dysplasia 4, hair/nail type	602032	AR	3
602033	14q32.2	Band heterotopia	600348	AR	3
602034	_	_	_	_	_
602035	_	_	_	_	_
602036	_	_	_	_	_
602037	4p14	{?Epidermodysplasia verruciformis, susceptibility to, 4}	618307	AR	3
602038	_	_	_	_	_
602039	_	_	_	_	_
602040	_	_	_	_	_
602041	_	_	_	_	_
602042	_	_	_	_	_
602043	_	_	_	_	_
602044	11q13.4	{Obesity, severe, and type II diabetes}	601665	AD,AR,Mu	3
602045	_	_	_	_	_
602046	_	_	_	_	_
602047	_	_	_	_	_
602048	7p22.1	Mental retardation, autosomal dominant 48	617751	AD	3
602049	22q13.1	Neutrophil immunodeficiency syndrome	608203	_	3
602050	_	_	_	_	_
602051	_	_	_	_	_
602052	_	_	_	_	_
602053	10p15.2	Gastric cancer, somatic	613659	_	3
602053	10p15.2	Prostate cancer, somatic	176807	_	3
602054	22q11.21	Conotruncal anomaly face syndrome	217095	_	3
602054	22q11.21	DiGeorge syndrome	188400	AD	3
602054	22q11.21	Tetralogy of Fallot	187500	AD	3
602054	22q11.21	Velocardiofacial syndrome	192430	AD	3
602055	_	_	_	_	_
602056	_	_	_	_	_
602057	_	_	_	_	_
602058	_	_	_	_	_
602059	_	_	_	_	_
602060	_	_	_	_	_
602061	_	_	_	_	_
602062	_	_	_	_	_
602063	11p15.5	Transaldolase deficiency	606003	AR	3
602064	8q21.13	Mental retardation, autosomal recessive 59	617323	AR	3
602065	_	_	_	_	_
602066	16p11.2	Convulsions, familial infantile, with paroxysmal choreoathetosis	602066	AD	3
602067	_	_	_	_	_
602068	_	_	_	_	_
602069	_	_	_	_	_
602070	_	_	_	_	_
602071	_	_	_	_	_
602072	12q24.31	Charcot-Marie-Tooth disease, recessive intermediate D	616039	AR	3
602073	_	_	_	_	_
602074	_	_	_	_	_
602075	_	_	_	_	_
602076	_	_	_	_	_
602077	_	_	_	_	_
602078	11q13.4	Fibrosis of extraocular muscles, congenital, 2	602078	AR	3
602079	1q24.3	Trimethylaminuria	602079	AR	3
602080	18q21.33	{Paget disease of bone 2, early-onset}	602080	AD	3
602081	7q31.1	Speech-language disorder-1	602081	AD	3
602082	5q31.1	Corneal dystrophy, Thiel-Behnke type	602082	AD	3
602083	10q21.1	Usher syndrome, type 1F	602083	AR	3
602084	_	_	_	_	_
602085	13q21-q32	Postaxial polydactyly, type A2	602085	AD	2
602086	14q12-q22	Arrhythmogenic right ventricular dysplasia 3	602086	AD	2
602087	2q32.1-q32.3	Arrhythmogenic right ventricular dysplasia 4	602087	AD	2
602088	9q31.1	Nephronophthisis 2, infantile	602088	AR	3
602089	_	_	_	_	_
602090	11q13.1	Dental anomalies and short stature	601216	AR	3
602090	11q13.1	Geleophysic dysplasia 3	617809	AD	3
602091	14q24.3	?Weill-Marchesani syndrome 3, recessive	614819	AR	3
602091	14q24.3	Glaucoma 3, primary congenital, D	613086	_	3
602091	14q24.3	Microspherophakia and/or megalocornea, with ectopia lentis and with or without secondary glaucoma	251750	AR	3
602092	11p15.1	Deafness, autosomal recessive 18A	602092	AR	3
602093	_	_	_	_	_
602094	_	_	_	_	_
602095	_	_	_	_	_
602096	12p11.23-q13.12	Alzheimer disease-5	602096	AD	2
602097	21q21	Usher syndrome, type 1E	602097	AR	2
602098	_	_	_	_	_
602099	15q21.1	Amyotrophic lateral sclerosis 5, juvenile	602099	AR	3
602100	_	_	_	_	_
602101	_	_	_	_	_
602102	_	_	_	_	_
602103	_	_	_	_	_
602104	4p16.3	Cherubism	118400	AD	3
602105	_	_	_	_	_
602106	_	_	_	_	_
602107	_	_	_	_	_
602108	_	_	_	_	_
602109	2p24.1	?Spondyloepimetaphyseal dysplasia	608728	AR	3
602109	2p24.1	Epiphyseal dysplasia, multiple, 5	607078	AD	3
602109	2p24.1	{Osteoarthritis susceptibility 2}	140600	AD	3
602110	_	_	_	_	_
602111	_	_	_	_	_
602112	_	_	_	_	_
602113	_	_	_	_	_
602114	_	_	_	_	_
602115	_	_	_	_	_
602116	_	_	_	_	_
602117	_	_	_	_	_
602118	_	_	_	_	_
602119	_	_	_	_	_
602120	_	_	_	_	_
602121	_	_	_	_	_
602122	_	_	_	_	_
602123	_	_	_	_	_
602124	_	_	_	_	_
602125	_	_	_	_	_
602126	_	_	_	_	_
602127	_	_	_	_	_
602128	_	_	_	_	_
602129	_	_	_	_	_
602130	_	_	_	_	_
602131	_	_	_	_	_
602132	_	_	_	_	_
602133	_	_	_	_	_
